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Abstract 
Liquid chromatography coupled with mass spectrometry (LC-MS) and 
tandem mass spectrometry (LC-MS2) are shown to have the sensitivity and 
functionality to detect protein/peptide modifications by fatty acyl chains in 
vitro and in vivo studies. Further analysis was also performed by direct 
infusion ion mobility separation coupled with mass spectrometry (IMS-MS) or 
tandem mass spectrometry (IMS-MS2). 
Peptide lipidation in vitro was investigated using the membrane active 
peptide, melittin. Non-enzymatic melittin lipidation by lysophospholipids has 
been observed for the first time. When the effect of lysophospholipids was 
studied in direct competition with diacylphospholipids, the acyl transfer from 
the lysophospholipids is seen to be preferential with acylation visible after just 
3 hour. The longer the interaction time, the greater the amount and number 
of modifications with double and triple acylation observed after 96 hour. The 
locations of the modifications identified through LC-MS2 were assigned on 
different sites of the peptide, including N-terminus, K7, S18, K21, K23, R22 
and R24 and with the highest reactivity towards N-terminus and K23. 
Comparing the lipidation of synthetic melittin (SynM) with the lipidation of 
naturally occurring melittin from venom of honey bee (BVM) highlights the 
effect of the PLA2 enzyme that is naturally present in BVM. Here, the action 
of the enzyme to hydrolyse the diacylphospholipid at the sn-2 position to give 
the corresponding lysophospholipid is reflected in the acyl transfer to the 
BVM such that the resulting lysophospholipid clearly dominates the acyl 
transfer to BVM.  In contrast, the acyl transfer to SynM clearly demonstrates 
that acyl transfer is possible in the absence of an enzyme. 
In vivo protein lipidation of one of the most abundant integral 
membrane proteins in mammalian eye lens, AQP0, was also studied. A wide 
range of acyl groups are shown to modify this protein at the known 
modification sites, N-terminus and at the amino acid residue K238, many of 
which are reported here for the first time. These acyl group modifications 
reflect the biological lipid composition of the membrane leaflet that the 
acylation sites are proximal to. 
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In an attempt to further distinguish between different forms of lipidated 
melittin, whether with the same acyl chain modification to different amino 
acids or to discriminate between palmitoylation and oleoylation modifications, 
travelling wave ion mobility spectrometry (TWIMS) coupled with MS or MS2 
was applied. Results suggested that resolving positional isomers of 
diacylphospholipids and lysophospholipids (sn-1 vs sn-2 positions) is not 
possible under the conditions described herein. However, the presence of 
fatty acyl chains covalently bound to melittin change the conformation of 
acylated melittin in the gas-phase such that for lower charge states it is 
possible to suggest a small degree of separation between palmitoylated and 
oleoylated melittin or their isomers including acylation on N-terminus vs K23. 
This small degree of separation is enough so that when combined with 
tandem mass spectrometry, the time-aligned product ion spectra are clearer 
and improve characterisation. 
To conclude, the research in this thesis has shown that two of the 
most abundant biomolecules, lipid and peptides/proteins that are known to 
exist in close proximity to each other, or interact with each other, are not as 
chemically inert as previously thought. This reactivity has been reflected 
herein via aminolysis reaction between membrane lipid composition and 
each of membrane active peptide, melittin and integral membrane protein, 
AQP0.     
iii 
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1.1. Cell membrane 
All living organisms are composed of cells, with either a single cell such 
as microscopic organism or multicellular such as large organism. The 
external boundary of the cell is the plasma membrane which is called the cell 
membrane, which surrounds the inner compartment of the cell containing 
nucleus and other organelles such as featured in eukaryote cell of animals 
and plants or without nucleus such that found in prokaryote cell or bacteria. 
Membranes are the basic unit for all living cells and have a specialised 
structure that favours their gate keeping function.1 These are dynamic 
structures that are made mainly of lipid, protein and carbohydrate2. Lipid 
molecules are the essential component of the cell, with protein molecules 
acting as a transport system of pumps and channels. These two main 
biomolecules facilitate the permeability of the membrane and control the 
movement of substances in and out of the cell to maintain the equilibrium.3-5  
The first structure of the cell membrane was described by Gorter et al. in 
1925 as a simple lipid-bilayer.6,7 This was followed by a number of 
researchers to further characterise membrane structure.7-9 Singer-Nicolson 
proposed the fluid-mosaic model in 1972.10,11 This is still the most popular 
model of the lipid membrane and includes amphiphilic lipid molecules 
arranged as two opposite sheets (leaflet, lamellae), together with protein 
molecules that can be present as integral or peripheral membrane proteins5 
as shown in Figure 1.1. A new insight of this fluid-mosaic model8,9,12 was 
obtained by Simons et al. and Brown et al. in 1997. They have extended the 
model to show lipid membrane domains or called lipid rafts13-17. 
The exoplasmic surface of the cell membrane is interacting with other 
cells and the existing components within the extracellular fluid, while the 
cytoplasmic surface contains the cell organelles, and the inclusions. 
Organelles in eukaryote cell include; nucleus, endoplasmic reticulum, Golgi 
apparatus, mitochondria, ribosomes, transport vesicles, cytoskeleton and 
lysosome.1,4    
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Figure 1.1. The fluid-mosaic model for a typical cell membrane as proposed by Singer-
Nicolson. Tail-to-tail phospholipid bilayer is shown in green; integral membrane 
proteins traversing the cell membrane are shown in blue; peripheral proteins on the 
surface of the cell membrane are shown in red. 
 
Further, peptide molecules also exist in the cell and they perform different 
interactions with the cell membrane through electrostatic interactions and/or 
hydrophobic interactions18. Such interactions depend on the amino acid (AA) 
composition of bound peptides, charge, structure and as well as the 
composition of bound lipid. An example for that is antimicrobial peptides 
(AMP), which are also known as membrane active peptides because of their 
amphiphilic behaviour that results from the presence of both hydrophobic and 
hydrophilic domains within the peptide.19 Lipid-peptide interactions were 
described by different mechanisms18-22 such as carpet mechanism, toroidal 
pore mechanism and barrel stave mechanism, as shown in Figure 1.2. 
Interestingly, all of these mechanisms are concentration dependent of bound 
peptide to lipid ratio (peptide:lipid). They cause membrane permeability 
(Figure 1.2 B) or pores in the membrane (Figure 1.2 C and D) only when 
peptide:lipid reaches a critical ratio that is known as critical amount or 
peptide:lipid*.18 
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Figure 1.2. Peptide-membrane binding mechanism. (A) Electrostatic interaction 
between peptide (pink) and membrane (green) below peptide:lipid
*
; (B) Carpet 
mechanism, disrupting ordered orientation of membrane lipids; (C) Toroidal pore 
mechanism, disrupting lipid-lipid interactions and curving the membrane by 
interacting aggregated peptides with polar head-groups then eventually pore 
formation in the membrane; (D) Barrel stave mechanism, disrupting lipid-lipid 
interaction by spanning aggregated peptides through the hydrophobic tail-groups of 
membrane bilayer and thus pore formation. 
 
1.2. Biomimetic membrane 
The complexity of natural membranes can be simplified by making 
artificial membranes or so called biomimetic membranes in order to perform 
different experimental analysis to explore the membrane’s phase behaviour, 
functions, properties and activity towards different species such as 
peptides/proteins, surfactants and pharmaceutical drugs. Common 
biomimetic membranes include: lipid monolayers, lipid vesicles or liposomes 
and supported lipid-bilayers.8 The most popular biomimetic membranes that 
best reflect the composition and structural design of natural membranes are 
liposomes,8,23-25 with a wide range of application in different fields such as in 
food industry26, cosmetic formulation27 and most importantly as 
pharmaceutical products for drug delivery24,28-30. Liposomes were first 
described by Bangham and Horne in 196231, and are formed spontaneously 
by dispersing dry lipids in aqueous phase. This results in formation of 
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spherical fluid membrane with onion structure called multilamellar vesicle 
(MLV) with a micron size (> 0.1 𝝁m). MLV can be downsized with a single 
lipid-bilayer using different methods, commonly using sonic energy in forms 
of sonication or mechanical energy in form of extrusion,23,28 as shown in 
Figure 1.3. Generally, liposomes with small diameter size, in range of 25-40 
nm,7 are generated by sonication23 and are called small unilamellar vesicle 
(SUV) but with less application because of their small sizes.7 While larger 
liposomes with a range of sizes depending on the pore size of the membrane 
filter, typically in range of 50-500 nm,7 are generated by extrusion23,32 and are 
called large unilamellar vesicle (LUV). LUVs have a broad application as 
biomimetic membranes because of their convenient size and symmetric 
distribution of lipids between inner and outer monolayers (≈ 1:1).7  
 
 
Figure 1.3. Schematic to illustrate different types of liposomes; multilamellar vesicle 
(MLV), large unilamellar vesicle (LUV) and small unilamellar vesicle (SUV). The 
enlarged fractions show the lipid-bilayer composition (green) in each layer.  
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1.3.  Membrane lipids 
Lipids in the membrane can be classified to phospholipids, sterols and 
glycolipids.7,8,33 Each lipid class can be further classified to a range of 
different sub-classes and this shows lipids diversity in the biological system 
with serving different functions. Their main three functions33 can be 
summarised to: first, energy storage; second, first and second messengers 
in signal transduction and molecular recognition processes; third, as a 
barrier between exoplasmic and cytoplasmic surfaces of the cell, a function 
that is driven by the amphiphilic principle of lipids with hydrophilic head-
groups interacting with aqueous phase and hydrophobic tail-groups 
interacting with each other. The amount and composition of lipids are 
different in various organisms and also in different cell functions within one 
organism. Because glycerophospholipids (GPL) are the most abundant lipid 
class in eukaryote membrane, mammals,7,8,33 and are broadly applied in this 
study, this will be discussed in more detail in this chapter.            
 
1.3.1. Phospholipids 
1.3.1.1. Glycerophospholipid (GPL) 
The basic unit for all glycerophosholipids (GPLs) is sn-glycero-3-
phosphate, Figure 1.4, either esterified at both sn-1 and sn-2 positions of the 
glycerol with a range of different fatty acids (X and Y) to form 
diacylphospholipids (PL) or esterified at just one position (sn-1 or sn-2) to 
give lysophospholipids (LPL). Different PL and LPL classes are classified 
depending on the different groups attached to the phosphate polar head-
group (Table 1.1). Generally, in nature the fatty acid in position sn-1 of the 
PLs is saturated preferentially, while in sn-2 position it is commonly 
unsaturated (≥ 1 double bond) and longer acyl chains7,34 with the cis 
conformation34. A number of common fatty acids35 esterified with PLs/LPLs 
are listed in Table 1.2. Interestingly, the major GPL class in natural cell are 
PLs7,8 and found to build up 40-60 mole%8 of the total lipid composition 
relative to < 5 mole%36,37 of the minor LPL class. An example, relevant to the 
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nature of this research for the proportion of different lipid classes is given for 
bovine and rabbit lenses38 (Table 1.3). 
 
 
Figure 1.4. Structural representation for GPLs.  
 
Table 1.1. Common head- groups (Z) with GPL lipid classes (see Figure 1.4). 
Molecular Structure of Z groups Name Net Charge at pH 7 
 Phosphatidic acid (PA) -1 
 
Phosphatidylglycerol (PG) -1 
 
Phosphatidylserine (PS) -1 
 
Phosphatidylinositol (PI) -1 
 
Phosphatidylcholine (PC) Neutral (zwitterionic) 
 
Phosphatidylethanolamine (PE) Neutral (zwitterionic) 
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Table 1.2. The common fatty acid chains (X and Y) present with GPLs (see Figure 1.4). 
Fatty Acid Structure 
Common 
Name 
Systematic Name 
Shorthand 
Name 
CH3(CH2)8COOH Capric n-Decanoic C10:0 
CH3(CH2)10COOH Lauric n-Dodecanoic C12:0 
CH3(CH2)12COOH Myristic n-Tetradecanoic C14:0 
CH3(CH2)14COOH Palmitic n-Hexadecanoic C16:0 
CH3(CH2)16COOH Stearic n-Octadecanoic C18:0 
CH3(CH2)18COOH Arachidic Eicosanoic C20:0 
CH3(CH2)5CH=CH(CH2)7COOH Palmitoleic 9-Hexadecenoic C16:1 (9) 
CH3(CH2)7CH=CH(CH2)7COOH Oleic Cis-9-Octadecenoic C18:1 (9) 
CH3(CH2)4CH=CHCH2CH=CH(CH2)7COOH Linoleic 
Cis,Cis-9,12-
Octadecadienoic 
C18:2 (9,12) 
CH3CH2CH=CHCH2CH=CHCH2CH=CH(CH2)7COOH α-Linolenic 
9,12,15-
Octadecatrienoic 
C18:3 (9,12,15) 
CH3(CH2)4CH=CHCH2CH=CHCH2CH=CH(CH2)4COOH γ-Linolenic 
6,9,12-
Octadecatrienoic 
C18:3 (6,9,12) 
 
Table 1.3. Mole% of different GPL compositions in bovine and rabbit eye lens 
membrane, created with data obtained by chromatography methods (Anderson et 
al.)
38
. Errors were reported as the standard error of the mean (SEM), when n=2. 
GPL Composition 
Mole% 
Bovine Rabbit 
PC 26.0 ± 0.7 22.6 ± 1.4 
PE 33.6 ± 1.6 27.9 ± 0.7 
PI 1.6 ± 0.3 1.5 ± 0.2 
PS 8.2 ± 1.0 12.3 ± 1.4 
LPC 0.9 ± 0.3 - 
LPE 3.1 ± 0.8 3.1 ± 0.6 
SM 22.3 ± 0.6 32.2 ± 0.9 
 
One of the most important features that cell membranes have is the 
asymmetric distribution of lipid composition on both inner and outer 
leaflets.7,8,39-43 This was first proposed by Bretscher in 1972 for mammalian 
erythrocytes membrane,39 but then proposed for different cell functions in 
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one organism and as well as in different organisms7,41,42. The reported data 
suggested that the inner leaflet of the lipid-bilayer (cytoplasmic) is rich with 
amino-based PLs such as PE and PS, while the outer leaflet of the lipid-
bilayer (exoplasmic) is rich with choline-based PLs such as PC and 
sphingomyelin (SM).39-43 Consequently, lipid asymmetry is not absolute 
because each PL is present on both membrane leaflets but in different 
amount.41 This asymmetry is shown to be preserved with asymmetric 
distribution of proteins within the membrane7,41,42 and this has a 
consequence on different functions provided by both membrane leaflets42. A 
recent study showed that lipid asymmetry regulates mechanical stability of 
the cell membrane and this is proven by interaction of skeletal proteins with 
PS constituent in the inner leaflet of red cell membrane.44 
Further, a good review by Braverman-Moser45 describes the 
importance and the relevant ratio for different plasmalogen lipids in various 
mammalian tissues. Plasmalogen lipids are a class of ether GPL45 that has a 
vinyl ether (1-O-(1-cis-alkenyl)) linkage at sn-1 position of the glycerol 
backbone instead of fatty acid (Figure 1.5 A), which is also known as 
plasmenyl. The other less abundant class of ether GPL is plasmanyl GPL 
with alkyl ether (1-O-alkyl) linkage at sn-1 position (Figure 1.5 B). 
Interestingly, it is found that the majority of PE lipid in eye lens of mammals is 
present in the form of plasmalogen PE38,46-48.  
 
 
Figure 1.5. Structural representation for the two common ether GPLs. (A) 
plasmalogen-/plasmenyl GPL and (B) plasmanyl GPL. Z is usually ethanolamine group 
(most common) or choline group (less common). See Table 1.1 and 1.2 for the 
molecular structure for different polar head-groups (Z) and hydrophobic acyl chains 
respectively. 
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1.3.1.1.1. Phase behavior of phospholipid bilayer 
Hydrated PL bilayers can exist in different phase states. This depends 
on PLs chemical structure, degree of hydration, temperature, pressure, ionic 
strength and pH8,49. Most PL bilayers exist as liquid-crystalline or fluid phase 
(Lα) under physiological conditions but sometimes in the gel phase or solid 
phase (Lβ
,).49 The fluid phase (Lα) of lipid-bilayer has a characteristic 
behavior when hydrophobic acyl chains are unsaturated. In the presence of 
cholesterol it can be liquid ordered (Lo) or in the absence of cholesterol liquid 
disordered (Ld)
8,43. PLs with saturated hydrophobic acyl chains are highly 
ordered, all are in trans conformation, and exhibit gel phase (Lβ
,) behavior. 
The intermediate phase between Lα and Lβ
, is called rippled gel phase 
(Pβ
,)8,18,35. Biological membranes with the characteristic of lipid diversity and 
different chemical identity for each lipid class in respect of their hydrophilic 
head-groups and hydrophobic fatty acyl chains are experiencing both fluid 
phase and gel phase behavior (Figure 1.6).8 
Although the phase transition of PLs is influenced by several factors, 
thermally phase transition is the most common factor that has been studied 
and more biological relevance,49 as there is a direct relation between 
thermally phase transition and membrane structure18. At a certain 
temperature the bilayer can exhibit phase changes or phase transition. At the 
pre-transition temperature (Tp) the lipid phase changes from Lβ
, to Pβ
,, and at 
the main transition temperature (Tm) from Pβ
, to Lα.
8,18,35 Interestingly, PCs 
can exhibit both Tp and Tm, while PEs just exhibit Tm.8,50 PLs with 
unsaturated fatty acyl chain have very low Tm (< 0 ˚C)18,50 compared to 
saturated counter parts; for example Tm is -16.5 ˚C for 1,2-dioleoyl-PC 
(DOPC)52,53 vs 41.3 ˚C for 1,2-dipalmitoyl-PC (DPPC)54-6. Further, PLs with 
longer acyl chains have higher Tm than shorter PLs. This is because of 
increasing van der Waals forces between longer acyl chains. High Tm is also 
found with fewer degrees of unsaturation due to the lower disruption in the 
ordered chain packing than higher degree of unsaturation.18,57 In addition, the 
polarity of PLs head-groups and their affinity to bind with water molecules 
has also a great impact on both Tm and Tp.35  
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Figure 1.6. The three phase states (Lβ
,
, L
α
 and Pβ
,
)  for hydrated PL bilayer with the 
illustration of transition temperatures (Tm and Tp) between each two phases in a 
reversible pathway.  
 
1.3.1.1.2. Action of Phospholipase enzyme on phospholipids  
The two low abundant water soluble amphiphilic monoacyl lipids in 
most biological membranes, LPL and free fatty acid (free FA),36,37,58,59 are 
principally formed by phospholipase enzyme on PL substrates58,60,61. The 
phospholipase enzyme family can be classified into four main classes (Figure 
1.7) including: first, PLA enzymes with PLA1 and PLA2 sub-classes, 
hydrolysis sn-1 and sn-2 positions of the PLs respectively; second, PLB 
enzymes, hydrolysis both sn-1 and sn-2 positions; third, PLC enzymes, 
hydrolysis the linkage between the phosphate head-group and glycerol 
backbone; fourth, PLD enzymes, forms phosphatidic acid by removing 
phosphate head-group from the PL.35,60-62 Interestingly, PLA2 enzyme with 
the mass of 13-15 kDa35,60,62 is the common component of many animal 
venoms and pancreatic juices60,62 and is one of the phospholipase enzymes 
that has been broadly studied61,62. Their major roles recorded to be 
inflammation regulation, immune function and smooth muscle contraction60. 
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In this chapter the focus will be on PLA2 enzyme due to the nature of the 
research has concentrated on venom of the bee. 
 
 
Figure 1.7. The cleavage sites of PL by the hydrolysis activity of phospholipase 
enzymes. Different polar head-groups and fatty acyl chains are provided in Tables 1.1 
and 1.2.  
 
Formation of an equimolar amount of LPC and free FA by PLA2 
activity63-65 is shown in Figure 1.8. Interestingly, it has been reported that the 
activity of this enzyme towards single lipid molecules is very low, while during 
lipid aggregation in the forms of micelle, liposome, or lipid-bilayer the activity 
of PLA2 is extensively enhanced.
37,58,62,64-68 In addition, in the aggregated 
lipid system this activity is also influenced by lipid composition,69 membrane 
phase in terms of gel phase and fluid phase,64,70,71 liposome curvature,72 
surface charge,73 monolayer surface pressure74 and interfacial water 
activity75.65 It is interesting to see that (Figure 1.8, bottom) the balanced size 
between head-group and tail-group sections in PC lipids provides cylindrical 
shape that favours their lipid-bilayer phase with low intrinsic curvature; LPCs 
with larger head-group size relative to their smaller tail-group prefer highly 
curved structure with inverted cone shape and micelle phase (non-bilayer 
phase); free FAs with much smaller head-group than LPCs form cone shape 
with inverted micelle phase (non-bilayer hexagonal HII phase).
2,7,18,64,76,77 
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Figure 1.8. The products LPC and free FA from the hydrolysis of PC by the PLA2 
enzyme (top route) and different polymorphic phases for aggregated lipid molecules 
in water for each of PC, LPC and free FA (bottom). 
 
1.3.1.1.3. The influence of lysophospholipid and fatty acid 
partitioning on lipid membrane  
The partitioning ability of LPCs and free FAs in both lipid phase and 
aqueous phase is shown to have a great impact on both membrane-
membrane2,59,76,78-85 and membrane-protein86-89 interactions. This is shown to 
be strongly related with LPC/free FA geometrical shape (see Figure1.8) and a 
consequent impact on morphological changes in the membrane.90,91 
Consequently, LPCs induce a positive curvature of the membrane upon their 
addition (Figure 1.9, route (a)), but a negative curvature is induced upon 
addition of free FA2,59 (Figure 1.9, route (b)). On the other hand, equimolar 
amounts of both LPC and free FA are reported to keep membrane bilayer 
structure with no curvature68,92-94 (Figure 1.9, route (c)). Consequently, the 
recorded disruption/destabilisation influence on the membrane by the 
individual addition of LPL and free FA such as morphology,79 
permeability,59,80,81 fusion process,82 and a consequent lysis84,85 will be 
reduced.2,76,92      
In addition, there are several factors that control the extent of LPL 
and/or free FA activity or incorporation into the membrane such as PLs phase 
behaviour whether they are in fluid phase or gel phase76,90,93,95-99. Also 
LPL/free FA chemical nature such as their acyl chain length and degree of 
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unsaturation37,90,85,92,94 plus head-group size and polarity37,58,77,100 have a 
great influence. Consequently, LPLs concentration above which they form 
micelles, the critical micelle concentration (CMC)37,56,101 is also highly 
affected (Table 1.4). CMC decreases by increasing the length of the acyl 
chain and increases by decreasing the size of the polar head-group. Below 
CMC just monomers exist, while above CMC the monomer concentration 
remains constant and is equal to CMC35. 
 
 
Figure 1.9. Incorporation of LPC, free FA and both LPC and free FA into the lipid-
bilayer of PC and their impact on lipid-bilayer curvature stress. 
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Table 1.4. The reported values for LPLs CMC
37,56
  at 25 °C in the following solutions: X, 
pure water and Y, buffer solution composed of 0.14 M NaCl + 0.02 M Tris-HCl (pH 
7.2)
37
. The comparative CMC value in different studies
101-103 
is also provided.   
Lysohospholipid (LPL) 
Head-Groups 
Size (nm
3
)
77
 
CMC (mM) for Specific LPLs in 
X 
CMC (mM) for 
Specific LPLs in Y 
Lysophosphatidylcholine (LPC) 0.101 
(C14:0) 
0.07,
37
 0.063,
101
 
0.043
102 
0.07,
37
 0.063,
101
 
0.043
102 
(C16:0) 
0.007,
37,103 
0.0083,
101
 
0.0043
102 
0.007,
37,103
 0.0083,
101 
0.0043
102 
(C18:1) 0.004
37 
0.004
37 
Lysophosphatidylserine  
(LPS) 
0.087 
(C14:0) - - 
(C16:0) - - 
(C18:1) - - 
Lysophosphatidylethanolamine 
(LPE) 
0.063 
(C14:0) - - 
(C16:0) - - 
(C18:1) - - 
Lysophosphatidylglycerol (LPG) - 
(C14:0) 3.0
37 
0.16
37 
(C16:0) 0.6
37 
0.018
37 
(C18:1) - - 
 
1.3.1.2. Sphingophospholipid (SPL) 
Sphingophospholipids (SPLs) are the second most abundant PL class 
with sphingosine backbone.1,5,7,8 Amide linked acyl chain sphingosine forms 
ceramide, while sphingomyelins (SM) formed by the attachment of choline or 
ethanolamine polar groups to the hydroxyl group of ceramide (Figure 1.10). 
SM is the major class of SPLs in animal cell membrane33,94 and they 
constitute 2-15%104 of total PLs. This ratio is even higher in some tissues 
such as brain, nervous tissue and ocular lens, for example in human eye lens 
they have found to build up > 25% of the total lens PLs.48 Their main features 
are their extensive ability to form hydrogen bonds and are asymmetric 
molecules because of the presence of very long fatty acyl chain of the amide 
linkage (longer than C20) and high degree of saturation relative to short 
paraffin residues on the sphingosine backbone.8,94,104,105 Consequently, they 
serve vital functions in the natural cell such as their participating with GPLs 
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as building blocks for cell membrane formation, signalling molecules and 
their involvement in formation of lipid rafts.8,104-106 Lipid rafts are localised 
regions in the membrane and known for their liquid ordered domain, 
characteristic resistance to solubilise by detergents and less fluidity than the 
rest of the cell membrane.8,13-17,107 It is also reported that there is a strong 
relation between the amount of lens SM and cataract eye lens. It is found that 
the amount of SM increases with increasing age and cataract.108-111  
 
 
Figure 1.10. Sphingomyelin (SM) structure, illustrating phosphatidylcholine head-
group (green) and fatty acid tail-group (pink) attached to the sphingosine backbone 
(blue). 
 
1.3.2. Sterols 
The other important lipid class in eukaryote membranes are sterols but 
they are rarely found in prokaryote membranes.1,5,7 Cholesterol is the major 
class of sterol in mammals1,5,7,8,108 and found at 30-50 mole% of total lipids8. 
It is composed of four cyclic rings with the polar hydroxyl group and 
hydrocarbon chain attached to it (Figure 1.11). Their excessive amount is 
found in lenses112,113 with the highest recorded amount in human lenses 
relative to other animal lenses.48,108 For example the concentration of 
cholesterol is 4-8 mg/g48,113 of whole lens weight in human lenses, while it is 
1-2 mg/g in rat and bovine lenses.113 The amount of cholesterol has also 
shown to be related with lens age and cataract.108-113 Interestingly, 
cholesterol increases membrane rigidity by introducing ordering distribution 
of the membrane to produce liquid ordered phase behaviour (Lo) and also 
shares the formation of lipid rafts with SM lipids.8,105,106,111,114-117 
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Figure 1.11. Cholesterol structure, illustrating hydroxyl head-group (green) and 
hydrocarbon tail-group (pink) attached to the steroid backbone (blue).    
 
1.4. Analytical methods for lipid analysis  
The lipidome represents the complete profile of lipid species present in a 
cell, organelle or tissue, while lipidomics represents the study of lipid profiles 
within biological systems.118,119 Performing lipidomics research is quite 
challenging because of the diversity and complexity in the cell membrane, 
while performing lipid analysis for synthetic standard samples is less 
challenging. Consequently, relying on multiple tools for lipid analysis is very 
much needed and each single analytical tool will offer some pros and cons 
during their application. 
Extraction techniques involving liquid-liquid extraction (LLE) and solid-
phase extraction (SPE) have been widely used in lipid analysis to clean-up 
the sample mixture by carefully selecting the best extraction solvent to 
disrupt lipid and non-lipid species interactions and subsequently removing 
non-lipid species to get efficient extraction. Chromatographic method is 
another separation tool with a broad application in this field. This includes 
gas phase chromatography (GC) which is not so common because the 
majority of cell membrane lipids are non-polar and non-volatile so they 
require an extra step of chemical modification in order to enable this type of 
analysis. Thin-layer chromatography (TLC) is another chromatographic 
technique which is widely used because of their versatility, quick and high 
efficiency. High-performance liquid chromatography (HPLC) is the most 
popular method through normal phase HPLC and reverse phase HPLC to 
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separate and target a wide range of lipid species in one analysis with no 
need for lipid modification prior their HPLC analysis and also with high 
sensitivity.119 In addition, nuclear magnetic resonance (NMR) spectroscopy is 
another applicable tool in lipid analysis. This involves 1H and 13C NMR for 
single PLs because of their complexity, while 31P NMR is more common in 
both individual and a mixture of lipids because of the ability of 31P NMR to 
provide separate signal for each PL class.120 However, NMR method is very 
insensitive and requires a large amount of sample solution to perform the 
analysis and is more challenging for crude lipid sample than individual 
sample analysis. 
Further, lipids can be analysed directly by mass spectrometry 
(MS)118,119,121 using the two common ionisation techniques, electrospray 
ionisation (ESI)122 and matrix-assisted laser desorption/ionisation (MALDI)123. 
This can be done without prior LC separation to produce intact lipid ions with 
the necessary level of sensitivity and high sample throughput. This is referred 
as shotgun lipidomics,119,124 but the main disadvantage of this method is ion 
suppression by ionisation competition between different available ionised 
specie and thus limiting sensitivity. On the other hand, coupling LC with MS 
(LC-MS) offers a solution to ion suppression and increasing the 
sensitivity,119,125 although LC slows down the sample throughput 
performance. Direct lipid identification based on their m/z in high resolution 
MS instruments refereed as top-down lipidomics, whereas using 
fragmentation (tandem) MS referred as bottom-up lipidomics.119,121 In 
addition, combining the advantages from MALDI-MS with imaging principle 
provides a powerful tool to map tissue and investigate lipids spatial 
distribution,126-130 while the anatomical integrity of the tissue is 
maintained.131,132 
Additional improvements and information in the field of lipid analysis has 
been gained by coupling ion mobility separation (IMS) with MS (IMS-MS) to 
provide not just accurate m/z information for the analyte but also structural 
(ion conformation) by measuring their collision cross-section (CCS) or drift 
time.133-135 The improvements in the analysis by using IMS-MS is found to be 
in the detection limit, speed of analysis, and selectivity.135,136 The three 
common IMS-MS techniques include; drift time ion mobility spectrometry 
19 
 
(DTIMS), travelling wave ion mobility spectrometry (TWIMS) and field-
asymmetric ion mobility spectrometry (FAIMS) or differential ion mobility 
spectrometry (DMS). IMS-MS has been widely applied in the field of 
peptide/protein gas phase study136 but just recently has shown its application 
in lipidomics analysis131,132,134,135.  
Separation by IMS-MS can be performed for both neutral lipids such as 
PC, PE and SM, which are readily ionised in positive ion mode, and 
negative/acidic lipids such as PS, PG, PA and PI, which are efficiently 
ionised in negative ion mode.121,132 Reported data showed that a sample 
composed of a mixture of lipids can be separated and classified based on 
their different head-group sizes with equivalent fatty acyl chains by 
measuring their structural changes in the gas phase and correlate it with the 
difference in their drift time.132,135,137-139 Faster mobility/smaller drift time were 
recorded for lipids with smaller head-group sizes such as PA, while slower 
mobility/larger drift time for lipids with larger head-group size such as PC. In 
addition, lipids with longer acyl chains have higher drift time than shorter acyl 
chains, while increasing the number of double bonds causes a decrease in 
drift time,132,140,141 but this has shown to have less impact on drift time than 
acyl chain length.140 On the other hand, separating lipid isomers such as cis-
isomer from trans-isomer,140 PLs from plasmalogen PLs and hydroxylated 
from non-hydroxylated lipids132 is more challenging due to little or no change 
in the drift time. Separating lipid isomers in terms of positioning fatty acyl 
substituents such as POPC from OPPC was only achieved under special 
IMS-MS conditions, for example by coupling dual stage collision induced 
dissociation (CID) fragmentation with TWIMS142 or by using DMS for cation 
adduct formation (Ag+) with the lipid of interest143. DMS was also shown its 
ability to quantify the amount of LPLs in biological samples through direct 
infusion (shotgun lipidomics) by using multiple reaction monitoring (MRM) 
mode and/or precursor ion scan (PIS).139 Further, it is also possible to 
localise the position of the double bond on PC lipids by using CID with 
TWIMS and it is not just applicable for synthetic standard lipid samples, but 
also in biological samples.142 
20 
 
1.5. Lipid-protein interaction  
The two most abundant biomolecules, lipids and proteins, serve a range 
of vital functions in the fluid system of the membrane. Their interactions can 
result in formations that possess new functions which differ from the 
individual function of the independent lipid or protein. This interaction 
depends on the type of available proteins and lipids. Soluble proteins in the 
membrane, extrinsic or peripheral membrane proteins, interact with the 
surface of the lipid membrane through electrostatic interactions, while 
proteins with hydrophobic domains, intrinsic or integral membrane proteins, 
interact with lipids by spanning through membrane lipid-bilayer.7 On the other 
hand, lipids either have no contact with proteins (bulk lipids) or they have a 
contact with proteins144,145 (Figure 1.12). Lipids with contact with proteins can 
be classified to two classes144,145; annular lipids (Figure 1.12A), they are 
known to have lower affinity to proteins with non-specific interactions; non-
annular lipids (Figure 1.12B), this class of lipid have higher affinity and 
specific interactions with membrane proteins to form lipid-protein complexes. 
Studying this lipid-protein interactions is very challenging,18,145,146 mainly 
due to the diversity of lipid/protein compositions in the cell, different phase 
behaviour/physical properties of lipids and how the presence and absence of 
proteins/peptides influence membrane lipids phase behaviour. In order to 
understand lipid-protein interactions, different analytical tools have applied 
with different outcomes. Electron spin resonance (ESR), often called electron 
paramagnetic resonance (EPR) and 2DIR are very useful techniques to 
follow dynamic/time scale of lipid-protein interactions.145-148 Both methods are 
known for their sensitivity and speed,145 but they are difficult to apply for 
biological samples148. EPR is also a useful technique to evaluate the number 
of lipid molecules which surrounds the membrane protein.146 Time-resolved 
fluorescence is another spectroscopy method to study lipid-protein interaction 
and shown its compatibility for biological samples.148 In addition, structural 
study of lipid-protein complex is also very useful to understand and 
characterise lipid-protein interactions. This has been done by using X-ray 
crystallography,149,150 2D electron crystallography,149,151 and solid-state 
NMR152.145,146,148  
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Figure 1.12. (A) Lipid-bilayer representation of regions where PLs are solvating 
membrane proteins by forming a shell around protein complex (annular lipids, pink), 
and (B) PLs buried within protein complex subunits (non-annular lipids, red). 
 
1.6. Protein lipidation  
The addition of an acyl group from a lipid molecule to a peptide or protein 
i.e. lipidation or fatty acylation produces a modified peptide/protein with 
higher molecular mass and hydrophobicity, and as a result a higher affinity to 
membrane. These include, cytoplasmically oriented modifications of post-
translational modifications (PTM) such as S-acylation (palmitoylation) and S-
prenylation, via thioester linkage, or co-translational modifications such as N-
myristoylation, via amide linkage, and also extracellularly oriented 
modifications such as cholesteroylation and glycosylphosphatidylinositol 
(GPI) anchoring.153-158 In addition of S-palmitoylation, N-palmitoylation via 
amide linkage also reported.157-159 Usually these processes of modification 
are done by enzyme catalysis in vivo,160 but non-enzymatic auto acylation 
has also been described.156 Modified proteins with modified physical 
properties153,154 have a great impact on protein localisation and different 
physiological functions, such as intracellular targeting, signalling pathways, 
protein-protein and protein-lipid interactions in different living organisms.156-
161 Protein lipidation is also reported to implicate in some human diseases 
such as cancer, diabetes and neurological disorders.157,162 In addition, 
Sachon et al. showed that chemically modified human growth hormone with 
palmitoylation towards ε-amino group of lysine is stable under extreme pH 
conditions with desired pharmacological properties, and palmitoylation also 
increases plasma half-life.158   
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Interestingly, the advantages of high sensitivity, accuracy and resolving 
power of some MS tools enabled the detection and/or quantification of a 
range of PTMs.158,161-172 A typical example for lipidated peptide/protein and 
their involvement in this study is melittin168-170 and AQP0154,165,167,171. Non-
enzymatic acyl transfer was recorded through aminolysis reaction of ester-
linked fatty acyl from PLs forming liposome to the N-terminus, side chains of 
internal lysine and serine residues of melittin within a short timescale of 3-4 
h.169,170 This non-enzymatic acyl transfer was also suggested in vivo in a 
recent publication for AQP0 by reporting a range of lipidation products that 
mirrors the PL composition of the membrane leaflet that AQP0 acylation sites 
are located in.172 However, earlier studies154,165,167,171 recorded AQP0 
lipidation but with only two acyl chains (palmitoyl and oleoyl) and with the 
lack to provide supporting evidence for acyl transfer from lens membrane to 
the protein.       
 
1.7. Melittin 
Melittin with two special properties; high basicity and surface activity173 is 
one of the most extensively utilized model peptides for studying. It is a highly 
positively charged peptide, +6 at physiological conditions, due to the 
presence of several basic amino acid (AA) residues in the total of 26 AA 
residues (Figure 1.13). It is principally a hydrophobic peptide because of the 
predominantly hydrophobic character at N-terminal portion (1-20 AA residue), 
while the C-terminal portion is predominantly hydrophilic (21-26 AA residues). 
Consequently, melittin is amphiphilic peptide and is readily soluble in water. 
In aqueous solution, within physiological pH, and low melittin concentration it 
is present as a monomer with a random coil disordered conformation. 
However, the absence of electrostatic repulsion between the stretch of 
positive charges under the conditions of increasing ion strength, 
concentration, pH and temperature174,175 causes four monomers to 
aggregate175 and form α-helical tetramer conformation with a kink at proline 
AA (P14) in each α-helix monomer (Figure 1.13).174,175 This structural 
conformation has been studied by different analytical tools175 including; 
circular dichroism (CD),176 fluorescence spectroscopy,177,178 NMR 
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spectroscopy179,180 and  X-ray crystallography181. Interestingly, melittin also 
exists as α-helical structure during its binding with lipid membranes or 
liposome and micelles.174,182-185 
 
 
Figure 1.13. α-Helix structure from tetramer aggregation of melittin, obtained from 
(PDB code: 2MLT). 26 AA residues of melittin is obtained from 
(https://pubchem.ncbi.nlm.nih.gov/compound/16133648); molecular formula, 
C
131
H
229
N
39
O
31
; average neutral mass, 2846.4694 Da. Highlighted AA residues in red 
represent positive sites of melittin at physiological condition. 
   
Melittin, a membrane active peptide, has a range of activities such as 
moderate antibacterial and antifungal activity at concentration ranges 
between 0.05-0.2%173 and it has a powerful hemolytic (membrane 
perturbation) activity173,174,186. This induces a leakage in the erythrocytes 
membrane and the release of hemoglobin and thus membrane permeability 
will be increased. This mainly depends on melittin concentration, in which 
above 1 µg/mL this hemolytic activity will be enhanced.174,186 This peptide is 
a major component in the venom of European honey bee (Apis mellifera) and 
present at a ratio 50% (w/w) of dry venom.173,174,187,188 The second most 
abundant biomolecule in the venom of honey bee is PLA2 at concentration 
10-12% (w/w) of the dry weight.187 The hydrolysis activity of this enzyme (see 
Figure 1.7) in the presence of (Ca2+)62,67 has reported to be enhanced by 
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melittin.182,189-191 Synergistic activity for both melittin and PLA2 on membrane 
lipids has also been suggested.182 
 
1.8. AQP0 in mammalian eye lens 
A clear vision is a vital physiological function of the eye. This function 
is provided by an avascular and transparent organ called lens. Both lens and 
cornea in the front of the eye are focusing images/light on the retina in the 
back of the eye (Figure 1.14). Eye lens is surrounded by lens capsule and 
underneath it there is a single layer of cuboidal epithelial cells in the 
front/anterior surface. These epithelial cells elongate, lose their light 
scattering intracellular organelles, synthesize particular crystallin proteins, 
replace their membrane transport proteins and consequently differentiate into 
fibre cells at the equator.192,193 Fibre cells are concentric layers and they 
constituent the bulk of the lens. They are continuously added to the lens 
throughout the life and thus an increase in the lens weight115 as there is no 
cell turnover in the lens.192-194 The younger fibre cells at the cortex are always 
renewed throughout the life by adding new cells to it in periphery, while the 
core fibre cells have the same original cell constituents that were present 
since birth.111,115,194-196 Interestingly, one of the public eye health problems is 
a cataract where the lens lose its transparency and consequently 
vision197,198. Cataract usually starts after the age of 40 years in human.198 
 
 
Figure 1.14. The structure of human eye (left) and the illustration of cellular fractions 
in the eye lens (right).  
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One of the most abundant integral membrane proteins in mammals 
which is produced by lens fibre cell is AQP0, also called aquaporin-0, major 
(membrane) intrinsic protein, MIP, MIP26, and MP26.199,200 Generally, 
Integral membrane proteins are of great importance in cellular processing in 
eukaryotes and they make-up one-third of the total proteins encoded by 
genome and large amount of drug targets.201 They serve as signalling 
molecules, transporters, cell-cell interaction, energy generation, vesicle 
trafficking and intracellular communication.201-203 The C-terminus and N-
terminus of all integral membrane proteins are located at the cytoplasmic 
surface and they all share tetraspanin properties, because they are 
composed of four membrane-spanning domains.204,203 
AQP0 is a member of aquaporin family with 28 kDa mass that 
comprises nearly 50% of protein in the lens membrane206-209. It has a number 
of different functions in the lens, the major functions being a water 
channel,149,210-214 formation of thin junctions in the lens membrane149,213,214 
and facilitating cell-to-cell adhesion207,215. Mutation in AQP0 gene leads to 
cataract formation in the eye,200,216 which indicates the importance of this 
protein and the need to understand its behaviour in relation to disease. The 
significance of this protein has meant it has attracted a lot of attention over 
the years. During this time a range of different modifications were recorded 
on AQP0 such as truncation,217-219 phosphorylation,201,206,218,220 
deamidation,165,201,218,221 and as well as lipidation154,165,171,172. However, 
recent publication172 with recording a broad range of novel lipidation products 
showed that whole range of lipidated AQP0 were not covered in previous 
works. 
Structural studies of this protein showed that it exhibits a tetramer 
complex in the membrane with six transmembrane α-helices.220,222,223 
Different conformations of junctional and non-junctional AQP0 is shown in 
Figure 1.15. It has been reported that formation of thin junction in the core of 
lens membrane is related with proteolytic digestion of AQP0 with a cleavage 
at intracellular C-terminus,149,213 while non-junctional AQP0 is specific for 
intact protein and both C-terminal and N-terminal regions have ordered 
conformation149.  Junctional and non-junctional AQP0 also exhibit different 
water pores and hydrogen bonding pattern. Further, lipid ratio in lens 
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membrane is low and their overall content is reported to be 4%,115 these lipid 
membranes are generally very rigid and this is suggested to be related to 
their high cholesterol content.114,115,195 They also have a restricted movement 
and this is because of their interaction with proteins (see Table 1.3 and 
chapter four, section 4.1.3 for details about lipid composition in the eye 
lens).108,111 AQP0 and membrane lipids are regarded as age related 
components in mature fibre cells of the lens because there is no or little 
cellular turnover in the lens,167,194,224-226 thus these two species are of high 
interest to study as they regarded as old as the lens itself. Lynnerup et al.225 
and Stewart et al.226 have used 14C bomb pulse to reveal proteins without 
turnover in the human eye lens.   
 
 
Figure 1.15. (A) The water pore in junctional AQP0 (right) and non-junctional AQP0 
(left). Red spheres represent water molecules in both junctional (3 water molecules) 
and non-junctional (7 water molecules). The middle data represents the calculated 
water pore profiles for both junctional AQP0 (purple, more constricted) and non-
junctional AQP0 (pink, less constricted). (B) Hydrogen bonding pattern of water 
molecules (dotted lines) in the pore of junctional AQP0 (right) and non-junctional 
AQP0 (left). Tyrosine AA residue (Tyr24) of AQP0 introduces a phenolic barrier and 
disrupt the hydrogen-bonding network. In junctional AQP0 all three water molecules 
are too far apart to form hydrogen bonds. Reprinted by permission from Macmillan 
Publishers Ltd: [Nature],
149
 copyright (2005). 
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2.1. Mass spectrometry (MS) 
A schematic of a generic mass spectrometer is given in Figure 2.1. 
Mass spectrometer workflow starts by ionising the analyte to generate gas 
phase ions in the ionisation source and a subsequent separation of ions in 
the mass analyser based on their mass to charge (m/z) ratio. This has 
enabled a substantial MS application in various branches of science and 
technology for qualitative and/or quantitative purposes. The m/z ratio as a 
function of ion abundance or so called mass spectrum for gas phase ionised 
atoms or groups of atoms was first measured by the first mass spectrometer 
invented by J. J. Thomson in 1912.1-3 
 
 
Figure 2.1. Schematic for mass spectrometer basic components. 
 
The application of mass spectrometers has been expanded to not just 
include analysis of small species but also larger species (macro molecules) 
such as peptides and proteins with the MS benefit in sensitivity, speed and 
resolution4-7. This has been more common since 1990 after two soft 
ionisation methods were invented, electrospray ionisation (ESI-MS) by Fenn 
et al.8-12 and matrix-assisted laser desorption/ionisation (MALDI-MS) by 
Tanaka et al.13,14. Once these larger molecules could be ionised in a manner 
that gave stable and intact precursor ions, it was possible to subject them to 
tandem mass spectrometry (tandem MS or MSn), primarily collision induced 
dissociation (CID). This tandem MS enabled detailed structural 
characterisation, as with small molecules, but for large biopolymers this 
meant sequence information or the order of building blocks. Consequently, 
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localising of any modifications such as post-translational modifications (PTM) 
or otherwise that these building blocks have.15-21  
In addition, the hyphenation ability between chromatography 
separation methods and ESI-MS,4,7,9,22 more commonly, or MALDI-MS,23-25 
less commonly, such as liquid chromatography (LC-MS) added an extra level 
of improvement in sample analysis by both MS and tandem MS. The main 
advantage is found in separating mixture components in a sample prior 
ionisation process and thus reducing ion suppression, increasing sensitivity, 
improving signal to noise ratio and a consequence improvement in 
quantification analysis.22-26  
 
2.1.1. Ion sources 
Different ion sources have different bearing on the ionisation of 
molecules because of the amount of energy, and the manner in which it is 
transferred to the sample, from the hardest, electron ionisation (EI) to the 
softest, nano-electrospray ionisation (nESI), as shown in Figure 2.2. The 
advantage of this is that a particular ionisation technique can target 
compounds with a characteristic chemical nature. Among this range of ion 
sources, detailed principles for ESI-MS and MALDI-MS have been discussed 
in this chapter because of their application to experimental analysis 
discussed in chapters three, four and five. 
 
 
Figure 2.2. The strength scale for the range of ionisation techniques. The acronyms 
for the ionisation sources from left to right include: electron ionisation (EI); chemical 
ionisation (CI); atmospheric pressure chemical ionisation (APCI); atmospheric 
pressure solids analysis probe (APCI); fast atom bombardment (FAB); matrix-assisted 
laser desorption/ionisation (MALDI); electrospray ionisation (ESI); nano-electrospray 
ionisation (nESI). 
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2.1.1.1. Electrospray ionisation (ESI-MS) 
Electrospray ionisation (ESI) is one of a range of atmospheric 
pressure ionisation (API) techniques.7,12,27 This method is suited to ionise 
small polar or ionic molecules and as well as larger biomolecules. A 
continuous flow of intact gas phase molecular ions will be introduced to the 
system and this is perfectly suited to be coupled with LC. ESI is based on 
dissolving an analyte in a polar solvent and subsequent change from 
condensed form in the solution to gas phase analyte ions (Figure 2.3). 
 
 
Figure 2.3. Schematic illustration of ESI source in positive ion mode. 
 
The ionisation process starts by passing the analyte solution through a 
stainless steel capillary needle under high voltage (±3 - ±4 kV). This high 
voltage in combination with the nebulising gas/sheath gas (typically dry 
nitrogen) around the capillary needle helps solvent evaporation and brings 
the sample into an aerosol of charged droplets.27,28 These charged droplets 
continuously undergo solvent evaporation and shrink in size with the aid of 
drying gas (nitrogen desolvation gas) and eventually form either positive 
gaseous ions in the positive ion mode ESI+ with the production of protonated 
species, [M + nH]n+ and/or adduct cation [M + nCation]n+ or negative gaseous 
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ions in the negative ion mode ESI- with the formation of deprotonated 
species [M - nH]n- and/or adduct anion [M + nAnion]n-. The ions will be drawn 
to the entrance of the mass analyser by the influence of a high vacuum from 
the mass analyser and a voltage gradient between the capillary needle and 
counter electrode of the source.  
The formation of gas phase ions or desolvation process in ESI is 
basically described by two proposed mechanisms; the charge residue model 
(CRM) and ion evaporation model (IEM).7,12,27,28 In both mechanisms there is 
the formation of smaller droplet sizes as a consequence of solvent 
evaporation (Figure 2.4). Consequently, increasing droplets surface charge 
density until they reach a limit when Coulomb repulsion exceeds surface 
tension and eventually Coulomb fission. This limit is known as Rayleigh limit. 
In CRM mechanism (Figure 2.4 (a)), the repeating process of solvent 
evaporation and Coulomb fission continues until a very small droplet with a 
single analyte ion is formed and eventually droplet desolvation to leave gas 
phase analyte ions, while in IEM mechanism (Figure 2.4 (b)) following the 
continues solvent evaporation and Coulomb fission and subsequent 
formation of smaller charged droplet, the surface electric field desorbs/emits 
the analyte ion from the droplet to leave gas phase analyte ions. It is 
proposed that CRM is more convenient for larger molecules such as peptides 
and proteins, whereas IEM is more applicable for small molecules.7 In 
addition, chain ejection model (CEM) is another ESI mechanism that has 
recently proposed by Konermann et al.29 to describe unfolded proteins.29,30 
Further, ESI is the most popular ionisation method for high molecular 
mass of peptides and proteins because of the presence of more than one 
ionisation site (multiple protonation sites) on the molecule. Therefore z 
increases so m/z falls to a lower mass range that is perfectly suited to the 
most mass analysers particularly significant for mass analysers with narrow 
m/z range.4-6,31    
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Figure 2.4. The two proposed mechanisms; (a) charge residue model (CRM) and (b) 
ion evaporation model (IEM), for describing desolvation process and a consequent 
gas phase analyte ion formation in ESI+.  
 
2.1.1.2. Matrix-assisted laser desorption/ionisation (MALDI-MS) 
  The basic principle in MALDI-MS2,32,33 starts first by mixing analyte 
molecule in the form of solid or liquid with a solution of small organic 
molecules called a matrix solution. The amount of an analyte is usually very 
little compared to the excessive amount of a matrix, this is shown to be in the 
range of 1:4000 and 1:40,000 of analyte:matrix molar ratio for 
peptides/proteins34,35. A spotted droplet of analyte:matrix mixture on a 
conductive target plate is then left for air dry and a subsequent formation of 
co-crystallised layer. After insertion of the target plate into the MS system 
under vacuum, a pulsed laser beam is used to irradiate analyte:matrix layer 
(Figure 2.5). This is often a pulsed nitrogen laser in UV-MALDI at 337 nm 
wavelength. A strong absorbance of matrix at the wavelength of the laser 
beam is suited to absorb energy readily and to become excited. 
Consequently, both matrix and analyte will be desorbed into the gas phase 
through sublimation/ablation. This followed by ionisation reaction, and this is 
reported to perform in different pathways such as gas phase photoionisation, 
excited-state proton transfer, ion-molecule reactions, desorption of preformed 
ions and energy pooling. Among these suggested mechanisms, proton 
transfer in the solid phase before desorption or gas phase proton transfer in 
the expanding plume from photo-ionised matrix molecules, are the two 
common ionisation pathways described in MADLI-MS with the subsequent 
formation of pulsed ions.2,32 
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Figure 2.5. Ionisation principle in MALDI source. 
 
MADLI ionisation method is very popular for non-volatile biomolecules 
of peptides and proteins,4,5,32,35,36 which is especially described and 
developed by Karas et al.37 and thereafter by Tanaka et al.13,14 Depending on 
the nature of the analyte and the selected matrix molecule, this technique 
produces predominantly either [M + H]+ in positive mode or [M - H]- in 
negative ion mode. The most common matrix in the field of protein analysis is 
sinapinic acid (SA), while peptide molecules can generally be best analysed 
from α-cyano-4-hydroxcinnamic acid (CHCA) or 2,5-dihdroxybenzoic acid 
(DHB).20,32,35 The discrete packet of ions is then drawn towards the mass 
analyser by negative accelerator plate.         
 
2.1.2. Mass analysers 
Ions formed in the ion source are focused and transmitted towards a 
mass analyser where they are separated based on their m/z ratio. There are 
many different types of mass analyser so focus will be given to describing 
linear ion traps (LIT-MS), quadrupoles (Q-MS), time-of-flight (ToF-MS) and 
Fourier transform ion cyclotron resonance (FTICR-MS) mass analysers as 
used within this project. No one mass analyser has the ideal functionality and 
performance, however by combining different mass analysers the 
advantages of each can be cumulative. For example, Q-MS has no 
functionality and poor performance during its individual application, however, 
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it is known for its relatively small, cheap, robustness and rapid scan rates at 
sampling frequency of > 10 Hz,38 while combining three quadrupoles (triple 
Q-MS or qQq-MS) performs different functionalities. On the other hand, 
FTICR-MS is the mass analyser with the extreme performance and 
functionality, although its disadvantage is relatively slow scan rates at 
sampling frequency of ≥ 1 Hz39,40. FTICR-MS is also known as the highest 
mass accuracy (< 1 ppm)39-41 and highest resolving power mass analyser (> 
106 FWHM at m/z 400)39-42.     
 In order to obtain certainty in the identity of investigated analytes and 
determining their elemental composition, the accurate mass measurement is 
required and can be achieved with some mass analysers such as ToF-MS 
and FTICR-MS. This can be calculated by using equation 2.1, which is 
usually quoted in parts per million (ppm). 
                
   ⁄                 ⁄           
   ⁄             
        Equation 2.1 
Accurate mass is largely depending on the stability and the resolving 
power (R) of the mass analyser. R represents the ability of a mass analyser 
to resolve two ion peaks with a small difference in their m/z value. This can 
be calculated using equation 2.2. All MS analysers described in this chapter 
use peak width definition. This definition is applicable for an isolated (single) 
peak, when ∆m is the full width at half maximum (FWHM) of the peak which 
is usually 50% (Figure 2.6).2,43 
  
  
  
                                                                                   Equation 2.2 
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Figure 2.6. Peak width definition for a single isolated peak. 
 
2.1.2.1. Quadrupole mass analyser (Q-MS) 
Multipole devices with an even number of poles form a quadrupolar 
field within the space between the poles, typically four (quadrupole), six 
(hexapole), or eight (octapole). Figure 2.7 gives an example with four poles, 
quadrupole MS (Q-MS),2,38,44-46 and demonstrates that the pairs of poles are 
acting as opposite pairs with applied positive potential for one pair +(U - Vcos 
ωt) and the negative potential -(U - Vcos ωt) for the other pair. They can be 
used as a mass analyser but with low resolution (peak width of 1 Da), and 
also as a focusing device (ion guide), or as a collision cell to perform tandem 
MS analysis.  
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Figure 2.7. Ions entrance in Z-axis direction and oscillation in X-Y plane in the 
quadrupole device, illustrate ions with a successive transmission (red sphere) and no 
transmission (yellow and purple spheres). Positive potential +(U - Vcos ωt) in X-Z 
plane and negative potential -(U - Vcos ωt) in Y-Z plane on each pair of the rod is also 
shown, where U/-U is the direct voltage or the magnitude of direct current (DC) 
potential, ω is the angular frequency (Hz) for radio frequency (RF), t is the time (s) and 
V is the amplitude of RF potential.  
 
Once the positive ions enter the device they will be attracted towards 
negative rods and if allowed to strike the rod, the ion will be discharged and 
the resulting neutral species lost. This would be the case at constant voltage 
but if the applied voltage on the rods rapidly changes polarity before the 
hitting process occurs then ions will change their direction. This creates a 
very high alternating field at the radio frequency (RF) and thus causes the 
ions to oscillate through the space between the Q rods. In the case of a fixed 
DC potential (U = 0) and applied RF (V) then all ions (all m/z) will be 
transmitted through Q at the same time making a convenient way to guide 
ions from one region to the next in a mass spectrometer. In such a case 
there will be no ion isolation or no MS spectrum and this is known as ion 
guide performance (Figure 2.8 A), while using both DC and RF together at a 
specific (DC/RF) ratio creates two regions for ions, a so called stable region 
for ions transmitting the device and reaching the detector (Figure 2.8 B and 
C) and an unstable region for non-transmitted ions and do not reach the 
detector (Figure 2.8 D). Scanning DC/RF at a constant ratio provides mass 
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separation for ions having a stable path (trajectory) in the Q space one at a 
time at a specific DC/RF ratio. 
 
 
Figure 2.8. Stability diagram for different ions with different masses (M1 < M2 < M3 < 
M4). Line A, represents transmission of all ions and no m/z separation this creates a 
quadrupole with ion guide performance; line B, poor resolution below optimum DC/RF 
ratio; line C, optimum resolution at optimum DC/RF ratio; line D, represents ions with 
unstable trajectory above optimum DC/RF ratio and no ion transmission.  
 
The mathematical equations which describe the motion of ions in the 
Q are given by a physicist Mathieu, as shown in Equation 2.3 and 2.4. 
   
     
          
                                                                   Equation 2.3 
   
     
        
                                                                    Equation 2.4 
In both equations, trapping parameters au and qu that are related to X-
axis and Y-axis are generated by application of both of DC voltage (U) and 
RF amplitude (V) on ions with mass (m) and charge (z) along the Q pathway. 
These ions travel along the Q without neutralize their charges when au and qu 
are less than the radius  of the Q (r˳), ω represents angular frequency and its 
value is constant by changing DC/RF ratio and e is the charge of an electron 
(1.6 x 10-19 C). 
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2.1.2.2. Linear ion trap mass analyser (LIT-MS) 
The two main types of ion trap are the linear ion trap (2D, LIT) and the 
Paul trap, also called a quadrupole ion trap (3D, QIT). They have similar 
principles of ion motion as described for Q devices.2,38,45-50 The LIT that is 
featured in LTQFT (ThermoFinnigan) and that is relevant to this project is 
called LTQ. It is composed of three sections; front and back sections 
(electrodes) are end-cap electrodes and the middle section is called the ring 
electrode, as shown in Figure 2.9. Each section has four rods (2 pairs) with 
opposite potential for each pair (see Figure 2.7). Ions enter the cavity of the 
LTQ through front section (Z-axis), and are spatially trapped by higher DC 
axial trapping voltage on end-cap electrodes relative to low DC voltage on 
the ring electrode. 
 
 
Figure 2.9. Linear ion trap (LTQ) as featured in the LTQFT (ThermoFinnigan). The three 
sections are described as front-, central- and back electrodes. Ions are delivered into 
the LTQ cavity on Z-axis and ejected through slits (exit electrodes) on X-axis towards 
detection system.   
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All trapped ions are stable and oscillate radially (X-Y plain) at low RF 
voltage, also known as main RF voltage or storage voltage. By applying a 
high alternating current (AC) voltage equal to the resonance frequency of 
trapped ions on exit rods (ramping main RF voltage) together with 0 DC 
voltage on end cap electrodes, the ions gain kinetic energy (Ekin) and their 
radial motion will be unstable. Consequently, ions are sequentially ejected in 
order of increasing mass towards the detector (X-axis) because higher mass 
ions have lower qx value (Equation 2.5), where k is the Boltzmann constant 
(1.38 x 10-23 m2 kg s-1 K-1), V is the RF voltage, e is the charge of an electron, 
and z and m are the number of charges and mass of the ion respectively. 
Separating ions in LTQ is directly related with the resonance frequency of the 
ions which is directly proportion to the ions m/z. 
    
 
  
  
   
                                                                       Equation 2.5 
The presence of helium gas within LTQ has a great advantage in 
improving LTQ performance in terms of mass resolution with peak width of 
0.1 Da and sensitivity and also its functionality in terms of performing tandem 
MS analysis. This gas acts as a damping gas to reduce Ekin of oscillated 
trapped ions through inelastic collision, and thus more ions can be 
accumulated. On the other hand, multiple collisions between isolated trapped 
ions with sufficient Ekin and helium atoms causes the ion to gain enough 
internal energy (Eint) to become collisionally activated. Such ions can then 
undergo unimolecular dissociation to give product ions. This is the basis of 
tandem MS by CID in an ion trap. Because the ions are spatially trapped, this 
stage can be repeated and thus achieve MSn (n ≥ 2, where n refers to the 
number of generations of ions being analysed). Both full scan MS and MSn in 
LTQ is recorded by ejecting trapped ions through slits on X-axis in the middle 
section or called exit rods to the ion detection system, which is commonly a 
conversion dynode detection system. 
In order to perform MSn analysis, an ion of interest will be isolated by 
increasing both DC and RF voltages to eject all trapped ions except the 
precursor ion. This is then excited by applying resonance excitation AC 
voltage on exit rods and followed by ejecting product ions by applying 
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resonance ejection AC voltage on exit rods. The limitation of LTQ during MSn 
analysis is due to the phenomenon that is known as low-mass-cut-off 
(LMCO) or one-third-cut-off, because product ions with qx less than 0.908 or 
product ions whose m/z are less than 1/3 of precursor ions are unstable 
(Figure 2.10) and cannot be detected by LTQ. The value of LMCO can be 
determined by activation q of precursor ion (Equation 2.6). 
          (
            
       
)                              Equation 2.6 
 
 
Figure 2.10. Stability diagram for trapped ions in LTQ device and illustrate ions with 
LMCO (beyond 0.908 q
x
). 
 
2.1.2.3. Fourier transform ion cyclotron resonance mass analyser 
(FTICR-MS) 
Fourier transform ion cyclotron resonance (FTICR) is another trapping 
device with the highest recorded resolving power and accurate mass 
measurement analyser (see section 2.1.2). This mass analyser can have a 
number of different shapes but the most common shape is segmented open 
end cylindrical shape, also called Penning trap, as shown in Figure 2.11.2,39-
42,51-59 The body of this analyser (ICR cell) is composed of a number of 
electrodes including; trapping electrodes are front and rear plates, excitation 
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electrodes and detection electrodes are around the centre of the cell. These 
electrodes work sequentially to provide a signal current (image/transient). 
 
 
Figure 2.11. FTICR segmented open ended cylindrical shape with the illustration of 
confined ions under the influence of magnetic field (B) and trapping potential.  
 
The cell is housed at the center of a strong and uniform (static) 
magnetic field (B), which is provided by a superconducting magnet. The 
strength of B varied between 3 Tesla to 21 Tesla59.39,42,53,54,56,58 Once a 
packet of ions has been injected to the ICR cell on Z-axis and parallel to B, 
they will be trapped by applying a trapping potential perpendicular to B. 
Consequently, spatially confined ions circulate (or precess) in the direction 
perpendicular on B by a motion known as cyclotron motion (ωc) on X-Y plane 
with small orbits and high frequency at 5 kHz-5 MHz. This is the dominant 
motion of trapped ions in ICR cell, however, the two other less desirable ions‘ 
motion can occur including; magnetron motion (ωm) on X-Y plane but with an 
orbit centered around circular orbit of cyclotron motion and smaller frequency 
at 1-100 Hz and as well as a trapping motion/axial oscillation (ωz) on Z-axis 
between trapping electrodes, as shown in Figure 2.12. These three motions 
of the packet of ions are generated by a combination of electric and magnetic 
fields to provide a complex three dimensional movement of ions. 
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Figure 2.12. Modes of ion motion within FTICR cell. (A) Cyclotron motion under the 
influence of magnetic field and free from electric field with the illustration of forces 
describing this ion motion; (B) A combination of cyclotron motion (blue), magnetron 
motion (green) and trapping motion (red) under the influence of both electric and 
magnetic fields. 
 
The overriding motion of ions (cyclotron motion) in the strong magnetic 
field can be described by balancing between two forces; Lorentz force (FL) 
which exerted on ions moving perpendicular to the magnetic field (Equation 
2.7) and centrifugal force (FC) which is exerted by ions motion (Equation 2.8), 
as shown in Equation 2.9. 
                                                                               Equation 2.7 
   
   
  
                                                                           Equation 2.8 
Balancing forces and equation rearrangement: 
    
   
  
              
 
 
 
  
  
                                          Equation 2.9 
Where, q is the ion‘s total charge (q = ze), z and m are the number of 
charges and ions mass respectively, ωc is the angular frequency of ions 
cyclotron motion, e is the charge of an electron, V is the velocity, B is the 
strength of the magnetic field and r is the radius of the ions orbit. The 
cyclotron frequency of ions (ƒc) is obtained by addition of an angular 
measurement (Equation 2.10). 
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                                                                Equation 2.10 
It is clear from Equation 2.10 that at constant B, ƒc is just dependent 
on the inverse m/z, and because the frequency of ions can be measured 
precisely, this offers unparalleled mass accuracy measurement by this 
analyser56. Further, ions ƒc has also the influence on providing the highest 
mass resolution performance. This is because ƒc value is independent on 
ions velocity and thus their kinetic enrgy.54-56 Equation 2.10 also shows that 
by increasing the strength of the magnetic field, ions ƒc also increases and 
thus increasing the mass accuracy and resolving power39,42,53-56 (Equation 
2.11), where R is the resolving power, ƒc is the cyclotron frequency and T is 
the duration of a transient54. In addition to the strength of the magnetic field 
and its homogeneity to achieve high performance FTICR mass analyser, high 
vacuum is also required. High vacuum in the range of 10-10-10-11 mbar in 
FTICR is essential in order to prevent collisions between trapped ions and 
neutral gas molecules and a subsequent effect on ƒc.
54,55 
  
   
 
                                                                      Equation 2.11 
Trapped ions have a very small orbit or radius of motion that must be 
enlarged in order to detect them. Applying an RF voltage on excitation plates 
causes increasing ions Ekin and a subsequent incur of ions radial motion 
away from the central axis in a circular path. This is evident when the 
frequency of RF field comes into resonance with the cyclotron frequency of 
the precessing ion packet. Ions of different m/z can be excited by applying a 
burst of RF voltage covering a range of frequencies. Following this excitation 
step, each packet of ions (a packet with the same m/z) pass close to the two 
opposite detection plates in turn and positive ions will draw electron to the 
plate (Figure 2.13). In this way packets of all ions with different m/z will be 
measured in one go. This produces a complex time domain spectrum which 
shows intensity as a function of time, which is then converted to frequency 
domain spectrum by using Fourier transform algorithm (FT) and by relating 
intensity as a function of frequency, and this followed by mass correction, 
gives the intensity as a function of m/z and the mass spectrum. It is 
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interesting to know that ion detection in FTICR is a non-destructive process 
and consequently the same packet of ion can also perform tandem MS 
experiments. 
 
 
Figure 2.13. Illustration of ion excitation (left) and ion detection (right) steps in FTICR 
cell.  
 
2.1.2.4. Time-of-flight mass analyser (ToF-MS) 
Time-of-flight (ToF) mass analyser2,60-64 is known for its very fast duty 
cycle, capable of collecting thousands of spectra per second, and relatively 
simple design. Basically, ToF requires a discrete packet of ions to enter a 
field free region and also called drift tube or flight tube. Ions will be 
accelerated from the ion source into a drift tube by applying potential 
difference (Vacc) between the accelerator plates (Figure 2.14). Consequently, 
ions in flight tube with mass (m) and velocity (V) will gain a Ekin, which is 
defined by Equation 2.12.  
     
 
 
                                                            Equation 2.12 
Where, ze represents total ion charge (q). The velocity of ions can be 
defined by the distance travelled (d) in time (t), Equation 2.13.   
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                                                                             Equation 2.13 
  Substituting Equation 2.13 in Equation 2.12 generates Equation 2.14. 
 
 
    ⁄                                                                  Equation 2.14 
Where, both d and Vacc are constant, this defines a direct proportion 
between m/z and time of flight (t), Equation 2.15. 
  ⁄                                                                              Equation 2.15 
This illustrates the detection of smaller ions first then followed by 
heavier ions carrying the same charge. The common detection device for 
ToF analyser is microchannel plate (MCP) with secondary electron multipliers 
(SEM). This basic principle of ToF analyser is applicable in both linear mode 
61-64 and reflectron mode 60. In linear mode ToF analyser, ions are detected at 
the end of a linear flight path (Figure 2.14 A) and this is more useful for larger 
ions (> 10 kDa) and with better sensitivity, while for smaller ions (< 10 kDa) 
and by using the same flight tube path with no change in its physical size, 
ions can be reflected by a series of electrodes (ion mirror) of increasing 
voltage (Figure 2.14 B). Consequently, in reflectron ToF ions will travel a 
further distance and a subsequent spectrum provide peaks that are spaced 
further apart along the m/z axis and consequently better mass resolution. In 
addition, the focusing effect of the reflectron ToF enhances the sensitivity of 
this MS analyser.  
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Figure 2.14. Schematic illustration of (A) linear ToF-MS and (B) reflectron ToF-MS. 
 
The characteristic feature of the formation of discrete packet of ions in 
MALDI-MS and the frequency at which the ion packets are produced by the 
laser beam makes this source fit perfectly with ToF analysers in both linear 
and reflectron modes to produce ions axially to the flight tube, while ESI 
features the formation of a continuous flow of ions. This problem has been 
resolved by introducing the ion beam perpendicular to the axis of ToF by 
using an electric gate and the concept of orthogonal acceleration (oa), in 
which ions are orthogonally entering the flight tube,2,62-64 as shown in Figure 
2.15. Consequently, ions are kicked 90˚ angle sideways and a subsequent 
formation of nice packet of ions. This is applicable in linear ToF and as well 
as reflectron ToF.  
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Figure 2.15. Schematic description of reflectron ToF-MS fitted with an orthogonal 
acceleration aperture (oa ToF). 
 
2.1.3. Tandem mass spectrometry of peptides and proteins 
Fragmentation in mass spectrometry starts by isolating specific ions 
and a subsequent bond dissociation by increasing ions internal energy. This 
is evident in formation of product ions which are charged and MS detected, 
as well as neutral fragments which are uncharged products and therefore not 
detected. Protein/peptide backbone cleavage by tandem MS enables the 
peptide or protein amino acid sequence to be determined. This can be done 
in two ways: the common ―bottom up‖ approach and the less common ―top 
down‖ approach.65-68 The bottom up approach for proteins includes the 
formation of a set of daughter peptides through proteolytic digestion. The 
mass of these product peptides is used as a ‗fingerprint‘ to define the identity 
of original protein through database searches or comparison with an in silico 
digest.66,67,69 In addition, performing tandem MS experiment on one or more 
digested peptides confirms a high degree of the amino acid sequence and as 
well as its advantage in localising peptide modifications. This can also be 
achieved by top down approach, which involves protein sequencing through 
tandem MS experiment directly from the intact protein under 
investigation.65,66,68,69 However, top down method is a more rapid method of 
protein sequencing because there is no need to do a time consuming 
digestion process and/or protein purification.  
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 In the field of proteomics, the cleavage of peptide/protein backbone 
creates product ions labelled as x, y, and z for charge retain on the C-
terminal of the peptide, while a, b, and c labels represent charge retain on the 
N-terminal of the peptide (Figure 2.16).2,18-21,70,71 The mass difference 
between consecutive product ions for the same series of ions such as bn and 
bn-1 provide amino acid sequence calculation for the peptide precursor ion. 
The product ions nomenclature of peptides was first described by Roepstorff 
and Fohlmann in 198470,72 and later developed by Biemann in 198871,72.  
 
 
Figure 2.16. Illustration of common cleavage sites of peptide backbone. The 
corresponding fragmentation products are highlighted in pink, green and blue for a/x-, 
b/y- and c/z-ions respectively.   
  
Fragmentation process is influenced by several factors such as amino 
acid composition, peptide size, excitation method, time scale of the used 
instrument and charge state of the ion.69,72 The common fragmentation 
techniques in the field of proteomics involve; collision induced dissociation 
(CID), electron capture dissociation (ECD) and electron transfer dissociation 
(ETD).65-69,72-77 For peptides, the weakest bond is the peptide linkage (CO-
NH) which when broken generates a series of b- and y-ions through CID 
mechanism, while ECD and ETD generates c- and z-ions through (N-Cα) 
bond dissociation.72,73,76 
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Different fragmentation techniques have different dissociation 
mechanisms and so provide complementary product ions and consequently 
different MS spectra and structural information. In ECD,65-68,73-77 low energy 
electrons (< 1 eV)67,68,76 interact with multiply protonated peptides/proteins 
and subsequently capture an electron through a very rapid process (< 10-12 
s)65 to form a reduced intermediate of cation radical [M + nH](n-1)+•. This 
intermediate is electronically excited and thus unstable; ultimately undergoing 
bond dissociation through (N-Cα) bond. The similar mechanism is described 
for ETD,68,73,75-77 but here the electron is supplied by radical anion rather than 
using free electrons.68,72,75-77 ECD is mainly implemented on FTICR-MS,66-
68,73-76 while ETD is more applicable in ion trap mass spectrometers68,72,73,75 
and further developed to be used in QToF-MS75. Both fragmentation 
techniques (ECD/ETD) are more powerful for larger proteins with high degree 
of charges (z > 2)67,72 and thus valuable in top down approach.65 They also 
provide higher sequence coverage68,72,73 and also localise and identify PTMs 
that can be missed by CID such as phosphorylation and 
glycosylation.67,68,72,73,74,76 This is because a covalent bond between these 
modified groups and the peptide side chains are sufficiently weak and 
cleaved by CID, while these weak bonds are preserved by ECD/ETD.68,73 
ECD has also the ability to cleave protein disulphide bonds.67 However, CID 
is the more common and robust fragmentation technique in the proteomics 
which can be associated with most mass spectrometers and to provide up to 
100%65 sequence coverage.72,75-77 In this chapter the focus will be on 
describing the basic principle of CID technique, because of its relevance to 
the research carried out in this project. 
 
2.1.3.1. Collision induced dissociation (CID) 
Collision induced dissociation (CID),67,72-79 also called collision 
activation dissociation (CAD) can be performed through two energy 
pathways: low energy CID (1-100 eV), which is commonly found in Q-MS and 
LIT-MS and high energy CID of several keV, which is seen in ToF-MS and 
sector instruments79.2,16,17,72,78-80 High energy CID has contribution from 
electronic processes as well as vibrational process to produce a-, x- and 
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immonium ions.2,72,78-80 It does not permit peptide rearrangement after the 
loss of a fragment because it is a very fast process and thus less than 10 
collisions will occur in this process. This type of CID is very useful in 
distinguishing between isobaric amino acid residues such as leucine and 
isoleucine and as well as reproducible fragmentation pattern.72 The ability of 
high energy CID to differentiate between leucine and isoleucine is due to side 
chain cleavage and the formation of additional product ions that termed as d- 
and w-ions. On the other hand, low energy CID is a vibrational excitation 
process with the predominant formation of b- and y-ions.2,72,78-80 This will be 
discussed in detail because of its relevance to the research carried out in this 
project. 
In low energy CID the dissociation process is performed in a slower 
time scale (around ms) that permits peptide rearrangement and multiple 
collisions (up to 100).72 The basic principle of low energy CID can be 
explained in two major steps. First, the targeted precursor ion (Mp) with high 
translational energy collides with a neutral gas (N) through inelastic 
collisions, typically argon or nitrogen, and energy transfer results in 
increasing the internal energy of the ion (Equations 2.16). Second 
(Equations 2.17), the internal energy of this vibrational excited state (Mp
+*, 
intermediate state) is distributed over all available covalent bonds. Such step 
leads the cleavage of the more labile bond (CO-NH), and unimolecular 
dissociation results to give a product ion (mb
+). Generally, first step is faster 
than the second step for fast moving ions. Dissociation process in CID can 
be explained mathematically by Equation 2.18.  
Mp
+  + N                Mp
+ * + N                                        Equation 2.16 
Mp
+*                      mb
+  +  mc                                              Equation 2.17 
   
 
    
                                                                      Equation 2.18 
Where E is the total available energy for the transfer of kinetic energy 
(Ekin) of the precursor ion to internal energy (Eint), Mp and N are the masses of 
precursor ion and collision neutral gas respectively.78,79 Interestingly, the 
quasi-equilibrium theory (QET) is commonly used to describe unimolecular 
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dissociation of gas phase ions under high vacuum. There are several factors 
affecting the efficiency of CID, some are related with the nature and size of 
the neutral gas78,79 and the others related with the nature (number of 
charges)81 and size82 of the precursor ion. In addition, the high pressure of 
the neutral collision gas has also influence on increasing multiple collisions 
for a single ion with the neutral gas and also the number of ions that are 
performing collisions.78,79      
 
2.2. Ion mobility separation (IMS) 
Ion mobility (IM) is an analytical tool that separates ions in the gas 
phase depending on their shape and size. Consequently, it can be possible 
to separate ions of the same m/z such as isomers, isobars and conformers. 
This technique was originally known as plasma chromatography and ion 
chromatography.83-85 It was first used to analyse volatile organic compounds 
and also to investigate the electronic structure of ions, and found wide 
application in the fields of military for monitoring chemical and biological 
weapons and explosives; security for the detection of explosives and more 
recently illegal drugs.85-87 A profound advantage of IMS in the field of 
biomolecules to analyse peptides/proteins87-90 and more recently in 
lipidomics91-93 is introduced from coupling IMS with MS to provide both 
structural (ion conformation) and m/z characteristics for an analyte. This has 
been commercially available in one instrument in the last 10 years.  
The simplest and oldest IMS technique is called drift time ion mobility 
spectrometry (DTIMS),85,87,94 Figure 2.17 A, which allows the calculation of 
ions collision cross-section (CCS or Ω) based on the recorded drift time (td) in 
the drift tube under static uniform electric field (5-100 V). Ions with extended 
structure have stronger interaction/collision with the buffer gas (high CCS) 
thus slow down them in the drift tube, while compact structures are travelling 
faster and with smaller CCS.94 Travelling wave ion mobility spectrometry 
(TWIMS)85,87,94 is another type of drift time IMS, Figure 2.17 B, which is 
featured in Synapt G2-s instrument and the relevant one for this project. This 
type of IMS is similar to DTIMS in measuring CCS for ions as a function of td 
but by applying an electrodynamic voltage instead of static electric field. This 
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is composed of a stacked ring ion guide (SRIG) to which a travelling voltage 
wave is applied. Ions are confined radially by the application of opposite RF 
voltage to adjacent electrodes. On the other hand, the application of pulsed 
DC voltage to each electrode in succession from one end to the other causes 
axial propel of the ions. The voltage will be stepped through the device and 
this creates travelling wave by which ions will be travelled. Field-asymmetric 
ion mobility spectrometry (FAIMS)85,87,94 or differential ion mobility 
spectrometry (DMS) is another type of IMS but with different separation 
principle from time based IMS devices (DTIMS and TWIMS). This device 
cannot be used to calculate CCS and is preferentially performing an ion filter 
process similar to quadruple mass filter.94      
 
 
Figure 2.17. Schematic illustration for comparison between (A) drift time ion mobility 
spectrometry (DTIMS) and (B) travelling wave ion mobility spectrometry (TWIMS).  
 
The basic principle of separation in IMS technique starts by injecting 
pre-formed gas phase ions from the ionisation source into a separation cell or 
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called drift tube that is filled with neutral buffer gas (usually helium) and 
operated under weak electric field (gradient). Consequently, ions under this 
condition will have a drift velocity (Vd, cm
2 s-1) which is directly proportion with 
the ion mobility (K, cm2 s-1 v-1) and the applied electric field (E, v cm-1),83-85,87 
as shown in Equation 2.19. 
                                                                              Equation 2.19 
Drift velocity (Vd) can be calculated by the time (td, s) taken for the ion 
to travel through the drift tube at distance (d, cm), as shown in Equation 2.20. 
      
 
  
                                                                  Equation 2.20 
The drift time (td) of ions is related to the effective area for the 
interaction between a single ion and the buffer gas, which is known as 
averaged cross-section area or collision cross-section (CCS or Ω, A2). This is 
calculated by Mason-Schamp equation (Equation 2.21). 
  
 
  
  
 
 
  
    
 
 
  
 
 
                                                          Equation 2.21 
This equation illustrates the dependent of CCS on ions charge (q = 
ze), the number density of buffer gas (N), the reduced mass of the complex 
product ion-buffer gas (𝝁), the absolute gas temperature (T) and the ion 
mobility (K). For macro molecules the value of 𝝁 can be regarded as a 
constant parameter because it approaches the mass of buffer gas,84 as 𝝁 = 
mM/(m+M), m and M are the masses of the buffer gas and the ion 
respectively. Consequently, the mobility constant (K) of the ions inversely 
proportion with CCS, Equation 2.22. The prediction of ions structure can be 
explained by comparing practical CCS to the theoretical CCS values for 
computer provided structure. 
    
 
 
                                                                              Equation 2.22 
Mobility separation of ions can be achieved by changing the speed 
and magnitude of the travelling wave voltage. Less collisions between 
smaller size ions and the buffer gas speed them to travel by the wave (small 
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CCS) relative to slower mobility of larger ions by experiencing greater 
collision (high CCS). Consequently, travelling wave voltage separates ions 
with different size through the device. On the other hand, separation of 
complex mixture can also be performed by using several travelling waves 
through the IMS cell in quick succession.94  
 
2.3. Schematic for applied instruments 
2.3.1. LTQFT  
All the results described in chapter three and some in chapter four 
were carried out on LTQFT (ThermoFinnigan Corporation) mass 
spectrometer equipped with Surveyor HPLC (ThermoFisher Scientific Inc.) as 
shown in Figure 2.18. Surveyor HPLC has quaternary pumps. 
 
 
Figure 2.18. The LTQFT (ThermoFinnigan) instrument schematic. 
 
The analyte mixture is first separated by HPLC as a function of 
hydrophobic affinity with an alkylsilica-based sorbent stationary phase. These 
separated species were passed through an Ion-Max ion source fitted with an 
ESI probe95. Ions were then guided through the instrument by an octapole 
and into the LIT. The LIT can operate as a stand-alone tandem mass 
spectrometer (and give the name LTQ by the manufacturers, 
ThermoFinnigan) to produce product ions through collision with helium gas 
by using CID principle, which are then detected either by using ICR cell or by 
using a conversion dynode58. 
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It is possible to pass the ion beam out the back of the LTQ and using 
quadrupole ion guides to move the ions into an FTICR cell. Accurate (1-2 
ppm) and high resolution (100,000 FWHM at m/z 400) data were processed 
on FTICR for precursor ion analysis in full MS mode and with acquiring mass 
range of 200-2000 m/z. The cylindrical ICR cell (Penning trap) is built in the 
center of an actively shielded superconducting magnet with field strength of 7 
Tesla, where ions are trapped, excited, ejected and detected sequentially to 
yield a transient current and a subsequent conversion to MS spectrum by FT 
system. Generally, the gradient vacuum system in LTQFT can be separated 
into three main regions: forevacuum (3.5 ᵡ 10-3 mbar); transfer area (3.0 ᵡ10-7 
mbar); ICR area (2.0 ᵡ 10-9 mbar).  
The detection process by using a conversion dynode device is 
happening by striking an ion to the surface of a concave metal which has an 
opposite potential from the striking ions, as shown in Figure 2.19. This yields 
more than one secondary particles, which are negative ions and electrons for 
positively charged striking ions. Subsequently, they are focused and 
accelerated towards electron multiplier by a voltage gradient. Striking the 
secondary particles to the inner walls of the electron multiplier cathode with 
sufficient energy will eject electrons. Ejected electrons in the funnel shape 
cathode lead to multiple collisions and emit more electrons before they are 
collected by anode. This formation of a cascade of electrons enables a 
measurable current at the end of cathode. This current then collected by 
anode which is proportional to the number of secondary particles striking the 
cathode.50  
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Figure 2.19. The conversion dynode detector, secondary electron multiplier (SEM) 
equipped with LTQ analyser. 
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2.3.2. Autoflex II ToF/ToF 
Autoflex II is a MALDI-ToF mass spectrometer (Bruker Daltonik 
GmbH) that performs at high vacuum pressure of about 8 ᵡ 10-7 mbar96 
(Figure 2.20).  
 
 
Figure 2.20. Schematic of Autoflex II ToF/ToF mass spectrometer (Bruker Daltonik 
GmbH). MALDI source and microchannel plate (MCP) detector are also enlarged and 
included.
96
 
 
MALDI ion source has a target plate on X-Y coordinates where 
analyte:matrix mixture is dried out. Following plate insertion, a positive or 
negative potential will be applied to the target (P1) at equal amount to the 
applied potential on the electrode (P2) at the beginning. Analyte:matrix 
mixture is then irradiated by a pulsed nitrogen laser at 337 nm to create 
ionised analyte with a typical initial velocity of 700 m/s from P1 o P2 (both are 
at equal potential). Consequently, ions with the same m/z have different 
velocity and kinetic energy (Ekin). This velocity distribution would act to 
decrease ToF-MS resolution and so Wiley-McClaren focusing in the ion 
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source, otherwise known as pulsed ion extraction (PIE), is used to correct 
this aberration and enhances both resolution and sensitivity on ToF analyser. 
PIE technique based on slopping the potential on P2 electrode from initial 
20 kV to 18 kV, which creates a potential difference between P1 and P2. Ions 
with the same m/z and different velocity and Ekin in this region influenced 
differently by this potential difference depending on their position, whether 
they are close to P1 (slower ions) or closer to P2 (faster ions). Generally, 
slower ions start on a greater potential difference than the fast ones and so 
have greater acceleration into the field free region (drift tube) relative to the 
initial faster ions in the source. Consequently, the arrival time at the detector 
is identical for ions with the same m/z and independent on their initial Ekin. 
Ions enter the ToF analyser in pulses where they are separated, and 
subsequently detected by a microchannel plate (MCP) detector containing 
secondary electron multiplier (SEM) in either linear mode or reflectron mode. 
This detector uses the same basic principle of amplifying the signal from the 
single particle (ion current) by generating a cascade of electrons (electrical 
current) as described for LTQ detector (See section 2.3.1) but instead of 
using a concave metal surface it uses MCP with millions of tiny channel, 
which are coated inside with a semi-conductive layer.96      
 
2.3.3. Synapt G2-s  
Synapt G2-s mass spectrometer (Waters Corporation) is equipped with 
ACQUITY ultra performance liquid chromatography (UPLCTM) I class (Figure 
2.21). UPLC system involves a binary solvent manager, sample manager 
and the detector. The separation system has better efficiency, resolution, 
sensitivity and speed of analysis than HPLC counterpart. This is because of 
the solid stationary phase specification of uses very small particles at sub 2 
micron, which can operate at very high pressures, up to 15,000 psi. However, 
UPLC does not have quaternary pumps as featured in Surveyor HPLC 
(ThermoFisher). 
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Figure 2.21. Schematic of online coupling between UPLC and Synapt G2-s instrument 
(Waters Corporation). Reproduced with the permission from Waters Corporation.  
 
Following chromatographic separation, the analyte is delivered to the 
ionisation source, which can be different interchangeable sources such as 
ESI, MALDI, ASAP, and ESCI. ESI source has been used for all work 
described herein. ESI probe has nebuliser gas, desolvation gas flow and the 
desolvation temperature. In addition, LockSpray was employed to provide 
mass correction by systematically introducing a reference compound with 
known mass. Subsequently, gas phase ions reach a StepWave transfer 
optics which is a form of a travelling wave ion guide and called StepWave ion 
guide, where all ions are focused and transferred to the next stage of a 
narrow bore ion guide. The off-axis design of the StepWave ion guide 
removes any neutral species entering the system. The focused ions then 
enter the quadrupole device (Q-MS), where they are separated (filtered) 
according to their m/z and then delivering ions into TriWave region.97  
TriWave region consists of three T-Wave ion guides with different 
distinct functions. The first and third T-Wave guides are called trap and 
transfer regions respectively. Their function is either delivering ions from 
earlier stage towards the next stage for full MS scan or they can be used as a 
collision cells to perform tandem MS analysis (via CID or ETD). The middle 
T-Wave ion guide is where the ion mobility separation (IMS) takes place. 
Subsequently, ions transferred to orthogonal acceleration ToF (oa ToF) with 
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dual-stage reflectron geometry, where the ions orthogonally accelerated 
down the flight tube by a high voltage pulse. The dual-stage reflectron 
reflects ions towards the mirror and this in turn reflects them back to the dual-
stage reflectron, where they will be finally reflected to the detector. Ions of 
different m/z arrives the detector (MCP, described in section 2.3.2) at different 
times, where they are amplified and digitized to create a mass spectrum. 
Three modes can be operated in oaToF-MS including; sensitivity, resolution 
and high resolution.97 
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Chapter three: Understanding the role of 
lysophosphatidylcholine (LPC) and 
diacylphosphatidylcholine (PC) in the lipidation of 
melittin  
 
 
 
Mimicking natural membranes provides a feasible way to study 
protein/peptide-membrane interactions. This in vitro interaction has been well 
documented by monitoring non-enzymatic fatty acyl transfer from liposomal 
diacylphospholipids to the N-terminus and the side chains of internal lysine of 
the membrane active peptide melittin.1-3 Lysophospholipid, however, is a by-
product in melittin lipidation and this study seeks to understand whether 
melittin could undergo fatty acylation from these monoacylphospholipids. 
Since both diacyl- and monoacylphospholipids (lysophospholipids) share 
ester-linked fatty acyl chains, it is hypothesised that both lipid classes could 
follow identical lipidation mechanisms. LC-MS has been used to study the 
reactions between melittin and diacylphospholipid and/or lysophospholipid. 
The results of this reaction has shown that (i) single and multiple acyl chains 
transfer in a non-enzymatic process; (ii) single acyl transfer is much faster 
than the second and third acyl transfer; (iii) transfer from lysophospholipid is 
relatively faster than diacylphospholipid; (iv) there is a competition between 
N-terminus vs K23 site of acylation and palmitoylation vs oleoylation 
modification. 
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3.1. Phase behaviour of the lipid systems studied 
Different phase behavior and the molecular shape of the lipids will 
have an effect upon their dispersion in the aqueous phase, this depends on 
several factors such as their molecular geometry and the way that multiple 
lipid molecules organize themselves (see chapter one, section 1.3.1.1.1 for 
more details). Lysophosphatidylcholines (LPC) self-assemble into micelles 
above the critical micelle concentration (CMC),4-8 while 
diacylphosphatidylcholines (PC) adopt lipid-bilayer phase5,7 (see Table 1.4, 
for the calculated CMC for each lysophospholipid (LPL)).  
Results reported by Van Echteld et al. from NMR studies5,9 suggest 
three distinct types of phase behavior occur for lipids upon the addition of 
PPC and/or OPC to each of DPPC and DOPC. This includes bilayer, micelle 
and mixed micelle-bilayer (Table 3.1). Similar results were also presented by 
Pantusa et al. from electron spin resonance (ESR) and spectrophotometric 
measurements.10 It is interesting to see that the influence of LPC 
incorporation into the membrane on the phase behavior lipid is mainly related 
to the type and amount added as well as the type of PC and the phase 
state.11-15 To follow acyl transfer from free LPCs, and upon their mixing with 
PCs to melittin, different lipid systems at different ratios were applied, as 
shown in Table 3.2. Based on the results provided in Table 3.1, the expected 
phase behavior of the different lipid systems applied in this study (Table 3.2) 
will be described as follows at 25 °Ϲ: micelle system (red); liposomal lipid-
bilayer (membrane) phase (green); a new system of mixed micelle-bilayer 
(blue).  
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Table 3.1. The phase behaviours in different lipid systems created with data obtained 
by NMR spectroscopy (Van Echteld et al.)
5
. 
Lipid System 
Composition 
Lipid System Phase Behaviour Temperature* (°C) 
PPC + DOPC 
100% bilayer (0%  micelle) at up to 35 mole% PPC 
Independent on 
temperature change 
≈ 50% bilayer (mixed micelle-bilayer) at 50 mole% PPC  
0% bilayer (100%  micelle) above 50 mole% PPC 
OPC + DOPC 
100% bilayer (0%  micelle) at 0 mole% OPC 
≈ 65-80% bilayer up to 40 mole% OPC 
≈ 100% bilayer at  50 mole% OPC  
0% bilayer (100%  micelle) at or above 75 mole% OPC 
PPC + DPPC 
100% bilayer (0%  micelle) at up to 60 mole% PPC 
25 (< Tm)  ≈ (75% bilayer -0% bilayer) above 60 mole% PPC  
0% bilayer (100%  micelle) at 100 mole% PPC 
100% bilayer (0%  micelle) at up to 25 mole% PPC 
45 (> Tm)  ≈ (70% bilayer-10% bilayer) from 35- 50 mole% PPC  
0% bilayer (100%  micelle) above 50 mole% PPC 
OPC + DPPC 
100% bilayer (0%  micelle) at 0 mole% OPC 
25 (< Tm)  ≈ (70% -10% bilayer) at up to 20 mole% OPC  
0% bilayer (100%  micelle) above 25 mole% OPC 
100% bilayer (0%  micelle) at 0 mole% OPC 
45 (> Tm)  
≈ 50% bilayer (mixed micelle-bilayer) at 25-30 mole% OPC  
100% bilayer at 50 mole% OPC 
0% bilayer (100%  micelle) above 50 mole% OPC 
*Phase transition temperature (Tm) is -16.5 °C and 41.3 °C for DOPC16,17 and DPPC18-20 
respectively. 
 
Table 3.2. The mole ratio for each lipid mixed with melittin in the reaction medium. The 
lipid abbreviations include 1,2-dioleoyl-phosphatidylcholine (DOPC), 1,2-dipalmitoyl-
phosphatidylcholine (DPPC), 1-oleoyl-2-hydroxy-phosphatidylcholine (OPC) and 1-
palmitoyl-2-hydroxyl-phosphatidylcholine (PPC). Highlighted columns in red indicate 
micelle system; green for membrane phase; blue for mixed micelle-bilayer system.    
Lipid System PPC:OPC DOPC DPPC 
DOPC:PPC 
 
DPPC:OPC 
 
%Lipid  
50:50 
100 100 
25:75 25:75 
50:50 50:50 
100:0 or 0:100 
75:25 75:25 
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3.2. Reaction of melittin with lysophospholipids 
The proposed mechanism for the aminolysis of ester-linked fatty acyl 
is shown in Figure 3.1. The reaction shows the formation of acyl-melittin as a 
main product, leaving the phosphatidylcholine moiety (glycerol-PC) as a by-
product. The incubated reaction mixture was separated by reverse phase LC 
and followed by MS analysis.  
 
 
Figure 3.1. Melittin aminolysis reaction with the sn-1 glyceryl ester of the LPC.  
 
3.2.1. Reaction of synthetic melittin (SynM) with 
oleoylphosphatidylcholine (OPC) 
The analysis of lipidation products following the incubation of SynM 
with 100% OPC for 24 h is shown in Figure 3.2. The incubations were done 
at a concentration of 0.65 mM for OPC, which is well above critical micelle 
concentration (CMC) (see Table 1.4 for LPLs CMC values). SynM with single 
oleoylation (SynMole) is clearly visible within the RT range 8.0-10.0 min. The 
longer retention of SynMole compared to un-reacted SynM highlights their 
increasing hydrophobicity. The extracted ion chromatogram for [SynMole + 
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4H]4+ at m/z 778.51 shows there are multiple co-eluting peaks around this RT 
(Figure 3.2 A), resulting from oleoyl modification of different amino acid (AA) 
residues: N-terminal amine and the three lysine with different reactivities.1-3 
The two most reactive sites were recorded as N-terminus and K23.2,3 This is 
also proposed herein indirectly through LC-MS by observing some diagnostic 
in-source product ions around this RT, and instantly informative without the 
need for MS2 analysis. Although, the instrument source conditions has been 
optimized in order to minimize in-source fragmentation. 
The first eluted peak around 8.7 min (Figure 3.2 A, peak (i)) suggests 
K23 oleoylation due to the presence of some y-ion dissociations that still 
reside oleoyl modification in the C-terminal portion of the peptide at m/z 
735.73 [y24ole + 4H]
4+ and 944.12 [y13ole + 2H]
2. These labile sites of the 
peptide backbone are the key points to assess which half of the peptide that 
resides the modification. The cleavage sites of melittin that correspond to b- 
and y-ions are shown in Figure 3.3.  In addition, the in-source dissociation of 
SynMole with the same cleavage sites were also observed around 8.9 min 
(Figure 3.2 A, peak (ii)), but at m/z 669.66 [y24 + 4H]4+ and 812.00 [y13 + 
2H]2+, correspond to the unmodified C-terminal portion and thus N-terminus 
oleoylation. It is interesting to know that the exact elution time for the in-
source product ions and the intact ions of SynMole excludes the possibility of 
the presence of in-solution dissociated peptides. In addition, there are two 
peaks at RT 11.3 and 11.5 min respectively, both corresponding to [M + H]+ 
of OPC and reflect the acyl group mobility between sn-1 and sn-2 positions of 
the LPC in a solution.2  
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Figure 3.2. Total ion chromatogram (TIC) for SynM/OPC incubated for 24 h at 37 °Ϲ, 
analysed on the LTQFT using LC-MS Method-II (see section 8.1.2.1.1). The inserted 
panel (A), is the extracted ion chromatogram (EIC) of m/z 778.51 (z=4) for single 
oleoylation (C18:1) product SynMole, different acylation sites were labelled as A(i) and 
A(ii). The organic impurities are indicated (black dots) 
 
 
Figure 3.3. The product ions nomenclature for melittin during amide bond cleavage of 
the peptide to yield b- and y-ions. 
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The mass spectra showing the different charge states (z=3-5) for 
SynMole, and the deconvoluted spectrum are given in Figure 3.4.  
 
 
Figure 3.4. (A) Mass spectra showing the different charge states (z=3-5) for SynMole; 
(B) deconvoluted mass spectrum showing [M + H]
+
.  
 
The sample incubation was performed for a range of different periods 
of time and each followed by LC-MS analysis. Interestingly, SynMole was not 
the only observed acylation product, but over longer incubation times the 
transfer of the second oleoyl (SynM2ole) and third oleoyl (SynM3ole) products 
were also detected. This is evident in SynM/OPC incubation over 168 h, as 
shown in Figure 3.5. This clearly shows the formation of SynMole first, 
followed by SynM2ole and then SynM3ole modifications. Moreover, at RT 9.5-
11.5 min, albeit eluting very close to the LPC, there is clear evidence for 
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double oleoylation (Figure 3.5 B, EIC of [M + 4H]4+ at m/z 844.82) and RT 
17.8-19.0 min illustrates the transfer of a third oleoyl group to SynM (Figure 
3.5 C, EIC of [M + 4H]
4+ at m/z 910.88). It is interesting to see that even 
greater hydrophobicity by adding the second and third acyl chains is 
consistent with increasing the RT for SynM2ole and SynM3ole over 11 min and 
18 min respectively. In addition, a peak at RT 17.0-18.5 min (Figure 3.5 B, 
EIC of [M + 4H]4+ at m/z 844.82) corresponds to SynM2ole. While retention 
time is consistent with the elution of SynM3ole, the observed m/z value 
indicates in-source dissociation of the triple oleoylation species is occurring. 
The third oleoyl modification is clearly very labile and therefore lost, and this 
is most likely related to the location of the modification or the tertiary structure 
of the triple modified peptide. Further, the multiple co-eluting peaks are still 
indicative of different nucleophilic reactivity on SynM towards ester-linked 
fatty acyl, as reported in previous study1-3.  
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Figure 3.5. The main chromatogram represents TIC for SynM/OPC incubated for 168 h 
at 37 °Ϲ, analysed on the LTQFT using LC-MS Method-II (see section 8.1.2.1.1). The 
insert panels are the EIC of (A) m/z 778.51 (z=4) for SynMole; (B) m/z 844.82 (z=4) for 
SynM2ole and labile SynM3ole; (C) m/z 910.88 (z=4) for SynM3ole. Single acylation sites 
labelled as A(i) for K23 site of oleoylation and A(ii) for N-terminus oleoylation. The 
organic impurities are indicated (black dots). 
 
All the modifications on SynM, single-, double-, and triple oleoylation, 
were observed as different charge states. The strongest abundant charge 
state for all species is for z=4, Figure 3.6 top (A-D); the corresponding 
deconvoluted spectra, deconvoluted to the protonated species are shown in 
Figure 3.6 bottom (A-D). The labile site of the peptide backbone is again 
recorded by observing y13ole and y24ole in-source product ions (see Figure 
3.3), indicative of K23 oleoylation (Figure 3.6 top A). These product ions were 
significantly found over 8.6 min for peak (i), Figure 3.5 A(i), which is the most 
abundant peak for SynMole. However, y13 and y24 in-source product ions 
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that show N-terminus oleoylation were confirmed as abundant ions over 8.9 
min for peak (ii), Figure 3.5 A(ii).  
Calculating the area under the peak for each of proposed oleoylated 
sites K23 and N-terminus showed that the order of reactivity is K23 > N-
terminus by the ratio of 1.5:1, for contributing OPC in the acylation process. 
While this reactivity was shown to be in the order of N-terminus > K23, for the 
contribution of liposomal PC lipids.2,3 This suggests OP’s greater reactivity 
towards K23. However, the effect of co-eluting chromatographic peaks for 
melittin oleoylation on different sites and the peak tailing make the precise 
quantification analysis hard to follow. Further, the presence of SynMole in 
sufficient abundance that when it fragments along the peptide backbone 
there are enough product ions to detect, while for SynM2ole and SynM3ole it is 
suspected that there are not enough product ions to detect. 
 
 
Figure 3.6. Analysis of SynM/OPC incubation over 168 h at 37 °Ϲ. (A) Results for 
SynMole around RT 8.6 min, (top) mass spectrum and (bottom) deconvoluted to [M + 
H]
+
. (B) Results for SynM2ole around RT 11.1 min, (top) mass spectrum and (bottom) 
deconvoluted to [M + H]
+
. (C) Results for labile SynM3ole around RT 17.8 min, (top) 
mass spectrum and (bottom) deconvoluted to [M + H]
+
. (D) Results for SynM3ole around 
RT 18.2 min, (top) mass spectrum and (bottom) deconvoluted to [M + H]
+
. 
 
The time dependence of acyl transfer is shown in Figure 3.7. The 
results show a continuous decrease in the amount of SynM throughout the 
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acylation process, while a rapid increase in the rate of single acylation is 
evident up to 48 h incubation then slows down and starts to decrease 
afterwards. This decrease in oleoylation is consistent with the addition of the 
second and third oleoyl fatty acyl chains to the peptide at the later incubation 
time. Overall, these data provide the first reported evidence of melittin 
lipidation (single and multiple) by LPC via non-enzymatic acyl transfer 
mechanism.  
 
 
Figure 3.7. The relationship between the peak area (A) for non-acylated SynM and 
acylated SynM with the incubation time in the OPC micelle system. Errors are plotted 
as the standard error of mean (SEM) of normalised peak area (n=2). The normalisation 
of SynMole peak area was performed as follows: %SynMole = peak area SynMole/total 
peak area of (SynM + SynMole + SynM2ole + SynM3ole) × 100, the same calculation was 
also applied for the other species. Peak areas were measured from EIC over all 
observed charge states at each point of the incubation. 
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3.2.2. Reaction of SynM with palmitoylphosphatidylcholine (PPC) 
The transfer of palmitoyl fatty acyl from PPC to SynM was also 
examined over different incubation times (Figure 3.8). It is interesting to see 
that by using PPC the addition of the second and third acyl chains are very 
slow even over 168 h. Consequently, the amount of SynMpal is steadily 
increasing over time rather than decreasing as was evident for SynM/OPC 
system (see Figure 3.7).  
 
 
Figure 3.8. The relationship between the peak area (A) for non-acylated SynM and 
acylated SynM with the incubation time in the PPC micelle system. Errors are plotted 
as the standard error of mean (SEM) of normalised peak area (n=2). Peak areas were 
measured from EIC over all observed charge states at each point of the incubation. 
The normalisation of peak areas were performed in the same way as described in 
Figure 3.7. 
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The observation of significant palmitoyl transfer following SynM/PPC 
incubation for 168 h the LC-MS analyses focused on samples obtained under 
these conditions. As with SynM/OPC, there are multiple co-eluting peaks 
observed for SynMpal (Figure 3.9 A, EIC for [M + 4H]
4+ at m/z 772.00), and 
have the same retention time as SynMole. The in-source product ions of y-ion 
dissociation (see Figure 3.3) for SynMpal at G3 (y24/y24pal) and P14 
(y13/y13pal) suggest K23 palmitoylation for the peak eluted at 8.6 min (Figure 
3.9 A(i), m/z 729.23 [y24pal + 4H]
4+ and 931.12 [y13pal + 2H]
2+) and N-
terminus palmitoylation for the peak eluted at 8.9 min (Figure 3.9 A(ii), m/z 
669.67 [y24 + 4H]4+ and 812.00 [y13 + 2H]2+). The relative reactivity for both 
lipidated sites of N-terminus and K23 were shown to be in the ratio of 1:1 by 
PPC. Likewise, SynM2pal was also observed (Figure 3.9 B, EIC for [M + 4H]
4+ 
at m/z 831.56). There is only indirect evidence for SynM3pal at retention time 
17-19 min (Figure 3.9 B, EIC of [M + 4H]4+ at m/z 831.56). This is because 
the m/z at this RT indicates SynM2pal, but it is known from SynM/OPC that at 
this RT both intact SynM3ole and SynM2ole with the labile nature of SynM3ole 
were also observed (see Figure 3.5). It is reasonable to extrapolate those 
findings here and propose that for SynM/PPC at RT 17-19 min SynM3pal is 
produced but could not be observed herein as the intact species (SynM3pal) 
but undergoes in-source dissociation to lose one palmitoyl acyl chain and 
thus leaves SynM2pal.  
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Figure 3.9. The main chromatogram represents TIC for SynM/PPC incubated over 168 
h at 37 °Ϲ, analysed on the LTQFT using LC-MS Method-II (see section 8.1.2.1.1). The 
insert panels are the EIC of (A) m/z 772.00 (z=4) for SynMpal; (B) m/z 831.56 (z=4) for 
SynM2pal and labile SynM3pal. Single acylation sites labelled as A(i) for K23 
palmitoylation and A(ii) for N-terminus palmitoylation. 
 
The mass spectra for all palmitoyl additions show the expected range 
of charge states, Figure 3.10 top (A-C); the corresponding deconvoluted 
spectra, deconvoluted to the protonated species are shown in Figure 3.10 
bottom (A-C). Ions with four protonation sites are still favored over other 
charge state distributions. In summary, the results strongly confirm the 
contribution of LPC in non-enzymatic peptide lipidation and the formation of 
single acylation first then followed by multiple acylation. 
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Figure 3.10. Analysis for SynM/PPC incubated for 168 h at 37 °Ϲ. (A) Results for 
SynMpal around RT 8.9 min, (top) mass spectrum and (bottom) deconvoluted to [M + 
H]
+
. (B) Results for SynM2pal around RT 11.2 min, (top) mass spectrum and (bottom) 
deconvoluted to [M + H]
+
. The labelled peak with the asterisk represents [PPC + H]
+
 
overlapping with SynM2pal. (C) Results for SynM3pal around RT 17.7 min, (top) mass 
spectrum and (bottom) deconvoluted to [M + H]
+
.  
 
3.2.3. Reaction of SynM with PPC:OPC mixtures 
The direct competition between LPCs was examined by incubating 
SynM with 50:50 OPC:PPC for 168 h (Figure 3.11). The two most abundant 
acylated peaks at 8.6 min and 8.9 min are labelled as K23 and N-terminus 
respectively. This has been confirmed by performing MS2 on m/z 772.0 and 
778.5, for [SynMpal + 4H]
4+ and [SynMole + 4H]
4+ respectively, as shown in 
Figures 3.12 and 3.13. Knowing that SynMpal vs SynMole and acylation on N-
terminus vs K23 are not completely separated chromatographically (Figure 
3.11 A), peak areas were measured for each species separately. Results 
show that in a mixture of PPC:OPC the N-terminus of SynM is acylated 
preferentially by the ratio of 2:1 (N-terminus:K23) for both palmitoyl and 
oleoyl acyl chains. This is by assuming that both N-terminal and K23 acylated 
species ionise the same.   
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Figure 3.11. The main chromatogram shows the TIC for SynM/50:50 PPC:OPC 
incubated for 168 h at 37 °Ϲ, analysed on the LTQFT using LC-MS Method-II (see 
section 8.1.2.1.1). The insert panel (A), is the EIC for SynMpal and SynMole.  
 
The product ions generated at 8.6 min of the chromatogram (Figure 
3.12) for precursor ions SynMpal (Figure 3.12 A) and SynMole (Figure 3.12 B) 
indicate acylation has taken place on K23. The most abundant product ions 
of y13pal/y13ole at m/z 931.4/944.4 for [M + 2H]
2+ and y24pal/y24ole at m/z 
972.5/981.1 for [M + 3H]3+ still indicate these sites of the peptide backbone 
as the most labile sites and thus efficiently produced during LC-MS2.  
101 
 
 
Figure 3.12. LC-MS
2
 spectra for SynM/50:50 PPC:OPC for the precursor ions at (A) m/z 
772.00 for [SynMpal + 4H]
4+
 and (B) m/z 778.51 for [SynMole + 4H]
4+
, which correspond in 
each case to single acylation observed at RT 8.6 min (see Figure 3.11 A). The 
sequence ladder of y-type and b-type ions is illustrated on each spectrum. The 
highlighted amino acid residues in blue and red indicate the K23 site of palmitoylation 
and oleoylation respectively. All b-ions are z=1, while y-ions are z=2 and/ or 3. Peptide 
fragments containing palmitoyl/oleoyl are marked with an asterisk. 
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In addition, LC-MS2 for precursor ions SynMpal (Figure 3.13 A) and 
SynMole (Figure 3.13 B) at 8.9 min generate product ions that confirm N-
terminus acylation. The most abundant product ion around this peak is still at 
m/z 812.2 [M + 2H]2+ for y13 ion.  
 
 
Figure 3.13. LC-MS
2
 spectra for SynM/50:50 PPC:OPC for the precursor ions at (A) m/z 
772.00 for [SynMpal + 4H]
4+
 and (B) m/z 778.51 for [SynMole + 4H]
4+
, which correspond in 
each case to single acylation observed at RT 8.9 min (see Figure 3.11 A). The 
sequence ladder of y-type and b-type ions is illustrated on each spectrum. The 
highlighted amino acid residues in blue and red indicate the N-terminus site of 
palmitoylation and oleoylation respectively. All b-ions are z=1, while y-ions are z=2 
and/ or 3. Peptide fragments containing palmitoyl/oleoyl are marked with an asterisk. 
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Moreover, monitoring the production of single acylation over different 
times clearly shows SynMpal is favoured over SynMole through all incubation 
times and becomes particularly significant at longer incubation times (Figure 
3.14). This indicates SynM has a greater reactivity with PPC than OPC. To 
conclude, the chemical identity of LPCs fatty acyl chain could play a role in 
easier palmitoyl transfer than oleoyl fatty acyl chain. Hence, PPC with shorter 
and saturated fatty acyl chain favors transfer to SynM over OPC with longer 
and unsaturated fatty acyl chain.      
 
 
Figure 3.14. The relationship between the peak area (A) for single acylation (SynMpal, 
blue diamonds and SynMole, red square) and the incubation time for SynM/50:50 
PPC:OPC at 37 °Ϲ. Peak areas were measured from EIC over all observed charge 
states at each point of the incubation. The normalisation of peak areas were 
performed in the same way as described in Figure 3.7. The insert panel (i) represents 
SynM acylation over 168 h of incubation; errors plotted as SEM of normalised peak 
area from 6 independent experimental repeats. 
 
A control experiment was conducted by using a mixture of 50:50 
PPC:OPC, but in the absence of SynM (Figure 3.15). The results suggest 
comparable ionisation efficiencies with ESI for both PPC and OPC. In 
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addition, both species were eluted as two peaks, consistent with the results 
reported by Dods et al2. The most abundant peak at a longer RT is for 1-acyl-
LPC, while the minor peak is for 2-acyl-LPC, as reported earlier2. The two 
positional isomers of LPC (1-acyl-LPC and 2-acyl-LPC) are formed by in-
solution migration of the acyl chain between both sn-1 and sn-2 positions of 
the lysophospholipid and were resolved and detected herein by LC-MS.    
 
 
Figure 3.15. EIC of (A) m/z 496.34 for [PPC + H]
+
 and (B)  m/z 522.36 for [OPC + H]
+
 for 
a mixture of 50:50 PPC:OPC, analysed on the LTQFT using LC-MS Method-II (see 
section 8.1.2.1.1).  
 
3.2.4. Reaction of bee venom melittin (BVM) with different 
lysophospholipids    
For further investigation, a number of lysophospholipids (LPLs) with 
different head groups have been incubated with BVM. The analysis was 
expanded by including; LPG (lysophosphatidylglycerol), LPE 
(lysophosphatidylethanolamine) and LPS (lysophosphatidylserine) in addition 
to LPCs to react with BVM at a ratio of 13:1 lipid:peptide. A pair of LPLs 
(each with different acyl group) was used at equal mole ratio. The results 
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(Figure 3.16) show that BVM can be acylated by all the LPLs investigated in 
this study, regardless of the differences in their polar head groups. 
Performing all the experiments under the same instrument conditions, 
the amount of single palmitoylation and oleoylation products over 168 h for 
each of SynM (see Figure 3.11) and BVM (Figure 3.16 A) incubation with 
50:50 PPC:OPC were compared. The results showed that SynM is more 
reactive to perform acylation process than BVM. This is evident in the 
formation of 39% and 33% for SynMpal and SynMole respectively relative to 
28% and 17% for BVMpal and BVMole respectively. 
 
 
Figure 3.16. Combined EIC for BVMpal and BVMole in equimolar mixture of (A) 
PPC:OPC; (B) PPC:OPS; (C) PPC:OPG; (D) PPC:OPE incubated at 37 °Ϲ over 168 h. 
Peak area for each species was measured individually from EIC (all charge states). 
The samples were analysed on the LTQFT using LC-MS Method-II (see section 
8.1.2.1.1).  Note: the final concentration for each LPL is 0.65 mM in lipid:peptide 
mixture, thus they are well above CMC (see Table 1.4 for LPLs CMC values). 
 
3.3. Reaction of SynM with diacylphosphatidylcholine (PC) 
The two common model lipid systems, DPPC and DOPC,21 were 
made as unilamellar liposomes and incubated with SynM at physiological 
conditions. These two lipid systems represent the two main lipids’ phase 
behavior (liquid crystalline phase (DOPC at 37 °C, > Tm) and gel phase 
(DPPC at 37 °C, < Tm)) and each with different acyl chain, which are known 
106 
 
to modify SynM. The reactivity of SynM acylation was followed over 168 h, 
Figure 3.17. All the modifications on SynM, single-, double-, and triple 
acylation, were observed in both liposomal systems. The in-source product 
ions of y13pal/y24pal (Figure 3.17 A(i)) and y13ole/y24ole (Figure 3.17 B(i)) for 
peak (i) and y13/y24 (Figure 3.17 A(ii) and B(ii)) for peak (ii) still show K23 
and N-terminus acylation respectively. N-terminus site of the peptide was 
shown to be acylated preferentially by each PC, supporting earlier results2,3.  
     
 
Figure 3.17. TIC for SynM incubation with (A) DPPC and (B) DOPC at 37 °Ϲ over 168 h, 
analysed by the LTQFT using LC-MS Method-II (see section 8.1.2.1.1). Single and 
multiple acylation on SynM are highlighted. 
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It is interesting to see that the acylation by-products PPC from 
SynM/DPPC (Figure 3.17 A) and OPC from SynM/DOPC (Figure 3.17 B) 
exist at a significant abundance relative to their low abundance in the solution 
of individual liposomes DPPC (Figure 3.18 A) and DOPC (Figure 3.18 B) but 
in the absence of SynM. This is further supported by measuring the amount 
of PC conversion to LPC in both experiments and for each species, as shown 
in Table 3.3. Results show that in the absence of SynM the naturally 
hydrolysis reaction of PC to produce LPC is very slow, while this process is 
faster during SynM reaction with PCs (Table 3.3). The amount of PC 
conversion into LPC in the presence of SynM is shown to be much faster for 
DPPC than DOPC. This shows faster acyl transfer from DPPC to SynM to 
leave greater amount of free PPC in the reaction medium than the slower 
reaction of DOPC to produce less OPC, however, both of PPC and OPC by-
products are also reacting with SynM in each peptide:lipid mixture and thus 
will be consumed by time. While at the same time both LPC by-products 
cause an increase in the rate of SynM acylation. This also supports 
preferential palmitoylation reaction over oleoylation reaction, as was 
described for PPC:OPC mixture (see Figure 3.14). 
 In addition, based on the results provided in Table 3.1 for lipids phase 
behavior, it is reasonable to extrapolate that each of DPPC and DOPC lipid 
systems still keep their bilayer properties over 168 h even though there is 
30.4% of  PPC and 11.2% of OPC in each system respectively. 
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Figure 3.18. Base peak chromatogram (BPC) for (A) DPPC liposome and (B) DOPC 
liposome, each incubated individually at 37 °Ϲ over 168 and analysed by the LTQFT 
using LC-MS Method-II (see section 8.1.2.1.1). The inserted panel (i), is the EIC of m/z 
496.34 for [PPC + H]
+
; (ii), is the EIC of m/z 522.36 for [OPC + H]
+
. 
 
Table 3.3. The percentage of total conversion for each of DPPC to PPC and DOPC to 
OPC. Subjected experiment represents SynM/DPPC and SynM/DOPC incubation over 
168 h at 37 °Ϲ (see Figure 3.17); control experiment represents individual incubation 
for each of DPPC and DOPC liposomes over 168 h at 37 °Ϲ (see Figure 3.18) but in the 
absence of SynM. The percentage of conversion was calculated from measuring the 
peak area for the EIC of each species as follows: %PPC = peak area PPC/total peak 
area (PPC + DPPC) × 100; %OPC = peak area OPC/total peak area (OPC + DOPC) × 
100. 
Experiment 
%PC and LPC 
%DPPC %PPC %DOPC %OPC 
Control experiment 99.9 0.1 98.9 1.0 
Subjected experiment 69.6 30.4 88.8 11.2 
 
3.4. Reaction of SynM with PC:LPC mixtures 
The effect of different PCs on SynM acylation is well characterised,1-3 
however, the competition between LPCs and PCs is not understood, so 
50:50 OPC:DPPC (Figure 3.19 A) and 50:50 PPC:DOPC (Figure 3.19 B) 
109 
 
were chosen as appropriate systems to present all the observed acylation 
products. It is clearly visible that over 168 h of sample incubation single, 
double and triple acyl groups were transferred to SynM. Interestingly, the 
results revealed the existence of SynM with palmitoylation and oleoylation 
modifications, indicating non-enzymatic acyl transfer from both LPC and PC. 
  
 
Figure 3.19. TIC for SynM incubation with a mixture of 50:50 LPC:PC, (A) OPC:DPPC 
and (B) PPC:DOPC at 37 °Ϲ over 168 h, analysed by the LTQFT using LC-MS Method-II 
(see section 8.1.2.1.1). Single and multiple acylation on SynM are highlighted. For 
details, see Appendix B Tables 9.3 and 9.4. 
 
3.4.1. Competitive acyl transfer from PC:LPC system to give SynM 
single acylation 
The lipid system consisting of PC and LPC was incubated with SynM 
over different times to monitor the amount of acyl transfer by time. Also 
examined was the possible competition between PC and LPC for acyl 
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transfer which was followed by incubating SynM with 75:25, 50:50 and 25:75 
of LPC:PC (Figures 3.20 and 3.21).  
Based on the results provided in Table 3.1 the expected phase 
behavior for all the lipid systems of OPC:DPPC (Figure 3.20 A-C) is a micelle 
phase. A lipid system 75:25 OPC:DPPC (Figure 3.20 A) evident faster 
oleoylation and this would be expected due to more OPC than DPPC. 
However, even with equimolar amount of OPC:DPPC (Figure 3.20 B) the 
acylation by OPC is still faster than by DPPC throughout the reaction despite 
there being twice as many acyl chains available from DPPC as from OPC. 
Greater reactivity of OPC over DPPC is still visible in 25:75 OPC:DPPC 
(Figure 3.20 C) up to 48 h despite there being far less OPC. As the reaction 
proceeds, DPPC will produce PPC that will also react with SynM and hence 
the palmitoylation reaction overtakes oleoylation. It is interesting to see that 
in all OPC:DPPC studied systems there is a rapid transfer of palmitoyl and 
oleoyl acyl chains initially (up to 48 h), which then slows down and/or 
decreases. This is what would be expected as there is the addition of the 
second and third acyl chains by proceeding the reaction further.  
 
 
Figure 3.20. The competitive production of SynM single acylation as a function of time 
for (A) 75:25 OPC:DPPC; (B) 50:50 OPC:DPPC and (C) 25:75 OPC:DPPC. The EIC peak 
area (all charge states) for single acylation was normalised relative to the summation 
of EIC peak area (all charge states) for (non-acylated SynM + single acylated SynM + 
double acylated SynM + triple acylated SynM). Average data for two experimental 
repeats are shown as red and blue plots for SynMole and SynMpal respectively.  
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Further, a micelle phase of lipid system 75:25 PPC:DOPC (Figure 
3.21 A) is shown to follow the same trend as described earlier for 75:25 
OPC:DPPC (see Figure 3.20 A). Greater reactivity of LPC over PC is also 
confirmed in 50:50 PPC:DOPC (Figure 3.21 B). Interestingly, this lipid system 
is suggested to form a mixed micelle-bilayer phase however there being the 
addition of reactive OPC from DOPC throughout proceeding the reaction. 
Faster oleoylation in 25:75 PPC:DOPC is as expected due to the excess 
amount of DOPC present and the production of reactive OPC by time. This 
system is proposed to exhibit a membrane bilayer phase initially, while this 
might change to mixed micelle-bilayer as the reaction proceeds due to the 
formation of the reactive OPC by-product. Once more the addition of the 
second and third acyl chains in PPC:DOPC (Figure 3.21 A-C) is what causes 
a decrease or a small change in the rate of single acylation over 90 h  and 
thereafter.  
 
 
Figure 3.21. The competitive production of SynM single acylation as a function of time 
for (A) 75:25 PPC:DOPC; (B) 50:50 PPC:DOPC and (C) 25:75 PPC:DOPC. The EIC peak 
area (all charge states) for single acylation was normalised relative to the summation 
of EIC peak area (all charge states) for (non-acylated SynM + single acylated SynM + 
double acylated SynM + triple acylated SynM). Average data for two experimental 
repeats are shown as red and blue plots for SynM
ole
 and SynM
pal
 respectively. 
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The mass spectrum for single acylation (RT 7.9-9.8 min) is given in 
Figure 3.22 A and B (PPC:DOPC) and 3.22 C and D (OPC:DPPC). 
Interestingly, the charge state distributions (z=3-5) are different in both 
systems. Higher abundance of SynMpal is evident when LPC present is PPC, 
Figure 3.22 A. Consequently, the peak at m/z 3085.00 for SynMpal is more 
intense than m/z 3111.01 for SynMole, in the deconvoluted spectra (Figure 
3.22 B). The analogous observation is made when the LPC is OPC; here the 
abundance of SynMole is greater than SynMpal, Figure 3.22 C and D.  
Greater reactivity of LPC over PC for SynM acylation is further 
supported by the in-source product ions in the deconvolved spectra, Figure 
3.22 B and D. For PPC:DOPC (Figure 3.22 B) the peptide cleavage at AA 
G3, m/z 2914.89 for y24pal, and AA P14, m/z 1861.23 for y13pal, which 
represent the C-terminus portion of SynM that carry palmitoyl chain, are more 
abundant than when the C-terminus portion carry oleoyl chain (m/z 2940.90 
for y24ole and  m/z 1888.25 for y13ole respectively), see Figures 3.3 for details 
about melittin cleavage sites. The analogous observation is made when the 
LPC is OPC; here the abundance of y24ole/y13ole is greater than y24pal/y13pal, 
Figure 3.22 D. In addition of these representative y-ions for acylation towards 
C-terminal portion, a number of y-ions correspond to the free peptide 
dissociation (non-acylated) at AA sites P14, T10, and G3 for y13, y17 and 
y24 ions respectively, illustrate the probability of the peptide acylation on the 
N-terminal of the peptide but proposed to be lost during peptide backbone 
cleavage. Further, product ions correspond to acylated peptide cleavage at 
AA R24 (b24pal + H2O) and (b24ole + H2O)
 indicate SynM acylation either on 
N-terminus or K23; both are reported as the most reactive sites of 
acylation.2,3 
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Figure 3.22. (A) Mass spectrum for SynM single acylation; (B) the deconvolution 
spectrum to [M + H]
+
. The spectra were obtained from the EIC (RT 7.9-9.8 min) for 
SynM/50:50 PPC:DOPC incubation at 37 °Ϲ over 168 h. (C) Mass spectrum for SynM 
single acylation; (D) the deconvolution spectrum to [M + H]
+
. The spectra  were 
obtained from EIC (RT 7.9-9.8 min) for SynM/50:50 OPC:DPPC incubation at 37 °Ϲ over 
168 h.  
 
Following the observation of LPCs’ strong contribution towards acyl 
transfer, selectivity of lipidation for the two most active sites on SynM (N-
terminus vs K23) was monitored. This is examined by monitoring the 
proportion of single acylation for different molar ratios of PC:LPC (100:0, 
75:25, 50:50, 25:75 and 0:100) at 48 and 168 h, as shown in Figure 3.23. It is 
interesting to see that both DPPC and DOPC phospholipids favour N-
terminus acylation, as reported earlier,1-3 or competing with K23 (slightly 
favours N-terminus), around 8.9 min, see also Figure 3.17, as shown in 
Figure 3.23 A-D (i-iv). While, LPCs have stronger selectivity towards K23 or 
competing with N-terminus (slightly favours K23), as shown in Figure 3.23 A-
D (ii-v). This illustrates different PC vs LPC selectivity towards N-terminus 
and K23 of SynM.  
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Figure 3.23. EIC for SynMpal (blue) and SynMole (red) for incubations between SynM 
and DPPC:OPC (A and B) and incubations between SynM and DOPC:PPC (C and D) at 
37 °Ϲ over 48 h and 168 h. (i) SynM incubation with 100% PC; (ii) SynM incubation with 
75:25 PC:LPC; (iii) SynM incubation with 50:50 PC:LPC (iv) SynM incubation with 
25:75 PC:LPC; (v) SynM incubation with 100% LPCs. A modification of K23 is at 8.6 
min and N-terminus is at 8.9 min, as shown previously in Figures 3.11 and 3.17. 
 
3.4.2. Competitive acyl transfer from PC:LPC system to give SynM 
double acylation 
Moving to the later retention times, the more hydrophobic double 
acylation products are eluting. At RT 9.5-11.9 min of the chromatogram (see 
Figure 3.19) a very complicated mixture of double acyl SynM was observed 
and is shown to consist of a combination of SynM2pal, SynM2ole and 
SynMpal+ole (Figure 3.24). Each of these combinations could further result 
from the modification of any one of 5 different active sites on the peptide (N-
terminus, K23, K21, K7 and S18),1-3 resulting in a total of 40 possible double 
acyl SynM species. 
As examined earlier (see section 3.4.1), the transfer of the first acyl 
group from LPC:PC mixture (equal mole ratio) is favoured by LPC. 
Interestingly, this is still evident in transfer of the second fatty acyl when both 
transition groups are from LPC. This can be seen in SynM2pal (m/z 3323.23) > 
SynM2ole (m/z 3376.26) for PPC:DOPC (Figure 3.24 A and B) and SynM2ole 
(m/z 3376.26) > SynM2pal (m/z 3323.23) for OPC:DPPC (Figure 3.24 C and 
D). Although there is a continuous introduction of LPC into the system from 
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the dissociation of PC during its reaction with SynM which can then go on to 
react with SynM, this process can be explained by the comparatively slow 
transfer from diacylphospholipids (see section 3.3) in conjunction with the 
high amount of free LPC that is already present in the system. However, 
participation by both lipids (LPC and PC) in the second acyl transfer shows 
SynMpal+ole (m/z 3350.25) as the most abundant species of the trio of double 
acylation products. This is because there are 2 isomer products (SynMpal+ole 
vs SynMole+pal) for each double acyl transfer on two different positions of the 
peptide.  
In addition, the two in-source product ions for the peptide dissociation 
at AA R22, m/z 2544.66 for (b22pal + H2O) and 2571.86 for (b22ole + H2O), 
indicate one modification, proposed to be on AA K23, and is lost, leaving the 
N-terminal portion of the peptide acylated (Figure 3.24 D). 
 
 
Figure 3.24. (A) Mass spectrum for SynM double acylation; (B) deconvolution 
spectrum to [M + H]
+
. The spectra (A and B) were obtained from the EIC (RT 9.5-11.8 
min) for SynM/50:50 PPC:DOPC incubation at 37 °Ϲ over 168 h. (C) Mass spectrum for 
SynM double acylation; (D) deconvolution spectrum to [M + H]
+
. The spectra (C and D) 
were obtained from the EIC (RT 9.6-11.9 min) for SynM/50:50 OPC:DPPC incubation at 
37 °Ϲ over 168 h.  
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3.4.3. Competitive acyl transfer from PC:LPC system to give SynM 
triple acylation 
The triple acylation of SynM provides an even more complicated 
picture than double acylation, because in such case, a total of 80 possible 
triple acylation products for 5 possible active sites (N-terminus, K23, K21, K7 
and S18)1-3 could result. A distribution of triple acylation products for 
SynM/50:50 PPC:DOPC incubation was observed at RT 17-19 min, as 
shown in Figure 3.25. This retention time window was deconvoluted and the 
mass spectra can be seen in Figure 3.25 B and shows the full extent of the 
triple acylated SynM species produced. As with double acylation (see section 
3.4.2), the two most abundant precursor ions with the contribution of both PC 
and LPC are SynM2pal+ole and SynM2ole+pal (m/z 3588.47 and m/z 3614.49 
respectively), while SynM3pal and SynM3ole (m/z 3562.46 and m/z 3640.51 
respectively) are less abundant. Once more the greater abundance of 
SynM3pal over SynM3ole and SynM2pal+ole over SynM2ole+pal for PPC:DOPC 
(Figure 3.25) indicates that there is greater contribution from the LPC than 
PC. Interestingly, the observation of intact SynM3pal (Figure 3.25 B) is 
suggesting enhanced reactivity towards SynM, but only when it is 
accompanied with DOPC, as intact triple palmitoylation was not observed in 
SynM reaction with PPC alone (see Figure 3.9). 
Closer examination of the RT window where the triple acylated SynM 
eluted reveals a distribution of ions with the same m/z as observed for double 
acylation (Figure 3.25). This suggests the presence of triple acylation in the 
analyte, but during ESI ionisation, one of the acyl groups on the peptide has 
been lost. The in-source dissociation ion (b24pal+ole + H2O) at m/z 3094.11 
corresponds to double acylated SynM cleavage at AA R24, this further 
suggests that the dissociation of triple acylated SynM is loosing one labile 
modification, leaving two acyl groups proposed to be on the N-terminus and 
K23 amino acid residue. 
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Figure 3.25. Incubation of SynM with 50:50 PPC:DOPC at 37 °Ϲ over 168 h. (A) Mass 
spectrum for SynM labile triple acylation and triple acylation averaged over RT 17-19 
min of the EIC; (B) the deconvolution spectrum to [M + H]
+
.  
 
  The analogous observation was made for the system of SynM/50:50 
OPC:DPPC (Figure 3.26). The intact and labile triple acylation modifications 
in this system are again indicating that the LPC has a more significant effect 
than PC. This is further supported by greater abundance of SynM multiple 
acylation from the LPC over PC as follows:  SynM2ole+pal > SynM2pal+ole >> 
SynM3ole > SynM3pal (Figure 3.26 B). 
118 
 
 
Figure 3.26. Incubation of SynM with 50:50 OPC:DPPC incubation at 37 °Ϲ over 168 h. 
(A) Mass spectrum for SynM labile triple acylation and triple acylation averaged over 
RT = 17-19 min of the EIC; (B) the deconvolution spectrum to [M + H]
+
.  
 
3.5. LC-MS2 analysis of SynM double acylation 
 The evidence of a second and third acyl transfer from the artificial 
membrane to SynM inspired further molecular characterisation to identify the 
modification sites of these multiple acylation products; this being known 
already for monoacylated SynM.2,3 Here, CID was performed on double 
acylated SynM precursor ions at m/z 832, 838 and 845 for [M + 4H]4+, which 
correspond to SynM2pal, SynMpal+ole and SynM2ole respectively. This provided 
benchmark information about the position of the second acyl group on SynM, 
however the number of co-eluting species with the same molecular formulae 
for the triple acylation was deemed too complicated and set aside for 
experiments into further separation. 
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3.5.1. LC-MS2 analysis of SynM2pal 
Isolating the precursor ion for SynM2pal at m/z 832 for [M + 4H]
4+ in the 
collision cell (MS2) gives multiple peaks between 9-11.5 min (Figure 3.27), 
which reflects the different locations that these two palmitoyl groups can 
modify on the peptide. There are clearly 6 peaks but tailing suggest others.    
 
 
Figure 3.27. TIC of product ions from the CID of SynM2pal at m/z 832 (z=4) for SynM and 
50:50 PPC:DOPC incubated over 168 h at 37 °Ϲ. Analysis was performed on the 
LTQFT using LC-MS Method-II (see section 8.1.2.1.1).  
  
The resulting b- and y-ions from the strongest peak of the 
chromatogram at 10.6 min (see Figure 3.27) gives a clear evidence of one 
palmitoyl on the N-terminus (G1) and the other palmitoyl towards C-terminus 
(K23), as shown in Figure 3.28 A and Table 3.4. Single palmitoylated product 
ions b3pal (GIG), b4pal (GIGA) and y5pal (RKRQQ) at m/z 466.2 (z=1), 537.2 
(z=1) and 477.3 (z=2) respectively, are the key ions that confirm this 
assignment. This is consistent with the understanding that the two most 
abundant sites of single acylation are K23 and N-terminus (see section 3.2.3, 
Figures 3.12 and 3.13). The second strongest peak at 10.1 min of the 
chromatogram (see Figure 3.27) showed SynM acylation on K7 and K21 
(Figure 3.28 B and Table 3.5). This is confirmed by observing non-
palmitoylated b4 (GIGA), b5 (GIGAV), b6 (GIGAVL) and y4-NH3 (KRQQ) 
ions at m/z 299.1, 398.2, 511.3 and 271.2 respectively. Moreover, each 
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terminus of the peptide with one palmitoyl modification could be further 
confirmed by the strong abundance y13pal at m/z 931 (Figure 3.28 A and B) 
for the peptide cleavage at AA P14.     
 
 
Figure 3.28. LC-MS
2
 spectra for precursor ion SynM2pal at m/z 832 for [M + 4H]
4+
 
at (A) 
10.6 min, corresponds to N-terminus/K23 double palmitoylation, and (B) 10.1 min, 
corresponds to K7/K21 double palmitoylation, of the EIC (see Figure 3.27, SynM/50:50 
PPC:DOPC). Peptide fragments containing single or double palmitoylation are marked 
with one asterisk and two asterisks respectively. Details provided in Tables 3.4 and 
3.5. 
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Table 3.4. Ions produced by fragmenting SynM2pal at m/z 832 (z=4) over 10.6 min of the 
EIC (see Figure 3.27, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus/K23 double palmitoylation (see Figure 3.28 A).   
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 466.2 1 H-GIG y24 972.7 3 GAVLKVLTTGLPALISWIKR
KRQQ-NH2 
b4 537.2 1 H-GIGA y22 929.7 3 VLKVLTTGLPALISWIKRKR
QQ-NH2 
b5 636.2 1 H-GIGAV y21 896.7 3 LKVLTTGLPALISWIKRKRQ
Q-NH2 
b6 749.3 1 H-GIGAVL y20 1286.8 2 KVLTTGLPALISWIKRKRQQ-
NH2 
b7 877.3 1 H-GIGAVLK y19 1223.6 2 VLTTGLPALISWIKRKRQQ-
NH2 
b8 976.7 1 H-GIGAVLKV y18 1173.9 2 LTTGLPALISWIKRKRQQ-
NH2 
b9 1089.6 1 H-GIGAVLKVL y17 1117.5 2 TTGLPALISWIKRKRQQ-NH2 
b10 1190.6 1 H-GIGAVLKVLT y16 1067.0 2 TGLPALISWIKRKRQQ-NH2 
b12 1348.6 1 H-GIGAVLKVLTTG y15 1016.5 2 GLPALISWIKRKRQQ-NH2 
b12 - H2O 1330.6 1 H-GIGAVLKVLTTG y14 987.9 2 LPALISWIKRKRQQ-NH2 
b12 - H2O 666.0 2 H-GIGAVLKVLTTG y13 931.4 2 PALISWIKRKRQQ-NH2 
b13 1461.4 1 H-GIGAVLKVLTTGL y13 621.5 3 PALISWIKRKRQQ-NH2 
b13 - H2O 1443.7 1 H-GIGAVLKVLTTGL y12 882.7 2 ALISWIKRKRQQ-NH2 
b15 816.1 2 H-GIGAVLKVLTTGLPA 
y11 847.4 2 LISWIKRKRQQ-NH2 
y10 790.6 2 ISWIKRKRQQ-NH2 
y9 734.2 2 SWIKRKRQQ-NH2 
y5 477.3 2 RKRQQ-NH2 
*Palmitoylation sites are highlighted in blue within the amino acid sequence of the peptide. 
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Table 3.5. Ions produced by fragmenting SynM2pal at m/z 832 (z=4) over 10.1 min of the 
EIC (see Figure 3.27, SynM/50:50 PPC:DOPC). Product ions correspond to K7/K21 
double palmitoylation (see Figure 3.28 B). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b4 299.1 1 H-GIGA y24 1051.9 3 GAVLKVLTTGLPALISWIK
RKRQQ-NH2 
b5 398.2 1 H-GIGAV y24 789.2 4 GAVLKVLTTGLPALISWIK
RKRQQ-NH2 
b6 511.3 1 H-GIGAVL y22 1009.2 3 VLKVLTTGLPALISWIKRK
RQQ-NH2 
b7 877.6 1 H-GIGAVLK y21 732.1 4 LKVLTTGLPALISWIKRKR
QQ-NH2 
b8 976.5 1 H-GIGAVLKV y20 938.5 3 KVLTTGLPALISWIKRKRQ
Q-NH2 
b9 1089.7 1 H-GIGAVLKVL y19 1223.7 2 VLTTGLPALISWIKRKRQQ
-NH2 
b10 1190.6 1 H-GIGAVLKVLT y18 1173.9 2 
LTTGLPALISWIKRKRQQ-
NH2 
b11 1291.6 1 H-GIGAVLKVLTT y17 1117.4 2 
TTGLPALISWIKRKRQQ-
NH2 
b12 1348.7 1 H-GIGAVLKVLTTG y16 1066.8 2 
TGLPALISWIKRKRQQ-
NH2 
b12 – H2O 1330.7 1 H-GIGAVLKVLTT G y15 1016.5 2 GLPALISWIKRKRQQ-NH2 
b12 – H2O  666.0 2 H-GIGAVLKVLTT G y14 987.9 2 LPALISWIKRKRQQ-NH2 
b13 1461.8 1 H-GIGAVLKVLTTGL y13 931.2 2 PALISWIKRKRQQ-NH2 
b13 – H2O 1443.7 1 H-GIGAVLKVLTTGL y13 621.5 3 PALISWIKRKRQQ-NH2 
b15 816.2 2 H-GIGAVLKVLTTGLPA 
y12 882.7 2 ALISWIKRKRQQ-NH2 
y11 847.2 2 LISWIKRKRQQ-NH2 
y10 790.8 2 ISWIKRKRQQ-NH2 
y9 734.0 2 SWIKRKRQQ-NH2 
y8 734.0 2 WIKRKRQQ-NH2 
y7 597.2 2 IKRKRQQ-NH2 
y6 541.1 2 KRKRQQ-NH2 
y4 - NH3 271.2 2 KRQQ-NH2 
*Palmitoylation sites are highlighted in blue within the amino acid sequence of the peptide. 
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The minor peak at 9.1 min of the chromatogram (see Figure 3.27) 
yielded ions with weak intensity to suggest no palmitoylation on N-terminus 
but rather located on S18 and K21 of the peptide sequence, as shown in 
Figure 3.29 A and Appendix B Table 9.5. This is consistent with low reactivity 
of these sites of the peptide in previous works.2,3 This is assigned from the 
most significant y132pal at m/z 1050.5 (z=2) for SynM2pal dissociation at AA 
P14 (PALISWIKRKRQQ), with two palmitoylation modification on the C-
terminus cleaved sequence. The following peak at 9.4 min (see Figure 3.27) 
showed two possibilities. Figure 3.29 B, once more, illustrates double 
palmitoylation on C-terminus portion of AAs K21 and K23, as shown in 
Appendix B Table 9.6, though at the same time there are other b- and y-ions 
represent the indication of one palmitoyl on N-terminus and the second 
palmitoyl on K21 (Figure 3.29 C and Appendix B Table 9.7). Hence, there is 
the suggestion of co-eluting species. The difference between the two 
assigned possibilities at 9.4 min can be quickly judged from P14 cleavage of 
the peptide for y132pal at m/z 1050.5 corresponds to K21/K23 double 
palmitoylation (z=2) and for y13pal at m/z 931.1 corresponds to N-
terminus/K21 double palmitoylation (z=2). 
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Figure 3.29. LC-MS
2
 spectra for precursor ion SynM2pal at m/z 832 for [M + 4H]
4+
 
at (A) 
9.1 min, corresponds to S18/K21 double palmitoylation, and (B and C) 9.4 min, 
corresponds to K21/K23 and N-terminus/K21 double palmitoylation respectively, of 
the EIC (see Figure 3.27, SynM/50:50 PPC:DOPC). Peptide fragments containing single 
or double palmitoylation are marked with one asterisk and two asterisks respectively. 
Details provided in Appendix B Tables 9.5-9.7.  
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 Two minor peaks at 10.9 min and 11.2 min (see Figure 3.27), albeit 
overlapping with the strongly abundant peaks of LPCs (see Figure 3.19 B) 
which is likely to effect their ionisation efficiency, suggest one palmitoyl on N-
terminus (G1) and the second palmitoyl towards the C-terminal portion. This 
interpretation can be quickly assessed by the observation of the most 
abundant peak at m/z 931.5 (z=2) for the peptide cleavage at AA P14 that 
corresponds to y13pal (Figure 3.30). Further, the presence of y5pal at m/z 
477.1 (z=2) represents SynM2pal dissociation at AA R22 where one palmitoyl 
acyl chain resides on the cleaved C-terminus sequence (RKRQQ). This 
suggests R22, K23 or R24 palmitoylation, however N-terminus and K23 
double acylation is already confirmed as eluting at 10.6 min (see Figure 3.28 
A and Table 3.4). Interestingly, SynM2pal dissociation at K23 for y4pal-NH3 
(z=2) at m/z 390.5 showed palmitoylated C-terminus sequence (KRQQ) at 
11.2 min, which is absent at 10.9 min. Consequently, The peak at 10.9 min is 
therefore assigned as N-terminus and R22 double palmitoylation (Figure 3.30 
A and Appendix B Table 9.8) and the peak at 11.2 min matches N-terminus 
and R24 double palmitoylation (Figure 3.30 B and Appendix B Table 9.9). 
These two newly proposed sites of acylation (R22 and R24) suggest that 
guanidinum groups undergo slow aminolysis reaction with the lipid acyl 
chains. 
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Figure 3.30. LC-MS
2
 spectra for precursor ion SynM2pal at m/z 832 for [M + 4H]
4+
 
at (A) 
10.9 min, corresponds to N-terminus/R22 double palmitoylation, and (B) 11.2 min, 
corresponds to N-terminus/R24 double palmitoylation, of the EIC (see Figure 3.27, 
SynM/50:50 PPC:DOPC). Peptide fragments containing single palmitoylation are 
marked with one asterisk. Details provided in Appendix B Tables 9.8 and 9.9.  
 
3.5.1.1. Summarised SynM2pal fragmentation 
A set of six co-eluting peaks (see Figure 3.27) for SynM2pal, when 
studied by CID, suggest seven possible SynM amino acid residues can be 
acylated, as shown in Table 3.6. Five residues had already been confirmed in 
previous work,2,3 while the two later new modification sites on SynM can be 
assigned. 
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Table 3.6. The sequence ladder of y-type and b-type ions for SynM2pal at different RTs 
(see Figure 3.27, SynM/50:50 PPC:DOPC). Product ions were produced by fragmenting 
the precursor ion of double palmitoylation at m/z 832 (z=4). Full details are provided in 
Tables 3.4, 3.5 and Appendix B Tables 9.5-9.9. 
RT (min) Acylated SynM Cleavage Sites
‡
 
9.1 
 
9.4 
 
 
 
 
 
10.1 
 
10.6 
 
10.9 
 
11.2 
 
‡The sequence site of palmitoylation is highlighted in blue. The cleavage site of b-ions 
indicated by pink arrow and y-ions by green arrows. 
 
3.5.2. LC-MS2 analysis of SynM2ole 
Multiple peaks between 8.5-12 min for SynM2ole at m/z 845 for [M + 
4H]4+ were examined by MS2 (Figure 3.31). The first peak at 8.8 min to elute 
is very hard to assign as it is low in abundance and overlaps with single 
acylation modification (see Figure 3.19 B) and hence there is the likelihood of 
ion suppression. The following peak at 9.2 min still suggests double acylation 
towards C-terminal (S18/K21 double oleoylation). This is assigned by the 
most significant y132ole at m/z 1076.1 (z=2) for SynM2ole cleavage at AA P14 
(Figure 3.32 A and Appendix B Table 9.10). Two possible assignments for 
double oleoylation are also confirmed at 9.6 min. Firstly, double oleoylation 
towards C-terminal (K21/K23 double oleoylation), Figure 3.32 B and 
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Appendix B Table 9.11, and secondly  N-terminus/K21 double oleoylation, 
Figure 3.32 C and Appendix B Table 9.12. Once more, the differentiation 
between these two assignments can be assessed from y132ole at m/z 1076.6 
for K21/K23 double oleoylation (z=2) and y13ole at m/z 944.4 for N-
terminus/K21 double oleoylation (z=2) for the P14 cleavage site.      
 
 
Figure 3.31. TIC of product ions from the CID of SynM2ole at m/z 845 (z=4) for SynM and 
50:50 PPC:DOPC incubated over 168 h at 37 °Ϲ. Analysis was performed on the 
LTQFT using LC-MS Method-II (see section 8.1.2.1.1).  
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Figure 3.32. LC-MS
2
 spectra for precursor ion SynM2ole at m/z 845 for [M + 4H]
4+
 
at (A) 
9.2 min, corresponds to S18/K21 double oleoylation, and (B and C) 9.6 min, 
corresponds to K21/K23 and N-terminus/K21 double oleoylation respectively, of the 
EIC (see Figure 3.31, SynM/50:50 PPC:DOPC). Peptide fragments containing single or 
double oleoylation are marked with one asterisk and two asterisks respectively. 
Details provided in Appendix B Tables 9.10-9.12.  
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The second most intense peak at 10.2 min corresponds to double 
oleoylation on K7 and K21 (Figure 3.33 A), and is followed by the most 
abundant ions for double oleoylation at 10.6 min correspond to AAs G1 (N-
terminus) and K23 (Figure 3.33 B). The product ions arise by K7/K21 double 
oleoylation are tabulated and shown in Appendix B Table 9.13, while G1/K23 
double oleoylation are shown in Appendix B Table 9.14. The presence of one 
oleoylation on C-terminus portion is assigned from y13ole at m/z 944 (Figure 
3.33 A and B) for SynM2ole cleavage at AA P14, leaving the other oleoyl 
towards N-terminus. 
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Figure 3.33. LC-MS
2
 spectra for precursor ion SynM2ole at m/z 845 for [M + 4H]
4+
 
at (A) 
10.2 min, corresponds to K7/K21 double oleoylation, and (B) 10.6 min, corresponds to 
N-terminus/K23 double oleoylation, of the EIC (see Figure 3.31, SynM/50:50 
PPC:DOPC). Peptide fragments containing single or double oleoylation are marked 
with one asterisk and two asterisks respectively. Details provided in Appendix B 
Tables 9.13 and 9.14. 
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The product ions arising from the two later co-eluting peaks at 10.9 
and 11.2 min (see Figure 3.31) suggest N-terminus/R22 double oleoylation 
(Figure 3.34 A and Appendix B Table 9.15) and N-terminus/R24 double 
oleoylation (Figure 3.34 B and Appendix B Table 9.16) respectively.  
 
 
Figure 3.34. LC-MS
2
 spectra for precursor ion SynM2ole at m/z 845 for [M + 4H]
4+
 
at (A) 
10.9 min, corresponds to N-terminus/R22 double oleoylation, and (B) 11.2 min, 
corresponds to N-terminus/R24 double oleoylation, of the EIC (see Figure 3.31, 
SynM/50:50 PPC:DOPC). Peptide fragments containing single oleoylation are marked 
with one asterisk. Details provided in Appendix B Tables 9.15 and 9.16. 
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3.5.2.1. Summarised SynM2ole fragmentation 
The seven possible assignments for SynM2ole modification are shown 
in Table 3.7. Overall, the results are analogous to the MS2 of the SynM2pal 
and have the same elution order. 
 
Table 3.7. The sequence ladder of y-type and b-type ions for SynM2ole at different RTs 
of the EIC (see Figure 3.31, SynM/50:50 PPC:DOPC). Ions produced by fragmenting 
the precursor ion of double oleoylation at m/z 845 (z=4). Full details are provided in 
Appendix B Tables 9.10-9.16. 
RT (min) Acylated SynM Cleavage Sites
‡
 
9.2 
 
9.6 
 
 
 
 
 
10.2 
 
10.6 
 
10.9 
 
11.2 
 
‡The sequence site of oleoylation is highlighted in red. The cleavage site of b-ions indicated 
by pink arrow and y-ions by green arrows. 
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3.5.3. LC-MS2 analysis of SynMpal+ole 
Fragmenting SynMpal+ole precursor ion at m/z 838 for [M + 4H]
4+ again 
gives multiple co-eluting peaks around 9-12 min of the chromatogram, as 
shown in Figure 3.35.  
 
 
Figure 3.35. TIC of product ions from the CID of SynMpal+ole at m/z 838 (z=4) for SynM 
and 50:50 PPC:DOPC incubated over 168 h at 37 °Ϲ. Analysis was performed on the 
LTQFT using LC-MS Method-II (see section 8.1.2.1.1).  
 
It is interesting to see that more complication arises during the 
examination of the ion at m/z 838 because there are two different acyl 
chains, palmitoyl and oleoyl, for each of the two modification sites of SynM. 
Hence, for each single chromatographic peak there will be two possibilities 
because when the modification is at a specific location RT is the same 
regardless of whether it is palmitoyl or oleoyl (see Figures 3.27 and 3.31). 
The first peak eluting at 9.1 min for example, gives evidence of two co-eluting 
species: S18 oleoyl and K21 palmitoyl (Figure 3.36 A and Appendix B Table 
9.17) and S18 palmitoyl and K21 oleoyl (Figure 3.36 B and Appendix B Table 
9.18). The presence of both palmitoyl and oleoyl modification towards the C-
terminus portion is confirmed from the most abundant peak for SynM 
cleavage at AA P14 for y13pal+ole at m/z 1063.5 (z=2). This ion is also evident 
at 9.5 min for both possibilities of K21 oleoyl and K23 palmitoyl (Figure 3.37 
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A and Appendix B Table 9.19) and also K21 palmitoyl and K23 oleoyl (Figure 
3.37 B and Appendix B Table 9.20) 
When both palmitoyl and oleoyl acyl chains are located towards C-
terminus of the peptide such as for S18/K21 or K21/K23 then most product 
ions were shown to be the same whether it is palmitoyl/oleoyl or changing the 
positions to oleoyl/palmitoyl (Figures 3.36 and 3.37). The key ions to 
differentiate between the two products were seen to be b18ole corresponding 
to S18 oleoyl and K21 palmitoyl, while it is b18pal for S18 palmitoyl and K21 
oleoyl (Figure 3.36). For K21 oleoyl and K23 palmitoyl the presence of y5pal is 
an indication of this product, while the presence of y4ole and y5ole ions show 
K21 palmitoyl and K23 oleoyl (Figure 3.37). In addition to K21/K23 
palmitoylation plus oleoylation at 9.5 min, N-terminus/K21 palmitoylation plus 
oleoylation is also confirmed at this RT (Figure 3.38 and Appendix B Tables 
9.21 and 9.22).   
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Figure 3.36. LC-MS
2
 spectrum for precursor ion SynMpal+ole at m/z 838 for [M + 4H]
4+
 
at 
9.1 min of the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). (A) S18 oleoylation and 
K21 palmitoylation; (B) S18 palmitoylation and K21 oleoylation. Peptide fragments 
containing single or double acylation are marked with one asterisk and two asterisks 
respectively. The peaks labelled with double dagger shows b18ole (A); b18pal (B). 
Details provided in Appendix B Tables 9.17 and 9.18. 
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Figure 3.37. LC-MS
2
 spectrum for precursor ion SynMpal+ole at m/z 838 for [M + 4H]
4+
 
at 
9.5 min of the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). (A) K21 oleoylation and 
K23 palmitoylation; (B) K21 palmitoylation and K23 oleoylation. Peptide fragments 
containing single or double acylation are marked with one asterisk and two asterisks 
respectively. The peaks labelled with double dagger shows y5pal (A); y5ole and y4ole (B). 
Details provided in Appendix B Tables 9.19 and 9.20. 
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Figure 3.38. LC-MS
2
 spectrum for precursor ion SynMpal+ole at m/z 838 for [M + 4H]
4+
 
at 
9.5 min of the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). (A) N-terminus 
oleoylation and K21 palmitoylation; (B) N-terminus palmitoylation and K21 
oleoylation. Peptide fragments containing single acylation are marked with one 
asterisk. Details provided in Appendix B Tables 9.21 and 9.22. 
 
 Product ions arising from the dissociation of SynMpal+ole acylation at 
10.2 min is confirmed as two possibilities: K7 oleoyl and K21 palmitoyl 
(Figure 3.39 A and Appendix B Table 9.23) and K7 palmitoyl and K21 oleoyl 
(Figure 3.39 B and Appendix B Table 9.24). There are also the two 
possibilities of N-terminus oleoyl and K23 palmitoyl (Figure 3.40 A and 
Appendix B Table 9.25) and N-terminus palmitoyl and K23 oleoyl (Figure 
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3.40 B and Appendix B Table 9.26) at 10.6 min. At both 10.2 min and 10.6 
min, SynMpal+ole dissociation at AA P14 clearly shows the C-terminus half 
resides one acylation modification, m/z 931 for y13pal or 944 for y13ole (z=2), 
and leaving the second acyl chain (palmitoyl or oleoyl) towards N-terminus.  
 
 
Figure 3.39. LC-MS
2
 spectrum for precursor ion SynMpal+ole at m/z 838 for [M + 4H]
4+
 
at 
10.2 min of the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). (A) K7 oleoylation and 
K21 palmitoylation; (B) K7 palmitoylation and K21 oleoylation. Peptide fragments 
containing single or double acylation are marked with one asterisk and two asterisks 
respectively. Details provided in Appendix B Tables 9.23 and 9.24. 
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Figure 3.40. LC-MS
2
 spectrum for precursor ion SynMpal+ole at m/z 838 for [M + 4H]
4+
 
at 
10.6 min of the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). (A) N-terminus 
oleoylation and K23 palmitoylation; (B) N-terminus palmitoylation and K23 
oleoylation. Peptide fragments containing single acylation are marked with one 
asterisk. Details provided in Appendix B Tables 9.25 and 9.26. 
 
Figure 3.41 shows N-terminus/R22 palmitoyl plus oleoyl, the product 
ions are tabulated and shown in Appendix B Tables 9.27 and 9.28. In 
addition, palmitoylation plus oleoylation on N-terminus and R24 is shown in 
Figure 3.42 and Appendix B Tables 9.29 and 9.30. The presence of one acyl 
chain towards C-terminus portion is still evident from the spectra at m/z 931 
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for y13pal or 944 for y13ole (z=2) for SynMpal+ole cleavage at AA P14, and is 
therefore indicates the second acyl group towards N-terminus of the peptide. 
 
 
Figure 3.41. LC-MS
2
 spectrum for precursor ion SynMpal+ole at m/z 838 for [M + 4H]
4+
 
at 
10.9 min of the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). (A) N-terminus 
oleoylation and R22 palmitoylation; (B) N-terminus palmitoylation and R22 
oleoylation. Peptide fragments containing single acylation are marked with one 
asterisk. Details provided in Appendix B Tables 9.27 and 9.28. 
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Figure 3.42. LC-MS
2
 spectrum for precursor ion SynMpal+ole at m/z 838 for [M + 4H]
4+
 
at 
11.2 min of the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). (A) N-terminus 
oleoylation and R24 palmitoylation; (B) N-terminus palmitoylation and R24 
oleoylation. Peptide fragments containing single acylation are marked with one 
asterisk. Details provided in Appendix B Tables 9.29 and 9.30. 
 
3.5.3.1. Summarised SynMpal+ole fragmentation 
The increase in the number of assigned double acylation products 
from 7 to 14 (Table 3.8) is clearly related to the presence of two different acyl 
chains on two different sites of SynM. The results show how complexity is 
introduced into the system by increasing the number of acyl chain transfers 
to SynM or how will be the outcomes by moving towards real world systems 
where lipid content is very heterogeneous.     
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Table 3.8. The sequence ladder of y-type and b-type ions for SynMpal+ole at different 
RTs (see Figure 3.35, SynM/50:50 PPC:DOPC). Product ions were produced by 
fragmenting the precursor ion of SynMpal+ole at m/z 838 (z=4). Full details are provided 
in Appendix B Tables 9.17-9.30. 
RT* (min) Acylated SynM Cleavage Sites
‡
 
9.1 
 
 
9.5 
 
 
 
 
 
 
 
 
 
10.2 
 
 
 
 
 
10.6 
 
 
 
 
 
10.9 
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11.2 
 
 
 
 
 
‡The sequence site of palmitoylation is highlighted in blue and oleoylation in red. The 
cleavage site of b-ions indicated by pink arrow and y-ions by green arrows. 
 
3.6. BVM vs SynM selectivity towards sn-1 and sn-2 acyl 
chains  
The reactivity difference in the lipidation process by each of SynM and 
naturally occurring melittin purified from bee venom (BVM) were further 
examined, see also section 3.2.4. The only difference between them is the 
presence of phospholipase A2 (PLA2) co-purified enzyme with BVM. This 
enzyme is known to hydrolyse the acyl group at the sn-2 position of the PC to 
give the LPC (1-acyl-LPC) and free fatty acid (free FA),22-26 as shown in 
Figure 3.43. These two released components therefore change membrane 
architecture and are also known to effect membrane structure and phase 
behaviour5,8-10 (see section 1.3.1.1). This effect is shown to be larger when 
free FA and LPC are added to pre-formed membranes.8,13 In our case for 
example, the unilamellar liposomes were made first then mixed with BVM, 
which in turn was expected to release LPC and free FA by the action of 
PLA2. In addition, cone shape LPC and nearly cylindrical shape FA at 
equimolar ratio form bilayers as for PCs.27 Consequently, their role in the 
lipidation process needs to be considered. A greater role of LPC over PC in 
the lipidation process is already apparent from the work discussed earlier 
when PC:LPC were mixed (see section 3.4), while the role of FA in lipidation 
is not known exactly. A covalent link between peptide/protein and fatty acyl 
chain is shown in several studies but does not provide a clear evidence for 
the source of the acyl chain, whether it comes from PC, LPC or free FA. LC-
MS analysis of human red cells has confirmed protein post-translational 
modification (PTM) by nitrated FA in vivo.28 Further, it is also important to 
consider the amount and the activity of PLA2 enzyme in the purchased 
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sample of BVM. The major component of bee venom is shown to be 40-50% 
(w/w) melittin by dry weight and the second most abundant component is 10-
12% (w/w) of PLA2.
29 However melittin is known to enhance PLA2 activity
30,31; 
the activity of PLA2 was indicated as ≤ 0.5% according to the supplier (Sigma 
Aldrich). 
 
 
Figure 3.43. The formation of LPC and free FA by the hydrolysis of sn-2 position of PC 
by PLA2 enzyme. 
 
3.6.1. Selectivity comparison using POPC and OPPC 
Acylation selectivity of melittin towards the sn-1 and sn-2 position of 
the PC was probed using the PC regioisomers POPC and OPPC, Figure 
3.44, each isomer being a mixed-chain PC (palmitoyl (C16:0) and oleoyl 
(C18:1)) reversed positions on the glycerol core. 
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Figure 3.44. Base peak chromatogram (BPC) of melittin incubation with each of POPC 
and OPPC liposomes at 37 °Ϲ over 168 h, analysed on the Synapt G2-s using LC-MS 
Method-III (see section 8.1.2.2.1). Single acylation products are highlighted. (A) BVM 
incubation with POPC; (B) BVM incubation with OPPC; (C) SynM incubation with 
POPC; (D) SynM incubation with OPPC. 
 
 Incubating SynM with each of POPC and OPPC unilamellar 
liposomes at physiological conditions showed a slight preference towards the 
acyl group at sn-1 position of the glycerol (Figure 3.45), which is in a good 
agreement with a previous study2. The same reaction with BVM showed a 
significant difference in acyl transfer between acyl groups at the sn-1 and sn-
2 positions, as shown in Figure 3.45. There is faster formation of BVMpal over 
BVMole when using POPC. This indicates faster palmitoyl transfer than oleoyl, 
while this was the opposite in OPPC membranes. Owing to PLA2 activity on 
PCs (see Figure 3.43), PPC (1-palmitoyl-LPC) plus oleoyl FA are released by 
PLA2 hydrolysis of POPC at sn-2, while OPC (1-oleoyl-LPC) plus palmitoyl 
FA are released by PLA2 hydrolysis of OPPC at sn-2 position. Consequently, 
both POPC and the enzymatically released PPC react with BVM and produce 
the major product from palmitoyl transfer. Similarly, both OPPC and released 
OPC participate in advanced oleoyl transfer to BVM. Interestingly, there is 
also evidence of a negligible role of released free FA over a predominant 
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released LPC role in lipidation process. These results confirm the activity of 
PLA2 in spite of its low abundance in the commercial sample. In addition, 
both LPCs (PPC and OPC) are also added to the system by incubating the 
peptide (B-VM and SynM) with the PC liposomes through lipidation reaction 
(see section 3.3), however both BVM and SynM share this later reaction and 
cannot account for the dramatic difference in lipidation reactivity for both 
peptides. 
 
 
Figure 3.45. Bar chart representation of the abundance for palmitoylated melittin (Mpal) 
and oleoylated melittin (Mole) following SynM and BVM incubation with each of POPC 
and OPPC at 37 °Ϲ over 96 h and 168 h. Errors plotted as SEM of normalised peak 
area (n=3). The normalisation of Mpal or Mole was performed relative to the summation 
of peak area for (non-acylated melittin + Mpal + Mole) in the reaction medium. Peak 
areas were measured from EIC of all observed charge states for each species. 
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Increasing melittin acylation with time is visible in these lipidation 
systems (Table 3.9 and see also Figure 3.45). The results also evident are 
that the melittin reaction with OPPC is marginally faster than that for POPC 
membranes (Table 3.9 and Figure 3.45). Interestingly, comparison between 
total acylated melittin in SynM and BVM indicates faster acylation by SynM 
over BVM for both POPC and OPPC membranes (Table 3.9 and Figure 
3.45). 
 
Table 3.9. The percentage of total conversion of unmodified melittin to total lipidated 
melittin following SynM and BVM incubation with each of POPC and OPPC at 37 °Ϲ 
over 96 and 168 h, see Figure 3.45.  
Incubation Time (h) 
%Total Lipidation* 
SynM + POPC SynM + OPPC BVM + POPC BVM + OPPC 
96 15 ± 0.9 17 ± 2.2 6 ± 0.7  7.5 ± 1.6 
168 26 ± 1.0 31 ± 1.4 11 ± 0.8 14.5 ± 1.0 
*Total lipidation product includes palmitoylated melittin plus oleoylated melittin (Mpal + Mole). 
Errors represent SEM of normalised peak area (n=3). 
 
To more closely mimic natural membranes in their lipid composition, a 
binary lipid system of biological relevance for PC:PS (4:1) was included in 
this study. This binary lipid system is also important to study the effect of lipid 
classes, PC (neutral) and PS (negative), on the lipidation of BVM. This is 
because earlier reports showed that melittin has a greater binding affinity for 
the membrane in the presence of negatively charged lipids.2,32-36 In addition, 
to differentiate between the effect of PS and PC post acyl transfer, different 
acyl chains on the PS have been used. The presence of stearoylated and 
linoleoylated BVM (BVMste and BVMlin) is an evident for PS participating in 
non-enzymatic acyl transfer (Figure 3.46) but at a lower level than that for PC 
(Table 3.10). This is consistent with the lower ratio of PS relative to PC in 
accordance with the composition of lipid membrane, and also supporting 
earlier results3. 
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Figure 3.46. Bar chart representation of the abundance for palmitoylated BVM 
(BVMpal), oleoylated BVM (BVMole), stearoylated BVM (BVMste) and linoleoylated BVM 
(BVMlin) following BVM incubation with each of POPC:SLPS and OPPC:SLPS at a ratio 
(4:1)  at 37 °Ϲ over 24 and 72 h. The samples were analysed on the LQFT using LC-MS 
Method-I (see section 8.1.2.1.1). Errors plotted as SEM of normalised peak area (n=2). 
The normalisation for each single acylation were performed relative to summation of 
peak area for (non-acylated BVM + BVMpal + BVMole + BVMste + BVMlin) in the reaction 
medium. Peak areas were measured from EIC of all observed charge states. 
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Table 3.10. The percentage of total conversion of unmodified BVM to lipidated BVM 
followed BVM incubated with each of POPC:SLPS and OPPC:SLPS (4:1) at 37 °Ϲ over 
24 and 72 h, see Figure 3.46.  
Incubation 
Time (h) 
% Total Lipidation* 
%Lipidation by PC + PS %Lipidation by PC  %Lipidation by PS  
BVM + 
POPC:SLPS 
BVM + 
OPPC:SLPS 
BVM + 
POPC:SLPS 
BVM + 
OPPC:SLPS 
BVM + 
POPC:SLPS 
BVM + 
OPPC:SLPS 
24 6 ± 2.7 4 ± 0.7 5.5 ± 2.5  3 ± 0.5 0.6 ± 0.9 0.5 ± 0.6  
72 15 ± 3.4 9  13 ± 3.1 6.5  2 ± 1.4 2.5  
*Total lipidation product include: BVMpal + BVMole + BVMste + BVMlin, for lipidation by PC + 
PS; BVMpal + BVMole, for lipidation by PC; BVMste + BVMlin, for lipidation by PS. Errors 
represent SEM of normalised peak area (n=2). 
 
In addition, comparing the relative ratio of acyl transfer from PC to 
BVM in the absence and presence of PS (see Tables 3.9 and 3.10 
respectively) shows that PS lipid enhances acyl transfer from PC to BVM, 
predominantly noticed in POPC system over OPPC. This is visible in the 
formation of 13% lipidated BVM over 72 h by neutral PC for 
BVM/POPC:SLPS system (see Table 3.10) relative to 6% conversion over 96 
h for BVM/POPC system (see Table 3.9), in agreement with the previous 
studies2.3. Moreover, faster stearoylation over linoleoylation (see Figure 
3.46), particularly clear over 72 h, is additionally supporting PLA2 activity in 
BVM to hydrolyse SLPS at its sn-2 position25,37-39 to release SPS as 
lysophospholipid, and this is in turn reacts with BVM in addition of its reaction 
with SLPS lipid.     
 For further investigation into PLA2 activity, LPC generation in the 
reaction medium was followed. A significant difference between PPC and 
OPC peak intensities was shown following incubation BVM with each of 
POPC and OPPC, while this difference is less significant for SynM (see 
Figure 3.44). This is very evident from Figure 3.47, which shows the peak 
area for each LPC during SynM and BVM reaction with each of POPC and 
OPPC liposomes. Much greater abundance of 1-acyl-LPC (PPC in POPC 
and OPC in OPPC) than 2-acyl-LPC in BVM reaction with artificial membrane 
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confirms PLA2 activity on sn-2 position, while both LPC by-products have a 
comparable abundance in SynM reaction with artificial membranes. 
 
 
Figure 3.47. Bar chart representation of PPC and OPC abundance following SynM and 
BVM incubation with each of POPC and OPPC at 37 °Ϲ over 96 and 168 h. Errors 
plotted as y-axis SEM of the peak area (A), when n=3. Peak areas were measured from 
EIC. 
 
3.6.2. Reaction with OPC:DPPC 
The role of PLA2 activity on PCs was extended in a parallel 
experiment comparing SynM and BVM reactions with 50:50 OPC:DPPC, 
Figure 3.48. SynM shows greater reactivity towards LPC over PC, yet again 
demonstrating faster formation of SynMole from the LPC over SynMpal from 
the PC throughout the different incubation times. On the other hand, BVM 
shows a competition between palmitoylation and oleoylation products. This is 
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because the presence of PLA2 naturally within BVM solution will hydrolyse 
DPPC first to release PPC in addition of its formation during aminolysis 
reaction between BVM and DPPC. This reflects in increasing the amount of 
PPC in the reaction medium over time and thus increasing the amount of 
palmitoyl transfer. Comparing SynM and BVM reactivity towards lipidation in 
this experiment, once more, shows SynM to have faster reactivity than that 
for BVM. This is calculated from the extent of melittin conversion to acylated 
melittin (Figure 3.48). The total conversion of non-acylated SynM to acylated 
SynM increased from ≈ 3% to 75% by increasing incubation time from 3h to 
168 h, while during this time the extent of BVM conversion is ≈ 1% to 50%. 
This is consistent with the earlier results described for SynM vs BVM 
reactivity in 50:50 PPC:OPC (see section 3.2.4).    
 
 
Figure 3.48. Bar chart representation of the abundance for palmitoylated melittin (Mpal) 
and oleoylated melittin (Mole) following SynM and BVM incubation with 50:50 
OPC:DPPC at 37 °Ϲ over different incubation times. The samples were analysed on 
the LTQFT using LC-MS Method-I (see section 8.1.2.1.1). Errors plotted as SEM of 
normalised peak area (n=2). Peak areas were measured from EIC of all observed 
charge states. The normalisation of melittin single acylation was performed as 
described in Figure 3.45.  
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3.7. Conclusion 
The diversity and complexity of biological membranes was simplified 
to include the most abundant lipid membrane, PC, and/or the less abundant 
lipid species, LPC, in the mimicked membrane to explore non-enzymatic fatty 
acyl transfer to melittin. The orientation of melittin helix in the plane of PC 
membrane and the penetration to approximately the depth of the glycerol 
groups of the lipid2,40 is consistent with the acyl transfer from PC membrane 
to the nucleophilic groups of melittin. Acyl transfer from LPCs herein also 
indicates a close proximity between melittin reactive groups and LPC 
carbonyl group of the acyl chain. The structure of monomeric melittin as α-
helical conformation within PC membranes40,41 or LPC micelles42 has been 
confirmed by different methods of analysis, including NMR,41,42 oriented 
circular dichroism (OCD) and X-ray diffraction40. Interestingly, for the first 
time, analysis for LPCs involved in the lipidation process is shown to behave 
differently than PCs counterpart. LPCs have greater reactivity than PCs, 
evident from melittin aminolysis reaction. This suggests a change in melittin 
orientation within LPC through a deeper penetration into the hydrophobic 
core of LPC micelle. This is also shown to have an effect in altering the 
proportion of selectivity on N-terminus > K23 by PC membrane bilayer phase 
to K23 > N-terminus by LPC micelle phase. The most reactive sites for 
acylation was found to be on N-terminal and K23 amino groups, while K7 and 
K21 amino groups together with hydroxyl group of S18 and guanidinium 
group of R22 and R24 are the less reactive sites. This is in agreement with 
the results described by Dods et al. for the contribution of amine basicity and 
the location of lipidated sites on the rate of melittin acylation. In addition, 
higher selectivity towards palmitoylation vs oleoylation is also confirmed 
herein via a competition of acyl transfer from PPC:OPC at equal mole ratio. 
This is clearly not related with the difference in the position of acyl chain 
and/or difference in ionisation efficiency of palmitoyl and oleoyl acyl chains, 
as both PPC and OPC are involved in acyl transfer from sn-1 position and 
with having similar ionisation efficiency. Consequently, melittin favours 
aminolysis reaction with saturated fatty acyl chain, palmitoyl, over 
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unsaturated fatty acyl chain, oleoyl, coming from the same sn-position of the 
lipid.    
The lipidation reaction is also found to be independent of PCs phase 
behaviour, as both DPPC gel phase and DOPC liquid crystalline phase 
membranes have shown similar results. This illustrates that changing the 
physical state of lipid-bilayer does not have an influence on changing melittin 
orientation in the PC membrane and therefore the extent of aminolysis 
reaction in melittin:DPPC vs melittin:DOPC is not affected. Consequently, the 
reactivity between lipid membrane and bound peptides/proteins can be 
expected in all membrane phases. The two sources of melittin peptide, SynM 
(PLA2-free) and BVM (containing PLA2), have shown to be acylated non-
enzymatically by artificial membranes under physiological conditions but at 
different reactivity.  It is interesting to see that lipidated melittin can be used 
as a probe to follow PLA2 activity towards PLs, and this can be applied in 
different PL systems to follow this activity. Overall, there is a broad 
relationship between lipid membrane and peptides/proteins, and this relation 
is further complicated by the peptide:membrane remaining attached together 
for longer durations. This was found by confirming the transfer of the second 
and third acyl chain in addition of single acylation. However, LC-MS can still 
deal with this complexity and provide basics for better understanding the 
insight of the biological membrane process. Consequently, melittin lipidation 
opens a gate to deal with unknown peptide/protein modifications occur in 
nature via non-enzymatic process and particularly important for long-lived 
proteins. 
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Chapter four: New insight to integral membrane 
protein (AQP0) lipidation by membrane lipids 
 
 
 
One of the most abundant integral membrane protein in mammals 
which is produced by lens fibre cells is AQP0, also called aquaporin-0, major 
(membrane) intrinsic protein, MIP, MIP26, and MP26. This protein was 
shown to undergo a range of post-translational modifications (PTM) with age, 
that effect cellular processing and disease. It was hypothesised that AQP0 
was lipidated by transfer from membrane through documenting oleoylated 
and palmitoylated AQP0.1 Therefore if this is true then there should be more 
than oleoyl and palmitoyl fatty acyl chains. The application of improved liquid 
chromatography coupled to mass spectrometry (LC-MS) herein reported for 
the first time a broad lipidation profile at both positions of N-terminus (M1) 
and K238 sites of AQP0 in both bovine and human eye lenses. Interestingly, 
the lipidation profile at both sites is shown to reflect the fatty acid composition 
of the cytoplasmic membrane leaflet proximal to the site of lipidaion.*2  
 
 
 
 
 
*Some of the results described in this chapter have also been reported in the 
following publication: Ismail, Vian S., Jackie A. Mosely, Antal Tapodi, Roy A. 
Quinlan, and John M. Sanderson. "The lipidation profile of aquaporin-0 
correlates with the acyl composition of phosphoethanolamine lipids in lens 
membranes." Biochimica et Biophysica Acta (BBA)-Biomembranes, 1858 
(2016): 2763-2768. 
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4.1. Analysis of the intact AQP0 from four different regions 
of bovine eye lens (b-AQP0) 
4.1.1. The identification of b-AQP0 modifications by ESI-LC-MS  
Integral membrane proteins have two distinct properties that introduce 
some challenges for their analysis by MS; they are hydrophobic in nature and 
are low in abundance.3,4 Despite AQP0’s hydrophobicity5 and increasing its 
hydrophobicity by lipidation modification,1,6,7 the protein was analysed and 
characterised herein as its intact form by using an MS friendly surfactant of 
pentafluorooctanoic acid (PFOA). PFOA is a volatile surfactant and it has 
been successfully used here for the first time to solubilise b-AQP0 membrane 
protein. The novel advantage of this surfactant is already described to 
solublise membrane protein pellet as well as its compatibility with MS 
because of its low boiling point and volatility.8 The four different age fractions 
of bovine AQP0 (b-AQP0) are b-AQP0-outer cortex, b-AQP0-inner cortex, b-
AQP0-outer nucleus, and b-AQP0-inner nucleus, Figure 4.1. All protein age 
fractions were solubilised with PFOA surfactant and analysed directly as the 
intact form by LC-MS (see section 8.2.2.1.1, for experimental details). 
It is interesting to know that, although the lens diameter decreases by 
moving from OC to the IN of the lens and thus expecting higher density of 
AQP0 in OC and decreases by moving towards IN, but a comparable amount 
of AQP0 is proposed in all of the four fractions. This is because graded 
refractive index in squid lenses has shown that proteins are densely packed 
in the nucleus fraction, while low protein density is found in the cortex 
fraction.9    
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Figure 4.1. Schematic diagram of bovine eye lens fractions according to the diameter 
of the membrane pellet. Different lens age fractions include OC = outer cortex (15 
mm); IC = inner cortex (10 mm); ON = outer nucleus (8 mm); IN = inner nucleus (4 
mm). 
 
The total ion chromatogram with a number of peaks eluting between 
6-14 min of the chromatogram was produced from LC-MS analysis of b-
AQP0-OC, as shown in Figure 4.2. The mass deconvolution spectrum was 
generated from the averaged MS spectrum over 9.7-10.9 min of the 
chromatogram, which contains several isotopomer envelopes (Figure 4.3).  
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Figure 4.2. Total ion chromatogram (TIC) of intact b-AQP0-OC analysis on the LTQFT 
using LC-MS Method-I (see section 8.1.2.1.1). The main peak in the chromatogram 
represents b-AQP0, the deconvolution mass spectrum [M + H]
+ 
over 9.7-10.9 min is 
shown in Figures 4.3 and 4.5. Lysophospholipids (LPL) and diacylphospholipids (PL) 
eluted around 6-10 min and 11-14 min of the chromatogram respectively.  
 
 
 
Figure 4.3. Deconvoluted mass spectrum at 9.7-10.9 min of the LC gradient from the 
provided chromatogram (see Figure 4.2) for the protonated species [M + H]
+
, modeled 
as a Gaussian distribution. Details provided in Table 4.1. 
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The most intense peak at m/z 28225.0 corresponds to the most 
abundant isotope for [M + H]+. Comparing this measured mass with the 
theoretical most abundant isotope [M + H]+ at m/z 28222.95, calculated from 
amino acid sequence of unmodified b-AQP0 (Figure 4.4), indicates a mass 
shift of 2.05 Da relative to unmodified b-AQP0. This suggests the presence of 
two asparagine (N) or glutamine (Q) deamidation sites on the analysed b-
AQP0, in agreement with the protein deamidation in previous reports1,5. 
Looking to the higher mass range, a number of low abundance species were 
observed and are assigned for b-AQP0 modification with phosphorylation, 
acylation, and some adduct ions added to the protein during sample 
preparation and storage process, details tabulated in Table 4.1. 
Lysophospholipids (LPL) and diacylphosholipids (PL) were also observed 
within this sample and eluted around 6-10 and 11-14 min respectively. 
 
 
Figure 4.4. Amino acid sequence for b-AQP0 obtained from (Uniprot entry P06624, 
http://www.uniprot.org/uniprot/P06624), with an average neutral mass of 28222.7 Da. 
The two reported sites of acylation, N-terminus (M1) and K238,
1
 highlighted in red. 
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Table 4.1. The identified modified proteins in deconvolved spectra of b-AQP0-OC.  
Entry m/z Meas
‡
 Mass Shift* Assignment of Identified Modifications 
1 28246.9 21.9 Na  
2 28266.9 41.9 Acetyl or Azide  
3 28304.9 79.9 P (Phosphorylation) 
4 28327.0 102.0 Na + P  
5 28358.9 133.9 Na + P + 2 × O (Oxidation)  
6 28463.2 238.2 Palmitoyl (C16:0)  
7 28489.1 264.1 Oleoyl (C18:1)  
8 28491.1 266.1 Stearoyl (C18:0)  
9 28513.1 288.1 Dihomo-γ-linolenoyl (C20:3)  
10 28515.0 290.0 Eicosadienoyl (C20:2)  
11 28535.1 310.1 Docosahexaenoyl (C22:6)  
12 28537.1 312.1 Docosapentaenoyl (C22:5)  
13 28543.5 318.5 Docosadienoyl (C22:2)  
14 28569.1 344.1 Oleoyl (C18:1) + P  
15 28571.1 346.1 Tetracosadienoyl (C24:2) or Stearoyl (C18:0) + P  
16 28623.4 398.4 Palmitoyl (C16:0) +  2 × P  
17 28627.2 402.2 Eicosadienoyl (C20:2) + P + 2 × O  
18 28749.1 524.1 Oleoyl (C18:1) + Linolenoyl (C18:3)  
19 28807.1 582.1 Palmitoyl (C16:0) + Oleoyl (C18:1) + P  
20 28823.3 598.3 Palmitoyl (C16:0) + Oleoyl (C18:1) + P + O  
21 28825.3 600.3 Palmitoyl (C16:0) + Stearoyl (C18:0) + P + O  
‡Meas: measured most abundant isotope, obtained from deconvolution spectrum [M + H]+ 
(see Figures 4.3 and 4.5). 
*Mass shifts calculated from the most abundant b-AQP0 at m/z 28225.0 (see Figure 4.3) and 
thus all modifications matches contain double deamidation. 
 
 
The use of sodium azide during storing membrane pellets to prevent 
bacterial growth (see section 8.2.1.2) accounts for some of the adduct ions 
observed for the intact b-AQP0 (Table 4.1, entries 1 and 2). Both adducts 
azide (N3
-) and acetyl (C2H3O) are proposed for the protein modification with 
the mass shift of 41.9 Da, however protein acetylation is more likely herein. 
This is because azide is unstable and anion organic molecule and more likely 
to form anionic adducts in the negative ion mode (ESI-). In addition, Gutierrez 
et al. also reported acetylation on AQP0 through direct tissue profiling.6 The 
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second most abundance envelope (Figure 4.3) at m/z 28304.9 is shown to be 
for phosphorylated b-AQP0 as there is 79.9 Da mass shift (Table 4.1, entry 
3). This phosphorylation modification is already documented for b-AQP0.5,10-
13 Protein modification with double oxidation is also observed (Table 4.1, 
entry 5), supporting previous studies.5 The oxidation process in lens can take 
place by photo and/or chemical oxidation which in turn has influence on lens 
constituents of lipids and proteins.14 These modifications followed by a series 
of species between 28450-28850 Da, suggested for b-AQP0 single acylation 
(Figure 4.5 A and panel B) and double acylation (Figure 4.5 C).  
 
 
Figure 4.5. Magnified regions of b-AQP0-OC single acylation and double acylation 
(see Figure 4.3) from deconvoluted mass spectrum for [M + H]
+
. (A) b-AQP0-OC single 
acylation at m/z 28450-28650, the insert spectrum (B) represents overlapping envelops 
of stearoyl (C18:0) with the most abundant oleoyl (C18:1), stearoyl peaks highlighted 
in blue; (C) b-AQP0-OC double acylation at m/z 28700-28850. Details provided in Table 
4.1. 
 
The most abundance species among this series is proposed to be for 
b-AQP0 oleoylation (C18:1) with 264.1 Da mass shift (Table 4.1, entry 7). In 
addition, a mass shift of 238.2 Da is also visible (Table 4.1, entry 6), which is 
consistent with the addition of palmitoylation modification (C16:0). These two 
PTMs in mammalian lenses have been documented in numerous 
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studies.1,6,7,15 Interestingly, the mass resolution is sufficient to resolve protein 
stearoylation (C18:0) from oleoylation (C18:1), Figure 4.5 panel B and Table 
4.1 entry 8. This novel acylation with other longer polyunsaturated acyl 
chains (C20, C22 and C24) were also observed here for the first time, Table 
4.1, entries 9-13. Most of the observed acylation modifications were also 
found together with phosphorylation (Table 4.1, entries 14-16) and/or 
oxidation (Table 4.1, entries 17, 20 and 21). It is difficult to assign the peak 
with m/z 28571.1 whether it represents modified b-AQP0 by tetracosadienoyl 
(C24:2) or stearoyl (C18:0) plus phosphorylation (Table 4.1, entry 15), 
because each of which provide 346.3 Da and 346.2 Da of theoretical 
monoisotopic mass respectively. Further, the possibility of b-AQP0 acylation 
with two acyl groups is also observed in this fraction but at low abundance 
(Figure 4.5 C and Table 4.1, entries 18-21). Coupling of two acyl chains with 
b-AQP0 had not been reported previously in vivo and shows the possibility of 
transfer of more than one acyl chain to the protein. 
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Moving from the outer part of the lens cortex fraction (OC) to the older 
fraction of the cortex (IC) is still evident the presence of intact b-AQP0 
together with a number of modification envelopes, as shown in Figure 4.6 
and Table 4.2.  
 
 
Figure 4.6. Deconvoluted mass spectrum at 9.7-10.9 min of the LC gradient for the 
protonated species [M + H]
+
 in the inner cortex (IC) fraction, modeled as a Gaussian 
distribution. Details provided in Table 4.2. 
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Table 4.2. The identified modified proteins in deconvolved spectra of b-AQP0-IC. 
Entry m/z Meas
‡
 Mass Shift* Assignment of Identified Modifications 
1 28246.8 21.8 Na  
2 28266.9 41.9 Acetyl  
3 28282.8 57.8 Acetyl + O 
4 28304.9 79.9 P 
5 28326.9 101.9 Na + P  
6 28463.2 238.2 Palmitoyl (C16:0)  
7 28489.2 264.2 Oleoyl (C18:1)  
8 28491.3 266.3 Stearoyl (C18:0)  
9 28513.0 288.0 Dihomo-γ-linolenoyl (C20:3)  
10 28514.9 289.9 Eicosadienoyl (C20:2)  
11 28529.1 304.1 Dihomo-γ-linolenoyl (C20:3) + O 
12 28535.2 310.2 Docosahexaenoyl (C22:6)  
13 28537.0 312.0 Docosapentaenoyl (C22:5)  
14 28543.2 318.2 Docosadienoyl (C22:2)  
15 28569.0 344.0 Oleoyl (C18:1) + P  
16 28571.1 346.1 Tetracosadienoyl (C24:2) or Stearoyl (C18:0) + P  
17 28623.0 398.0 Palmitoyl (C16:0) +  2 × P  
18 28743.3 518.3 Palmitoyl (C16:0) + Oleoyl (C18:1) + O 
19 28771.3 546.3 Oleoyl (C18:1) + Stearoyl (C18:0) + O 
20 28795.9 570.9 Oleoyl (C18:1) + Eicosadienoyl (C20:2)  + O 
21 28807.0 582.0 Palmitoyl (C16:0) + Oleoyl (C18:1) + P  
22 28823.2 598.2 Palmitoyl (C16:0) + Oleoyl (C18:1) + P + O  
23 28825.1 600.1 Palmitoyl (C16:0) + Stearoyl (C18:0) + P + O  
‡Meas: measured most abundant isotope, obtained from deconvolution spectrum [M + H]
+
 
(see Figures 4.6 and 4.7). 
*Mass shifts calculated from the most abundant b-AQP0 at m/z 28225.0 (see Figure 4.6) and 
thus all modifications matches contain double deamidation. 
 
 
 
 
 
 
 
168 
 
Similarly, single acylated and double acylated b-AQP0 are still visible 
in this fraction of b-AQP0-IC (Figure 4.7 and Table 4.2). This illustrates the 
lens composition similarity in both outer and inner fractions of the lens cortex. 
It is visible that more oxidation found with acylated b-AQP0-IC than b-AQP0-
OC, suggesting increasing the level of oxidation in the lens with age. 
Increasing the level of protein oxidation with increasing lens age is 
documented in different studies.16-18 Interestingly, higher level of protein 
oxidation (oxidative damage) has also shown to be directly related with the 
lens cataract.16-18 
 
 
Figure 4.7. Magnified regions of b-AQP0-IC single acylation and double acylation (see 
Figure 4.6) from deconvoluted mass spectrum for [M + H]
+
. (A) b-AQP0-IC single 
acylation at m/z 28450-28650; (B) b-AQP0-IC double acylation at m/z 28700-28850. 
Details provided in Table 4.2. 
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 The older lens fraction, b-AQP0-ON, with a range of modified species 
were recorded, as shown in Figure 4.8 and Table 4.3.  
 
 
Figure 4.8. Deconvoluted mass spectrum at 9.7-10.9 min of the LC gradient for the 
protonated species [M + H]
+
 in the outer nucleus (ON) fraction, modeled as a Gaussian 
distribution. Details provided in Table 4.3. 
 
Table 4.3. The identified modified proteins in deconvolved spectra of b-AQP0-ON. 
Entry m/z Meas
‡
 Mass Shift* Assignment of Identified Modifications 
1 28246.9 22.0 Na  
2 28266.9 42.0 Acetyl  
3 28278.9 54.0 Na + 2 × O  
4 28282.9 58.0 Acetyl + O 
5 28304.8 79.9 P 
6 28326.9 102.0 Na + P  
7 28384.8 159.9 2 × P  
8 28463.4 238.5 Palmitoyl (C16:0)  
9 28489.1 264.2 Oleoyl (C18:1)  
10 28491.2 266.3 Stearoyl (C18:0)  
11 28513.2 288.3 Dihomo-γ-linolenoyl (C20:3)  
12 28515.0 290.1 Eicosadienoyl (C20:2)  
13 28529.0 304.1 Dihomo-γ-linolenoyl (C20:3) + O 
14 28535.2 310.3 Docosahexaenoyl (C22:6)  
15 28539.1 314.2 Docosatetraenoyl (C22:4)  
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16 28543.0 318.1 Docosadienoyl (C22:2)  
17 28569.1 344.2 Oleoyl (C18:1) + P  
18 28571.1 346.2 Tetracosadienoyl (C24:2) or Stearoyl (C18:0) + P  
19 28807.1 582.2 Palmitoyl (C16:0) + Oleoyl (C18:1) + P  
20 28825.4 600.5 Palmitoyl (C16:0) + Stearoyl (C18:0) + P + O  
‡Meas: measured most abundant isotope, obtained from deconvolution spectrum [M + H]
+
 
(see Figures 4.8 and 4.9). 
*Mass shifts calculated from the most abundant b-AQP0 at m/z 28224.9 (see Figure 4.8) and 
thus all modifications matches contain double deamidation. 
 
 
All single acylation modifications in this fraction (Figure 4.9 A) are 
consistent with the previous recorded acylations in the cortex fractions (see 
Tables 4.1 and 4.2) except docosatetraenoyl (C22:4), Table 4.3, entry 15. 
Interestingly, fewer double acylation modifications were observed in this 
fraction, as shown in Figure 4.9B. 
 
 
Figure 4.9. Magnified regions of b-AQP0-ON single acylation and double acylation 
(see Figure 4.8) from deconvoluted mass spectrum for [M + H]
+
. (A) b-AQP0-ON single 
acylation at m/z 28450-28650; (B) b-AQP0-ON double acylation at m/z 28700-28850. 
Details provided in Table 4.3. 
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The oldest section of the lens, b-AQP0-IN, with all identified 
modifications are shown in Figure 4.10 and Table 4.4. The number of 
observed single and double acylated b-AQP0 in this fraction is much less 
than the identified acylations in the other fractions (see Figures 4.5, 4.7 and 
4.9), as shown in Figure 4.11. It is interesting to see that triple and quadruple 
oxidation products is only observed in this fraction (Table 4.4, entries 14 and 
15), this is additionally suggest higher level of oxidation in older lens 
fractions. 
 
 
Figure 4.10. Deconvoluted mass spectrum at 9.7-10.9 min of the LC gradient for the 
protonated species [M + H]
+
 in the inner nucleus (IN) fraction, modeled as a Gaussian 
distribution. Details provided in Table 4.4. 
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Table 4.4. The identified modified proteins in deconvolved spectra of b-AQP0-IN. 
Entry m/z Meas
‡
 Mass Shift* Assignment of Identified Modifications 
1 28246.7 21.8 Na  
2 28266.7 41.8 Acetyl  
3 28282.9 58.0 Acetyl + O 
4 28304.8 79.9 P 
5 28326.9 102.0 Na + P  
6 28347.3 122.4 Acetyl + P  
7 28358.8 133.9 Na + P + 2 × O  
8 28384.8 159.9  2 × P  
9 28463.2 238.3 Palmitoyl (C16:0)  
10 28489.5 264.6 Oleoyl (C18:1)  
11 28491.2 266.3 Stearoyl (C18:0)  
12 28513.0 288.1 Dihomo-γ-linolenoyl (C20:3)  
13 28515.1 290.2 Eicosadienoyl (C20:2)  
14 28616.3 391.4 Oleoyl (C18:1) + P + 3 × O    
15 28871.4 646.5 Palmitoyl (C16:0) + Oleoyl (C18:1) + P + 4 × O  
‡Meas: measured most abundant isotope, obtained from deconvolution spectrum [M + H]
+
 
(see Figures 4.10 and 4.11). 
*Mass shifts calculated from the most abundant b-AQP0 at m/z 28224.9 (see Figure 4.10) 
and thus all modifications matches contain double deamidation. 
 
 
Figure 4.11. Magnified regions of b-AQP0-IN single acylation and double acylation 
(see Figure 4.10) from deconvoluted mass spectrum for [M + H]
+
. (A) b-AQP0-IN single 
acylation at m/z 28450-28650; (B) b-AQP0-IN double acylation at m/z 28700-28900. 
Details provided in Table 4.4. 
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Moreover, for the set of samples processed and analysed in one 
batch, a distinct difference can be seen in the abundance of b-AQP0 in 
moving from the cortex (younger) to the nucleus (older) fractions of the lens, 
as shown in Figure 4.12. This is in agreement with the reduction in the signal 
intensity of the intact AQP0 as a result of increasing protein truncation and 
other PTMs in the nucleus fraction of the lens.6,7 Consequently, a 
heterogeneous population of AQP0 species is introduced.7 Interestingly, a 
relative ratio between non-acylated b-AQP0 and acylated b-AQP0 for the 
most abundant oleoyl product (see Figures 4.2, 4.6, 4.8 and 4.10) has shown 
a comparable amount of oleoylation in the three fractions of OC, IC and ON, 
but with the lowest amount in IN. Therefore, it is proposed that increasing 
protein homogeneity causes ion suppression and resulting in decreasing 
sensitivity to detect low abundance species. However, the relation between 
acylated b-AQP0 and lens age can be further characterised through 
quantitative analysis of digested samples, this can be found in later sections 
in this chapter (see section 4.2). 
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Figure 4.12. Combined extracted ion chromatogram (EIC) for intact b-AQP0 at m/z 
831.2 (z=34), 911.5 (z=31), 1046.4 (z=27), 1086.6 (z=26), 1177.0 (z=24) and 1345.0 (z=21) 
for all the four different bovine lens fractions including (A) OC; (B) IC; (C) ON; (D) IN. 
Analysed on LTQFT using LC-MS Method-I (see section 8.1.2.1.1). 
 
4.1.2. The identification of truncated proteins by ESI-LC-MS 
 C-terminal truncation of b-AQP0 is observed at different sites (Figure 
4.13 and Table 4.5), in agreement with the previous recorded truncations.13,19 
Interestingly, AQP0 truncations at K238 (Table 4.5, entries 1 and 2) and E244 
(Table 4.5, entry 3) are observed herein for the first time. The most abundant 
truncation site at T260 (Table 4.5, entry 7) is consistent with the previous 
study.13 This truncated protein (1-260) is also found to be phosphorylated 
(Table 4.5, entries 8 and 9) or oleoylated (Table 4.5, entry10). The results 
also show that the number of observed truncated proteins decrease in 
moving from the older section of the lens (Figure 4.13 A and B) to the cortex 
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fraction (Figure 4.13 C), consistent with reports for age dependent truncation 
in bovine13,19 and human lenses6,7,20,21. 
 
 
Figure 4.13. Deconvoluted mass spectra at 9.7-10.9 min of the LC gradient for the 
protonated species [M + H]
+
 in the fractions (A) IN, (B) ON and (C) IC, modeled as a 
Gaussian distribution. Details provided in Table 4.5. 
 
Table 4.5. The identified truncated proteins in deconvolved spectra of b-AQP0-IN. 
Entry m/z Meas* 
C-terminal 
Truncation Site 
Assignment of Identified Truncation Proteins 
1 25630.5 K238 (1-238) + Deamidation 
2 25711.5 K238 (1-238) + P + 2 × Deamidation  
3 26244.9 E244 (1-244) + 2 × Deamidation 
4 26447.0 E246 (1-246) + 2 × Deamidation 
5 26526.9 E246 (1-246) + P + 2 × Deamidation  
6 27058.4 T252 (1-252) + 2 × Deamidation 
7 27911.8 T260 (1-260) + 2 × Deamidation 
8 27992.6 T260 (1-260) + P + 2 × Deamidation  
9 28094.7 T260 (1-260) + 2 ᵡ P + Na + 2 × Deamidation  
10 28176.6 T260 (1-260) + Oleoyl (C18:1) + 2 × Deamidation  
*Meas: measured most abundant isotope, obtained from deconvolution spectrum [M + H]
+
, 
(see Figure 4.13). 
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4.1.3. The identification of neutral lipid classes in bovine lens by ESI-
LC-MS  
 The inner leaflet of mammalian cytoplasmic membranes is rich with 
phosphatidylethanolamine (PE), phosphatidylserine (PS) and 
phosphatidylinositol (PI), while the outer (exoplasmic) leaflet is rich with 
sphingomyelin (SM) and phosphatidylcholine (PC) which reflects the 
asymmetric nature of the membrane.22 LC-MS analysis of b-AQP0 directly 
after isolation from lens samples by decapsulation and aqua–dissection 
showed the presence of a range of neutral PLs (PC, PE and SM) and as well 
as LPLs (LPE and LPCs) through ESI+ MS (Table 4.6), while negatively 
charged PLs (PI and PS) have not been included in this study of lipids. This 
is because the nature of the analysis focused around ESI+ MS to facilitate 
the detection of the protein-based compounds. Moreover, the identified PLs 
here (PC, PE and SM), Table 4.6, were also reported to be the major eye 
lens membrane lipids.14,23-28  
In addition, the presence of 19 plasmalogen PE (Table 4.6, entries 47, 
50-52, 54, 57-60, 65-72, and 75-76) relative to 11 PE (Table 4.6, entries 48, 
49, 53, 55, 56, 61-64, 73 and 74) suggest the abundance of PE that exists as 
plasmalogen (PEpl) lipid. This is supported in previous studies by reporting 
the presence of major PE lipids in the form of PEpl.23,24,29 Plasmalogen PE 
lipids are biosynthesized in peroxisomes.30,31 Mutations in the enzymes that 
are responsible for their synthesis changes their cellular level. Consequently, 
their deficiency causes several disease related to brain, lens and bone 
development.30,31 The results here also show SM association with palmitoyl 
(C16:0) and nervonoyl (C24:1), Table 4.6, entries 15, 18 and 20-23, in good 
agreement with reports of SM rich with these identified fatty acyl 
chains14,24,25,27,32. 
 
 
 
177 
 
Table 4.6. Free neutral PLs and LPLs identified in the four fractions of bovine lens 
extracts. LPLs and PLs eluted at 6-10 min and 11-14 min of the chromatogram 
respectively (see Figure 4.2).  
Entry Lipid Class Theor* m/z
 
[M + H]
+ 
Meas m/z [M + H]
+
 
Error 
(ppm) 
1 LPC (14:0) 468.3085 468.3087 0.4 
2 LPC (16:1) 494.3241 494.3244 0.6 
3 LPC (16:0) 496.3398 496.3399 0.2 
4 LPC (18:1) 522.3554 522.3557 0.6 
5 LPC (18:0) 524.3711 524.3714 0.6 
6 LPE (16:1) 452.2772 452.2774 0.4 
7 LPE (16:0) 454.2928 454.2931 0.7 
8 LPE (17:1) 466.2928 466.293 0.4 
9 LPE (17:0) 468.3085 468.3087 0.4 
10 LPE (18:1) 480.3085 480.3086 0.2 
11 LPE (18:0) 482.3241 482.3243 0.4 
12 LPE (19:1) 494.3241 494.3244 0.6 
13 LPE (19:0) 496.3398 496.3399 0.2 
14 LPE (22:6) 526.2928 526.2933 0.95 
15 SM (34:1) 703.5748 703.5754 0.85 
16 SM (36:1) 731.6061 731.6066 0.7 
17 SM (38:2) 757.6218 757.6229 1.45 
18 SM (40:2) 785.6531 785.6541 1.3 
19 SM (40:1) 787.6687 787.6688 0.1 
20 SM (41:2) 799.6687 799.6692 0.6 
21 SM (42:3) 811.6687 811.6696 1.1 
22 SM (42:2) 813.6844 813.6856 1.5 
23 SM (43:2) 827.7000 827.7029 3.5 
24 SM (44:2) 841.7157 841.7180 2.7 
25 PC (28:0) 678.5068 678.5075 1.0 
26 PC (29:1) 690.5068 690.5072 0.6 
27 PC (30:0) 706.5381 706.5386 0.7 
28 PC (32:1)
† 
716.5589 716.5595 0.8 
29 PC (31:1) 718.5381 718.5391 1.4 
30 PC (31:0) 720.5538 720.5548 1.4 
31 PC (32:0)
‡ 
720.5902 720.5910 1.1 
32 PC (32:3) 728.5225 728.5209 2.2 
33 PC (32:2)
 
 730.5381 730.5388 0.95 
34 PC (34:1)
†
 730.5745 730.5752 0.95 
35 PC (32:1) 732.5538 732.5543 0.7 
36 PC (32:0) 734.5694 734.5701 0.95 
37 PC (34:1)
†
 744.5902 744.5911 1.2 
38 PC (34:0)
†
 746.6058 746.6067 1.2 
39 PC (34:3) 756.5538 756.5522 -2.1 
40 PC (34:2) 758.5694 758.5713 2.5 
41 PC (36:1) 758.6058 758.6086 3.7 
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42 PC (34:1) 760.5851 760.5858 0.9 
43 PC (34:0) 762.6007 762.6015 1.05 
44 PC (35:4) 768.5538 768.5521 -2.2 
45 PC (36:4) 782.5694 782.5682 -1.5 
46 PC (36:3) 784.5851 784.5837 -1.8 
47 PE (33:1)
†
 688.5276 688.5322 6.7 
48 PE (32:1) 690.5069 690.5421 -1.6 
49 PE (33:0) 690.5432 690.5072 0.43 
50 PE (34:2)
†
 700.5276 700.5283 1.0 
51 PE (34:1)
†
 702.5432 702.5438 0.85 
52 PE (35:2)
†
 714.5432 714.5415 -2.4 
53 PE (34:2) 716.5225 716.5225 0.0 
54 PE (35:1)
†
 716.5589 716.5595 0.8 
55 PE (34:1) 718.5382 718.5391 1.25 
56 PE (34:0) 720.5538 720.5548 1.4 
57 PE (36:4)
†
 724.5276 724.526 -2.2 
58 PE (36:3)
†
 726.5432 726.5417 -2.1 
59 PE (36:2)
†
 728.5589 728.5596 1.0 
60 PE (36:1)
†
 730.5745 730.5748 0.4 
61 PE (36:0) 732.5902 732.5924 3.0 
62 PE (36:4) 740.5225 740.5208 -2.3 
63 PE (36:3) 742.5382 742.5377 -0.7 
64 PE (36:2) 744.5538 744.5546 1.1 
65 PE (37:1)
†
 744.5902 744.5953 6.8 
66 PE (37:0)
†
 746.6058 746.6067 1.2 
67 PE (38:6)
†
 748.5276 748.5266 -1.3 
68 PE (38:5)
†
 750.5432 750.5442 1.3 
69 PE (38:4)
†
 752.5589 752.5598 1.2 
70 PE (38:3)
†
 754.5745 754.5759 1.85 
71 PE (38:2)
†
 756.5902 756.5924 2.9 
72 PE (38:1)
†
 758.6058 758.6086 3.7 
73 PE (38:5) 766.5382 766.5364 -2.3 
74 PE (38:4) 768.5538 768.5538 0.0 
75 PE (40:7)
†
 774.5432 774.5439 0.9 
76 PE (40:6)
†
 776.5589 776.5598 1.1 
*Theoretical (Theor) m/z of lipids [M + H]
+
 obtained from lipidomics gateway 
(http://www.lipidmaps.org/data/structure/LMSDSearch.php). 
†The presence of alkenyl ether (plasmalogen) substituent. 
‡The presence of alkyl ether substituent. 
 
Association of lens lipids with AQP0 showed that lipids are tightly 
integrated into the protein’s architecture where they can affect the function, 
structure, quaternary assembly, and the stability of the membrane protein.33 
The observation of intact AQP0 lipidation with different acyl chains herein 
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assumed to be reflecting this tight lipid-protein interaction in vivo. To avoid 
protein acylation by the detected lipids in vitro, the extraction of lipids were 
performed by using monophasic methanol34 or cold acetone was used to 
precipitate AQP0 protein and thus separated from insoluble PLs in acetone35. 
Both methods were successfully applied to remove PEs, PCs and SMs but 
not LPCs and LPEs. This is most likely related with LPLs higher dispersion in 
aqueous solution and thus remains attached with the protein in aqueous 
layer.  
Further, the relationship between lens membrane lipids and b-AQP0 
acylation profile has been followed by the major fatty acyl compositions found 
with bovine major lens PLs. Interestingly, the most abundant acylated b-
AQP0 in all of the four different age fractions is oleoylated b-AQP0 (Figures 
4.5, 4.7, 4.9 and 4.11 (panel A in all)), which predicted to reflect the major 
oleoyl composition associated with PE in mammals14,24,29,36. In addition, PE 
and PC were also found to be rich with palmitoyl (C16:0) and stearoyl (C18:0) 
alongside longer fatty acyl chains, reflect natural abundance24,29,32,36. 
Although SM is rich with palmitoyl (C16:0) and nervonoyl (C24:1),24 the 
contribution of SM fatty acyl chains in lipidation is not described herein. This 
is because unlike the ester-linked fatty acyl chain in PC/PE, the amide-linked 
fatty acyl chain in SM is unable to perform aminolysis reaction with proteins 
without a catalyst37. The recorded fatty acyl composition in weight% for 
bovine lens PE and PC lipids24 are given in Table 4.7.  
 
Table 4.7. Weight% of fatty acyl groups in bovine lens PE and PC lipids obtained by 
GC-MS/TLC analysis.
24 
Acyl Group Weight% in PE Weight% in PC 
C16:0 12.9 64.0 
C16:1 3.3 3.0 
C18:0 9.5 4.3 
C18:1 63.8 19.1 
C20:0 Trace 0.4 
C20:1 1.9 0.3 
C20:3 2.4
§
 Trace 
§This value represents the combination between C20:3 and C22:0 (these were not 
separated).  
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4.1.4. Analysis of the intact b-AQP0 by MALDI-MS 
 Performing further MS analysis on the same batch of samples (intact 
b-AQP0), as was shown in section 4.1.1, with MALDI-ToF-MS instrument 
showed a consistent result as was obtained on ESI-FTICR-MS by monitoring 
the intact b-AQP0 as the most abundant species in all four different age 
fractions of the lens, as shown in Figure 4.14. The measured mass of [M + 
H]+ is detected at around 28220 Da for full-length (1-263), which is a broad 
and tail peak. This is most likely related with the presence of a number of 
expected modified species with b-AQP0. This is not surprising that biological 
samples on MALDI analysis in the absence of LC separation can experience 
difficulties in the detection of poor signals such as lipidation modifications, as 
there are a large number of components competing in ionisation thus 
suppressing the efficiency to detect low abundance and higher mass species. 
The lower detection efficiency on MALDI for larger proteins is already well 
documented.38,39 This is shown to be related with the instrument issue and/or 
chemical behaviour of the ions in the gas-phase or solution-phase.38 In 
addition of singly protonated b-AQP0, doubly protonated was also detected 
at around m/z 14100. The abundance of intact b-AQP0 protein decreases by 
moving from cortex fraction to core fraction of the lens (Figure 4.14), yet 
again demonstrating increasing protein homogeneity in the older fractions of 
the lens,6,7 and consistent with the analysis performed using ESI-FTICR-MS 
(see section 4.1.1). 
Interestingly, a number of different noticeable outcomes have been 
observed between cortex and core sections of the lens. A labelled band with 
b-AQP0 (1-246) is around m/z 26400 for [M + H]+, which is an indication of C-
terminal protein truncation, confirming the previous results (Table 4.5, entry 
4). The truncated product of b-AQP0 (1-246) is hard to resolve from the noisy 
signal in b-AQP0-OC (Figure 4.14 A) but its peak intensity increases for the 
older sections of the lens and reaches its maximum amount in both b-AQP0-
ON and b-AQP0-IN (Figure 4.14 C and D). This indicates an increasing 
amount of protein truncation with increasing the age of the lens, consistent 
with the previous results (see Figure 4.13). The other outstanding difference 
between the young and old lens fractions is the presence of two overlapped 
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peaks with apices at m/z 19800 and 19900 Da, only observed in b-AQP0-OC 
fraction (Figure 4.14 A). The split peak is proposed to be α-crystallin 
protein,19,40 which is another abundant protein in lens fibre cell and found as 
αA-crystallin (1-173) and αB-crystallin (1-175) at 19790 and 20037 Da 
respectively (theoretical neutral average mass). This protein has shown to 
function as a molecular chaperone.41 Moreover, looking to the magnified 
region of α-crystallin (Figure 4.14, panel Ai) shows peak tailing. This is 
proposed to account for modifications (phosphorylation) on α-crystallin, as 
both of AQP0 and α-crystallin proteins in lens have shown to undergo a 
number of different modifications with age. In addition, the formation of 
different salt adducts and matrix adducts in MALDI-MS have also the 
influence on peak tailing and broadening of the peak. 
 
 
Figure 4.14. MALDI mass spectra for b-AQ0-OC (A), b-AQ0-IC (B), b-AQ0-ON (C) and b-
AQ0-IN (D). The insert spectrum (i) represents a magnified region around m/z 20 kDa 
of the spectrum, which is α-crystallin protein. 
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4.2. Exploring the modifications on AQP0 by LC-MS analysis 
4.2.1. Analytical approach in proteolytic analysis of bovine AQP0 (b-
AQP0) 
The intact protein analysis provides key information about the 
presence of various modifications on b-AQP0 but without assigning the site 
of modifications. However, treating b-AQP0-OC with dithiothreitol (DTT) 
reducing agent and followed by tryptic digestion has recorded a range of 
eluted peaks around 1-12.5 min of the chromatogram by LC-MS (Figure 
4.15). This can be split into three main regions; the first region contain the 
common non-acylated peptides at 1-7.5 min of the chromatogram, and the 
second region is the most interesting region where the lipidated peptide [234-
259] (Figure 4.15, Region A) and lipidated peptide [1-5] (Figure 4.15, Region 
B) were eluted over 7.3-8.0 min and 10.0-11.0 min respectively. In addition, 
the third region with the late elution time contain LPLs over 9.3-12.5 min of 
the chromatogram.  
 
 
Figure 4.15. TIC from trypsin digestion of b-AQP0-OC, analysed on LTQFT using LC-
MS Method-I (see section 8.1.2.1.1) and digestion protocol Method-A (see Table 8.1 
and section 8.2.2.1.2). The two highlighted regions (Region A) and (Region B) 
represent the regions that contain lipidated peptide [234-259] and lipidated peptide [1-
5] respectively. The most abundant peaks highlighted with asterisk around Region B 
represent LPLs. 
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 The protein cleavage sites at C-terminus of lysine (K) and Arginine 
(R) amino acid residues by trypsin were achieved to confirm about 70% of 
the protein sequence coverage (183 of 263 amino acid (AA) residues), as 
shown in Figure 4.16. Deamidation modification were identified on peptide 
[153-187], peptide [234-259], peptide [239-259] and peptide [239-263]. The 
three later deamidation residues are in agreement with the previous 
findings1,5,11,42 for non-enzymatic43,44 conversion of N246 to aspartic acid 
(D246), while, it is interesting to see that deamidated peptide [153-187] is not 
within the recorded C-terminus deamidation sites of b-AQP0. This suggests 
that deamidation does occur to the residue close to N-terminus and thus 
suggesting deamidation on either N154 or N184. In addition, phosphorylation 
and oxidation modifications were also recorded herein, covering the same 
amino acid residues reported for serine (S) phosphorylation5,10-13 and 
tryptophan (W) oxidation5. The results also support similar modifications 
found on intact b-AQP0 (see section 4.1.1). 
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Figure 4.16. The highlighted regions of the protein represent the confirmed peptides 
from b-AQP0-OC tryptic digestion, using digestion protocol Method-A (see Table 8.1 
and section 8.2.2.1.2) and LC-MS Method-I (see section 8.1.2.1.1). Peptide residues 
with the observed modifications illustrated in bright colours; peptide residues with 
more than one missed cleavages (MCL) presented on each specific sequence. Details 
tabulated in Appendix C Table 9.31.  
 
The missing portion of the protein (30% for peptide [34-85] and 
peptide [86-113]) is quite a significant portion. These two missing peptides 
are among six transmembrane domains, which are known for their spanning 
in the lipid-bilayer and are rich with neutral and non-polar amino acid 
residues (Figure 4.17)5. Consequently, their more hydrophobic nature and 
position in the membrane could be account for preventing identifying them in 
the digestion mixture. 
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Figure 4.17. “Topology of b-AQP0 with six transmembrane domains spanning the lens 
lipid-bilayer. The predicted tryptic cleavage sites of the protein highlighted in grey”. 
Reprinted with permission from, Jun Han and Kevin L. Schey, Journal of Proteome 
Research, 3, 807-812. Copyright (2004) American Chemical Society.  
 
 The two lipidated peptides, peptide [1-5] and peptide [234-259], were 
assigned herein with palmitoyl (C16:0), oleoyl (C18:1) and novel stearoyl 
(C18:0) acyl chains, as shown in Figure 4.18 and Table 4.8). The two former 
acylations were also reported previously,1,7,15 while stearoylation is not 
documented before. This is also reassures the observed lipidation species in 
the intact protein analysis. Further, the elution times for the lipidation profile 
increase in the order of palmitoyl < oleoyl < stearoyl for both peptide sets. 
This is consistent with the RT increasing by increasing the length of acyl 
chain and decreasing the number of unsaturation,45 also shown in previous 
work46,47. 
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Figure 4.18. Combined EIC for (A) peptide [234-259] at m/z 997.5610 palmitoyl (C16:0), 
m/z 1006.2328 oleoyl (C18:1) and m/z 1006.9034 stearoyl (C18:0); (B) peptide [1-5] at 
m/z 972.5945 palmitoyl (C16:0), m/z 998.6106 oleoyl (C18:1) and m/z 1000.6292 stearoyl 
(C18:0), using digestion protocol Method-A (see Table 8.1 and section 8.2.2.1.2) and 
LC-MS Method-I (see section 8.1.2.1.1). The asterisk represents the LPL elution peak 
at the indicated RT. Details provided in Table 4.8.  
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Table 4.8. The identified acylated peptides followed trypsin digestion of b-AQP0-OC. 
Theor m/z
‡
 Meas m/z
‡
 z 
RT 
(min)
 
 
Error 
(ppm) 
Assignment 
234
LSILKGSRPSESNGQPEVTGEPVELK
259
 
997.5602 997.5610 3 7.41 0.8 
Peptide [234-259] + (C16:0) + 1 × 
Deamidation/Palmitoyl 
1006.2321 1006.2328 3 7.54 0.7 
Peptide [234-259] + (C18:1) + 1 × 
Deamidation/Oleoyl 
1006.9039 1006.9034 3 7.80 -0.5 
Peptide [234-259] + (C18:0) + 1 × 
Deamidation/Stearoyl 
1
MWELR
5
 
972.5951 972.5945 1 10.24 0 Peptide [1-5] + (C16:0)/Palmitoyl 
998.6107 998.6106 1 10.40 -0.1 Peptide [1-5] + (C18:1)/Oleoyl 
1000.6264 1000.6292 1 10.90 2.8 Peptide [1-5] + (C18:0)/Stearoyl 
‡Both theoretical (Theor) and measured (Meas) m/z are for the monoisotopic peak. 
Theoretical mass obtained from mMass software. 
 
Moreover, the digestion mixture is missing lipidated peptides with 
longer acyl chains (C20, C22 and C24) that are recorded in the intact form of 
the protein. This is assumed to be related with their lower biological 
abundance and therefore lower ionisation efficiency. In addition, they are 
more hydrophobic nature so late RT and co-elution with LPLs (see Figure 
4.15 and 4.18 B) accounts for suppressing them. In summary, modified 
peptides with deamidation, phosphorylation, oxidation and acylation are 
consistent with the modifications on the intact b-AQP0. The two new 
recorded modifications here are N154 or N184 deamidation and also 
stearoylation modification on each of peptide [1-5] and peptide [234-259]. 
 
4.2.1.1. Method development: improving the LC separation and the 
proteolytic digestion 
4.2.1.1.1. Optimising the LC-MS   
 In attempt to separate co-eluting species and search for any extra 
products, the chromatography was optimised, within the limits of the 
instrumentation available. The difference between the two chromatographic 
methods is shown in Figure 4.19. 
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Figure 4.19. The two LC methods over (I) 20 min and (II) 35 min used for separating 
tryptic digestion mixture of b-AQP0 on the LTQFT. These methods described as (I) LC-
MS Method-I and (II) LC-MS Method-II in the experimental chapter (see sections 
8.1.2.1.1). The LC eluents labelled as B for 0.1% formic acid in acetonitrile and C for 
0.1% formic acid in methanol.  
 
The improved LC method (Figure 4.19 (II)) evident that LPLs are now 
eluted between 11-15 min of the chromatogram and thus no longer 
overlapped with acylated peptides which are now over 7.5-10.8 min (Figure 
4.20). Consequently, this new LC method enabled a wider range of acylated 
peptides to be detected, many of which have not been previously reported. 
Newly identified peptides are given in Figure 4.20 and further listed in detail 
in Appendix C Table 9.32. 
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Figure 4.20. Combined EIC for (A) peptide [234-259] at m/z 997.5615 palmitoyl (C16:0), 
m/z 1006.2326 oleoyl (C18:1) and m/z 1006.9040 stearoyl (C18:0); (B) peptide [1-5] at 
m/z 1014.6039 oleoyl (C18:1) + O, m/z 970.5791 palmitoleoyl (C16:1), m/z 1020.5957 
arachidonoyl (C20:4), m/z 972.5951 palmitoyl (C16:0), m/z 1022.6125 dihomo-γ-
linolenoyl (C20:3), m/z 998.6116 oleoyl (C18:1), m/z 1024.6285 eicosadienoyl (C20:2), 
m/z 1000.6272 stearoyl (C18:0) and m/z 1026.6427 eicosenoyl (C20:1). Using digestion 
protocol Method-A (see Table 8.1 and section 8.2.2.1.2) and LC-MS Method-II (see 
section 8.1.2.1.1). Details provided in Appendix C Table 9.32. 
 
The consistency between the abundance of b-AQP0 lipidation profile 
(Figure 4.21) and the fatty acyl composition for bovine lens PE lipid (see 
Table 4.7) is visible on both lipidated peptides. In addition, the abundance of 
lipidation profile on peptide [1-5] is much stronger than that on peptide [234-
259] although each peptide set has different ionisation efficiency. This is also 
account for missing C20 fatty acyl lipids on peptide [234-259]. On the other 
hand, protein modifications with acyl groups longer than C20, specifically 
C22 and C24 observed for the intact b-AQP0 (see Figure 4.5 and Table 4.1), 
were not observed as tryptic peptides. The absence of C24 is more likely 
related with its lower abundance, as observed from the lowest abundance of 
the equivalent acylated intact protein, combined with increased 
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hydrophobicity and reduced ionisation efficiency. However, although C22 acyl 
chains, (C22:2) and (C22:5), have strong abundance with intact form of 
AQP0 but still cannot be revealed by digestion. Overall, optimising LC 
conditions showed a significant improvement in detecting different novel 
acylation profile and inspired further optimisation to identify any extra 
modifications within the digestion mixture. 
 
 
Figure 4.21. The abundance of identified lipidated peptides described in Figure 4.20 
for both lipidated sites of peptide [1-5] and peptide [234-29]. The peak area (A) for 
each species has summed over all observed charge states, (z=1-2) for peptide [1-5]; 
(z=2-4) for peptide [234-259]. All acylated species of peptide [234-259] matches 
contain one deamidation. The abundance of peptide [1-5] oleoylation include the 
summation of peak area for peptide [1-5]ole and peptide [1-5]ole + O, while the other 
acylation products include just their individual peak area. Errors reported as the 
standard error of the mean (SEM) of peak area when n=2. Details are tabulated in 
Appendix C Table 9.32. 
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4.2.1.1.2. Optimising the proteolytic digestion  
 Different tryptic digestion conditions were tested with a view to 
exploring the more hydrophobic part of the membrane protein b-AQP0, the 
results are summarised in Table 4.9. Many of which were also applied in 
different studies to explore peptide mapping of hydrophobic peptides. 
 
Table 4.9. Results obtained from different digestion protocols/LC-MS methods used 
for b-AQP0-OC. *Note: details for each digestion protocol (see sections 8.2.2.1.2, and 
8.2.2.2.1) or LC-MS (see sections 8.1.2.1.1 and 8.2.2.2.1) is provided in the 
experimental chapter.   
Entry 
Digestion 
Protocol* 
LC-MS Method* Reagents 
Included 
%Protein 
Sequence 
Coverage 
Lipidation Products 
Peptide [1-5] Peptide [234-259] 
LTQFT 
1 Method-A 
LC-MS Method-I DTT 70 3 3 
LC-MS Method-II DTT 89 8 3 
2 Method-B LC-MS Method-II DTT + Urea 11 0 0 
3 Method-C LC-MS Method-II DTT + PFOA 70 8 1 
 Synapt G2-s  
4 Method-A LC-MS Method-IIII DTT 54 0 0 
5 Method-C LC-MS Method-IIII DTT + PFOA 41 0 0 
6 Method-D LC-MS Method-IIII DTT + SDS 100 10 6 
 
The detailed results for b-AQP0 digestion by using Method-A is 
already discussed in earlier section (see section 4.2.1). Further, urea is one 
of the common protein denaturant48,49 prior proteolytic digestion which has 
been also examined in this study, however one of its disadvantage is the 
effective role of urea to denature the protein only when it presents at very 
high concentration which must be diluted to a low level that is still keep the 
enzyme activity48. This massive dilution is evident in getting just 11% 
sequence coverage (Table 4.9, entry 2). On the other hand, protein 
solubilisation is another important step to increase the protein sequence 
coverage in the proteolytic digestion. The advantage of the surfactant PFOA 
for solubilising b-AQP0 as its intact form is already shown herein for the first 
time (see section 4.1.1) whilst being compatible with LC-MS. Using this 
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surfactant in combination with DTT reducing agent has shown good 
sequence coverage with a number of lipidation products (Table 4.9, entry 3). 
However, the absence of PFOA has shown to advantage in both protein 
sequence coverage and/or the number of lipidation peptides (Table 4.9, entry 
1 (LC-MS Method-II) and entry 4). Interestingly, major improvement is 
achieved by using ionic surfactant/detergent SDS (sodium dodecyl sulfate), 
which reported its compatibility with LC-MS for solubilising and denaturing 
integral membrane proteins50 (Table 4.9, entry 6). Overall, different digestion 
protocols (reagents) provide different outcomes for both protein sequence 
coverage and the number of lipidation products with regarding SDS as the 
optimum digestion condition for b-AQP0.  
 
4.2.2. Biological approach in proteolytic analysis of b-AQP0  
The advantage of SDS in protein digestion is clearly visible in 
achieving 100% protein sequence coverage with a range of modified 
peptides, as shown in Figure 4.22. 
 
193 
 
 
Figure 4.22. The highlighted regions of the protein represent the confirmed peptides 
from b-AQP0-OC tryptic digestion, using digestion protocol Method-D and LC-MS 
Method-IIII (see section 8.2.2.2.1). Peptide residues with the observed modifications 
illustrated in bright colours; peptide residues with more than one missed cleavages 
(MCL) presented on each specific sequence. Details tabulated in Appendix C Table 
9.33.  
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 Moreover, Protein digestion with SDS is also shown to enhance the 
detection of more hydrophobic acyl chains (C22:2 and C22:5) together with 
the other shorter acyl chains, as shown in Figures 4.23 and 4.24. 
 
 
Figure 4.23. Mass spectra for the range of acylated products for peptide [234-259] 
from trypsin digestion of b-AQP0-OC, using digestion protocol Method-D and LC-MS 
Method-IIII (see section 8.2.2.2.1). Each spectrum labelled with the acyl group identity, 
see Appendix C Table 9.34 for detailed information about the acyl groups added to the 
peptide [234-259]. The lines were made thicker just to stand out the peaks of interest.  
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Figure 4.24. Mass spectra for the range of acylated products for peptide [1-5] from 
trypsin digestion of b-AQP0-OC, using digestion protocol Method-D and LC-MS 
Method-IIII (see section 8.2.2.2.1). Each spectrum labelled with the acyl group identity, 
see Appendix C Table 9.34 for detailed information about the acyl groups added to the 
peptide [1-5]. 
 
It is interesting to see the consistency between the lipidation profile on 
both peptide sets of peptide [1-5] and peptide [234-259], Figure 4.25, that are 
both embedded in the cytoplasmic leaflet of lens lipid-bilayer (see Figure 
4.17). This cytoplasmic leaflet in bovine lens is known to be rich with PE 
lipid,22 which has fatty acid composition (see Table 4.7) that matches the 
observed lipidated profile herein. Consequently, one can strongly predict in 
vivo lipid transfer from membrane lipids to membrane protein.    
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Figure 4.25. The abundance of identified lipidated peptides described in Figures 4.23 
and 4.24 for both lipidated sites of peptide [234-259] and peptide [1-5] respectively. 
The peak area (A) represents the summation of peak area over all observed charge 
states for each acylated peptide, (z=1-2) for peptide [1-5]; (z=2-4) for peptide [234-259]. 
All acylated species of peptide [234-259] matches contain one deamidation. The 
abundance of peptide [1-5] oleoylation include the summation of peak area for peptide 
[1-5]ole and peptide [1-5]ole + O; the abundance of  peptide [234-259] oleoylation 
include the summation of peak area for peptide [234-259]ole and peptide [234-259]ole + 
P, while the other acylation products include just their individual peak area. Errors 
reported as the standard error of the mean (SEM) of peak area when n=2. Details are 
tabulated in Appendix C Table 9.34. 
 
In addition, the presence of four truncation sites towards C-terminus of 
the protein has been confirmed, as shown in Table 4.10. These truncation 
sites were also identified in the intact form of the protein (see Table 4.5). 
Interestingly, all truncated peptides are assigned with lipidation modification 
but this is not surprising as all truncated peptides are residing K238 AA which 
is reported to be lipidated1. Consequently, both lipidation and truncation 
process are not mutually exclusive events. 
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Table 4.10. The deconvoluted truncated peptides identified from b-AQP0-OC tryptic 
digestion, using digestion protocol Method-D and LC-MS Method-IIII (see section 
8.2.2.2.1). 
Truncation 
Site 
AA 
Residue 
Sequence + 
Modifications 
Theor m/z
 ‡
 
[M + H]
+ 
Meas m/z
‡
 
[M + H]
+
 
RT 
(min) 
10
2
 × 
Total 
ALipidation
§
 
(a.u.) 
Error 
(ppm) 
K238 [229-238] 
SVSERLSILK 
[1×Oleoyl] 
1395.9191 1395.9211 5.7 1 ± 0.7 1.4 
E244 
[234-244] LSILKGSRPSE 1186.6796 1186.6784 3.57 203.5 ± 21 -1 
[234-244] 
LSILKGSRPSE 
[1×P] 
1266.6459 1266.6442 2.97 137 ± 14 -1.3 
[234-244] 
LSILKGSRPSE 
[1×Palmitoyl] 
1424.9092 1424.9054 5.7 0.6 ± 0.02 -2.7 
[234-244] 
LSILKGSRPSE 
[1×Stearoyll] 
1452.9406 1452.9422 5.89 1.5 ± 0.3 1.1 
[234-244] 
LSILKGSRPSE 
[1×Oleoyl] 
1450.9249 1450.926 5.77 2 ± 0.1 0.8 
[234-244] 
LSILKGSRPSE 
[Eicosenoyl] 
1478.9562 1478.9562 6.25 0.3 ± 0.07 3.1 
[234-244] 
LSILKGSRPSE 
[1×Eicosadienoyl] 
1476.9406 1476.935 5.89 0.6 ± 0.03 -3.8 
[234-244] 
LSILKGSRPSE [1× 
Dihomo-γ-linolenoyl] 
1474.9249 1474.9254 5.7 0.6 ± 0.06 0.3 
N246 
[229-246] 
SVSERLSILKGSRP
SESN 
[1×Deamidation; 
1×P] 
2026.9811 2026.9861 3.53 38 ± 7 2.5 
[229-246] 
SVSERLSILKGSRP
SESN 
[1×Deamidation; 
1×Oleoyl] 
2211.26 2211.2566 5.41 31 ± 9 -1.5 
[234-246] 
LSILKGSRPSESN 
[1×Deamidation] 
1388.7385 1388.7382 3.53 178 ± 24 -0.2 
[234-246] 
LSILKGSRPSESN 
[1×Deamidation; 
1×P] 
1468.7048 1468.7038 3 114 ± 16 -0.7 
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[234-246] 
LSILKGSRPSESN 
[1×Deamidation; 
1×Palmitoyl] 
1626.9681 1626.9812 5.67 0.7 ± 0.08 8.1 
[234-246] 
LSILKGSRPSESN 
[1×Deamidation; 
1×Oleoyl] 
1652.9839 1652.9758 5.73 1 ± 0.07 -4.9 
[239-246] 
GSRPSESN 
[1×Deamidation] 
834.3594 834.3596 2.13 21 ± 19 0.2 
[239-246] 
GSRPSESN 
[1×Deamidation; 
1×P] 
914.3257 914.3272 0.87 2.5 ± 0.2 1.6 
T260 
[234-260] 
LSILKGSRPSESNG
QPEVTGEPVELKT 
[1×Deamidation] 
2853.4848 2853.4814 3.82 95 ± 7 -1.1 
[239-260] 
GSRPSESNGQPEV
TGEPVELKT 
[1×Deamidation] 
2299.1055 2299.1065 3.29 61 ± 0.8 0.4 
[239-260] 
GSRPSESNGQPEV
TGEPVELKT 
[1×Deamidation; 
1×P] 
2379.0718 2379.0794 2.68 8 ± 0.8 3.2 
‡Both theoretical (Theor) and measured (Meas) m/z are for the monoisotopic peak. 
Theoretical mass obtained from MassLynx software (V4.1). 
§ The peak area (A) represents the summation of peak area over all observed charge states 
for each identified peptide. Errors reported as SEM (n=2). 
    
4.2.2.1. The localisation of acylation modifications on b-AQP0 by LC-
MS2  
 Performing LC-MS2 experiment on digested b-AQP0 yielded a profile 
of product ions for the different peptide species. The most intense oleoyl-
modified b-AQP0 is confirmed by isolating the precursor ion at m/z 998.61 
(z=1) and 1006.23 (z=3) for each peptide [1-5] (Figure 4.26 A and Table 4.11) 
and peptide [234-259] (Figure 4.26 B and Table 4.12). The confirmed sites of 
oleoylation (M1 and K238) are consistent with the results in previous study1. 
This is also in agreement with the nucleophilic character of the N-terminal 
amino group and the ε-amino group of the K238 on the protein in the 
aminolysis reaction.46,47,51 However, although both K238 and K259 are 
nucleophile candidates in the peptide [234-259], but K238 is the only 
acylation candidate within this peptide sequence because if K259 is acylated 
then this site will be blocked and no longer available for trypsin cleavage.  
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Figure 4.26. MS
2
 spectra of (A) peptide [1-5] + oleoyl (C18:1) for [M + H]
+
 and (B) 
peptide [234-259] + oleoyl (C18:1) for [M + 3H]
3+
, using Synapt G2-s (see section 
8.2.2.2.2). Peptide fragments containing oleoyl acyl chain are marked with an asterisk. 
The b- and y-ion series are clearly labelled and correlate to the sequences given 
above each corresponding spectrum. Oleoylated residues are labelled in red and the 
deamidation site for peptide [234-259]ole is given in blue. For more details, see Tables 
4.11 and 4.12. 
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Table 4.11. Product ions identified following the isolation and fragmentation of the [M 
+ H]
+
 precursor ion N-oleoylated peptide [1-5]  at m/z 998.61. The amino acid residue 
highlighted in red indicates the site of oleoylation. 
Ion 
AA 
Residues 
Meas m/z z Sequence Ladder 
Error 
(ppm)
 
[M + H]
+
  [1-5] 998.6114 1 MWELR 0.1 
[M + H]
+
 - H2O [1-5] 980.6007 1 MWELR 0 
b2 [1-2] 582.3705 1 MW -4.1 
b3 [1-3] 711.4169 1 MWE 2.0 
b4 [1-4] 824.5013 1 MWEL 2.1 
y1 [5-5] 175.12 1 R 2.9 
y2 [4-5] 288.2026 1 LR -3.5 
y3 [3-5] 417.2466 1 ELR 1.0 
y4 [2-5] 603.3261 1 WELR 1.0 
y1-NH3 [5-5] 158.0921 1 R -5.7 
y2-NH3 [4-5] 271.1756 1 LR -5.2 
y3-NH3 [3-5] 400.2203 1 ELR 1.7 
y4-NH3 [4-5] 586.2962 1 WELR -4.8 
im1 [1-1] 368.3018 1 M 8.4 
im4 [4-4] 86.0973 1 L 3.5 
 
Table 4.12. Product ions identified following the isolation and fragmentation of the [M 
+ 3H]
3+
 precursor ion K238-oleoylated peptide [234-259] at m/z 1006.23. The amino 
acid residue highlighted in red indicates the site of oleoylation and the deamidation 
site marked in blue. 
Ion 
AA 
Residues 
Meas m/z z Sequence Ladder 
Error 
(ppm)
 
[M + 3H]
3+
 [1-26] 1006.2350 3 LSILKGHSRPSESNGQPEVTGEPVELK 2.4 
b2 [1-2] 201.1223 1 LS -8.0 
b3 [1-3] 314.2082 1 LSI 0.6 
b3-H2O [1-3] 296.1982 1 LSI 2.7 
b4 [1-4] 427.2898 1 LSIL -5.4 
b5 [1-5] 819.6353 1 LSILK 3.7 
b6 [1-6] 876.6532 1 LSILKG -0.7 
b8 [1-8] 1119.7899 1 LSILKGSR 2.6 
b11 [1-11] 1432.9186 1 LSILKGSRPSE 3.0 
b12 [1-12] 1519.9474 1 LSILKGSRPSES 0.7 
b13 [1-13] 1634.9824 1 LSILKGSRPSESN 5.6 
b14 [1-14] 1692.0016 1 LSILKGSRPSESNG 4.0 
b15 [1-15] 1820.0564 1 LSILKGSRPSESNGQ 1.7 
b17 [1-17] 1023.5779 2 LSILKGSRPSESNGQPE -0.3 
b18 [1-18] 1073.1144 2 LSILKGSRPSESNGQPEV 1.9 
b20 [1-20] 1152.1464 2 LSILKGSRPSESNGQPEVTG -0.5 
b21 [1-21] 1216.6732 2 LSILKGSRPSESNGQPEVTGE 4.0 
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b24 [1-24] 1379.2488 2 LSILKGSRPSESNGQPEVTGEPVE -1.0 
b25 [1-25]  1435.7754 2 LSILKGSRPSESNGQPEVTGEPVEL -11.7 
y1 [26-26] 147.1120 1 K -9.5 
y2 [25-26] 260.1950 1 LK -9.2 
y3 [24-26] 389.2440 1 ELK 10.3 
y5 [22-26] 585.3618 1 PVELK 1.0 
y6 [21-26] 714.4044 1 EPVELK 0.8 
y7 [20-26] 771.4258 1 GEPVELK 0.8 
y8 [19-26] 872.4722 1 TGEPVELK -0.8 
y9 [18-26] 971.5371 1 VTGEPVELK -4.3 
y11 [16-26] 1197.6351 1 PEVTGEPVELK -1.3 
y11 [16-26] 599.3212 2 PEVTGEPVELK -1.8 
y12 [15-26] 663.3529 2 QPEVTGEPVELK 2.0 
y13 [14-26] 1382.6914 1 GQPEVTGEPVELK -18.2 
y14 [13-26] 749.3701 2 NGQPEVTGEPVELK -7.5 
y15 [12-26] 792.8876 2 SNGQPEVTGEPVELK -5.3 
y18 [9-26] 949.4547 2 PSESNGQPEVTGEPVELK -0.7 
y19 [8-26] 1027.5114 2 RPSESNGQPEVTGEPVELK 5.3 
y20 [7-26] 1071.0187 2 SRPSESNGQPEVTGEPVELK -3.1 
y21 [6-26] 1099.5314 2 GHSRPSESNGQPEVTGEPVELK -1.2 
y22 [5-26] 1295.7069 2 KGHSRPSESNGQPEVTGEPVELK 3.1 
y23 [4-26] 1352.2496 2 LKGHSRPSESNGQPEVTGEPVELK 3.5 
y24 [3-26] 1408.7911 2 ILKGHSRPSESNGQPEVTGEPVELK 2.9 
y25 [2-26] 1452.2937 2 SILKGHSRPSESNGQPEVTGEPVELK -6.4 
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Stearoylation and palmitoylation modifications are also confirmed at 
M1 and K238 sites of the protein by LC-MS2, as shown in Figures 4.27 and 
4.28. 
 
 
Figure 4.27. MS
2 
spectra of (A) peptide [1-5] + stearoyl (C18:0) [M + H]
+ 
and (B) peptide 
[234-259] + stearoyl (C18:0) [M + 3H]
3+
, using Synapt G2-s (see section 8.2.2.2.2). 
Peptide fragments containing stearoyl acyl chain are marked with an asterisk. The b- 
and y-ion series are clearly labelled and correlate to the peaks that correspond to 
peptide fragments. For details, see appendix chapter (see Appendix C Tables 9.35 and 
9.36). 
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Figure 4.28. MS
2 spectra of (A) peptide [1-5] + palmitoyl (C16:0) [M + H]
+ 
and (B) 
peptide [234-259] + palmitoyl (C16:0) [M + 3H]
3+
, using Synapt G2-s (see section 
8.2.2.2.2). Peptide fragments containing palmitoyl acyl chain are marked with an 
asterisk. The b- and y-ion series are clearly labelled and correlate to the peaks that 
correspond to peptide fragments.  For details, see appendix chapter (see Appendix C 
Tables 9.37 and 9.38). 
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Further MS2 analysis enables localising M1 acylation by (C16:1) and 
C20 acyl chains (Figures 4.29 and 4.30), while unfortunately their resident on 
K238 could not be confirmed. This was due to their low signal-to-noise (S/N) 
ratio and thus there are not enough ions to produce a meaningful MS2 
spectrum.  
 
 
Figure 4.29. MS
2 
spectra of (A) peptide [1-5] + palmitoleoyl (C16:1) [M + H]
+
 and (B) 
peptide [1-5] + dihomo-γ-linolenoyl (C20:3) [M + H]
+
, using Synapt G2-s (see section 
8.2.2.2.2). Peptide fragments containing palmitoleoyl or dihomo-γ-linolenoyl acyl 
chains are marked with an asterisk. The b- and y-ion series are clearly labelled and 
correlate to the peaks that correspond to peptide fragments. For details, see appendix 
chapter (see Appendix C Tables 9.39 and 9.40). 
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Figure 4.30. MS
2
 spectra of (A) peptide [1-5] + eicosadienoyl (C20:2) [M + H]
+ 
and (B) 
peptide [1-5] + eicosenoyl (C20:1) [M + H]
+
, using Synapt G2-s (see section 8.2.2.2.2 
Peptide fragments containing eicosadienoyl or eicosenoyl acyl chains are marked 
with an asterisk. The b- and y-ion series are clearly labelled and correlate to the peaks 
that correspond to peptide fragments. For details, see appendix chapter (see 
Appendix C Tables 9.41and 9.42). 
 
4.2.2.2. The effect of lens aging on the peptide modifications in b-
AQP0 
The relationship between lens age and the amount of protein 
modification has been followed herein by using the optimised conditions as 
described in Table 4.9 (entry 6). It is interesting to see that the level of N-
terminus lipidation does not show a significant change by increasing the age 
of the lens except for ON fraction, which shows the lowest level of lipidation, 
as shown in Figure 4.31.  
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Figure 4.31. The relative percentage of each single lipidation and total lipidation 
modification on N-terminus site of b-AQP0, using digestion protocol Method-D and 
LC-MS Method-IIII (see section 8.2.2.2.1). The normalisation of each acylation ratio on 
peptide [1-5] is performed relative to the equivalent non-acylated peptide residue 
(reference peptide) although both acylated and non-acylated peptide residues 
presumed to be very different in their ionisation efficiency. The ratio of peptide [1-5]pal 
= peak area peptide [1-5]pal / summed peak area (total of all lipidation on peptide [1-5] + 
reference peptide [1-5]); the ratio of peptide [1-5]ole = peak area peptide [1-
5]ole/summed peak area (total of all lipidation on peptide [1-5] + reference peptide [1-5]) 
and etc. Errors represent SEM, when n=2. 
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On the other hand, K238 shows a higher level of lipidation in the older 
fractions of the lens, consistent with the increasing of lipidation from the 
membrane with time (Figure 4.32 and Appendix C Figure 9.1). This is also in 
agreement with the increasing of the other protein PTMs such as truncation, 
deamidation and phosphorylation with age.13,20,21,40  The exact reason behind 
this difference in N-terminus vs K238 lipidation proportion with lens age is not 
known exactly, as both lipidated sites are located in the cytoplasmic leaflet of 
the lens. However, this could be suggested in relation with the highest degree 
of PTMs (truncation, deamidation, oxidation and phosphorylation) towards C-
terminus of the protein.5,10-13,20,21,40 Consequently, it can be concluded that 
each lipidation site has independent reactivity towards membrane lipids. 
Overall, N-terminus lipidation is more abundance than K238 lipidation but 
throughout one lens fraction the relative ratio of N-terminus:K238 total 
lipidation in the young and old lens fractions showed different outcomes. The 
lipidation ratio of N-terminus:K238 is nearly comparable in each of ON (7:5) 
or IN (23:7) relative to a significant  difference in the lipidation ratio of N-
terminus:K238 for OC (22:1) or IC (29:4). Consequently, it can be concluded 
that K238 is highly conserved in the youngest fraction of the lens (OC).   
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Figure 4.32. The relative percentage of each single lipidation species and total 
lipidation on K238 AA site, using digestion protocol Method-D and LC-MS Method-IIII 
(see section 8.2.2.2.1). This lipidation site was assigned on different peptides 
including truncated peptides ([229-238], [234-244], [229-246] and [234-246], see Table 
4.10) and as well as non-truncated peptide [234-259]. K238 lipidation for each 
acylation modification represents the summation of peak area for acylation on both 
truncated and non-truncated peptides. The normalisation of each acylation ratio is 
performed relative to the reference non-acylated peptide [234-259], as described in 
Figure 4.31. Errors represent SEM, when n=2. 
 
Increasing protein truncation has been well described for intact protein 
analysis (see sections 4.1.2 and 4.1.4), and consistent with earlier 
results.6,7,13,19-21 This is also evident in the digestion mixture during 
monitoring lipidation ratio vs truncation ratio for truncated peptides (Figure 
4.33). This is when truncated peptides with K238 site of acylation were 
normalised relative to a reference non-acylated peptide with non-truncation 
site of peptide [234-259], as shown in Figure 4.33, trend B. On the other 
209 
 
hand, increasing the amount of protein truncation with lens age has shown to 
be reflected in decreasing the amount of protein lipidation during 
normalisation relative to a reference non-acylated peptide with truncation 
site. This trend is confirmed by using three different truncated peptides such 
as peptide [229-246] (Figure 4.33, trend Ai), peptide [234-244] (Figure 4.33, 
trend Aii) and peptide [234-246] (Figure 4.33, trend Aiii).  
 
 
Figure 4.33. The relative ratio of K238 lipidation on truncated peptides (trends Ai-Aiii) 
vs the relative ratio of truncation (trend B) in the four different bovine lens fractions, 
using digestion protocol Method-D and LC-MS Method-IIII (see section 8.2.2.2.1). The 
summation of all observed lipidation products on different truncated peptides were 
added together and the peak area was normalised relative to non-acylated peptide 
with the truncation site such as peptide [229-246] (trend Ai), peptide [234-244] (trend 
Aii) and peptide [234-246] (trend Aiii) as follows: %lipidation on truncated peptide = 
peak area total lipidation on truncated peptide/summed peak area (total lipidation on 
truncated peptide + reference peptide [229-246]) × 100. Peptide [234-244] and peptide 
[234-246] will follow the same. The relative ratio of truncation were calculated by 
normalisation of total lipidation products on truncated peptides relative to non-
acylated peptide with non-truncation site such as peptide [234-259] as follows: 
%truncation = peak area total lipidated truncated peptide/summed peak area (total 
lipidated truncated peptide + reference peptide [234-259]) × 100. Errors represent 
SEM, when n=2. 
210 
 
 Moreover, the relation between lens age and AQP0 modification 
(deamidation, phosphorylation and truncation) is well documented in previous 
studies,13,20,21,40 whilst AQP0 oxidation dependent on lens age has not been 
described in earlier researches. The two identified peptides with oxidation 
modification, peptide [157-187] and peptide [197-226], herein were followed 
to monitor the level of protein oxidation in different lens fractions. 
Interestingly, oxidised peptide [157-187] shows a slight increase in the level 
of oxidation by increasing lens age, while the level of oxidation on peptide 
[197-226] is significantly different between the older and younger fractions of 
the lens. This finding agrees with the age effect on increasing protein 
oxidation16-18 (see section 4.1.1), however in vitro protein oxidation during 
sample preparation should be also take into account.     
 
Table 4.13. The proportion of oxidation level in the four different lens age fractions, 
using digestion protocol Method-D and LC-MS Method-IIII (see section 8.2.2.2.1). The 
data presented represent normalised peak area (A) for oxidised peptides to the 
summation of oxidised plus non-oxidised equivalent peptides. Errors represent SEM, 
when n=2.  
Lens Fractions 
%Oxidation 
Peptide [157-187] + 1 × O Peptide [197-226] + 2 × O 
OC 32 ± 3 6 ± 0.2 
IC 32 ± 0.2 4.5 ± 1 
ON 35 25 
IN 40 14 
 
4.2.2.3. Bovine lens PE/PEpl correlation with acylated b-AQP0  
Correlating the relative proportions of naturally occurring transferrable 
fatty acyl composition of the major abundant PE/PEpl lipids in bovine 
lens23,24,28 (Table 4.14) and the abundance of acylated b-AQP0 shows a 
strong correlation for both N-terminus and K238 lipidation sites, as shown in 
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Figure 4.34 and Appendix C Figure 9.2. Consequently, this strong correlation 
is supporting the concept of lipid transfer from host membrane to the protein. 
 
Table 4.14. Bovine lens transferrable fatty acid composition by lipid type created with 
data obtained by MS methods (Deeley et al.)
28
. Note: Error propagations are SEM. 
Acyl Group PE nmol/g* PEpl
†
 nmol/g Total PE (PE + PEpl) nmol/g 
C14:0 0 0 0 
C15:0 0 0 0 
C16:0 42.9 ± 4.0  0 42.9 ± 4.0  
C16:1 13.5 ± 0.4 0 13.59 ± 0.4  
C18:0 20.5 ± 1.5 6.9 ± 0.5 27.4 ± 1.6 
C18:1 239.5 ± 14.3 88.1 ± 2.2 327.6 ± 14.4  
C18:2 3.9 ± 0.2 0 3.9 ± 0.2  
C20:1 5.3 ± 0.6 0 5.3 ± 0.6  
C20:2 0 0 0 
C20:3 4.0 ±0.6 4.0 ± 0.3 8.0 ± 0.7  
C20:4 5.2 ± 0.5 7.7 ± 1.1 12.9 ± 1.2  
C22:2 0 0 0 
C22:4 0 0 0 
C22:5 0 0 0 
†Lipid classes suffixed with “pl” refer to plasmalogen lipids which combine totals for both 
alkyl and alkenyl ether plasmalogens. There is a contribution of one mole of ester-linked fatty 
acyl chain per PEpl lipid. 
*There is a contribution of two moles of ester-linked fatty acyl chain per PE lipid.    
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Figure 4.34. Correlations between the amount of ester-linked transferrable fatty acyl 
content of bovine lens lipids and the peak area for lipidated peptides (ALipidation) of (A) 
b-AQP0-OC and (B) b-AQP0-IN, using digestion protocol Method-D and LC-MS 
Method-IIII (see section 8.2.2.2.1). Lipid data obtained from lipidomics MS analysis
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(see Table 4.14). Peak areas for N-terminus acylation were calculated from EIC of each 
acylation on peptide [1-5], while peak areas for K238 acylation were calculated from 
EIC of each acylation on non-truncated peptide [234-259] and truncated peptides 
([229-238], [234-244], [229-246] and [234-246]). Errors plotted as X-axis SEM (fatty acyl 
content, n=4) and Y-axis SEM (peak area for lipidated peptides, n=2). The line and the 
R
2
 statistic are from linear regression analysis. The ρ-value represents the Pearson 
correlation coefficient (r) and the p-value represents the t-test of the correlation 
coefficient.  
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 Skewed distribution of the data is clearly visible in Figure 4.34. This is 
because the abundance of oleoyl (C18:1) in both protein lipidation and fatty 
acyl content data is an order of magnitude greater than that of the other fatty 
acyl profile. This reflects in generating much weaker correlation for the other 
data points by eliminating (C18:1) point, as shown in Figure 4.35. 
 
 
Figure 4.35. Correlations between the amount of PE ester-linked transferrable fatty 
acyl content of bovine lens lipids and the peak areas for lipidated peptides of b-AQP0. 
These graphs were created by using the exact data as in Figure 4.34 A (PE acyl 
content) but by excluding the most abundant oleoylated data. The line and the R
2 
statistic are from linear regression analysis. 
 
4.2.3. Biological approach in proteolytic analysis of h-AQP0  
Different human lenses were obtained from male donors ages 22 
(M22), 56 (M56), and 80 (M80) and female donors ages 56 (F56) and 76 
(F76) have been decapsulated and dissected to the two major age fractions 
of the cortex (h-AQP0-C, younger fraction) and nucleus (h-AQP0-N, older 
fraction). The two main eye lens fraction is shown in Figure 4.36. 
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Figure 4.36. Schematic diagram for human eye lens fractions. Different lens age 
fractions include C = cortex fraction/the youngest (4 mm) and N = nucleus fraction/the 
oldest (8 mm).  
 
The amino acid sequence of h-AQP0 is shown in Figure 4.37 with the 
illustration of protein spanning the lens membrane lipid-bilayer. Theoretical 
average neutral mass of h-AQP0 is 28121.5 Da, calculated from the provided 
AA sequence from Uniprot entry P30301 
(http://www.uniprot.org/uniprot/P30301).  
 
 
Figure 4.37. Characteristic representation of h-AQP0 amino acid sequence, created 
from Protter open source software package (http://wlab.ethz.ch/protter/start/). Both 
terminus stand out in cytoplasmic region of the cell and all six transmembranes are 
also highlighted. 
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Extracted and purified h-AQP0 from each individual human donor was 
subjected to trypsin digestion as per Method-D (see experimental section 
8.2.2.2.1). Following completion, the mixture was analysed using LC-MS 
Method-IIII. Full protein sequence coverage is shown in Figure 4.38 for male 
donor age 22 (M22) as an example typical of the five individual samples. 
Protein PTM including deamidation, phosphorylation and oxidation have 
been observed and recorded in this study with h-AQP0 as previously 
documented1,5,13,52.  
 
 
Figure 4.38. The highlighted regions of the protein represent the confirmed peptides 
from h-AQP0-N male donor age 22 (M22) tryptic digestion, using digestion protocol 
Method-D and LC-MS Method-IIII (see section 8.2.2.2.1). Peptide residues with the 
observed modifications illustrated in bright colours; peptide residues with more than 
one missed cleavages presented on each specific sequence. Details tabulated in 
Appendix C Table 9.43.  
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 Evidence for lipidated peptides were seen over 5.0-5.6 and 6.4-7.4 
min RT ranges of the chromatogram corresponding to peptide [227-263] 
and/or peptide [229-263] (Figure 4.39) and peptide [1-5] (Figure 4.40) 
respectively. This corroborates the work by Schey et al.1 and Wenke et al.7, 
who showed modification by oleoyl (C18:1) and palmitoyl (C16:0). Work 
herein now shows these two modifications together with a range of newly 
observed acyl chains including pentadecenoylation (C15:1), palmitoleoylation 
(C16:1), stearoylation (C18:0), eicosenoylation (C20:1), dihomo-Ɣ-
linolenoylation (C20:3), arachidonoylation (C20:4) and docosahexaenoylation 
(C22:6). 
  
 
Figure 4.39. Mass spectra for the range of acylated products for (i) peptide [227-263] 
and (ii-vii) peptide [229-263], from trypsin digestion of h-AQP0-N male donor age 22 
(M22), using digestion protocol Method-D and LC-MS Method-IIII (see section 
8.2.2.2.1). Each spectrum labelled with the acyl group identity, see Appendix C Table 
9.44 for detailed information about the acyl groups added to the provided peptides. 
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Figure 4.40. Mass spectra for the range of acylated products for peptide [1-5] from 
trypsin digestion of h-AQP0-N male donor age 22 (M22), using digestion protocol 
Method-D and LC-MS Method-IIII (see section 8.2.2.2.1). Each spectrum labelled with 
the acyl group identity, see Appendix C Table 9.44 for detailed information about the 
acyl groups added to the peptide [1-5]. 
 
As shown in Figures 4.39 and 4.40, protein modification by (C15:1) 
and (C22:6) were just recorded for h-AQP0 and were not seen for b-AQP0 
(see Figures 4.23 and 4.24). The presence of poly unsaturated omega-3 fatty 
acyl chain (C22:6) with h-AQP0 is an additional supporting evidence for 
membrane lipid association in protein lipidation in vivo, as this fatty acyl 
species was found by Deeley et al.28 just with human lens and not found with 
bovine lens. On the other hand, although C15 fatty acyl chain was recorded 
for both human and bovine lenses at low abundance by Deeley et al.,28 its 
presence within the h-AQP0 lipidation profile herein and the absence with b-
AQP0 is proposed to be related with the food intake by the human. 
Interestingly, Liao et al.53 has already reported the change in PTMs of plasma 
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proteins when purple sweet potato, a root vegetable, was incorporated into 
the daily diet. This was followed by detecting the largest percentage of 
protein methylation using MS-based approach.53 
 In addition, the localization of M1- (N-terminus) and K238-oleoylation 
were confirmed in the product ion spectra for h-AQP0-N (M22), as shown in 
Figure 4.41. This is consistent with the characterized lipidation sites in b-
AQP0 (see section 4.2.2.1) and as it is reported in previous study1. 
 
 
Figure 4.41. MS
E
 spectra of (A) peptide [1-5]ole (C18:1) and (B) peptide [229-263]ole 
(C18:1). Using digestion protocol Method-D and LC-MS Method-IIII (see section 
8.2.2.2.1). Peptide fragments containing oleoyl acyl chain are marked with an asterisk. 
The b- and y-ion series are clearly labelled and correlate to the sequences given 
above each corresponding spectrum. Oleoylated residues are labelled in red and the 
deamidation sites (N246 and N259) for peptide [229-263]ole are given in blue. For 
details, see appendix chapter (see Appendix C Tables 9.45 and 9.46 for more details). 
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 As summarized in Table 4.15, truncation in h-AQP0 is observed 
towards the C-terminus of the protein (D243, N246 and N259) similar to b-
AQP0 (see Table 4.10). This non-enzymatic process6,52 is well-documented 
in the literature6,7,20,21,52 by presenting h-AQP0 truncation as an early age 
process and increasing the amount of truncation with age. It is interesting to 
see that most truncated peptides are also acylated with the two most 
abundant lipidation species herein (palmitoylation and oleoylation). This is 
consistent with K238 residency within the truncated peptide sequences and 
its high reactivity towards lens lipids. Although there is no direct evidence in 
this study to specify whether truncation or lipidation are happening first in 
vivo, the presence of protein lipidation in a 4-month human lens and the 
absence of protein truncation in this young age as reported by Wenke et al. 
in a MALDI imaging MS7 suggests the protein lipidation is a faster process 
than truncation.   
 
Table 4.15. The deconvoluted truncated peptides identified from h-AQP0-N male donor 
age 22 (M22) tryptic digestion, using digestion protocol Method-D and LC-MS Method-
IIII (see section 8.2.2.2.1) 
Truncation 
Site 
AA Residue 
Sequence + 
Modifications 
Theor m/z
 ‡
 
[M + H]
+ 
Meas m/z
‡
 
[M + H]
+
 
RT 
(min) 
10
2
 × 
Total 
ALipidation
§
 
(a.u.) 
Error 
(ppm) 
243 
[227-243] 
LKSISERLSVLKGA
KPD [1×Palmitoyl] 
2079.3157 2079.3046 5.31 1.6 -5.3 
[227-243] 
LKSISERLSVLKGA
KPD [1×Oleoyl] 
2105.3313 2105.3209 5.38 3.6 -4.9 
[229-243] 
SISERLSVLKGAKP
D 
1599.907 1599.9064 3.72 190.1 -0.4 
[229-243] 
SISERLSVLKGAKP
D [1×Oleoyl] 
1864.1523 1864.1485 5.51 23.4 -2.0 
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246 
[229-246] 
SISERLSVLKGAKP
DVSN 
[1×Deamidation] 
1901.0344 1901.0342 3.72 124.3 -0.1 
[229-246] 
SISERLSVLKGAKP
DVSN 
[1×Deamidation; 
1×Palmitoyl ] 
2139.2642 2139.2641 5.37 3.7 0.05 
[229-246] 
SISERLSVLKGAKP
DVSN 
[1×Deamidation; 
1×Oleoyl ] 
2165.2798 2165.2756 5.48 26.5 -1.9 
[234-246] 
LSVLKGAKPDVSN 
[1×Deamidation] 
1328.7426 1328.7379 3.36 187.1 -3.5 
[234-246] 
LSVLKGAKPDVSN 
[1×Deamidation; 
Palmitoyl] 
1566.9722 1566.9708 5.67 0.4 -0.9 
[234-246] 
LSVLKGAKPDVSN 
[1×Deamidation; 
Oleoyl] 
1592.9879 1592.9802 5.73 1.1 -4.8 
[239-246] 
k.GAKPDVSN.g 
[1×Deamidation] 
788.3790 788.3776 2.32 38.8 -1.8 
259 
[229-259] 
SISERLSVLKGAKP
DVSNGQPEVTGE
PVELN 
[1×Deamidation] 
3250.6807 3250.6814 3.69 23.8 0.2 
[234-259] 
LSVLKGAKPDVSN
GQPEVTGEPVELN  
[1×Deamidation] 
2678.3889 2678.3851 3.40 100.0 -1.4 
[239-259] 
GAKPDVSNGQPE
VTGEPVELN 
[1×Deamidation] 
2138.0254 2138.0258 2.75 125.4 0.2 
‡Both theoretical (Theor) and measured (Meas) m/z are for the monoisotopic peak. 
Theoretical mass obtained from MassLynx software (V4.1). 
§ The peak area (A) represents the summation of peak area over all observed charge states 
for each identified peptide. 
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Moreover, the abundance of lipidation profile on N-terminus vs K238 
of h-AQP0-N is shown in Figure 4.42. It is clearly visible that the acylation 
species with the same acyl chain on both lipidation sites are comparable in 
their abundance.  
 
 
Figure 4.42. The abundance of each identified lipidation modification on K238 and N-
terminus site of h-AQP0-N male donor age 22 (M22), using digestion protocol Method-
D and LC-MS Method-IIII (see section 8.2.2.2.1). The peak area (A) represents the 
summation of peak area over all observed charge states for each acylated peptide, 
(z=1-2) for peptide [1-5]; (z=3-5) for peptide [227-263] and peptide [229-263]. All 
acylated species on peptide [227-263] and peptide [229-263] matches contain two 
deamidated sites. The abundance of N-terminus acylation were calculated  for each 
individual acyl chain of peptide [1-5] except N-oleoylation which include the 
summation of peptide [1-5]ole and peptide [1-5]ole + O; The abundance of K238 
acylation were calculated  for each individual acyl chain of peptide [229-263] except 
K238-palmitoylation and K238-oleoylation. K238-palmitoylation include the summation 
of peak area calculated for palmitoylated non-truncated peptide [229-263] and 
truncated peptides (peptide [227-243], peptide [229-246] and peptide [234-246]); K238-
oleoylation include the summation of peak area calculated for oleoylated non-
truncated peptides (peptide [229-263] and peptide [227-263]) plus truncated peptides 
(peptide [227-243], peptide [229-243], peptide [229-246] and peptide [234-246]). 
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4.2.3.1. The effect of lens aging on h-AQP0 modifications 
In order to illustrate the relation between protein lipidation and the lens 
age, total lipidation ratios were calculated in each of the five different human 
candidates, as shown in Figure 4.43. It is interesting to see that all the five 
candidates share two distinct results: first, %K238 lipidation is more 
abundant than %N-terminus lipidation; second, %N-terminus and %K238 
lipidation is increasing by increasing the lens age (cortex to nucleus) with 
regarding that this change is more profound for N-terminus lipidation than 
K238. In addition, generally each of male and female sample sets were 
shown to exhibit an increase in %K238 and %N-terminus lipidation by 
increasing human age, although this trend is difficult to be shown for  all.  
 
 
 
 
 
223 
 
 
Figure 4.43. The relative ratio of total lipidation modification on N-terminus and K238 
sites of h-AQP0 in 5 different human candidates. Total lipidation includes the 
summation of all observed lipidation on each of N-terminus or K238 of the protein. 
The normalisation of each acylation ratio on N-terminus is performed relative to the 
reference non-acylated peptide [1-5], see Figure 4.31; normalisation of each acylation 
ratio on K238 is performed relative to the reference non-acylated peptide [229-263] 
after summing the peak area of K238  lipidation on truncated peptides (peptide [227-
243], peptide [229-243], peptide [229-246] and peptide [234-246]) and non-truncated 
peptides (peptide [227-246] and peptide [229-246]), see Figure 4.32. 
 
Increasing protein truncation with age is still visible for human lenses 
(Figure 4.44, trend Y) as was described for bovine lenses (see Figure 4.33). 
However, this truncation trend is shown to be in a linear correlation with 
increasing K238 lipidation for truncated peptides, as shown in Figure 4.44, 
trends Xi-Xiii. This has been confirmed by using three different truncated 
peptides for normalisation process, including peptide [229-243], peptide [229-
246] and peptide [234-246]. 
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Figure 4.44. The relative ratio of K238 lipidation on truncated peptides (trends Xi-Xiii) 
vs the relative ratio of truncation (trend Y) for five different human lens candidates 
(nucleus fraction), using digestion protocol Method-D and LC-MS Method-IIII (see 
section 8.2.2.2.1). The summation of all observed lipidation products on different 
truncated peptides were added together and the peak area was normalised relative to 
non-acylated peptide with the truncation site such as peptide [229-243] (trend Xi), 
peptide [229-246] (trend Xii) and peptide [234-246] (trend Xiii) as follows: %lipidation 
on truncated peptide = (peak area total lipidation on truncated peptide)/summed peak 
area (total lipidation on truncated peptide + reference peptide [229-243]) × 100. Peptide 
[229-246] and peptide [234-246] will follow the same calculation. The relative ratio of 
truncation were calculated by normalisation of total lipidation products on truncated 
peptides relative to non-acylated peptide with non-truncation site such as peptide 
[229-263] as follows: %truncation = (peak area total lipidated truncated 
peptide)/summed peak area (total lipidated truncated peptide + reference peptide [229-
263]) × 100.  
  
 Moreover, calculating the level of oxidation on two different peptide 
sets, including peptide [154-187] and peptide [188-228] showed an 
interesting finding of elevated amount of protein oxidation in the cortex 
fraction relative to nucleus fraction of the lens (Table 4.16). However, this is 
shown to be unexpected and different from what has been observed for b-
AQP0, as there was being more oxidation in the nucleus fraction than cortex 
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fraction of the eye lens (see Table 4.13). In addition, there is not a significant 
change in the level of protein oxidation with increasing human age in this 
study.  
 
Table 4.16. The level of h-AQP0 oxidation in the five different human eye lens 
candidates, including male donor age 22 (M22), male donor age 56 (M56), male donor 
age 80 (M80), female donor age 56 (F56) and female donor age 76 (F76). Using 
digestion protocol Method-D and LC-MS Method-IIII (see section 8.2.2.2.1). The data 
presented represent normalised peak area (A) for oxidised peptides to the summation 
of oxidised plus non-oxidised equivalent peptides in both cortex and nucleus 
fractions of the lens. 
Human Lens 
Samples 
%Oxidation 
Cortex Fraction Nucleus Fraction 
Peptide [154-187] 
+ 1 × O 
Peptide [188-228] 
+ 2 × O 
Peptide [154-187] 
+ 1 × O 
Peptide [188-228] 
+ 2 × O 
M22 48 39 39 21 
M56 53 46 36 16 
M80 45 56 28 14 
F56 44 43 29 13 
F76 41 36 27 14 
 
 
4.2.3.2. Human lens lipid correlation with acylated h-AQP0  
Ester-linked fatty acyl composition with the major PE lipid and the 
minor PS and PI lipids in human lens is shown in Table 4.17. Owing to know 
that both lipidated sites, N-terminus (M1) and K238, are located in the 
cytoplasmic leaflet of the membrane, a correlation was drawn between 
lipidated peptides in h-AQP0 (M22) and transferrable fatty acyl content of 
cytoplasmic lipid composition, as shown in Figure 4.45. Stronger correlations 
are found between lipidation profile and (PE + PEpl)/total (PE/PS/PI) lipid 
composition, while poorer correlation is produced with PE lipid. This indicates 
that a mixed system of fatty acyl lipid transfer from cytoplasmic lipid 
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composition as a whole is more appropriate than a single lipid component. 
Similar correlations were also recorded for other human samples (M56, M80, 
F56 and F76), see Appendix C Figures 9.3-9.6.  
   
Table 4.17. Human lens transferrable fatty acid composition by lipid type created with 
data obtained by MS methods (Deeley et al.)
28
. Note: Error propagations are SEM.   
Acyl 
Group 
PE nmol/g PEpl
†
 nmol/g 
Total PE 
(PE + PEpl)
†
 
nmol/g 
Total PS 
(PS + PSpl)
† 
nmol/g 
PI nmol/g 
Total All 
(PE + PS + PI) 
nmol/g 
C14:0 0 0 0 0 0 0 
C15:0 0 0 0 0 0 0 
C16:0 24.8 ± 2 0 24.8 ± 2 11.7 ± 1.2 0 36.5 ± 2.3 
C16:1 5.3 ± 0.8 0 5.3 ± 0.8 0 0 5.3 ± 0.8 
C18:0 38.2 ± 1.8 12.3 ± 1.8 50.5 ± 9.3 40.2 ± 3.3 16.2 ±2.6  106.9 ± 10.2 
C18:1 85.1 ± 2.85 295.7±15.4 380.8±15.7  265.65 ± 10.5 1.5 ± 0.9  647.95 ± 18.9 
C20:1 0 0 0 3.6 ± 0.2 0 3.6 ± 0.2 
C20:3 0 0 0 0 2.5 ± 0.3 2.5 ± 0.3 
C20:4 48.4 ± 9.4 40.2 ± 3.5 88.6 ± 10 13.1 ± 2.2 15.2 ± 2.8  116.9 ± 10.6 
C22:3 0 13.9 ± 2.1 13.9 ± 2.1 0 0 13.9 ± 2.1 
C22:4 0 11.3 ± 3.4 11.3 ± 3.4 0 0 11.3 ± 3.4 
C22:5 0 8.9 ± 1 8.9 ± 1 0 0 8.9 ± 1 
C22:6 0 9.4 ± 0.7 9.4 ± 0.7 3.6 ± 0.7 0 13 ± 1 
†Lipid classes suffixed with “pl” refer to plasmalogen lipids which combine totals for both 
alkyl and alkenyl ether plasmalogens. 
 
227 
 
 
Figure 4.45. Correlations between the amount of ester-linked transferrable fatty acyl 
content of human lens lipids and the peak areas for lipidated peptides of (A) h-AQP0-
C male donor age 22 (M22) and (B) h-AQP0-N male donor age 22 (M22), using 
digestion protocol Method-D and LC-MS Method-IIII (see section 8.2.2.2.1). Lipid data 
obtained from lipidomics MS analysis
28 
(see Table 4.17). Peak areas for N-terminus 
acylation were calculated from EIC of each acylation on peptide [1-5], while peak 
areas for K238 acylation were calculated by summing peak area from EIC of each 
acylation on non-truncated peptides (peptide [227-263] and peptide [229-263]) and 
truncated peptides (peptide [227-243], peptide [229-243], peptide [229-246] and peptide 
[234-246]). Errors plotted as X-axis SEM (fatty acyl content, n=4). The line and the R
2
 
statistic are from linear regression analysis. The ρ-value represents the Pearson 
correlation coefficient (r) and the p-value represents the t-test of the correlation 
coefficient.  
 
4.3. The lipid-binding amphipathic helix in AQP0  
Crystallographic study on AQP0 crystal54 showed different interactions 
between the N-terminus and C-terminus amino acid residues, which 
influences the conformation structure of this protein. Based on the results in 
this study, it is also true to conclude that both lipidation sites of AQP0, the N-
terminus (M1) and C-terminus (K238) are adjacent to the cytoplasmic leaflet 
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of the plasma membrane, as shown in Figure 4.46. This suggests the 
presence of direct relation between lipidation profile on these two lipidated 
sites and the membrane lipid content of the cytoplasmic leaflet. 
 
 
Figure 4.46. X-ray structure for cattle AQP0 monomer obtained from protein Data Bank 
(PDB) 2b6p code.
54
 The six helices spanning the lipid membrane are shown as H1-H6; 
the two loops are HB and HE; the C-terminal cytoplasmic tail is CT. Both lipidation 
sites are labelled as M1 and K238. 
 
By calculating the helical wheel conformation of [214-263] sequence of 
b-AQP0 and h-AQP0 by using 18-AA analysis window, this is the 
HELIQUEST software and available at (http://heliquest.ipmc.cnrs.fr),55 it is 
possible to predict that this sequence forms a lipid-binding amphipathic helix. 
This has been enabled by using a factor called discrimination factor (D). 
Helices with discrimination factor greater than 0.68 are shown to have a high 
propensity for lipid-binding.56,57 Consequently, the calculated helices (8-15) in 
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the provided sequence have a high lipid-binding region (Figure 4.47). 
Interestingly, all of these lipid-binding regions of the protein have K238 AA 
residue in their sequence. 
 
 
Figure 4.47. Variation in discrimination factor (D) according to human and bovine helix 
number. Discrimination factor (D) calculated using the equation D = 0.944 (<μH>) + 
0.33 (z).
56,57 
Eight helices (8-15) with D > 0.68 located above the highlighted blue 
horizontal line. Detailed data are given in Appendix C Tables 9.47 and 9.48.  
 
Helices (10-12) with the highest discrimination factor are shown in 
Figure 4.48. Interestingly, lipidation site (K238) lies at the boundary of the 
predicted hydrophobic face of the helix, a feature that is known to promote 
acyl transfer from lipids to peptides that localise interfacially47. 
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Figure 4.48. Application of 18-AA analysis window from HELIQUEST
54
 to examine 
[214-263] region of (A) b-AQP0 and (B) h-AQP0. The sequence in this region is 
214
LGSLLYDFLLFPRLKSVSERLSILKGSRPSESNGQPEVTGEPVELKTQAL
263
 and
 
214
LGSLLYDFLLFPRLKSISERLSVLKGAKPDVSNGQPEVTGEPVELNTQAL
263 
for b-AQP0 
and h-AQP0 respectively. Helix 10 (i) corresponds to amino acid [10-27] of this 
sequence (equivalent to [223-240] of b-AQP0 and h-AQP0); helix 11 (ii) corresponds to 
[11-28] (equivalent to [224-241] of b-AQP0 and h-AQP0); helix 12 (iii) corresponds to 
[12-29] (equivalent to [225-242] of b-AQP0). K238 amino acid residue is indicated by an 
asterisk. 
 
4.4. Conclusion 
AQP0 is an interesting protein to study age related PTMs, as this 
protein is subjected to different modifications with lens age. This is 
particularly important because there is no protein turnover in mature fibre cell 
of the lens.6,7,20,58 Among different modifications observed on AQP0 in this 
research such as deamidation, phosphorylation, oxidation, truncation, 
acetylation, and lipidation, a focus will be given to lipidated AQP0. The 
lipidation of AQP0 by membrane lipids has shown herein through observing a 
broad lipidation profile on two lipidated sites of N-terminus and K238 site of 
the protein. The presence of protein reactive sites, amino group, proximal to 
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lipid fatty acyl chains is a principle step for acyl transfer in protein:lipid 
system.46,47 For AQP0, the location of both lipidated sites sufficiently close to 
the cytoplasmic leaflet of lipid membrane has shown by Gonen et al.54 
through X-ray structure. Additionally, 18-AA analysis window from 
HELIQUEST supports this by showing a lipid-binding ability for peptide 
helices with K238 site at the boundary of the helix. This direct interaction 
between lipid membrane and AQP0 is reflected herein by drawing a linear 
correlation between lipidated sites of AQP0 and the amount of transferrable 
fatty acyl composition from the most abundant PE/PEpl lipid in the 
cytoplasmic leaflet of the membrane.  
Further, according to the results discussed for observing a broad 
lipidation profile on AQP0 and their moderate overall extent of modification, if 
AQP0 is lipidated enzymatically in vivo then an enzyme is required that 
shows two distinct features: first, relatively low efficiency in acyl transfer; 
second, poor selectivity towards acyl groups but also favours oleoyl transfer. 
Such an enzyme has not yet been observed. Consequently, it is more likely 
that acyl group transfer occurs via chemical-based ester aminolysis 
mechanism, as this method accounts both for the low efficiency of transfer 
and the differences observed between human and bovine lipidation profile. In 
addition, increasing protein modification as a function of lens age is 
suggested to reflect non-enzymatic process in vivo.6,7,21,52 This is also 
proposed for AQP0 lipidation herein, as both b-AQP0 and h-AQP0 evident an 
accumulated amount of protein lipidation by moving from cortex fraction to 
the nucleus fraction of the lens. 
Increasing protein aggregation with age16 is an important factor 
causing the lens to lose its transparency and becomes more rigid,18 therefor 
the formation of lens cataract.16-19 Similar to AQP0, crystallins have also 
shown to undergo a number of age-related modifications.17,19 This has 
reflected in their aggregation with age and thus lens cataract.14,16,18 However, 
fatty acylated crystallin has not yet been observed and thus their effect on 
protein aggregation is not known. Therefore, further study is required to 
determine the effect of age-related lipidation on protein aggregation or 
structure and their outcomes on health and disease. 
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Chapter five: Application of ion mobility separation-
mass spectrometry (IMS-MS) to the analysis of 
phosphatidylcholine and synthetic lipidated melittin 
analogues 
 
 
 
To study isomeric/isobaric structure of biomolecule classes such as 
lipids and peptides, a technique is required that has the potential to resolve 
different structures with the same m/z. This can be achieved to some degree 
using liquid chromatography coupled with mass spectrometry (LC-MS) or 
tandem MS (LC-MS2).1-8 The resolution can be improved by using ion 
mobility separation (IMS), and particularly powerful during its coupling with 
MS and/or LC-MS.8 Herein, traveling wave ion mobility spectrometry 
(TWIMS) was used to correlate ions structure and/or conformation with drift 
time. The arrival time distributions (ATDs) are related to the physical size and 
number of charge states on the peptide. Acylated melittin with lower charge 
states, triply and quadruply, are found to be interesting candidate ions in the 
mobility cell and to be studied herein by TWIMS as a benchmark to begin  
distinguish between acylated melittin isomers. Triply and quadruply ions are 
also found to have more conformational changes and slower mobility. Partial 
resolution between N-Mpal vs K23-Mpal and N-Mole vs K23-Mole were 
suggested by transfer collision fragmentation approach coupled with TWIMS 
through time-aligned product ions with their corresponding precursor ions. In 
addition, although no difference in ATDs were observed for isomer mixtures 
of DOPC vs SLPC or POPC vs OPPC, partial resolution was observed 
between PPC and OPC or DOPC and DPPC.       
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5.1. Analysis of phosphatidylcholine by ion mobility 
separation-mass spectrometry (IMS-MS) 
5.1.1. IMS-MS analysis of lysophosphatidylcholine (LPC) 
Lysophosphatidylcholine (LPC) is a sub-class of phosphatidylcholines 
but with a single acyl chain at the sn-1 position. The two LPCs used in this 
study are 1-oleoyl-phosphatidylcholine (OPC) and 1-palmitoyl-
phosphatidylcholine (PPC) with a distinct difference in the length of the acyl 
chain for palmitoyl (C16:0) and oleoyl (C18:1). Herein, the aim was to 
separate overlapped peaks obtained from liquid chromatography for 
PPC:OPC mixture and also the two in-solution positional isomers of 1-acyl-
LPC and 2-acyl-LPC for each species (see chapter three, Figure 3.15) using 
the advantages in the analytical tool of ion mobility separation coupled with 
mass spectrometry (IMS-MS). For that, traveling wave ion mobility 
spectrometry (TWIMS) was used based on the principle of recording an ion’s 
drift time (td) in the mobility cell in a relevance time. However, results for 
direct infusing of individual LPC solutions into ESI-IMS-MS showed a single 
broad peak in the mobilogram for each of PPC (Figure 5.1) and OPC (Figure 
5.2) with the closeness in their arrival time or td. This illustrates that the 
arrival time distributions (ATDs) for both LPCs will be overlapped in a mixture 
of both species. In addition, the two isomeric LPC forms for each species are 
suggested to have the same td and hard to be resolved under these 
conditions, although, this separation has partially achieved previously using 
LC-MS (see chapter three, Figure 3.15).  
     
239 
 
 
Figure 5.1. (A) Mobilogram display for individual PPC, analysed on the Synapt G2-s 
through direct infusion IMS-MS (TWIMS). (B) Arrival time distribution (ATD) display 
from extracted ion mobilogram (EIM) for PPC at m/z 496.3. The insert panel (i) is the 
mass spectrum for PPC. 
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Figure 5.2. (A) Mobilogram display for individual OPC, analysed on the Synapt G2-s 
through direct infusion IMS-MS (TWIMS). (B) ATD display from EIM for OPC at m/z 
522.4. The insert panel (i) is the mass spectrum for OPC. 
 
Performing the experiments at the same time and under the same 
instrument conditions, a mixture of 50:50 PPC:OPC (Figure 5.3) showed 
comparable results as was described for each individual species (see 
Figures 5.1 and 5.2) and also see Table 5.1. A relatively longer ATD for OPC 
than PPC (Figure 5.3 and Table 5.1) is suggested to be reflected by higher 
number of -CH2- group in oleoyl, as reported by Zhang et al.
9 Consequently, 
OPC will experience more interactions or collisions with the buffer gas and as 
a result it travels slower in the mobility cell. However, at the same time, the 
presence of one carbon-carbon double bond in OPC bent the molecule and 
decrease the conformational space occupied by two hydrogen atoms.9 
Therefore some reduction in OPC’s ATD and thus overlapped with PPC’s 
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ATD. The influence of the presence of double bond in the acyl chain on 
reducing the td is well documented in earlier reports.
8-13 
 
 
Figure 5.3. ATD display from comparison EIMs for PPC at m/z 496.3 and OPC at m/z 
522.4 taken from 50:50 OPC:PPC mixture and analysed on the Synapt G2-s through 
direct infusion IMS-MS (TWIMS).    
 
Table 5.1. ATDs obtained from the mobilogram for each of PPC and OPC individually 
and from a mixture of 50:50 PPC:OPC, analysed on the Synapt G2-s through direct 
infusion IMS-MS (TWIMS).  
Sample Meas
‡
 m/z 
ATD 
td (Bins) 
PPC 496.3 75 
OPC 522.4 77 
PPC:OPC 
PPC 496.3 75 
OPC 522.4 78 
‡Meas: measured m/z for [M + H]+. 
 
5.1.2. IMS-MS analysis of diacylphosphatidylcholine (PC) 
Examining a number of PCs with various acyl chain length, including 
1,2-dimyrstoyl-PC (DMPC), 1,2-dipalmitoyl-PC (DPPC), 1-oleoyl-2-palmitoyl-
PC (OPPC),  1-palmitoyl-2-oleoyl-PC (POPC), 1-stearoyl-2-linoleoyl-PC 
(SLPC) and  1,2-dioleoyl-PC (DOPC), Table 5.2, has shown six distinct peaks 
in the ATD display for the six individual lipid species each with its 
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corresponding td, as shown in Figure 5.4 and Table 5.3. While only four 
peaks were observed for the equimolar mixture of all the six analysed PCs 
(Figure 5.5 and Table 5.3). This is because the two regioisomers POPC vs 
OPPC and isobaric species of DOPC vs SLPC with exactly the same m/z 
could not be resolved herein by TWIMS and shown as a single broad peak 
for each pair of PC isomers (Figure 5.5). This is not surprising, as Castro-
Perez et al. showed that the position of the fatty acyl chain in sn-1 and sn-2 
position of POPC vs OPPC could only be achieved by using collision-induced 
dissociation (CID) coupled with TWIMS.14 By showing that sn-2 position of 
PC precursor ion fragments preferentially over sn-1 position due to the 
tertiary α-hydrogen atom that forms hydrogen bond with the carbonyl oxygen 
of the sn-1 that hinders the fragmentation at this position.14 Further, Kyle et 
al. showed that when both PC acyl chains with different length in a pair of 
positional PC isomers are saturated or have the same number and 
orientation of double bonds could be separated by IMS-MS  because the lipid 
is more elongated when longer acyl chain is in the sn-1 position.8 However, 
this is not applied herein, as POPC vs OPPC being mixed-chain between 
saturated and unsaturated PCs, while DOPC vs SLPC are a pair of PCs with 
the same number of -CH2- group, but different number of double bonds. 
 
Table 5.2. Different diacylphosphatidylcholine lipids with their chemical formula, fatty 
acyl chains and theoretical masses. 
Phospholipids Nomenclature 
Molecular 
Formula 
Fatty Acyl Chain 
Theor m/z
 ‡
 
[M + H]
+ 
1,2-dimyristoyl-PC (DMPC) 
 
C36H72NO8P (C14:0/C14:0) 678.5074 
1,2-dipalmitoyl-PC (DPPC) 
 
C40H80NO8P (C16:0/C16:0) 734.5700 
1-palmitoyl-2-oleoyl-PC (POPC) 
 
C42H82NO8P (C16:0/C18:1) 760.5856 
1-oleoyl-2-palmitoyl-PC (OPPC) 
 
C42H82NO8P (C18:1/C16:0) 760.5856 
1-stearoyl-2-linoleoyl-PC (SLPC) 
 
C44H84NO8P (C18:0/C18:2) 786.6013 
1,2-dioleoyl-PC (DOPC) 
 
C44H84NO8P (C18:1/C18:1) 786.6013 
‡Theoretical (Theor) m/z is obtained from MassLynx software (V4.1). 
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Figure 5.4. ATD display from EIM for six individual PCs including, DMPC, DPPC, 
POPC, OPPC, SLPC and DOPC and analysed on the Synapt G2-s through direct 
infusion IMS-MS (TWIMS). ATDs were displayed from EIM for (i) DMPC at m/z 678.5; (ii) 
DPPC at m/z 734.6; (iii) OPPC at m/z 760.6; (iv) POPC at m/z 760.6; (v) SLPC at m/z 
786.6; (vi) DOPC at m/z 786.6. 
 
 
Figure 5.5. ATD display from EIM for equimolar mixture of six PCs including, DMPC: 
DPPC:POPC:OPPC:SLPC:DOPC and analysed on the Synapt G2-s through direct 
infusion IMS-MS (TWIMS). ATDs were displayed from EIM for DMPC at m/z 678.5; 
DPPC at m/z 734.6; OPPC/POPC at m/z 760.6; SLPC/DOPC at m/z 786.6. 
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Table 5.3. ATDs obtained from the mobilogram for each of individual PC lipids 
including, DMPC, DPPC, POPC, OPPC, SLPC and DOPC and equal mole ratio for a 
mixture of all the subjected PCs herein. Sample solutions were analysed on the 
Synapt G2-s through direct infusion IMS-MS (TWIMS).  
Sample 
Meas
‡
 m/z 
ATD 
td (Bins) 
Individual PCs 
DMPC 
 
678.5 111 
DPPC 
 
734.6 122 
POPC 
 
760.6 125 
OPPC 
 
760.6 124 
SLPC 
 
786.6 127 
DOPC 
 
786.6 127.5 
Mixture of PCs 
(DMPC : DPPC : POPC : OPPC : SLPC : DOPC) 
  
DMPC 
 
678.5 110 
DPPC 
 
734.6 121 
POPC/OPPC 
 
760.6 124.5 
SLPC/DOPC 
 
786.6 128 
‡Meas: measured m/z for [M + H]+. 
 
Results also show that DMPC with the shortest acyl chains or lowest 
number of -CH2- group (Table 5.3) has the highest mobility and thus lowest 
ATD, which is far enough from all the other PCs to expect a complete 
resolution by TWIMS. However, all the other PCs have close ATDs and 
therefore could not be fully resolved by TWIMS. Once more, increasing the 
number of -CH2- groups of the fatty acyl chain has shown to be directly 
correlate with increasing ATD. This is consistent with the results described 
for PPC/OPC (see section 5.1.1), and also as reported earlier8-11.   
Interestingly, lipid isomers that could not be resolved by TWIMS or 
DTIMS could be resolved by field-asymmetric ion mobility spectrometry 
(FAIMS) a type of differential ion mobility spectrometry (DMS).6,15-17 
Maccarone et al.15 showed that POPC could be resolved from OPPC 
regioisomer by DMS through cation adduct formation between silver ion (Ag+) 
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and carbon-carbon double bond of the oleoyl fatty acyl chain. The main 
reason that FAIMS is so powerful for lipid separation is due to a strong 
orthogonality between FAIMS and MS, while this orthogonality is found to be 
poor between TWIMS/DTIMS and MS.6,17,18 This is because in FAIMS there 
is a weaker correlation between ion’s m/z from MS with the difference of the 
mobility (∆K) but this correlation is stronger with the absolute mobility (K) in 
TWIMS or DTIMS.6,17,18 Consequently, a single trend line occupied by lipid 
ions with similar charge state (predominantly z=1) in the IMS-MS space is 
reported to be separated better with FAIMS than that with TWIMS or 
DTIMS.6,17,18  
 
5.2. Analysis of synthetic lipidated melittin analogues by ion 
mobility separation-mass spectrometry (IMS-MS) 
Synthesized lipidated melittin analogues with individual acyl chains, 
including palmitoyl (Mpal) and oleoyl (Mole) at the two most reactive lipidation 
sites,19,20 N-terminus and K23, (see chapter three, section 3.2.3) were 
directly infused to IMS-MS. Intact ions of Mpal (Figure 5.6) and Mole (Figure 
5.7) were observed at three different charge states together with some in-
source product ions. The results clearly show that different charge states are 
moving at different speeds in the drift tube under the influence of electrical 
field. Quintuply charge states have shown to travel faster (shorter ATD), while 
triply charged ions travel slower (longer ATD). This illustrates that although 
quintuply charged ions are less folded than triply charged ions because 
Coulomb repulsion overcomes attractive intramolecular interactions by 
increasing peptide/protein charge state, as reported by Clemmer et al.21 and 
Wu et al.22, quintuply charged ions are still arrived first. This is because 
peptides/proteins with higher charge states are attracted more and thus 
travel faster under the influence of the electric field. 
 
246 
 
 
Figure 5.6. Mobilogram display for (A) N-Mpal and (B) K23-Mpal, analysed on the Synapt 
G2-s through direct infusion IMS-MS (TWIMS). 
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Figure 5.7. Mobilogram display for (A) N-Mole and (B) K23-Mole, analysed on the Synapt 
G2-s through direct infusion IMS-MS (TWIMS). 
 
 Further, ions with lower charge state have also shown to experience 
more conformational changes than higher charge state, as shown in Figures 
5.8 and 5.9. The ATDs for N-Mpal [M + 3H]
3+ (Figure 5.8 (i) and (iv)) and K23-
Mpal [M + 3H]
3+ (Figure 5.9 (i) and (iv)) showed only two peaks, while this has 
zoomed in mobilogram display and showed three conformations (Figures 5.8 
(iv) and 5.9 (iv)) instead of two conformations (Figures 5.8 (i) and 5.9 (i)). The 
middle peak is therefore not resolved from the first peak. Increasing ions 
conformational changes by decreasing the number of charge states on the 
peptide can be concluded by more proton mobility on the free available basic 
amino acid residues on the peptide backbone, as melittin has 6 basic sites 
(see chapter one, section 1.7). Consequently, based on the location of the 
proton the peptide can exhibit different conformations. Interestingly, for triply 
charged ions the two conformations with lower ATD and therefore the more 
compact conformation are very similar for N-Mpal at ATD = 95 and 102 (Figure 
5.8 (iv)) and K23-Mpal at ATD = 95 and 100 (Figure 5.9 (iv)) and therefor they 
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could not be expected to be resolved by TWIMS. However, the more 
elongated conformation with the highest ATD shows a difference in ATD 
between N-Mpal at ATD = 113 (Figure 5.8 (iv)) and K23-Mpal at ATD = 108 
(Figure 5.9 (iv)) and therefore could expect some degree of resolution in such 
case. In addition, N-Mpal [M + 4H]
4+ shows two conformations (Figure 5.8 (ii) 
and (v)) but only the conformation with the lowest ATD (td = 68 bins) were 
seen for K23-Mpal [M + 4H]
4+ (Figure 5.9 (ii) and (v)). This could be concluded 
by more constrained palmitoyl acyl chain on K23 site than N-terminus of the 
peptide. The highest charge state for N-Mpal [M + 5H]
5+ (Figure 5.8 (iii) and 
(vi)) and K23-Mpal [M + 5H]
5+ (Figure 5.9 (iii) and (vi)) showed only one peak 
for each isomer with identical ATD. Consequently, no isomer resolution could 
be expected at this charge state. Fewer conformational structures for Mpla at 
higher charge states is suggested to be related with  the existence of less 
free basic sites for the proton to move on the peptide backbone. 
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Figure 5.8. ATD display from EIM for N-Mpal at (i) m/z 1028.7 [N-Mpal + 3H]
3+
; (ii) m/z 
771.8 [N-Mpal + 4H]
4+
; (iii) m/z 617.6 [N-Mpal + 5H]
5+
. Zoomed in sections of the 
mobilogram display for N-Mpal at (iv) m/z 1028.7; (v) m/z 771.8; (vi) m/z 617.6. Analysed 
on the Synapt G2-s through direct infusion IMS-MS (TWIMS).  
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Figure 5.9. ATD display from EIM for K23-Mpal at (i) m/z 1028.7 [K23-Mpal + 3H]
3+
; (ii) m/z 
771.8 [K23-Mpal + 4H]
4+
; (iii) m/z 617.6 [K23-Mpal + 5H]
5+
. Zoomed in sections of the 
mobilogram display for K23-Mpal at (iv) m/z 1028.7; (v) m/z 771.8; (vi) m/z 617.6. 
Analysed on the Synapt G2-s through direct infusion IMS-MS (TWIMS). 
 
 Similarly, more conformational changes for lower charge states is 
evident for N-Mole [M + 3H]
3+ (Figure 5.10 (i) and (iv)) and K23-Mole [M + 3H]
3+ 
(Figure 5.11 (i) and (iv)) but this conformational changes reduced by 
increasing the peptide charge states to quadruply and quintuply charged ions 
for each of  N-Mole (Figure 5.10 (ii-vi)) and K23-Mole (Figure 5.11 (ii-vi)). It is 
interesting to see that when oleoyl acyl chain is bound to the peptide a 
greater difference in ADTs is evident between N-Mole and K23-Mole for all the 
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three charge states. It is then proposing a promising resolution between both 
lipidated sites when they will come together in a mixture. 
 
 
Figure 5.10. ATD display from EIM for N-Mole at (i) m/z 1037.4 [N-Mole + 3H]
3+
; (ii) m/z 
778.3 [N-Mole + 4H]
4+
; (iii) m/z 622.8 [N-Mole + 5H]
5+
. Zoomed in sections of the 
mobilogram display for N-Mole at (iv) m/z 1037.4; (v) m/z 778.3; (vi) m/z 622.8. Analysed 
on the Synapt G2-s through direct infusion IMS-MS (TWIMS).  
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Figure 5.11. ATD display from EIM for K23-Mole at (i) m/z 1037.4 [K23-Mole + 3H]
3+
; (ii) 
m/z 778.3 [K23-Mole + 4H]
4+
; (iii) m/z 622.8 [K23-Mole + 5H]
5+
. Zoomed in sections of the 
mobilogram display for K23-Mole at (iv) m/z 1037.4; (v) m/z 778.3; (vi) m/z 622.8. 
Analysed on the Synapt G2-s through direct infusion IMS-MS (TWIMS).  
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 Results by comparing ATDs for Mpal and Mole (Table 5.4) showed that 
both palmitoylated isomers of N-Mpal and K23-Mpal are overlapped with N-Mole 
and therefore it suggests a struggle in resolving between these three species 
in a mixture, while the ATD for K23-Mole is far from the other species and thus 
proposing to be distinguished from the other acylated species. Non-acylated 
melittin (M) was also examined herein by TWIMS as a control experiment 
(Figure 5.12). Lower ATD for non-acylated species relative to acylated 
species is consistent with the smaller size of M and thus travels faster in the 
mobility cell. Once more greater conformation structure for triply charged ions 
(Figure 5.12 (i) and (iv)) is evident relative to fewer conformation structure for 
quadruply (Figure 5.12 (ii) and (v)) and quintuply charged ions (Figure 5.12 
(iii) and (vi)). 
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Table 5.4. ATDs obtained from the mobilogram for each individual species of non-
acylated melittin (M), N-Mpal, K23-Mpal, N-Mole and K23-Mole and equimolar mixture of 
(M:N-Mpal:K23-Mpal:N-Mole:K23-Mole).  
Sample 
Meas
‡
 m/z z 
ATD 
Individual species td (Bins) 
M 
949.3 3 
85 
99 
712.2 4 59 
570.0 5 50 
N-Mpal 
 
1028.7 3 
95 
102 
113 
771.8 4 
67 
77 
617.6 5 53 
K23-Mpal 
 
1028.7 3 
95 
100 
108 
771.8 4 68 
617.6 5 53 
N-Mole 
 
1037.4 3 
95 
115 
778.3 4 68 
622.8 5 54 
K23-Mole 
 
1037.4 3 
113 
130 
778.3 4 79 
622.8 5 66 
Mixture    
M 
949.3 3 
86 
99 
712.2 4 59 
570.0 5 48 
N-Mpal/K23-Mpal 
 
1028.7 3 
95 
100 
113 
771.8 4 
66 
76 
617.6 5 
47 
53 
N-Mole/K23-Mole 
 
1037.4 
 
3 
 
94 
102 
110 
115 
778.3 4 
67 
69 
78 
622.8 5 
48 
53 
58 
‡Measured (Meas) m/z is for the monoisotopic peak. 
255 
 
 
Figure 5.12. ATD display from EIM for non-acylated melittin (M)
 
at (i) m/z 949.3 [M + 
3H]
3+
; (ii) m/z 712.2 [M + 4H]
4+
; (iii) m/z 570.0 [M + 5H]
5+
. Zoomed in sections of the 
mobilogram display is for (iv) m/z 949.3; (v) m/z 712.2; (vi) m/z 570.0. Analysed on the 
Synapt G2-s through direct infusion IMS-MS (TWIMS).  
 
Analyses for individual species suggested that, at least for the triply 
charged ion, the isomers could be separated so in an effort to see if the four 
species could be resolved from one mixture an equimolar ratio of all the 
peptide species were directly infused and analysed by TWIMS. Figure 5.13 
(i) shows three unresolved peaks for Mole but the zoomed in region from the 
mobilogram confirms four conformations (see Table 5.4). Similar results was 
also found with the other charge states (Figure 5.13 (ii-vi) and see Table 5.4). 
The higher number of peptide conformations for each species and at each 
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charge state in the mixture relative to fewer conformations when individual 
species were analysed (see Table 5.4) clearly suggests that all the four 
acylated species N-Mole vs K23-Mole isomers and N-Mpal vs K23-Mpal isomers 
were detected in the mixture but hardly to be resolved clearly under these 
conditions. The resolution between a pair of isomers is more promising for 
lower charge states with broader peak shapes (when z=3 and 4), Figure 5.13 
(i), (ii), (iv) and (v), than higher charge state with sharper peak shape (Figure 
5.13 (iii) and (vi). This is further supported in the results obtained from the 
analysis of non-acylated melittin by TWIMS (see Table 5.4). Because during 
travelling non-acylated melittin through the mobility cell as its individual form 
or during its mixing with the other acylated species, preserved its 
conformation structure at all the three different charge states and thus with 
identical ATDs in both analyses (see Table 5.4). On the other hand, acylated 
melittin isomers show a change in their conformation structure and also their 
ATDs upon their mixing (see Table 5.4). This clearly suggests the effect of 
bounded fatty acyl chains on the conformation of melittin in the gas phase.       
In addition, comparing the same charge states for Mpal vs Mole (Figure 
5.13), results show that Mpal is slightly shifted towards shorter ATDs than 
higher ATDs for Mole, this is when there is 26 Da mass difference between 
Mpal (C16:0) and Molel (C18:1). Consequently, Mpal is suggested to be partially 
resolved from Mole by using their different in m/z to extract the ion and then 
comparing their ATDs.   
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Figure 5.13. ATD display from comparison of EIMs for (i) N-Mole/K23-Mole at m/z 1037.4 
[M + 3H]
3+
; (ii) N-Mole/K23-Mole at m/z 778.3 [M + 4H]
4+
; (iii) N-Mole/K23-Mole at m/z 622.8 
[M + 5H]
5+
; (iv) N-Mpal/K23-Mpal at m/z 1028.7 [M + 3H]
3+
; (v) N-Mpal/K23-Mpal at m/z 771.8 
[M + 4H]
4+
; (vi) N-Mpal/K23-Mpal at m/z 617.6 [M + 5H]
5+
obtained from an equimolar 
mixture of N-Mole:K23-Mole:N-Mpal:K23-Mpal, and analysed on the Synapt G2-s through 
direct infusion IMS-MS (TWIMS).  For details, see Table 5.4. 
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5.3. Ion mobility separation and transfer cell CID 
fragmentation (IMS-MS2) for synthetic lipidated melittin 
Further IMS analysis was carried out on the different isomeric 
structures of synthesized lipidated melittin in order to localize the site of 
lipidation and study the ability of IMS to improve the analysis. CID of the 
precursor ions for individual Mpal at m/z 772 [Mpal + 4H]
4+ and Mole at m/z 778 
[Mole + 4H]
4+ were performed in the transfer cell of TWIMS. Accumulated 
product ions were found to be time-aligned with their corresponding 
precursor ions, as shown in Figures 5.14 and 5.15. The results clearly show 
a broad peak for each isomer but with a slight shift of ATDs for K23 lipidation 
species towards shorter td. This is evident for each of K23-Mpal (Figure 5.14 
A, 95 ATD) vs N-Mpal (Figure 5.14 B, 96 ATD) and K23-Mole (Figure 5.15 A, 96 
ATD) vs N-Mole (Figure 5.15 B, 99 ATD).   
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Figure 5.14. Mobilogram display for product ions obtained through collision 
fragmentation of precursor ion [Mpal + 4H]
4+
 at m/z 771.8 for each individual species of 
(A) K23-Mpal and (B) N-Mpal through the transfer cell on Synapt G2-s by direct infusion 
IMS-MS (TWIMS). 
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Figure 5.15. Mobilogram display for product ions obtained through collision 
fragmentation of precursor ion [Mole + 4H]
4+
 at m/z 778.3 for each individual species of 
(A) K23-Mole and (B) N-Mole through the transfer cell on Synapt G2-s by direct infusion 
IMS-MS (TWIMS).  
 
To illustrate whether fragmentation approach in transfer cell allows 
further resolution of lipidated melittin isomers, a mixture of K23-Mpal vs N-Mpal 
and K23-Mole vs N-Mole were directly infused to ESI-IMS-MS and followed by 
collision fragmentation of Mpal and Mole precursor ions at m/z 772 and 778 for 
[Mpal + 4H]
4+ and [Mole + 4H]
4+ respectively. Figure 5.16 (A) shows just a hint 
of two peaks, but not clearly resolved. However, extracting the most 
abundant diagnostic product ion of y13 for N-Mpal at m/z 812 [y13 + 2H]
2+ 
(Figure 5.16 B) and y13pal for K23-Mpal at m/z 931 [y13pal + 2H]
2+ (Figure 5.16 
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C) it is again evident that K23-Mpal shifts towards lower ATD (Figure 5.16 C, 
90 ATD) and N-Mpal towards higher ATD (Figure 5.16 B, 105 ATD). 
Consequently, a broad peak from the total ion mobilogram contains more 
than one species and can be split into three main regions, including front 
region (i), middle region (ii) and tail region (iii). The product ion spectrum of b- 
and y-ions from (i) (Figure 5.16 D) confirms the presence of palmitoyl 
modification just on K23 amino acid residue, while b- and y-ions obtained 
from mass spectrum of (iii) (Figure 5.16 E) confirms N-terminus site of 
palmitoylation. This illustrates that time-aligned product ions of K23-Mpal is 
resolved from those of N-Mpal by controlling the time where each isomer 
travels in the drift cell. The middle region (ii) is the overlap region for both 
isomeric species and enriched with their corresponding product ions (Figure 
5.16 A, 100 ATD).  
Similarly, time-aligned product ions obtained from isomeric oleoylated 
mixture of K23-Mole shifts towards lower ATD (Figure 5.17 C, 93 ATD) relative 
to N-Mole towards higher ATD (Figure 5.17 B, 108 ATD) by extracting y13ole at 
m/z 944 [y13ole+ 2H]
2+ and y13 at m/z 812 [y13 + 2H]2+ respectively. The 
corresponding spectrum for each isomer species is shown in Figure 5.17 D 
and E. The results also evident some improvement in the resolution between 
Mpal (Figure 5.16 A) and Mole (Figure 5.17 A) because their corresponding 
time-aligned product ions in IMS-MS2 (Figures 5.16 and 5.17) show a greater 
difference in ATDs relative to much closer ATDs for intact ions in IMS-MS 
(Table 5.4). The application of TWIMS was also reported by Santos et al.23 for 
separating peptide isomers modified with peptide cross-linking agent at 
different sites of the peptide. 
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Figure 5.16. (A) Total ATD for [Mpal + 4H]
4+
 upon CID in the transfer cell on Synapt G2-s 
by direct infusion IMS-MS
2
 (TWIMS). (B) ATD from EIM at m/z 812.0 for y13 ion (N-Mpal). 
(C) ATD from EIM at m/z 931.2 for y13pal ion (K23-Mpal). (D) Product ion spectrum 
corresponding to (C) at region (i), and labelled y-ions with the asterisk represent 
modified sites with palmitoyl towards K23 amino acid residue. (E) Product ion 
spectrum corresponding to (B) at region (iii), and labelled b-ions with the asterisk 
represent modified sites with palmitoyl towards N-terminus. All b-ions are singly 
protonated, while y-ions are doubly and/ or triply protonated. 
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Figure 5.17. (A) Total ATD for [Mole + 4H]
4+
 upon CID in the transfer cell on Synapt G2-s 
by direct infusion IMS-MS
2
 (TWIMS). (B) ATD from EIM at m/z 812.0 for y13 ion (N-Mole). 
(C) ATD from EIM at m/z 944.2 for y13ole ion (K23-Mole). (D) Product ion spectrum 
corresponding to (C) at region (i), and labelled y-ions with the asterisk represent 
modified sites with oleoyl towards K23 amino acid residue. (E) Product ion spectrum 
corresponding to (B) at region (iii), and labelled b-ions with the asterisk represent 
modified sites with oleoyl towards N-terminus. All b-ions are singly protonated, while 
y-ions are doubly and/ or triply protonated.  
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5.4. Conclusion 
Since isomeric modified peptides or more precisely altering the 
position of post-translational modification (PTM) on peptides/proteins can 
have a critical influence on biological activity and functions,23-25 different 
strategies of analyses were performed herein. The two LPCs with palmitoyl 
(PPC) and oleoyl (OPC), also known to modify melittin readily, were shown to 
have different ATDs but that different is not sufficient to fully resolve them by 
TWIMS. This was also evident in DPPC vs DOPC, but DMPC with the 
smallest size is proposed to be fully resolved from the other PCs. The 
resolution is even harder for PC isomers POPC vs OPPC and DOPC vs 
SLPC, as they could not be resolved under the conditions described herein. 
This is not surprising, as PCs/LPCs with one charge state (z=1) and thus one 
trend line is very hard to be resolved by TWIMS as their intact form or without 
any further structural modification.  
Unlike PCs with a single trend line, multiple trend lines corresponding 
to multiple charge states for acylated melittin suggested there is a potential to 
distinguish between Mpal from Mole or their isomers including acylation on N-
terminus vs K23, and particularly evident for triply and quadruply ions. The 
presence of fatty acyl chains covalently bound to melittin is suggested to 
have an influence on changing peptide conformation in the gas phase. The 
location of the fatty acyl chain towards N-terminus and K23 of the peptide 
was also found to provide interesting results, as it is believed that fatty acyl 
chains on N-terminus of the peptide might be more flexible, while on K23 it 
can be either stick up or lie along the peptide backbone. Particularly was 
evident for N-Mole vs K23-Mole when z=3 and 4. This suggested to be related 
with the kink by carbon-carbon double bond in oleoyl acyl chain. The position 
of the acyl chain could also be suggested to reflect in shifting of time-aligned 
product ions corresponds to K23 acylation precursor ion towards shorter ATD 
than time-aligned product ions corresponds to N-terminus acylation precursor 
ion through collision transfer fragmentation approach coupled with TWIMS. 
The complexity reflected by being both lipid and peptide molecules attached 
to each other has been studied herein by TWIMS for the first time. However, 
results show that further analytical and as well as instrumental approaches 
265 
 
are required in order to overcome this complexity and to obtain a complete 
resolution between lipidated peptide isomers.   
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6.1. Conclusion 
The research in this thesis has shown that two of the most abundant 
biomolecules, lipid and peptides/proteins that are known to exist in close 
proximity to each other, or interact with each other, are not as chemically 
inert as previously thought.  
In the absence of an enzyme and in physiological conditions, the lipids 
that form cell membranes can react with and modify melittin via aminolysis 
reaction in as a little as three hours. This provides lipidated products (PTMs) 
with increased hydrophobicity and is therefore likely to be missed by 
standard (LC-based) analytical approaches. Consequently, further steps are 
required to improve LC-based methods in order to detect more hydrophobic 
species. These hydrophobic species are proposed to have higher affinity to 
the hydrophobic part (fatty acyl chain) of membrane lipids and thus sit within 
the cell membrane. Further, studies of synthetic lipidated peptides have 
shown that increasing hydrophobicity via lipidation can modulate biological 
activity, biophysical properties and secondary structure.1,2 These changes 
have shown to be highly implicated by the chemical structure of the attached 
fatty acyl chains and the site of acylation. This implies that lipidated peptide 
can find an application in drug design/pharmacology through binding to target 
receptors, as was proposed for synthetic lipidated peptides1,2.   
Although the level of LPL is generally low in natural cells,3,4 the 
amount is proposed to increase during fatty acyl transfer from PLs to 
peptides thus leaving free LPL, as well as LPL production via enzymatic 
hydrolysis (phospholipase) of PLs. Therefore, lipidation does not just produce 
modified peptides with modified structure and function but also LPLs which 
have recently gained more attention. This is because despite LPL’s role in 
phospholipid metabolism, they have been recently shown to exhibit a broad 
range of biological activities. They have used for developing drugs and 
targeting diseases and they also play important roles in the development, 
activation and regulation of the immune system.5,6 However, the results 
presented in this thesis also shows acyl transfer in LPL:melittin system even 
at a faster acylation rate than that for PL:melittin system. Consequently, 
lipidation can be proposed between lipids with ester-linked fatty acyl chain 
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and the amino groups of membrane active peptides/proteins. As melittin is 
recorded to be the most reactive peptide to perform non-enzymatic lipidation7 
and is the major component of honey bee venom,8,9 elucidating the role of 
lipidated melittin on its activity in the venom when a mammal has been sting  
could facilitate targeted therapies or intervention for the allergic reactions 
caused by bee sting. This is because melittin is reported to be basically 
responsible for pain and allergens in bee, wasp and ant.8,9 
Study of non-enzymatic acyl transfer for melittin:lipid system in vitro 
provides the basics to start understanding lipidated proteins in vivo. AQP0 
has become the focus of special attention because it undergoes many types 
of PTMs with age, thus increasing protein heterogeneity. Generally, these 
PTMs of proteins alter their conformation and function.10-12 Frequently 
recorded phosphorylation on C-terminal AQP0 was recorded to reduce 
binding affinity of calmodulin and thus regulating water permeability of 
AQP0.13,14 C-terminal truncated AQP0 encourages the protein to from cell-
cell junction by removing protein-protein binding region,14-16 while reported 
deamidation and isomerization of AQP0 were not fully characterised.14,17,18 
Modified AQP0 with fatty acylation (palmitoylation and oleoylation) may target 
the protein to lipid raft regions of the plasma membrane.14,19,20 Consequently, 
all of these protein modifications are contributing in their localization and 
functioning in vivo. The detection of a broad range of lipidated AQP0 in this 
research, including palmitoyl (C16:0), palmitoleoyl (C16:1), stearoyl (C18:0), 
oleoyl (C18:1), eicosenoyl (C20:1), dihomo-γ-linolenoyl (C20:3) and 
arachidonoyl (C20:4) for both human and bovine eye lens candidates; 
eicosadienoyl (C20:2), docosadienoyl (C22:2) and docosapentaenoyl (C22:5) 
only for bovine eye lenses; pentadecenoyl (C15:1) and docosahexaenoyl 
(C22:6) only for human eye lenses, illustrates that protein fatty acylation is 
not just restricted to the two major observed protein fatty acylation in vivo, 
including myristoylation and palmitoylation12,21,22 and recently 
oleoylation14,19,20. These newly observed lipidated species of AQP0 suggest 
non-enzymatic based acyl transfer because a specific enzyme that is 
responsible to perform fatty acyl transfer to lysine site of the protein has not 
yet been identified, as also suggested by Marilyn Resh12 and Wenke et al.14. 
The observation of lipidated AQP0 products that mirror fatty acyl composition 
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of PE lipid composition of cytoplasmic leaflet of the membrane proximal to 
lipidated sites additionally suggests chemical lipidation reaction rather than 
enzymatic acyl transfer. 
Finding a range of fatty acylation modification on AQP0, a long-lived 
protein in the lens, suggests similar lipidation pattern for other long-lived 
proteins in the lens or other tissues. Therefore, characterizing and 
understanding the mechanism/activity of these newly recorded lipidated 
products provide a new insight to understand the role of these lipidation on 
health and disease. This is because there is the awareness of the relation 
between long-lived proteins and the resultant protein PTMs with aging and 
age-related diseases, however, details of this remain to be elucidated.23-25        
Greater hydrophobicity is also found for the heterogeneous mixture of 
possible acylation products, particularly evident when more than one acyl 
chain is transferred to membrane active peptide, melittin, and the integral 
membrane protein, AQP0. This means both factors, heterogeneity and 
hydrophobicity, will cause the MS signal for each species will be low and 
further increase the challenges during their analysis. This is a challenge for 
understanding the real biological processes within a biological system. 
Further analysis by ion mobility separation coupled with mass spectrometry 
(IMS-MS) suggests that covalently bound fatty acyl chains wrap around the 
peptide and therefore performing less structural changes in the gas-phase by 
changing the composition or the position of the fatty acyl chain. 
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7.1. Future work 
The aminolysis reaction between melittin/AQP0 and ester-linked fatty 
acyl chains of lipids that form cell membrane have been characterised in this 
research. Although melittin acylation has been extensively studied herein, 
other membrane active peptides such as magainin II, PGLa, LAK1, LAK3 and 
penetratin are also reported.1 However, investigating this non-enzymatic acyl 
transfer is further required to include a comparison study between membrane 
active peptides and other peptides that do no exhibit membrane binding and 
permeation due to missing the threshold hydrophobicity and are called non-
membrane active peptides. This is also important to study the biological 
activity of lipidated peptides. In addition, although lipidated proteins are 
known to regulate protein structure and function,2-4 lipidated AQP0 with a 
broad range of saturated and unsaturated fatty acyl chains with their 
consequences on AQP0 function/structure in the lens is not studied herein. 
Following the activity of lipidated AQP0 in vivo would be particularly important 
in evaluating the relationship between lipidated AQP0 and cataract of eye 
lens and thus proposing a cure without a need for operation. Therefore 
including non-MS based analytical approach is important to investigate non-
acylated vs acylated peptide/protein structures such as using circular 
dichroism (CD), solid-state NMR, and X-ray crystallography. These methods 
of analysis could also provide an insight into investigating differences 
between melittin:PC vs melittin:LPC binding structure and the outcomes of 
the difference in lipidation reactivity between the two systems that have been 
reported in this research. In addition, the application of recent improvements 
in computational studies or called molecular modelling5 will provide valuable 
information on the peptide/protein-membrane interactions. 
Further analysis is also required to take cells and incubate with melittin 
and analyse the possible products. The challenge here would be to detect 
such a low amount of hydrophobic products. Improving liquid 
chromatography (LC) and mass spectrometry (MS) instrument parameters 
could also have a great impact on observing previously undetected low 
abundance modified peptides/proteins. One approach could be the 
application of nanospray MS in attempt to increase the sensitivity. Using long 
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gradient chromatography is also essential, as was found in enhancing protein 
identification from biological complex mixture or whole cell extracts.6,7 Further 
improvement will be to deal with dynamic range problem8 due to the 
incredibly low abundance of modify peptides in the presence of highly 
abundant unmodified peptide. If a successful extraction of acylated peptides 
will be achieved and followed by their study alone then there will be a 
potential to optimise the chromatography separation for these species. 
Collision induced dissociation (CID) was exclusively used as a 
fragmentation technique throughout this research to characterise/localise 
lipidation sites. However, using other fragmentation techniques such as 
electron capture dissociation (ECD) and electron transfer dissociation (ETD) 
may further characterise lipidation products and produce complementary 
tandem mass spectra. Because theses electron-based techniques are known 
to be more favourable towards labile modification, cleaving the backbone 
bonds and preserving the modified side chain.9-11  
More challenges were found in resolving overlapped peaks in 
chromatography. Even with single acylation products in one of the four 
abundant places of acylation on melittin we could barely resolve 
chromatographically different acyl modifications on the same amino acid 
residue. Consequently, this is a challenge for quantification approach for 
lipidated products and thus a lack in fully understanding the kinetics of 
lipidated peptides/proteins. This research shows that for acylated peptides 
with lower charge state the different isomers have conformations sufficiently 
different to begin to separate by ion mobility separation (IMS) coupled with 
MS or MS2, but there is still much here that can be improved. One approach 
could be to use other ion mobility gases other than N2 that has been used in 
this study, such as Ar, CO2, He or mixtures of these regarding their difference 
in polarizabilities, sizes, and shapes.12 Kaszycki et al.13 showed that adding 
light gases such as He to heavier gases such as N2 tremendously improves 
the separation of isomeric species of peptide, protein and lipids. Using He-
rich gases in IMS is also suggested by Shvartsburg et al.14 to improve the 
resolution of lipid isomers. 
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In addition, investigating experimental parameters surrounding sample 
preparation can also explore further details. Such that include optimizing 
enzymatic digestion, pH control and adding/removing salts. Adding salt 
cations12,15 such as Li or Na to change peptide/lipid ions from protonated 
species to cation may make the cation to sit in a different place on the 
acylated product. This may affect charge state distribution, ionisation and 
collision cross-section (CCS or Ω). This would also help electron-based 
tandem MS. Wu et al.15 showed that replacing a proton by sodium for peptide 
ions cause a decrease in CCS. This is because Na ion strongly coordinates 
with functional groups on the peptide backbone and stabilizes gas phase 
conformation.  
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8.1. Sample preparation and instrument parameters for 
chapter three - Understanding the role of 
lysophosphatidylcholine (LPC) and 
diacylphosphatidylcholine (PC) in the lipidation of 
melittin 
8.1.1. Chemicals and sample preparation 
8.1.1.1. Liposome and lysophospholipid preparation 
All diacylphospholipids (PLs) 1,2-dioleoyl-sn-glycero-3-
phosphatidylcholine (DOPC), 1,2-dipalmitoyl-sn-glycero-3-
phosphatidylcholine (DPPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphatidylcholine (POPC), 1-oleoyl-2-palmitoyl-sn-glycero-3- 
phosphatidylcholine (OPPC), and 1,2-dimyristoyl-sn-glycero-3-
phosphatidylcholine (DMPC) were purchased from Sigma-Aldrich, UK while 
1-stearoyl-2-linoleoyl-sn-glycero-3-phosphatidylcholine (SLPC) and 1-
stearoyl-2-linoleoyl-sn-glycero-3-phosphatidylserine (SLPS) were purchased 
from Avanti Polar Lipids, USA. Lysophospholipids (LPLs) 1-oleoyl-2-hydroxy-
sn-glycero-3-phosphatidylcholine (OPC), 1-palmitoyl-2-hydroxy-sn-glycero-3-
phosphatidylcholine (PPC), 1-oleoyl-2-hydroxy-sn-glycero-3-
phosphatidylserine (OPS), 1-oleoyl-2-hydroxy-sn-glycero-3-
phosphatidylethanolamine (OPE), and 1-oleoyl-2-hydroxy-sn-glycero-3-
phosphatidylglycerol (OPG) were purchased from Avanti Polar Lipids, USA. 
Stock solutions of PLs were prepared in CHCl3 at 1 mg/mL. Chloroform was 
purchased from Fisher Scientific, UK. These solutions were then used to 
produce individual PC liposomes and/or a binary lipid system of 4:1 molar 
ratio for PC:PS. A volume of dissolved PC was transferred to a highly 
cleaned 5 mL round bottom flask. After mixing well (vortex-mixer), the 
organic solvent was removed in vacuo to leave a thin film of lipid on the side 
of the flask. The lipid film was then left overnight under vacuum to remove 
any residual organic solvent. The concentration of lipid was made to 1 mg/mL 
in aqueous buffer solution: 10 mM sodium bicarbonate (NaHCO3) and 90 mM 
sodium chloride (NaCl), pH 7.4. The lipid dispersion in 1 mL aqueous buffer 
solution was then subjected to five freeze-thaw cycles (from liquid nitrogen 
temperature to 55 °Ϲ) and extruded 10 times through a track-etched 100 nm 
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polycarbonate membrane (Whatman), using a thermobarrel extruder 
(Northern Lipids Inc., Burnaby, Canada) under a stream of N2 to give a 100 
nm diameter of unilamellar liposomes. The extruder was warmed first at 50 
°Ϲ, which is a temperature above phase transition temperature for all 
prepared lipids. LPL solutions were prepared by dilution in the aqueous 
buffer solution (10:90 NaHCO3:NaCl, pH 7.4)  to a final concentration of 1.3 
mM. 
 
8.1.1.2. Melittin acylation preparation 
Synthetic melittin (SynM, ≥ 97℅ by HPLC, UK) and extracted melittin 
from bee venom (BVM, 85℅ by HPLC, UK) were purchased from Sigma-
Aldrich, and a stock solution was prepared at approximately 1 mg/mL in 
water. Water was purified using Milli-Q Direct Q system from Millipore 
(Millipore (UK) Ltd) with resistivity approximately 18.2 MΩ cm. The actual 
concentration was determined using absorbance measurement on UV 
spectrophotometer (VARIAN Carry 50 Bio) at wavelength (λ = 280 nm) with 
molar absorption coefficient 5500 M-1cm-1 for the tryptophan amino acid 
residue.1 The dispersed LPLs and PC liposomes were then combined at 
molar ratios: 100:0, 75:25, 50:50, 25:75 and 0:100 in addition of 50:50 a pair 
of LPLs with different acyl chains. Prepared lipid solutions then mixed with 
SynM and/or BVM so as to give the molar ratio 1:13 of peptide:total lipid ratio 
(peptide:lipid), giving a final concentration of 50 µM of peptide and 0.65 mM 
of lipid. The final peptide:lipid mixture incubated at 37 °Ϲ for 0, 3, 24, 48, 96, 
and 168 h respectively, diluted by a factor of 5 in water and analysed by 
reverse phase LC-MS. 
 
8.1.2. LC-MS and instrument parameters 
8.1.2.1. LC-MS on LTQFT instrument 
8.1.2.1.1. LC-FTICR-MS 
The positive ion mass spectra were recorded over m/z 200-2000 using 
an LTQFT mass spectrometer equipped with a 7 Tesla magnet 
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(ThermoFinnigan Corporation, Bremen, Germany). Electrospray ionisation 
(ESI) was used to generate positive ions from the following conditions: 
source voltage 4.0 kV, capillary voltage 30.0 V, capillary temperature 350.0 
°Ϲ and tube lens 100.0 V. The auxiliary gas flow and sweep gas flow were 
set at 5.0 arbitrary units; nitrogen sheath gas flow at 15.0 arbitrary units. 
Separation was achieved by reverse phase LC (Surveyor HPLC from 
ThermoFisher Scientific Inc.) using an Xbridge C18 column: 3.5 µm particle 
size and 2.1 mm internal diameter, 100 mm length (Waters UK, Manchester, 
UK) by injecting 5 µL sample volumes into a solvent flow rate of 200 µL/min. 
LC separation used the following eluents: aqueous phase (A) was 0.1% (v/v) 
formic acid in water; organic phase (B) consisted of 0.1% (v/v) formic acid in 
acetonitrile; organic phase (C) consisted of 0.1% (v/v) formic acid in 
methanol. The organic solvents for the LC mobile phases were purchased 
from Scientific Fisher, UK.  
 LC-MS Method-I used a total run time of 20 min with the 
reverse phase gradient composed of 95% A: 5% B to 5% A: 
95% B over 10 min, followed by 5 mins washing at 5% A: 95% 
B, then 5 min re-equilibration at 95%A: 5% B.  
 LC-MS Method-II used a 35 min LC run with the reverse phase 
gradient of 95% A: 5% B to 5% A: 95% B over 10 min, followed 
by 5 min at 100% B and 15 min at 100% C, with 5 min re-
equilibration at 95%:A5% B. 
Xcalibur software version 2.0.7 was used for data acquisition and 
processing used the embedded program Qual Browser (ThermoFisher 
Scientific Inc.). The spectral deconvolution was also performed with Qual 
Browser (ThermoFisher Scientific Inc.). The charge state distribution was 
deconvoluted to [M + H]+ in each case. R Statistical Environment2 in the 
XCMS package3 was also applied for further data processing. 
 
8.1.2.1.2. LC-LTQ-MS2 
For tandem MS experiments (MS2), the precursor ion was isolated 
with a fixed isolation window of 4 m/z in the LTQ mass analyser and 
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activated through collisions with helium gas with normalised collision energy 
at 25%. Product ions resulting from the collision induced dissociation (CID) 
were measured in the linear ion trap (LTQ) The same mass spectrometer 
settings and LC conditions were used as described earlier (see section 
8.1.2.1.1). 
 
8.1.2.2. LC-MS on Synapt G2-s instrument 
8.1.2.2.1. LC-QToF-MS 
The Synapt G2-s (Waters corp.) was operated using ESI to generate 
positive ions. The source settings were optimized at 1.0 kV of capillary 
voltage, 20.0 V sample cone, and a source offset at 40.0 V. The source and 
desolvation temperature were set at 150.0 and 300.0 °Ϲ respectively with 
using cone gas and desolvation gas flow at 60.0 and 450.0 L/h respectively. 
The samples were separated on Xbridge C18 column, the same column that 
used and described earlier (see section 8.1.2.1.1), by injecting 1 µL sample 
volume at a solvent flow rate of 600 µL/min using Acquity UPLCTM I class.  
 LC-MS Method-III a 6 min LC separation used the following 
reverse phase gradient: 80% A: 20% B to 40% A: 60% B 
followed by 30% A: 70% B and then 5% A: 95% B over 4 min, 
followed by 1.4 min at 5% A: 95% B and 0.6 min re-equilibration 
at 80% A: 20% B.  
A full scan ToF-MS over the mass range of 50-2000 m/z was recorded in 
the resolution mode. The data was acquired in centroid format and fully 
processed using MassLynx software version 4.1 SCN924.  
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8.2. Sample preparation and instrument parameters for 
chapter four - New insight to integral membrane protein 
(AQP0) lipidation by membrane lipids 
8.2.1. Chemicals and sample preparation 
8.2.1.1. Chemicals 
Bovine eye lenses from calves (age 6–12 months) were obtained from 
Linden Burradon Food Supply (FSA Approval No.2056). Human lenses from 
different candidates were obtained: male donors ages 22 (M22), 56 (M56), 
and 80 (M80) and female donors ages 56 (F56) and 76 (F76) from the Bristol 
Eye Bank with national research ethics committee approval and were used 
as recommended by the Declaration of Helsinki and following the procedures 
recommended under the Human Tissue Authority license to the University of 
Durham. All the required chemicals to make various buffers for the 
bovine/human lens membrane washing and extraction were purchased from 
VWR. Proteomics grade trypsin from porcine pancreas, dithiothreitol (DTT) 
and sodium dodecyl sulfate (SDS) were purchased from Sigma-Aldrich, UK. 
Pentafluorooctanoic acid (PFOA) was purchased from Analytical grade. 
Purified water was used for all the preparations. 
  
8.2.1.2. Lens membrane extraction 
Integral membrane proteins were purified by designing a sequential 
extraction method,4 this then adapted to purify human/bovine lens 
membranes rich in AQP0 protein5,6. The sequential extraction method was as 
follows: buffer 1 contains 10 mM sodium phosphate (pH 7.4), 100 mM NaCl 
and 5 mM EDTA; buffer 2 contains 10 mM sodium phosphate (pH 7.4), 1.5 
M NaCl and 5 mM EDTA; buffer 3 contains 10 mM ammonium bicarbonate 
containing 1 mM EDTA pH 8.0; buffer 4 contains 10 mM sodium phosphate 
(pH 7.4), 8 M urea and 5 mM EDTA; buffer 5 composed of a highly basic 
solution of 0.1 M NaOH. All buffers were kept at 4 °C. A ratio of 2:1 
buffer:lens was maintained throughout the procedure. The bovine eye lenses 
were decapsulated and the lenses aqua-dissected by stirring in buffer 1 to 
remove sequentially the youngest (cortical) fibre cells through to the oldest 
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(nuclear) fibre cells. Lens fibre cell extracts were first Dounce homogenized 
and then centrifuged (rav = 30,000 x g 20 minutes, 4 °C; Beckman JA-20 
rotor) to separate the membrane and cytosol fractions. Membrane fractions 
were defined by the diameter of the residual lens membranes in the 
remaining pellet, generating four different b-AQP0 age fractions as follows; b-
AQP0-outer cortex 15 mm (b-AQP0-OC, the youngest), b-AQP0-inner cortex 
10 mm (b-AQP0-IC), b-AQP0-outer nucleus 8 mm (b-AQP0-ON) and the 
oldest part of b-AQP0-inner nucleus 4 mm (b-AQP0-IN, the oldest). 
Membrane pellets from the four different lens regions were re-suspended in 
the appropriate buffer in the sequence above, Dounce homogenized, stirred 
for 20 min and then re-centrifuged. Membranes were always washed once 
with buffer 1 when transitioning to a new extraction buffer. At the conclusion 
of the extraction procedure, membrane pellets were stored in buffer 3 
containing 0.02% sodium azide (w/v) as a preservative and kept at 4 °C until 
analysis. Human lens samples were initially prepared similarly as described7, 
and stored at −20 °C, before completing the extraction protocol with buffers 
3-5 as described above. The two main fractions obtained from human lens 
pellet were h-AQP0-cortex 4 mm (b-AQP0-C, the youngest) and h-AQP0-
nucleus 8 mm (h-AQP0-N, the oldest). 
 
8.2.2. LC-MS and instrument parameters 
The applied LC-MS methods and digestion protocols is provided in 
Table 8.1. The digestion protocols; Method-A, Method-B, Method-C and 
Method-D will be discussed and explained in the following sections 8.2.2.1.2 
and 8.2.2.2.1. LC-MS methods, Method-I and Method-II, were discussed in 
section 8.1.2.1.1, While Method-IIII will be discussed in section 8.2.2.2.1.   
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Table 8.1. Different digestion protocols and LC-MS methods used in AQP0 analysis. 
Digestion 
Protocol 
Reagent Method Description 
LC-MS 
method 
Method-A DTT (protein reducing agent) 10 µL DTT (100 mM) 
Method-I and 
Method-II 
Method-B DTT + Urea (protein denaturant) 
10 µL DTT (100 mM) + 7 M Urea, followed 
by dilution so as to give less than 1 M urea 
Method-II 
Method-C DTT + PFOA (surfactant) 10 µL DTT (100 mM) + 0.8% (w/v) PFOA Method-II 
Method-D DTT + SDS (surfactant/detergent) 
10 µL DTT (100 mM) + 100 µL (0.1% 
(w/v)) SDS 
Method-IIII 
 
 
8.2.2.1. LC-MS on LTQFT instrument 
8.2.2.1.1. Analysis of intact protein by LC-FTICR-MS 
An aliquot of suspended b-AQP0 in buffer 3 plus 0.02% sodium azide 
was solubilized in 0.8% PFOA (w/v) and centrifuged using a mini centrifuge 
for 1 minute. The supernatant was analysed using a reverse phase LC using 
an Xbridge BEH300 C4 column: 3.5 μm particle size and 2.1 mm internal 
diameter, 150 mm length (Waters Ltd., USA) by injecting 5 μL sample 
volumes into a solvent flow rate of 200 μL/min. The same LC and MS 
conditions that described in section 8.1.2.1.1 (LC-MS Method-I) were also 
applied for intact b-AQP0 analysis. Data were acquired and processed using 
Xcalibur software. 
 
8.2.2.1.2. Analysis of protein digestion by LC-FTICR-MS 
An aliquot of 100 μL re-suspended b-AQP0 in buffer 3 plus 0.02% 
sodium azide was combined with the reagents represented in Table 8.1, 
Methods A-C. This followed by adding 10 μL of trypsin (0.2 mg/mL in a 50 
mM acetic acid) in each described method, and the solution then incubated 
for 24 h at 37 °C. The supernatant solution after 1 min centrifugation was run 
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on LC-FTICR-MS using Method-I and/or Method-II through Xbridge C18 
column and the same conditions described in section 8.1.2.1.1. 
 
8.2.2.2. LC-MS on Synapt G2-s instrument 
8.2.2.2.1. Analysis of protein digestion by LC-QToF-MS 
An aliquot of 100 μL re-suspended AQP0 in buffer 3 plus 0.02% sodium 
azide digested using the following digestion protocol: Method-D (see Table 
8.1) 10 min sample sonication at 37 °C (Ultrawave Ltd., Cardiff, UK), followed 
by centrifuging the sample for 2 min at 13000 rpm and then the supernatant 
was discarded and 100 μL of 0.1% (w/v) SDS was added, followed by adding 
10 μL of each DTT (100 mM) and trypsin (0.2 mg/mL in a 50 mM acetic acid). 
After gentle mixing, the mixture was incubated at 37 °C for 24 h and 
centrifuged for 2 min at 13000 rpm. The supernatant was analysed by LC-
QToF-MS. Reverse phase LC was performed by injecting 5 μL digested 
sample at a flow rate 400 μL/min. MassLynx was used for full data 
processing (se section 8.1.2.2.1).  
 LC-MS Method-IIII A 12 min LC run used the following reverse phase 
gradient: 95% A: 5% B to 5% A: 95% B over 8 minute followed by 5% 
A: 95% B for 2 minute and then 95% A: 5% B over 2 minute for 
column re-equilibration by using the same Xbridge C18 column and 
the A and B eluent compositions as described in section 8.1.2.1.1. 
Details for MS conditions are given in section 8.1.2.2.1. 
 
8.2.2.2.2. Analysis of protein digestion by LC-QToF-MS2 and LC-
QToF-MSE 
Using the same LC conditions (see section 8.2.2.2.1, LC-MS Method-
IIII) and MS conditions (see section 8.1.2.2.1), tandem MS spectra were 
obtained by collision induced dissociation (CID) in the trap cell of the 
Triwave. This is performed by using helium as a collision gas. MS2 of an 
isolated precursor ion or MSE for all ions were acquired with a trap collision 
energy ramp set at 30–50 eV. 
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8.2.3. Analysis of intact protein by MALDI-ToF-MS (Autoflex II 
instrument) 
MALDI-MS analysis was performed on intact b-AQP0 samples by 
calibrating the instrument first for a mixture of standard proteins. The 
standard calibrant made of myoglobin, cytochrome c, and ubiquitin mixture 
and they were mixed with sinapinic acid (SA) matrix which made in 30:70 
acetonitrile:water with 0.1% trifluoroacetic acid (TFA) at a ratio of 1:9. Prior 
spotting 2 ᵡ 0.5 µL aliquots of this pre-prepared matrix:protein calibration 
solution on top of each other, spot 0.5 µL of SA matrix made in ethanol and 
allow it to air dry. The same preparation and spotting conditions were also 
applied on the biological sample of b-AQP0 after extracting from bovine 
lenses. The data were acquired on Autoflex II MALDI-ToF spectrometer with 
337 nm nitrogen laser (Bruker Daltonics Ltd., Coventry, UK) in positive linear 
mode by using 200 shots for each 45 laser pulses. Methanol and acetone 
were used for cleaning a ground steel target plate before using. Data were 
processed using Flex Analysis version from 3.0 Bruker Daltonics Ltd. 
(Coventry, UK).   
 
8.2.4. Prediction of potential lipid binding regions 
Sections in the C-terminal region of AQP0 with the potential for lipid 
binding were identified using HELIQUEST8 and the Discrimination Factor, D, 
calculated using the equation D = 0.944 (<μH>) + 0.33 (z).9 When this 
discrimination factor is above 0.68, the corresponding sequence can be 
considered to be a (potential) lipid-binding region9,10. 
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8.3. Sample preparation and instrument parameters for 
chapter five - Application of ion mobility separation-
mass spectrometry (IMS-MS) to the analysis of 
phosphatidylcholine and synthetic lipidated melittin 
analogues 
8.3.1. Chemicals and sample preparation 
The purchase details and the preparation of stock solutions for PCs 
(DOPC, DMPC, DPPC, SLPC, POPC and OPPC) and LPCs (PPC and OPC) 
were described earlier in section 8.1.1.1. Sample solutions of PC and LPC 
were diluted from stock solution (1 mg/mL) to 0.5 µg/mL with 1:1 
water:acetonitrile with 0.1% (v/v) formic acid. Synthetic lipidated melittin 
analogous, including N-palmitoyl melittin (N-Mpal), K23-palmitoyl melittin 
(K23-Mpal), N-oleoyl melittin (N-Mole) and K23-oleoyl melittin (K23-Mole) were 
synthesized by ALMAC (Elvingston Science Centre by Gladsmuir, East 
Lothian, Scotland, UK) and were prepared as stock solution in water at 
concentration 1 mg/mL. This then diluted to 1 µg/mL with 1:1 
water:acetonitrile with 0.1% (v/v) formic acid. All solutions were directly 
infused into ESI-IMS-MS at a flow rate of 5 µL/min using a syringe pump 
(Harvard Apparatus, Holliston, MA, U.S.). 
 
8.3.2. IMS-MS/MS2 and instrument parameters on Synapt G2-s 
instrument 
8.3.2.1. IMS-MS analysis for phosphatidylcholine  
For ion mobility separation by using traveling wave ion mobility 
spectrometry (TWIMS), N2 drift gas was used at a flow rate of 70 mL/min. An 
optimised T-wave velocity of 1000 m/s and T-wave height of 40 V was used. 
The source settings (ESI+) were optimized at 1.5 kV of capillary voltage, 50.0 
V sample cone, and a source offset at 30.0 V. The source and desolvation 
temperature were set at 150.0 and 500.0 °Ϲ respectively with using cone gas 
and desolvation gas flow at 60.0 and 500.0 L/h respectively. A full scan ToF-
MS over the mass range of 50-2000 m/z was recorded in the resolution 
mode. Data were acquired in continuum format for 1 min and at 1 second 
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scan time. The data was processed using MassLynx software version 4.1 
SCN924 and DriftScope version 2.7.  
 
8.3.2.2. IMS-MS/MS2 analysis for synthetic lipidated melittin analogues 
TWIMS by using N2 drift gas was optimised at T-wave velocity of 800 m/s 
and T-wave height of 40.0 V for both IMS-MS and IMS-MS2. The source 
settings (ESI+) were optimized at 3.0 kV of capillary voltage, 70.0 V sample 
cone, and a source offset at 50.0 V. The source and desolvation temperature 
were set at 150.0 and 350.0 °Ϲ respectively with using cone gas and 
desolvation gas flow at 60.0 and 600.0 L/h respectively. Data were acquired 
for 3 min and at 1 second scan time. For IMS-MS2 a precursor ion was 
selected at the resolving quadruplole and followed by ion mobility separation. 
Collision energy (CID) in the transfer cell of Triwave (TWIMS) was used to 
fragment isolated precursor ion with a ramp Transfer collision energy at 20-
35 eV by using helium as a collision gas, while trap collision energy set at 
fixed collision energy of 4 eV. MassLynx was used for data processing (see 
section 8.3.2.1).   
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9.1. Appendix A 
 
Table 9.1. Amino acid residues with their abbreviation and molecular mass. 
AA Molecular 
Formula 
3-Letter 
Code 
1-Letter 
Code 
Mass 
(Da) 
AA Molecular 
Formula 
3-Letter 
Code 
1-Letter 
Code 
Mass 
(Da) 
Glycine 
(C2H3NO) 
Gly G 57 
Aspartic acid 
(C4H5NO3) 
Asp D 115 
Alanine 
(C3H5NO) 
Ala A 71 
Glutamine 
(C5H8N2O2) 
Gin Q 128 
Serine 
(C3H5NO2) 
Ser S 87 
Lysine 
(C6H12N2O) 
Lys K 128 
Proline 
(C5H7NO) 
Pro P 97 
Glutamic acid 
(C5H7NO3) 
Glu E 129 
Valine 
(C5H9NO) 
Val V 99 
Methionine 
(C5H9NOS) 
Met M 131 
Threonine 
(C4H7NO2) 
Thr T 101 
Histidine 
(C6H7N3O) 
His H 137 
Cysteine 
(C3H5NOS) 
Cys C 103 
Phenylalanine 
(C9H9NO) 
Phe F 147 
Isoleucine 
(C6H11NO) 
lie I 113 
Arginin 
(C6H12N4O) 
Arg R 156 
Leucine 
(C6H11NO) 
Leu L 113 
Tyrosine 
(C9H9NO2) 
Tyr Y 163 
Aspargine 
(C4H6N2O2) 
Asn N 114 
Tryptophan 
(C11H10N2O) 
Trp W 186 
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Table 9.2. The structure and nomenclature for common phospholipids used in this 
research.  
Phospholipids 
Nomenclature 
Phospholipids Structure 
1,2-dioleoyl-sn-
glycero-3-
phosphatidylcholine 
(DOPC)  
1,2-dipalmitoyl-sn-
glycero-3-
phosphatidylcholine 
(DPPC) 
 
1,2-dimyristoyl-sn-
glycero-3-
phosphatidylcholine 
(DMPC) 
 
1-stearoyl-2-linoleoyl-
sn-glycero-3-
phosphatidylcholine 
(SLPC)  
1-palmitoyl-2-oleoyl-
sn-glycero-3-
phosphatidylcholine 
(POPC) 
 
1-oleoyl-2-palmitoyl-
sn-glycero-3- 
phosphatidylcholine 
(OPPC)  
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1-stearoyl-2-linoleoyl-
sn-glycero-3- 
phosphatidylserine 
(SLPS)  
1-oleoyl-2-hydroxy-
sn-glycero-3-
phosphatidylcholine 
(OPC)  
1-palmitoyl-2-
hydroxy-sn-glycero-3-
phosphatidylcholine 
(PPC)  
1-oleoyl-2-hydroxy-
sn-glycero-3-
phosphatidylserine 
(OPS)  
1-oleoyl-2-hydroxy-
sn-glycero-3-
phosphatidylethanola
mine (OPE)  
1-oleoyl-2-hydroxy-
sn-glycero-3-
phosphatidylglycerol 
(OPG)  
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9.2. Appendix B: Supplementary information for Chapter 
three - Understanding the role of lysophosphatidylcholine 
(LPC) and diacylphosphatidylcholine (PC) in the lipidation of 
melittin 
 
Table 9.3. The range of single and multiple acylation ions observed from SynM/50:50 
PPC:DOPC incubation at 37 °Ϲ for 168 h.  
1
H-GIGAVLKVLTTGLPALISWIKRKRQQ-NH2
26
 
m/z
 
Theor
‡
 m/z Meas
‡
 z 
Error 
(ppm) 
RT
 
(min)
 
 
Assignment 
1037.3404 1037.3423 3 1.83 
8.9 SynMole/single oleoylation 778.2572 778.2580 4 1.03 
622.8072 622.8076 5 0.64 
1028.6686 1028.6689 3 0.29 
8.5 SynMpal/single palmitoylation 771.7532 771.7532 4 0.00 
617.6040 617.6048 5 1.30 
1125.4222 1125.4205 3 -1.51 
11.0 SynM2ole/double oleoylation 844.3185 844.3196 4 1.30 
675.6562 675.6562 5 0.00 
1108.0784 1108.0811 3 2.44 
11.0 SynM2pal/double palmitoylation 831.3107 831.3117 4 1.20 
665.2500 665.2509 5 1.35 
1116.7503 1116.7489 3 -1.25 
11.0 SynMpal+ole / single palmitoylation + single oleoylation 837.8146 837.8157 4 1.31 
670.4531 670.4540 5 1.34 
1125.4222 1125.4242 3 1.78 
17.8 SynM3ole/labile triple oleoylation 
844.3185 844.3190 4 0.59 
1108.0784 1108.0554 3 -20.76 
17.7 SynM3pal/labile triple palmitoylation 
831.3107 831.3108 4 0.12 
1116.7503 1116.7476 3 -2.42 
17.7 
SynM2pal+ole or SynM2ole+pal/labile (double palmitoylation 
+ single oleoylation) or (double oleoylation + single 
palmitoylation) 
837.8146 837.8159 4 1.55 
670.4531 670.4553 5 3.28 
1213.5040 1213.5038 3 -0.16 
18.1 SynM3ole/triple oleoylation 
910.3798 910.3758 4 -4.39 
1187.4883 1187.4899 3 1.35 
18.2 SynM3pal/triple palmitoylation 
890.8681 890.8683 4 0.22 
1204.8321 1204.8300 3 -1.74 
18.1 SynM2ole+pal/double oleoylation + single palmitoylation 
903.8759 903.8759 4 0.00 
1196.1602 1196.1633 3 2.59 
18.2 SynM2pal+ole/double palmitoylation + single oleoylation 
897.3720 897.3736 4 1.78 
‡Both theoretical (Theor) and measured (Meas) m/z values are for the monoisotopic peak. 
Theoretical mass obtained from mMass software (V5.5). 
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Table 9.4. The range of single and multiple acylation ions observed from SynM/50:50 
OPC:DPPC incubation at 37 °Ϲ for 168. 
1
H-GIGAVLKVLTTGLPALISWIKRKRQQ-NH2
26
 
m/z
 
Theor
‡
 m/z Meas
‡
 z 
Error 
(ppm) 
RT
 
(min)
 
 
Assignment 
1037.3404 1037.3405 3 0.09 
8.6 SynMole/single oleoylation 778.2572 778.2585 4 1.67 
622.8072 622.8077 5 0.80 
1028.6686 1028.6687 3 0.10 
8.5 SynMpal/ single palmitoylation 771.7532 771.7542 4 1.30 
617.6040 617.6046 5 0.97 
1125.4222 1125.4232 3 0.89 
11.0 SynM2ole/double oleoylation 844.3185 844.3193 4 0.95 
675.6562 675.6549 5 -1.92 
1108.0784 1108.0789 3 0.45 
11.0 SynM2pal/double palmitoylation 831.3107 831.3115 4 0.96 
665.2500 665.2499 5 -0.15 
1116.7503 1116.7505 3 0.18 
11.0 SynMpal+ole/single palmitoylation + single oleoylation 837.8146 837.8159 4 1.55 
670.4531 670.4542 5 1.64 
1125.4222 1125.4195 3 -2.40 
17.7 SynM3ole/labile triple oleoylation 
844.3185 844.3195 4 1.18 
831.3107 831.3134 4 3.25 17.7 SynM3pal/labile triple palmitoylation 
1116.7503 1116.7491 3 -1.07 
17.8 
SynM2pal+ole or SynM2ole+pal/labile (double palmitoylation 
+ single oleoylation) or (double oleoylation + single 
palmitoylation) 
837.8146 837.8154 4 0.95 
670.4531 670.4537 5 0.89 
1213.504 1213.5011 3 -2.39 
18.2 SynM3ole/triple oleoylation 
910.3798 910.3813 4 1.65 
1187.4883 1187.4921 3 3.20 
18.1 SynM3pal/triple palmitoylation 
890.8681 890.8680 4 -0.11 
1204.8321 1204.8315 3 -0.50 
18.2 SynM2ole+pal/double oleoylation + single palmitoylation 
903.8759 903.8751 4 -0.89 
1196.1602 1196.1632 3 2.51 
18.2 SynM2pal+ole/double palmitoylation + single oleoylation 
897.3720 897.3710 4 -1.11 
‡Both theoretical (Theor) and measured (Meas) m/z values are monoisotopic. Theoretical 
mass obtained from mMass software (V5.5). 
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Table 9.5. Ions produced by fragmenting SynM2pal at m/z 832 (z=4) over 9.1 min of the 
EIC (see Figure 3.27, SynM/50:50 PPC:DOPC). Product ions correspond to S18/K21 
double palmitoylation (see Figure 3.29 A). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b4 299.1 1 H-GIGA y24 1051.3 3 
GAVLKVLTTGLPALISWIKRKRQ
Q-NH2 
b5 398.1 1 H-GIGAV y24 789.0 4 
GAVLKVLTTGLPALISWIKRKRQ
Q-NH2 
b6 511.4 1 H-GIGAVL y22 1008.8 3 
VLKVLTTGLPALISWIKRKRQQ-
NH2 
b8 738.4 1 H-GIGAVLKV y21 976.0 3 
LKVLTTGLPALISWIKRKRQQ-
NH2 
b9 851.5 1 H-GIGAVLKVL y20 938.1 3 KVLTTGLPALISWIKRKRQQ-NH2 
b10 953.0 1 H-GIGAVLKVLT y19 1342.5 2 VLTTGLPALISWIKRKRQQ-NH2 
b12 1110.6 1 H-GIGAVLKVLTTG y18 1293.2 2 LTTGLPALISWIKRKRQQ-NH2 
b13 1223.7 1 H-GIGAVLKVLTTGL 
y17 1236.7 2 TTGLPALISWIKRKRQQ-NH2 
y16 1186.1 2 TGLPALISWIKRKRQQ-NH2 
y15 1135.5 2 GLPALISWIKRKRQQ-NH2 
y14 1107.1 2 LPALISWIKRKRQQ-NH2 
y13 1050.5 2 PALISWIKRKRQQ-NH2 
y13 700.7 3 PALISWIKRKRQQ-NH2 
y12 1002.1 2 ALISWIKRKRQQ-NH2 
y10 910.3 2 ISWIKRKRQQ-NH2 
y9 853.6 2 SWIKRKRQQ-NH2 
y7 598.1 2 IKRKRQQ-NH2 
y6 541.0 2 KRKRQQ-NH2 
y5 357.7 2 RKRQQ-NH2 
*Palmitoylation sites are highlighted in blue within the amino acid sequence of the peptide. 
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Table 9.6. Ions produced by fragmenting SynM2pal at m/z 832 (z=4) over 9.4 min of the 
EIC (see Figure 3.27, SynM/50:50 PPC:DOPC). Product ions correspond to K21/K23 
double palmitoylation (see Figure 3.29 B). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b4 299.3 1 H-GIGA y24 1052.1 3 
GAVLKVLTTGLPALISWIKRKR
QQ-NH2 
b5 398.2 1 H-GIGAV y24 789.0 4 
i.GAVLKVLTTGLPALISWIKRK
RQQ-NH2 
b6 511.3 1 H-GIGAVL y22 1009.0 3 
VLKVLTTGLPALISWIKRKRQQ
-NH2 
b8 738.6 1 H-GIGAVLKV y21 976.0 3 
LKVLTTGLPALISWIKRKRQQ-
NH2 
b9 851.6 1 H-GIGAVLKVL y20 938.3 3 
KVLTTGLPALISWIKRKRQQ-
NH2 
b10 952.9 1 H-GIGAVLKVLT y19 1342.9 2 
VLTTGLPALISWIKRKRQQ-
NH2 
b12 1110.7 1 H-GIGAVLKVLTTG y18 1293.1 2 LTTGLPALISWIKRKRQQ-NH2 
b13 1223.6 1 H-GIGAVLKVLTTGL 
y17 1236.7 2 TTGLPALISWIKRKRQQ-NH2 
y16 1186.1 2 TGLPALISWIKRKRQQ-NH2 
y15 1135.5 2 GLPALISWIKRKRQQ-NH2 
y14 1106.8 2 LPALISWIKRKRQQ-NH2 
y13 1050.2 2 PALISWIKRKRQQ-NH2 
y13 700.9 3 PALISWIKRKRQQ-NH2 
y12 1001.8 2 ALISWIKRKRQQ-NH2 
y11 966.2 2 LISWIKRKRQQ-NH2 
y10 910.0 2 ISWIKRKRQQ-NH2 
y9 853.6 2 SWIKRKRQQ-NH2 
y8 809.5 2 WIKRKRQQ-NH2 
y6 659.4 2 KRKRQQ-NH2 
*Palmitoylation sites are highlighted in blue within the amino acid sequence of the peptide. 
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Table 9.7. Ions produced by fragmenting SynM2pal at m/z 832 (z=4) over 9.4 min of the 
EIC (see Figure 3.27, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus/K21 double palmitoylation (see Figure 3.29 C). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 466.2 1 H-GIG y24 972.5 3 
GAVLKVLTTGLPALISWIKR
KRQQ-NH2 
b4 537.3 1 H-GIGA y21 896.7 3 
LKVLTTGLPALISWIKRKRQ
Q-NH2 
b5 636.2 1 H-GIGAV y19 1223.6 2 
VLTTGLPALISWIKRKRQQ-
NH2 
b6 749.2 1 H-GIGAVL y18 1174.0 2 
LTTGLPALISWIKRKRQQ-
NH2 
b7 877.4 1 H-GIGAVLK y17 1117.5 2 
TTGLPALISWIKRKRQQ-
NH2 
b8 976.1 1 H-GIGAVLKV y16 1066.9 2 TGLPALISWIKRKRQQ-NH2 
b9 1089.6 1 H-GIGAVLKVL y15 1016.1 2 GLPALISWIKRKRQQ-NH2 
b10 1190.9 1 H-GIGAVLKVLT y14 987.8 2 LPALISWIKRKRQQ-NH2 
b12 1348.6 1 H-GIGAVLKVLTTG y13 931.1 2 PALISWIKRKRQQ-NH2 
b12 - H2O 1330.7 1 H-GIGAVLKVLTTG y13 621.4 3 PALISWIKRKRQQ-NH2 
b12 - H2O 666.0 2 H-GIGAVLKVLTTG y12 883.0 2 ALISWIKRKRQQ-NH2 
b13 1461.5 1 H-GIGAVLKVLTTGL y11 847.3 2 LISWIKRKRQQ-NH2 
b13 - H2O 1443.7 1 H-GIGAVLKVLTTGL y10 790.6 2 ISWIKRKRQQ-NH2 
b15 816.1 2 H-GIGAVLKVLTTGLPA 
y9 734.1 2 SWIKRKRQQ-NH2 
y6 1080.1 1 KRKRQQ-NH2 
y4 558.3 1 KRQQ-NH2 
y4 – NH3  541.8  1 KRQQ-NH2 
*Palmitoylation sites are highlighted in blue within the amino acid sequence of the peptide. 
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Table 9.8. Ions produced by fragmenting SynM2pal at m/z 832 (z=4) over 10.9 min of the 
EIC (see Figure 3.27, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus/R22 double palmitoylation (see Figure 3.30 A). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 466.2 1 H-GIG y24 972.4 3 
GAVLKVLTTGLPALISWIKR
KRQQ-NH2 
b4 537.2 1 H-GIGA y22 929.5 3 
VLKVLTTGLPALISWIKRKR
QQ-NH2 
b5 636.3 1 H-GIGAV y21 896.6 3 
LKVLTTGLPALISWIKRKRQ
Q-NH2 
b6 749.4 1 H-GIGAVL y20 859.0 3 
KVLTTGLPALISWIKRKRQQ
-NH2 
b7 877.5 1 H-GIGAVLK y19 1223.7 2 
VLTTGLPALISWIKRKRQQ-
NH2 
b7  439.7 2 H-GIGAVLK y18 1173.8 2 
LTTGLPALISWIKRKRQQ-
NH2 
b8 976.6 1 H-GIGAVLKV y17 1117.5 2 
TTGLPALISWIKRKRQQ-
NH2 
b9 1089.6 1 H-GIGAVLKVL y16 1067.1 2 TGLPALISWIKRKRQQ-NH2 
b10 1190.4 1 H-GIGAVLKVLT y15 1016.5 2 GLPALISWIKRKRQQ-NH2 
b12 1348.7 1 H-GIGAVLKVLTTG y14 987.9 2 LPALISWIKRKRQQ-NH2 
b12 - H2O 1330.7 1 H-GIGAVLKVLTTG y13 931.5 2 PALISWIKRKRQQ-NH2 
b12 - H2O  665.9 2 H-GIGAVLKVLTTG y13 621.5 3 PALISWIKRKRQQ-NH2 
b13 1461.8 1 H-GIGAVLKVLTTGL y12 882.9 2 ALISWIKRKRQQ-NH2 
b13 - H2O 1443.8 1 H-GIGAVLKVLTTGL y11 847.4 2 LISWIKRKRQQ-NH2 
b15  815.9 2 H-GIGAVLKVLTTGLPA 
y10 790.8 2 ISWIKRKRQQ-NH2 
y9 734.0 2 SWIKRKRQQ-NH2 
y5 477.1 2 RKRQQ-NH2 
*Palmitoylation sites are highlighted in blue within the amino acid sequence of the peptide. 
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Table 9.9. Ions produced by fragmenting SynM2pal at m/z 832 (z=4) over 11.2 min of the 
EIC (see Figure 3.27, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus/R24 double palmitoylation (see Figure 3.30 B). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 466.2 1 H-GIG y24 972.2 3 
GAVLKVLTTGLPALISWIKRK
RQQ-NH2 
b4 537.1 1 H-GIGA y22 929.5 3 
VLKVLTTGLPALISWIKRKRQ
Q-NH2 
b5 636.3 1 H-GIGAV y21 896.6 3 
LKVLTTGLPALISWIKRKRQQ
-NH2 
b6 749.4 1 H-GIGAVL y20 859.1 3 
KVLTTGLPALISWIKRKRQQ-
NH2 
b7 877.6 1 H-GIGAVLK y19 1223.4 2 
VLTTGLPALISWIKRKRQQ-
NH2 
b7  439.4 2 H-GIGAVLK y18 1173.8 2 
LTTGLPALISWIKRKRQQ-
NH2 
b8 976.6 1 H-GIGAVLKV y17 1117.4 2 TTGLPALISWIKRKRQQ-NH2 
b9 1089.7 1 H-GIGAVLKVL y16 1067.4 2 TGLPALISWIKRKRQQ-NH2 
b10 1190.7 1 H-GIGAVLKVLT y15 1016.5 2 GLPALISWIKRKRQQ-NH2 
b12 1348.7 1 H-GIGAVLKVLTTG y14 987.9 2 LPALISWIKRKRQQ-NH2 
b12 - H2O 1330.8 1 H-GIGAVLKVLTTG y13 931.5 2 PALISWIKRKRQQ-NH2 
b12 - H2O  665.9 2 H-GIGAVLKVLTTG y13 621.5 3 PALISWIKRKRQQ-NH2 
b13 1461.8 1 H-GIGAVLKVLTTGL y12 882.7 2 ALISWIKRKRQQ-NH2 
b13 - H2O 1443.8 1 H-GIGAVLKVLTTGL y11 847.5 2 LISWIKRKRQQ-NH2 
b15  816.3 2 H-GIGAVLKVLTTGLPA 
y10 790.3 2 ISWIKRKRQQ-NH2 
y9 733.3 2 SWIKRKRQQ-NH2 
y8 - NH3 681.4 2 WIKRQQ-NH2 
y5 477.1 2 RKRQQ-NH2 
y5 - NH3 468.5 2 RKRQQ-NH2 
y4 - NH3 390.5 2 KRQQ-NH2 
*Palmitoylation sites are highlighted in blue within the amino acid sequence of the peptide. 
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Table 9.10. Ions produced by fragmenting SynM2ole at m/z 845 (z=4) over 9.2 min of the 
EIC (see Figure 3.31, SynM/50:50 PPC:DOPC). Product ions correspond to S18/K21 
double oleoylation (see Figure 3.32 A). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b4 299.1 1 H-GIGA y24 1069.1 3 
GAVLKVLTTGLPALISWIKRK
RQQ-NH2 
b5 398.2 1 H-GIGAV y22 1026.3 3 
VLKVLTTGLPALISWIKRKRQ
Q-NH2 
b6 511.3 1 H-GIGAVL y21 993.4 3 
LKVLTTGLPALISWIKRKRQQ-
NH2 
b12 1348.7 1 H-GIGAVLKVLTTG y20 955.7 3 
KVLTTGLPALISWIKRKRQQ-
NH2 
b13 1461.8 1 H-GIGAVLKVLTTGL 
y19 1368.6 2 
VLTTGLPALISWIKRKRQQ-
NH2 
y18 1318.6 2 LTTGLPALISWIKRKRQQ-NH2 
y17 1262.6 2 TTGLPALISWIKRKRQQ-NH2 
y16 1211.8 2 TGLPALISWIKRKRQQ-NH2 
y15 1161.6 2 GLPALISWIKRKRQQ-NH2 
y14 1132.0 2 LPALISWIKRKRQQ-NH2 
y13 1076.1 2 PALISWIKRKRQQ-NH2 
y13 - H2O 1066.9 2 PALISWIKRKRQQ-NH2 
y13 718.3 3 PALISWIKRKRQQ-NH2 
y12 1027.6 2 ALISWIKRKRQQ-NH2 
y11 992.1 2 LISWIKRKRQQ-NH2 
y10 935.6 2 ISWIKRKRQQ-NH2 
y7 610.3 2 IKRKRQQ-NH2 
y6 554.2 2 KRKRQQ-NH2 
y5 714.4  1 RKRQQ-NH2 
*Oleoylation sites are highlighted in red within the amino acid sequence of the peptide. 
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Table 9.11. Ions produced by fragmenting SynM2ole at m/z 845 (z=4) over 9.6 min of the 
EIC (see Figure 3.31, SynM/50:50 PPC:DOPC). Product ions correspond to K21/K23 
double oleoylation (see Figure 3.32 B). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b4 299.1 1 H-GIGA y24 1069.2 3 
GAVLKVLTTGLPALISWIKRKRQQ
-NH2 
b5 398.2 1 H-GIGAV y22 1026.4 3 
VLKVLTTGLPALISWIKRKRQQ-
NH2 
b6 511.3 1 H-GIGAVL y19 1368.7 2 VLTTGLPALISWIKRKRQQ-NH2 
b10 952.5 1 H-GIGAVLKVLT y18 1318.9 2 LTTGLPALISWIKRKRQQ-NH2 
b12 1110.6 1 H-GIGAVLKVLTTG y17 1262.7 2 TTGLPALISWIKRKRQQ-NH2 
b13 1223.6 1 H-GIGAVLKVLTTGL 
y16 1211.9 2 TGLPALISWIKRKRQQ-NH2 
y15 1161.5 2 GLPALISWIKRKRQQ-NH2 
y14 1132.8 2 LPALISWIKRKRQQ-NH2 
y13 1076.6 2 PALISWIKRKRQQ-NH2 
y13-H2O 1067.6 2 PALISWIKRKRQQ-NH2 
y13 718.3 3 PALISWIKRKRQQ-NH2 
y12 1028.3 2 ALISWIKRKRQQ-NH2 
y11 992.8 2 LISWIKRKRQQ-NH2 
y10 935.9 2 ISWIKRKRQQ-NH2 
y8 835.8 2 WIKRKRQQ-NH2 
y7 742.2 2 IKRKRQQ-NH2 
y5 490.3 2 RKRQQ-NH2 
*Oleoylation sites are highlighted in red within the amino acid sequence of the peptide. 
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Table 9.12. Ions produced by fragmenting SynM2ole at m/z 845 (z=4) over 9.6 min of the 
EIC (see Figure 3.31, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus/K21 double oleoylation (see Figure 3.32 C). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 492.3 1 H-GIG y24 981.0 3 
GAVLKVLTTGLPALISWIKRKRQQ-
NH2 
b4 563.2 1 H-GIGA y21 1356.6 2 LKVLTTGLPALISWIKRKRQQ-NH2 
b5 662.3 1 H-GIGAV y19 1236.4 2 VLTTGLPALISWIKRKRQQ-NH2 
b6 775.3 1 H-GIGAVL y18 1187.0 2 LTTGLPALISWIKRKRQQ-NH2 
b7 903.4 1 H-GIGAVLK y17 1130.5 2 TTGLPALISWIKRKRQQ-NH2 
b8 1002.6 1 H-GIGAVLKV y16 1079.8 2 TGLPALISWIKRKRQQ-NH2 
b9 1115.6 1 H-GIGAVLKVL y15 1029.4 2 GLPALISWIKRKRQQ-NH2 
b10 1216.7 1 H-GIGAVLKVLT y14 1001.0 2 LPALISWIKRKRQQ-NH2 
b12 1374.7 1 H-GIGAVLKVLTTG y13 944.4 2 PALISWIKRKRQQ-NH2 
b13 1487.8 1 H-GIGAVLKVLTTGL 
y13 630.1 3 PALISWIKRKRQQ-NH2 
y12 895.2 2 ALISWIKRKRQQ-NH2 
y11 860.4 2 LISWIKRKRQQ-NH2 
y10 803.3 2 ISWIKRKRQQ-NH2 
y9 746.9 2 SWIKRKRQQ-NH2 
y8 703.7 2 WIKRKRQQ-NH2 
y7 609.2 2 IKRKRQQ-NH2 
y5 714.5  1 RKRQQ-NH2 
y4 558.5  1 KRQQ-NH2 
*Oleoylation sites are highlighted in red within the amino acid sequence of the peptide. 
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Table 9.13. Ions produced by fragmenting SynM2ole at m/z 845 (z=4) over 10.2 min of 
the EIC (see Figure 3.31, SynM/50:50 PPC:DOPC). Product ions correspond to K7/K21 
double oleoylation (see Figure 3.33 A). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b4 299.1 1 H-GIGA y24 1069.1 3 
GAVLKVLTTGLPALISWIKRKR
QQ-NH2 
b5 398.2 1 H-GIGAV y24 801.8 4 
GAVLKVLTTGLPALISWIKRKR
QQ-NH2 
b6 511.3 1 H-GIGAVL y22 1026.0 3 
VLKVLTTGLPALISWIKRKRQQ-
NH2 
b7 903.5 1 H-GIGAVLK y21 993.9 3 
LKVLTTGLPALISWIKRKRQQ-
NH2 
b8 1002.6 1 H-GIGAVLKV y20 1432.5 2 
KVLTTGLPALISWIKRKRQQ-
NH2 
b9 1115.7 1 H-GIGAVLKVL y19 1236.7 2 VLTTGLPALISWIKRKRQQ-NH2 
b10 1216.6 1 H-GIGAVLKVLT y18 1187.0 2 LTTGLPALISWIKRKRQQ-NH2 
b11 1317.8 1 H-GIGAVLKVLTT y17 1130.5 2 TTGLPALISWIKRKRQQ-NH2 
b12 1374.7 1 H-GIGAVLKVLTTG y17 754.3 3 TTGLPALISWIKRKRQQ-NH2 
b13 1487.8 1 H-GIGAVLKVLTTGL 
y16 1079.6 2 TGLPALISWIKRKRQQ-NH2 
y15 1029.2 2 GLPALISWIKRKRQQ-NH2 
y14 1000.7 2 LPALISWIKRKRQQ-NH2 
y13 944.4 2 PALISWIKRKRQQ-NH2 
y13 630.1 3 PALISWIKRKRQQ-NH2 
y12 895.8 2 ALISWIKRKRQQ-NH2 
y11 860.4 2 LISWIKRKRQQ-NH2 
y10 803.4 2 ISWIKRKRQQ-NH2 
y9 747.6 2 SWIKRKRQQ-NH2 
y8 703.8 2 WIKRKRQQ-NH2 
y7 609.2 2 IKRKRQQ-NH2 
y6 553.5 2 KRKRQQ-NH2 
y4 - NH3 271.2 2 KRQQ-NH2 
*Oleoylation sites are highlighted in red within the amino acid sequence of the peptide. 
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Table 9.14. Ions produced by fragmenting SynM2ole at m/z 845 (z=4) over 10.6 min of 
the EIC (see Figure 3.31, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus/K23 double oleoylation (see Figure 3.33B). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 492.3 1 H-GIG y24 980.9 3 
GAVLKVLTTGLPALISWIKRKRQQ
-NH2 
b4 563.3 1 H-GIGA y24 736.0 4 
GAVLKVLTTGLPALISWIKRKRQQ
-NH2 
b5 662.3 1 H-GIGAV y22 938.4 3 
VLKVLTTGLPALISWIKRKRQQ-
NH2 
b6 775.3 1 H-GIGAVL y21 1356.7 2 LKVLTTGLPALISWIKRKRQQ-NH2 
b7 903.6 1 H-GIGAVLK y21 905.5 3 LKVLTTGLPALISWIKRKRQQ-NH2 
b8 1002.5 1 H-GIGAVLKV y21 678.9 4 LKVLTTGLPALISWIKRKRQQ-NH2 
b9 1115.6 1 H-GIGAVLKVL y20 868.0 3 KVLTTGLPALISWIKRKRQQ-NH2 
b10 1216.7 1 H-GIGAVLKVLT y19 1236.4 2 VLTTGLPALISWIKRKRQQ-NH2 
b12 1374.7 1 H-GIGAVLKVLTTG y18 1187.0 2 LTTGLPALISWIKRKRQQ-NH2 
b13 1488.0 1 H-GIGAVLKVLTTGL 
y17 1130.2 2 TTGLPALISWIKRKRQQ-NH2 
y17 754.3 3 TTGLPALISWIKRKRQQ-NH2 
y16 1079.7 2 TGLPALISWIKRKRQQ-NH2 
y15 1029.4 2 GLPALISWIKRKRQQ-NH2 
y14 1000.9 2 LPALISWIKRKRQQ-NH2 
y13 944.5 2 PALISWIKRKRQQ-NH2 
y13 630.1 3 PALISWIKRKRQQ-NH2 
y12 895.8 2 ALISWIKRKRQQ-NH2 
y11 860.4 2 LISWIKRKRQQ-NH2 
y10 803.7 2 ISWIKRKRQQ-NH2 
y9 747.1 2 SWIKRKRQQ-NH2 
y8 703.8 2 WIKRKRQQ-NH2 
y7 609.1 2 IKRKRQQ-NH2 
y5 490.0 2 RKRQQ-NH2 
y4 822.9  1 KRQQ-NH2 
y4 - NH3 806.1  1 KRQQ-NH2 
*Oleoylation sites are highlighted in within the amino acid sequence of the peptide. 
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Table 9.15. Ions produced by fragmenting SynM2ole at m/z 845 (z=4) over 10.9 min of 
the EIC (see Figure 3.31, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus/R22 double oleoylation (see Figure 3.34 A). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 492.3 1 H-GIG y24 981.4 3 
GAVLKVLTTGLPALISWIKRKRQQ
-NH2 
b4 563.2 1 H-GIGA y24 735.9 4 
GAVLKVLTTGLPALISWIKRKRQQ
-NH2 
b5 662.3 1 H-GIGAV y22 938.3 3 
VLKVLTTGLPALISWIKRKRQQ-
NH2 
b6 775.2 1 H-GIGAVL y21 1356.7 2 LKVLTTGLPALISWIKRKRQQ-NH2 
b7 903.4 1 H-GIGAVLK y21 905.5 3 LKVLTTGLPALISWIKRKRQQ-NH2 
b8 1002.7 1 H-GIGAVLKV y21 678.9 4 LKVLTTGLPALISWIKRKRQQ-NH2 
b9 1115.6 1 H-GIGAVLKVL y20 867.7 3 KVLTTGLPALISWIKRKRQQ-NH2 
b10 1216.7 1 H-GIGAVLKVLT y20 650.5 4 KVLTTGLPALISWIKRKRQQ-NH2 
b12 1374.7 1 H-GIGAVLKVLTTG y19 1236.5 2 VLTTGLPALISWIKRKRQQ-NH2 
b13 1487.9 1 H-GIGAVLKVLTTGL 
y18 1187.5 2 LTTGLPALISWIKRKRQQ-NH2 
y17 1130.6 2 TTGLPALISWIKRKRQQ-NH2 
y17 754.2 3 TTGLPALISWIKRKRQQ-NH2 
y16 1080.2 2 TGLPALISWIKRKRQQ-NH2 
y15 1029.6 2 GLPALISWIKRKRQQ-NH2 
y14 1001.0 2 LPALISWIKRKRQQ-NH2 
y13 944.4 2 PALISWIKRKRQQ-NH2 
y13 630.2 3 PALISWIKRKRQQ-NH2 
y12 895.6 2 ALISWIKRKRQQ-NH2 
y11 860.0 2 LISWIKRKRQQ-NH2 
y10 803.8 2 ISWIKRKRQQ-NH2 
y9 747.5 2 SWIKRKRQQ-NH2 
y8 703.7 2 WIKRKRQQ-NH2 
y7 609.1 2 IKRKRQQ-NH2 
y5 490.1 2 RKRQQ-NH2 
y4 558.5  1 KRQQ-NH2 
*Oleoylation sites are highlighted in red within the amino acid sequence of the peptide. 
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Table 9.16. Ions produced by fragmenting SynM2ole at m/z 845 (z=4) over 11.2 min of 
the EIC (see Figure 3.31, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus/R24 double oleoylation (see Figure 3.34 B). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 492.3 1 H-GIG y24 981.1 3 
GAVLKVLTTGLPALISWIKRKRQQ-
NH2 
b4 563.1 1 H-GIGA y24 736.3 4 
GAVLKVLTTGLPALISWIKRKRQQ-
NH2 
b5 662.3 1 H-GIGAV y22 938.3 3 VLKVLTTGLPALISWIKRKRQQ-NH2 
b6 775.4 1 H-GIGAVL y21 1356.9 2 LKVLTTGLPALISWIKRKRQQ-NH2 
b7 903.5 1 H-GIGAVLK y21 905.4 3 LKVLTTGLPALISWIKRKRQQ-NH2 
b8 1002.6 1 H-GIGAVLKV y21 679.0 4 LKVLTTGLPALISWIKRKRQQ-NH2 
b9 1115.7 1 H-GIGAVLKVL y20 867.7 3 KVLTTGLPALISWIKRKRQQ-NH2 
b10 1216.8 1 H-GIGAVLKVLT y20 650.6 4 KVLTTGLPALISWIKRKRQQ-NH2 
b12 1374.7 1 H-GIGAVLKVLTTG y19 1236.1 2 VLTTGLPALISWIKRKRQQ-NH2 
 
b13 
 
1487.9 
 
1 
 
H-GIGAVLKVLTTGL 
y18 1187.0 2 LTTGLPALISWIKRKRQQ-NH2 
y17 1130.4 2 TTGLPALISWIKRKRQQ-NH2 
y17 754.2 3 TTGLPALISWIKRKRQQ-NH2 
y16 1079.7 2 TGLPALISWIKRKRQQ-NH2 
y15 1029.1 2 GLPALISWIKRKRQQ-NH2 
y14 1001.1 2 LPALISWIKRKRQQ-NH2 
y13 944.4 2 PALISWIKRKRQQ-NH2 
y13 630.1 3 PALISWIKRKRQQ-NH2 
y12 895.7 2 ALISWIKRKRQQ-NH2 
y11 860.5 2 LISWIKRKRQQ-NH2 
y10 803.8 2 ISWIKRKRQQ-NH2 
y9 747.3 2 SWIKRKRQQ-NH2 
y8 703.7 2 WIKRKRQQ-NH2 
y7 609.1 2 IKRKRQQ-NH2 
y5 490.4 2 RKRQQ-NH2 
y4 822.8  1 KRQQ-NH2 
*Oleoylation sites are highlighted in red within the amino acid sequence of the peptide. 
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Table 9.17. Ions produced by fragmenting SynMpal+ole at m/z 838 (z=4) over 9.1 min of 
the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). Product ions correspond to S18 
oleoylation and K21 palmitoylation (see Figure 3.36 A). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b4 299.2 1 H-GIGA y24 1060.9 3 
GAVLKVLTTGLPALISWI
KRKRQQ-NH2 
b5 398.2 1 H-GIGAV y24 795.4 4 
GAVLKVLTTGLPALISWI
KRKRQQ-NH2 
b6 511.3 1 H-GIGAVL y22 1017.5 3 
VLKVLTTGLPALISWIKR
KRQQ-NH2 
b8 738.8 1 H-GIGAVLKV y20 1419.9 2 
KVLTTGLPALISWIKRKR
QQ-NH2 
b9 851.6 1 H-GIGAVLKVL y20 946.7 3 
KVLTTGLPALISWIKRKR
QQ-NH2 
b12 1110.8 1 H-GIGAVLKVLTTG y19 1355.7 2 
VLTTGLPALISWIKRKRQ
Q-NH2 
b13 1223.7 1 H-GIGAVLKVLTTGL y18 1306.5 2 
LTTGLPALISWIKRKRQQ
-NH2 
b15 – NH3 1374.6 1 H-GIGAVLKVLTTGLPA y17 1249.5 2 
TTGLPALISWIKRKRQQ-
NH2 
b16 753.7 2 H-GIGAVLKVLTTGLPAL y16 1199.0 2 
TGLPALISWIKRKRQQ-
NH2 
b17 809.8 2 H-GIGAVLKVLTTGLPALI y15 1148.7 2 
GLPALISWIKRKRQQ-
NH2 
b18 985.0 2 H-GIGAVLKVLTTGLPALIS 
y14 1119.2 2 LPALISWIKRKRQQ-NH2 
y13 1063.5 2 PALISWIKRKRQQ-NH2 
y13 709.7 4 PALISWIKRKRQQ-NH2 
y10 922.8 2 ISWIKRKRQQ-NH2 
y9 866.3 2 SWIKRKRQQ-NH2 
*Oleoylation and palmitoylation sites are highlighted in red and blue respectively within the 
amino acid sequence of the peptide. 
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Table 9.18. Ions produced by fragmenting SynMpal+ole at m/z 838 (z=4) over 9.1 min of 
the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). Product ions correspond to S18 
palmitoylation and K21 oleoylation (see Figure 3.36 B). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b4 299.2 1 H-GIGA y24 1060.9 3 
GAVLKVLTTGLPALISWIK
RKRQQ-NH2 
b5 398.2 1 H-GIGAV y24 795.4 4 
GAVLKVLTTGLPALISWIK
RKRQQ-NH2 
b6 511.3 1 H-GIGAVL y22 1017.5 3 
VLKVLTTGLPALISWIKRK
RQQ-NH2 
b8 738.8 1 H-GIGAVLKV y20 1419.9 2 
KVLTTGLPALISWIKRKR
QQ-NH2 
b9 851.6 1 H-GIGAVLKVL y20 946.7 3 
KVLTTGLPALISWIKRKR
QQ-NH2 
b12 1110.8 1 H-GIGAVLKVLTTG y19 1355.7 2 
VLTTGLPALISWIKRKRQ
Q-NH2 
b13 1223.7 1 H-GIGAVLKVLTTGL y18 1306.5 2 
LTTGLPALISWIKRKRQQ-
NH2 
b15 – NH3 1374.6 1 H-GIGAVLKVLTTGLPA y17 1249.5 2 
TTGLPALISWIKRKRQQ-
NH2 
b16 753.7 2 H-GIGAVLKVLTTGLPAL y16 1199.0 2 
TGLPALISWIKRKRQQ-
NH2 
b17 809.8 2 H-GIGAVLKVLTTGLPALI y15 1148.7 2 GLPALISWIKRKRQQ-NH2 
b18 971.9 2 H-GIGAVLKVLTTGLPALIS 
y14 1119.2 2 LPALISWIKRKRQQ-NH2 
y13 1063.5 2 PALISWIKRKRQQ-NH2 
y13 709.7 3 PALISWIKRKRQQ-NH2 
y10 922.8 2 ISWIKRKRQQ-NH2 
y9 866.3 2 SWIKRKRQQ-NH2 
*Oleoylation and palmitoylation sites are highlighted in red and blue respectively within the 
amino acid sequence of the peptide. 
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Table 9.19. Ions produced by fragmenting SynMpal+ole at m/z 838 (z=4) over 9.5 min of 
the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). Product ions correspond to K21 
oleoylation and K23 palmitoylation (see Figure 3.37 A). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b4 299.1 1 H-GIGA y24 1060.7 3 
GAVLKVLTTGLPALISW
IKRKRQQ-NH2 
b5 398.2 1 H-GIGAV y24 795.6 4 
GAVLKVLTTGLPALISW
IKRKRQQ-NH2 
b6 511.4 1 H-GIGAVL y22 1017.4 3 
VLKVLTTGLPALISWIK
RKRQQ-NH2 
b8 738.6 1 H-GIGAVLKV y20 1419.5 2 
KVLTTGLPALISWIKRK
RQQ-NH2 
b9 851.5 1 H-GIGAVLKVL y19 1355.8 2 
VLTTGLPALISWIKRKR
QQ-NH2 
b12 1110.8 1 H-GIGAVLKVLTTG y18 1306.5 2 
LTTGLPALISWIKRKRQ
Q-NH2 
b13 1223.6 1 H-GIGAVLKVLTTGL y17 1249.4 2 
TTGLPALISWIKRKRQ
Q-NH2 
b15 – NH3 1374.6 1 H-GIGAVLKVLTTGLPA y16 1199.1 2 
TGLPALISWIKRKRQQ-
NH2 
b19 946.3 2 H-GIGAVLKVLTTGLPALISW y15 1148.4 2 
GLPALISWIKRKRQQ-
NH2 
b20 1002.7 2 H-GIGAVLKVLTTGLPALISWI 
y14 1119.2 2 
LPALISWIKRKRQQ-
NH2 
y13 1063.5 2 PALISWIKRKRQQ-NH2 
y13 709.5 3 PALISWIKRKRQQ-NH2 
y10 923.3 2 ISWIKRKRQQ-NH2 
y9 866.1 2 SWIKRKRQQ-NH2 
y8 822.5 2 WIKRKRQQ-NH2 
y7 729.4 2 IKRKRQQ-NH2 
y5 476.7 2 RKRQQ-NH2 
*Oleoylation and palmitoylation sites are highlighted in red and blue respectively within the 
amino acid sequence of the peptide. 
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Table 9.20. Ions produced by fragmenting SynMpal+ole at m/z 838 (z=4) over 9.5 min of 
the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). Product ions correspond to K21 
palmitoylation and K23 oleoylation (see Figure 3.37 B). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b4 299.2 1 H-GIGA y24 1060.7 3 
GAVLKVLTTGLPALISWI
KRKRQQ-NH2 
b5 398.2 1 H-GIGAV y24 795.6 4 
GAVLKVLTTGLPALISWI
KRKRQQ-NH2 
b6 511.4 1 H-GIGAVL y22 1017.4 3 
VLKVLTTGLPALISWIKR
KRQQ-NH2 
b8 738.6 1 H-GIGAVLKV y20 1419.9 2 
KVLTTGLPALISWIKRKR
QQ-NH2 
b9 851.5 1 H-GIGAVLKVL y19 1355.8 2 
VLTTGLPALISWIKRKRQ
Q-NH2 
b12 1110.8 1 H-GIGAVLKVLTTG y18 1306.5 2 
LTTGLPALISWIKRKRQ
Q-NH2 
b13 1223.6 1 H-GIGAVLKVLTTGL y17 1249.4 2 
TTGLPALISWIKRKRQQ-
NH2 
b15 – NH3 1374.6 1 H-GIGAVLKVLTTGLPA y16 1199.0 2 
TGLPALISWIKRKRQQ-
NH2 
b19 946.3 2 H-GIGAVLKVLTTGLPALISW y15 1148.4 2 
GLPALISWIKRKRQQ-
NH2 
b20 1002.7 2 H-GIGAVLKVLTTGLPALISWI 
y14 1119.2 2 LPALISWIKRKRQQ-NH2 
y13 1063.5 2 PALISWIKRKRQQ-NH2 
y13 709.5 3 PALISWIKRKRQQ-NH2 
y10 923.3 2 ISWIKRKRQQ-NH2 
y9 866.1 2 SWIKRKRQQ-NH2 
y8 822.5 2 WIKRKRQQ-NH2 
y7 729.4 2 IKRKRQQ-NH2 
y5 490.4 2 RKRQQ-NH2 
y4 412.3 1 KRQQ-NH2 
*Oleoylation and palmitoylation sites are highlighted in red and blue respectively within the 
amino acid sequence of the peptide. 
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Table 9.21. Ions produced by fragmenting SynMpal+ole at m/z 838 (z=4) over 9.5 min of 
the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus oleoylation and K21 palmitoylation (see Figure 3.38 A). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 492.3 1 H-GIG y24 972.3 3 
GAVLKVLTTGLPALISWIKRKR
QQ-NH2 
b4 563.3 1 H-GIGA y21 896.7 3 
LKVLTTGLPALISWIKRKRQQ-
NH2 
b5 662.3 1 H-GIGAV y20 859.1 3 
KVLTTGLPALISWIKRKRQQ-
NH2 
b6 775.3 1 H-GIGAVL y19 1223.6 2 
VLTTGLPALISWIKRKRQQ-
NH2 
b8 1002.7 1 H-GIGAVLKV y18 1174.2 2 LTTGLPALISWIKRKRQQ-NH2 
b9 1115.6 1 H-GIGAVLKVL y17 1117.7 2 TTGLPALISWIKRKRQQ-NH2 
b10 1216.8 1 H-GIGAVLKVLT y16 1066.6 2 TGLPALISWIKRKRQQ-NH2 
b12 1374.7 1 H-GIGAVLKVLTTG y15 1016.5 2 GLPALISWIKRKRQQ-NH2 
b13 1487.8 1 H-GIGAVLKVLTTGL y14 987.9 2 LPALISWIKRKRQQ-NH2 
b13 - H2O 1469.7 1 H-GIGAVLKVLTTGL 
y13 931.2 2 PALISWIKRKRQQ-NH2 
y13 621.5 3 PALISWIKRKRQQ-NH2 
y12 882.9 2 ALISWIKRKRQQ-NH2 
y11 847.2 2 LISWIKRKRQQ-NH2 
y10 790.6 2 ISWIKRKRQQ-NH2 
y9 733.7 2 SWIKRKRQQ-NH2 
y7 597.1 2 IKRKRQQ-NH2 
y6 1080.1 1 KRKRQQ-NH2 
y4 558.4  1 KRQQ-NH2 
y4 - NH3 541.9 1 KRQQ-NH2 
*Oleoylation and palmitoylation sites are highlighted in red and blue respectively within the 
amino acid sequence of the peptide. 
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Table 9.22. Ions produced by fragmenting SynMpal+ole at m/z 838 (z=4) over 9.5 min of 
the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus palmitoylation and K21 oleoylation (see Figure 3.38 B). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 466.3 1 H-GIG y24 980.8 3 
GAVLKVLTTGLPALISWI
KRKRQQ-NH2 
b4 537.1 1 H-GIGA y21 1356.8 2 
LKVLTTGLPALISWIKRK
RQQ-NH2 
b5 636.5 1 H-GIGAV y21 904.8 3 
LKVLTTGLPALISWIKRK
RQQ-NH2 
b6 749.2 1 H-GIGAVL y21 679.1 4 
LKVLTTGLPALISWIKRK
RQQ-NH2 
b8 976.6 1 H-GIGAVLKV y20 1299.9 2 
KVLTTGLPALISWIKRKR
QQ-NH2 
b9 1089.6 1 H-GIGAVLKVL y20 650.7 4 
KVLTTGLPALISWIKRKR
QQ-NH2 
b10 1190.8 1 H-GIGAVLKVLT y19 1236.7 2 
VLTTGLPALISWIKRKRQ
Q-NH2 
b12 1348.8 1 H-GIGAVLKVLTTG y18 1187.5 2 
LTTGLPALISWIKRKRQQ
-NH2 
b12 - H2O 1330.8 1 H-GIGAVLKVLTTG y17 1130.5 2 
TTGLPALISWIKRKRQQ-
NH2 
b12 - H2O 666.2 2 H-GIGAVLKVLTTG y16 1080.1 2 
TGLPALISWIKRKRQQ-
NH2 
b13 1461.7 1 H-GIGAVLKVLTTGL y15 1029.1 2 
GLPALISWIKRKRQQ-
NH2 
b13 - H2O 1443.8 1 H-GIGAVLKVLTTGL y14 1000.9 2 LPALISWIKRKRQQ-NH2 
b18 972.3 2 H-GIGAVLKVLTTGLPALIS 
y13 944.4 2 PALISWIKRKRQQ-NH2 
y13 630.1 3 PALISWIKRKRQQ-NH2 
y12 896.7 2 ALISWIKRKRQQ-NH2 
y10 803.2 2 ISWIKRKRQQ-NH2 
y9 747.2 2 SWIKRKRQQ-NH2 
y8 703.8 2 WIKRKRQQ-NH2 
y7 609.1 1 IKRKRQQ-NH2 
y4 558.4  1 KRQQ-NH2 
y4 – NH3 541.9 1 KRQQ-NH2 
*Oleoylation and palmitoylation sites are highlighted in red and blue respectively within the 
amino acid sequence of the peptide. 
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Table 9.23. Ions produced by fragmenting SynMpal+ole at m/z 838 (z=4) over 10.2 min of 
the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). Product ions correspond to K7 
oleoylation and K21 palmitoylation (see Figure 3.39 A). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b4 299.1 1 H-GIGA y24 1060.6 3 
GAVLKVLTTGLPALISW
IKRKRQQ-NH2 
b5 398.2 1 H-GIGAV y24 795.4 4 
GAVLKVLTTGLPALISW
IKRKRQQ-NH2 
b6 511.3 1 H-GIGAVL y22 1017.7 3 
VLKVLTTGLPALISWIK
RKRQQ-NH2 
b7 903.6 1 H-GIGAVLK y22 763.8 4 
VLKVLTTGLPALISWIK
RKRQQ-NH2 
b8 1002.6 1 H-GIGAVLKV y21 1476.2 2 
LKVLTTGLPALISWIKR
KRQQ-NH2 
b9 1115.7 1 H-GIGAVLKVL y20 1419.9 2 
KVLTTGLPALISWIKRK
RQQ-NH2 
b10 1216.7 1 H-GIGAVLKVLT y19 1223.6 2 
VLTTGLPALISWIKRKR
QQ-NH2 
b10 - H2O 1198.9 1 H-GIGAVLKVLT y18 1174.0 2 
LTTGLPALISWIKRKRQ
Q-NH2 
b11 1317.7 1 H-GIGAVLKVLTT y17 1117.4 2 
TTGLPALISWIKRKRQQ
-NH2 
b12 1374.7 1 H-GIGAVLKVLTTG y16 1067.3 2 
TGLPALISWIKRKRQQ-
NH2 
b12 - H2O 1356.6 1 H-GIGAVLKVLTTG y15 1016.4 2 
GLPALISWIKRKRQQ-
NH2 
b12 - H2O 678.1 2 H-GIGAVLKVLTTG.l y14 987.6 2 
LPALISWIKRKRQQ-
NH2 
b13 1488.0 1 H-GIGAVLKVLTTGL y13 931.1 2 PALISWIKRKRQQ-NH2 
b13 - H2O  1470.1 1 H-GIGAVLKVLTTGL y13 621.5 3 PALISWIKRKRQQ-NH2 
b14 - H2O  783.2 2 H-GIGAVLKVLTTGLP y9 733.5 2 SWIKRKRQQ-NH2 
b18  985.1 2 H-GIGAVLKVLTTGLPALIS 
y7 597.5 2 IKRKRQQ-NH2 
y6 1080.5  1 KRKRQQ-NH2 
y6 540.9 2 KRKRQQ-NH2 
y6 - NH3 1063.5 1 KRKRQQ-NH2 
y4  558.3 1 KRQQ-NH2 
*Oleoylation and palmitoylation sites are highlighted in red and blue respectively within the 
amino acid sequence of the peptide. 
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Table 9.24. Ions produced by fragmenting SynMpal+ole at m/z 838 (z=4) over 10.2 min of 
the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). Product ions correspond to K7 
palmitoylation and K21 oleoylation (see Figure 3.39 B). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b4 299.1 1 H-GIGA y24 1060.6 3 
GAVLKVLTTGLPALISW
IKRKRQQ-NH2 
b5 398.2 1 H-GIGAV y24 795.4 4 
GAVLKVLTTGLPALISW
IKRKRQQ-NH2 
b6 511.3 1 H-GIGAVL y22 1017.7 3 
VLKVLTTGLPALISWIK
RKRQQ-NH2 
b7 877.5 1 H-GIGAVLK y22 763.8 4 
VLKVLTTGLPALISWIK
RKRQQ-NH2 
b8 976.6 1 H-GIGAVLKV y21 1476.2 2 
LKVLTTGLPALISWIKR
KRQQ-NH2 
b9 1089.6 1 H-GIGAVLKVL y20 1419.9 2 
KVLTTGLPALISWIKRK
RQQ-NH2 
b10 1190.7 1 H-GIGAVLKVLT y19 1236.6 2 
VLTTGLPALISWIKRKR
QQ-NH
2
 
b11 1291.7 1 H-GIGAVLKVLTT y18 1187.2 2 
v.LTTGLPALISWIKRKR
QQ-NH
2
 
b11 - H2O 1273.7 1 H-GIGAVLKVLTT y17 1130.3 2 
TTGLPALISWIKRKRQQ
-NH
2
 
b12 1348.6 1 H-GIGAVLKVLTTG y16 1080.0 2 
TGLPALISWIKRKRQQ-
NH
2
 
b12 - H2O 1330.8 1 H-GIGAVLKVLTTG y15 1030.1 2 
GLPALISWIKRKRQQ-
NH
2
 
b12 - H2O 665.9 2 H-GIGAVLKVLTTG y14 1000.7 2 
LPALISWIKRKRQQ-
NH
2
 
b13 1461.8 1 H-GIGAVLKVLTTGL y13 944.3 2 PALISWIKRKRQQ-NH
2
 
b15 816.1 2 H-GIGAVLKVLTTGLPA y13 630.1 3 PALISWIKRKRQQ-NH
2
 
b18  972.4 2 H-GIGAVLKVLTTGLPALIS 
y12 896.4 2 ALISWIKRKRQQ-NH
2
 
y11 860.0 2 LISWIKRKRQQ-NH
2
 
y10 803.2 2 ISWIKRKRQQ-NH
2
 
y9 745.9 2 SWIKRKRQQ-NH
2
 
y8 703.5 2 WIKRKRQQ-NH2 
y7 610.5 2 IKRKRQQ-NH2 
y4 558.3 2 KRQQ-NH2 
*Oleoylation and palmitoylation sites are highlighted in red and blue respectively within the 
amino acid sequence of the peptide. 
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Table 9.25. Ions produced by fragmenting SynMpal+ole at m/z 838 (z=4) over 10.6 min of 
the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus oleoylation and K23 palmitoylation (see Figure 3.40 A). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 492.3 1 H-GIG y24 972.3 3 
GAVLKVLTTGLPALISWIKRKR
QQ-NH2 
b4 563.3 1 H-GIGA y22 929.6 3 
VLKVLTTGLPALISWIKRKRQQ
-NH2 
b5 662.3 1 H-GIGAV y21 896.6 3 
LKVLTTGLPALISWIKRKRQQ-
NH2 
b6 775.3 1 H-GIGAVL y20 858.9 3 
KVLTTGLPALISWIKRKRQQ-
NH2 
b8 1002.6 1 H-GIGAVLKV y19 1223.6 2 
VLTTGLPALISWIKRKRQQ-
NH2 
b9 1115.6 1 H-GIGAVLKVL y18 1173.9 2 LTTGLPALISWIKRKRQQ-NH2 
b10 1216.8 1 H-GIGAVLKVLT y17 1117.8 2 TTGLPALISWIKRKRQQ-NH2 
b12 1374.7 1 H-GIGAVLKVLTTG y16 1067.0 2 TGLPALISWIKRKRQQ-NH2 
b13 1487.7 1 H-GIGAVLKVLTTGL y15 1016.3 2 GLPALISWIKRKRQQ-NH2 
b13 - H2O 1470.1 1 H-GIGAVLKVLTTGL 
y14 988.0 2 LPALISWIKRKRQQ-NH2 
y13 931.4 2 PALISWIKRKRQQ-NH2 
y13 621.5 3 PALISWIKRKRQQ-NH2 
y12 882.9 2 ALISWIKRKRQQ-NH2 
y11 847.3 2 LISWIKRKRQQ-NH2 
y10 790.5 2 ISWIKRKRQQ-NH2 
y9 734.0 2 SWIKRKRQQ-NH2 
y8 690.8 2 WIKRKRQQ-NH2 
y7 598.6 2 IKRKRQQ-NH2 
y6 1080.3  1 KRKRQQ-NH2 
y5 952.9  1 RKRQQ-NH2 
y5 476.9  2 RKRQQ-NH2 
y4 796.4  1 
KRQQ-NH2 
y4 - NH3 779.7  1 KRQQ-NH2 
*Oleoylation and palmitoylation sites are highlighted in red and blue respectively within the 
amino acid sequence of the peptide. 
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Table 9.26 Ions produced by fragmenting SynMpal+ole at m/z 838 (z=4) over 10.6 min of 
the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus palmitoylation and K23 oleoylation (see Figure 3.40 B). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 466.3 1 H-GIG y24 980.0 3 
GAVLKVLTTGLPALISWIKRKRQ
Q-NH2 
b4 537.2 1 H-GIGA y22 938.3 3 
VLKVLTTGLPALISWIKRKRQQ-
NH2 
b5 636.2 1 H-GIGAV y21 1356.7 2 
LKVLTTGLPALISWIKRKRQQ-
NH2 
b6 749.1 1 H-GIGAVL y21 905.3 3 
LKVLTTGLPALISWIKRKRQQ-
NH2 
b7 877.4 1 H-GIGAVLK y20 1299.9 2 
KVLTTGLPALISWIKRKRQQ-
NH2 
b8 976.6 1 H-GIGAVLKV y20 867.5 3 
KVLTTGLPALISWIKRKRQQ-
NH2 
b9 1089.7 1 H-GIGAVLKVL y19 1236.5 2 
k.VLTTGLPALISWIKRKRQQ-
NH2 
b10 1190.2 1 H-GIGAVLKVLT y18 1186.8 2 LTTGLPALISWIKRKRQQ-NH2 
b12 1348.6 1 H-GIGAVLKVLTTG y17 1130.6 2 TTGLPALISWIKRKRQQ-NH2 
b12 - H2O 1330.8 1 H-GIGAVLKVLTTG y16 1080.1 2 TGLPALISWIKRKRQQ-NH2 
b12 - H2O 666.1 2 H-GIGAVLKVLTTG y15 1029.5 2 GLPALISWIKRKRQQ-NH2 
b13 1461.7 1 H-GIGAVLKVLTTGL y14 1001.0 2 LPALISWIKRKRQQ-NH2 
b13 - H2O 1443.7 1 H-GIGAVLKVLTTGL 
y13 944.4 2 PALISWIKRKRQQ-NH2 
y13 630.2 2 PALISWIKRKRQQ-NH2 
y12 896.6 2 ALISWIKRKRQQ-NH2 
y11 860.4 2 LISWIKRKRQQ-NH2 
y10 803.7 2 ISWIKRKRQQ-NH2 
y9 746.7 2 SWIKRKRQQ-NH2 
y7 703.8 2 IKRKRQQ-NH2 
y5 609.1 2 RKRQQ-NH2 
y4 822.6  1 KRQQ-NH2 
y4 411.4  2 KRQQ-NH2 
*Oleoylation and palmitoylation sites are highlighted in red and blue respectively within the 
amino acid sequence of the peptide. 
 
 
320 
 
Table 9.27. Ions produced by fragmenting SynMpal+ole at m/z 838 (z=4) over 10.9 min of 
the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus oleoylation and R22 palmitoylation (see Figure 3.41 A). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 492.3 1 H-GIG y24 972.2 3 
GAVLKVLTTGLPALISWIKRKR
QQ-NH2 
b4 563.2 1 H-GIGA y22 929.8 3 
VLKVLTTGLPALISWIKRKRQQ-
NH2 
b5 662.3 1 H-GIGAV y21 896.8 3 
LKVLTTGLPALISWIKRKRQQ-
NH2 
b6 775.3 1 H-GIGAVL y20 859.0 3 
KVLTTGLPALISWIKRKRQQ-
NH2 
b8 1002.5 1 H-GIGAVLKV y19 1223.6 2 VLTTGLPALISWIKRKRQQ-NH2 
b9 1115.7 1 H-GIGAVLKVL y18 1173.8 2 LTTGLPALISWIKRKRQQ-NH2 
b10 1216.7 1 H-GIGAVLKVLT y17 1117.9 2 TTGLPALISWIKRKRQQ-NH2 
b12 1374.7 1 H-GIGAVLKVLTTG y16 1067.1 2 TGLPALISWIKRKRQQ-NH2 
b13 1487.7 1 H-GIGAVLKVLTTGL y15 1016.5 2 GLPALISWIKRKRQQ-NH2 
b13 – H2O 1470.2 1 H-GIGAVLKVLTTGL 
y14 988.1 2 LPALISWIKRKRQQ-NH2 
y13 931.4 2 PALISWIKRKRQQ-NH2 
y13 621.6 2 PALISWIKRKRQQ-NH2 
y12 882.8 2 ALISWIKRKRQQ-NH2 
y11 847.3 2 LISWIKRKRQQ-NH2 
y10 790.4 2 ISWIKRKRQQ-NH2 
y9 734.1 2 SWIKRKRQQ-NH2 
y8 690.7 2 WIKRKRQQ-NH2 
y7 598.6 2 IKRKRQQ-NH2 
y6 1080.1  1 KRKRQQ-NH2 
y5 953.2  1 RKRQQ-NH2 
y4 558.6  1 KRQQ-NH2 
y4 - NH3 541.3  1 KRQQ-NH2 
*Oleoylation and palmitoylation sites are highlighted in red and blue respectively within the 
amino acid sequence of the peptide. 
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Table 9.28. Ions produced by fragmenting SynMpal+ole at m/z 838 (z=4) over 10.9 min of 
the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus palmitoylation and R22 oleoylation (see Figure 3.41 B). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 466.3 1 H-GIG y24 980.0 3 
GAVLKVLTTGLPALISWIKRKRQ
Q-NH2 
b4 537.2 1 H-GIGA y22 938.4 3 
VLKVLTTGLPALISWIKRKRQQ-
NH2 
b5 636.2 1 H-GIGAV y21 1356.7 2 
LKVLTTGLPALISWIKRKRQQ-
NH2 
b6 749.3 1 H-GIGAVL y21 905.0 3 
LKVLTTGLPALISWIKRKRQQ-
NH2 
b7 877.4 1 H-GIGAVLK y20 867.8 3 KVLTTGLPALISWIKRKRQQ-NH2 
b8 976.6 1 H-GIGAVLKV y18 1186.9 2 LTTGLPALISWIKRKRQQ-NH2 
b9 1089.6 1 H-GIGAVLKVL y17 1130.5 2 TTGLPALISWIKRKRQQ-NH2 
b12 - H2O 1330.8 1 H-GIGAVLKVLTTG y16 1080.1 2 TGLPALISWIKRKRQQ-NH2 
b12 - H2O  666.0 2 H-GIGAVLKVLTTG.l 
y15 1029.5 2 GLPALISWIKRKRQQ-NH2 
y14 1000.8 2 LPALISWIKRKRQQ-NH2 
y13 944.4 2 PALISWIKRKRQQ-NH2 
y13 630.2 3 PALISWIKRKRQQ-NH2 
y12 896.4 2 ALISWIKRKRQQ-NH2 
y11 860.4 2 LISWIKRKRQQ-NH2 
y10 803.7 2 ISWIKRKRQQ-NH2 
y9 747.2 2 SWIKRKRQQ-NH2 
y8 703.8 2 WIKRKRQQ-NH2 
y7 609.1 2 IKRKRQQ-NH2 
y5 978.8 1 RKRQQ-NH2 
y5 489.9 1 RKRQQ-NH2 
y4 558.3  1 KRQQ-NH2 
y4 - NH3 541.1 1 KRQQ-NH2 
*Oleoylation and palmitoylation sites are highlighted in red and blue respectively within the 
amino acid sequence of the peptide. 
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Table 9.29. Ions produced by fragmenting SynMpal+ole at m/z 838 (z=4) over 11.2 min of 
the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus oleoylation and R24 palmitoylation (see Figure 3.42 A). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 492.2 1 H-GIG y24 972.3 3 
GAVLKVLTTGLPALISWIKRKRQ
Q-NH2 
b4 563.2 1 H-GIGA y22 929.7 3 
VLKVLTTGLPALISWIKRKRQQ-
NH2 
b5 662.4 1 H-GIGAV y21 896.3 3 
LKVLTTGLPALISWIKRKRQQ-
NH2 
b6 775.2 1 H-GIGAVL y20 859.0 3 
KVLTTGLPALISWIKRKRQQ-
NH2 
b8 1002.6 1 H-GIGAVLKV y19 1223.7 2 VLTTGLPALISWIKRKRQQ-NH2 
b9 1115.6 1 H-GIGAVLKVL y18 1174.2 2 LTTGLPALISWIKRKRQQ-NH2 
b10 1216.7 1 H-GIGAVLKVLT y17 1117.7 2 TTGLPALISWIKRKRQQ-NH2 
b12 1374.7 1 H-GIGAVLKVLTTG y16 1066.9 2 TGLPALISWIKRKRQQ-NH2 
b13 1487.7 1 H-GIGAVLKVLTTGL y15 1016.4 2 GLPALISWIKRKRQQ-NH2 
b13 – H2O 1469.8 1 H-GIGAVLKVLTTGL 
y14 988.0 2 LPALISWIKRKRQQ-NH2 
y13 931.5 2 PALISWIKRKRQQ-NH2 
y13 621.5 3 PALISWIKRKRQQ-NH2 
y12 882.8 2 ALISWIKRKRQQ-NH2 
y11 847.2 2 LISWIKRKRQQ-NH2 
y10 790.8 2 ISWIKRKRQQ-NH2 
y9 734.2 2 SWIKRKRQQ-NH2 
y8 690.8 2 WIKRKRQQ-NH2 
y7 598.0 2 IKRKRQQ-NH2 
y6 1080.1  1 KRKRQQ-NH2 
y5 953.2  1 RKRQQ-NH2 
y4 796.1  1 KRQQ-NH2 
y4 - NH3 779.5  1 KRQQ-NH2 
*Oleoylation and palmitoylation sites are highlighted in red and blue respectively within the 
amino acid sequence of the peptide. 
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Table 9.30. Ions produced by fragmenting SynMpal+ole at m/z 838 (z=4) over 11.2 min of 
the EIC (see Figure 3.35, SynM/50:50 PPC:DOPC). Product ions correspond to N-
terminus palmitoylation and R24 oleoylation (see Figure 3.42 B). 
b-Ions m/z z Sequence Ladder* y-Ions m/z z Sequence Ladder* 
b3 466.3 1 H-GIG y24 981.1 3 
GAVLKVLTTGLPALISWIKRKRQQ
-NH2 
b4 537.2 1 H-GIGA y22 938.7 3 
VLKVLTTGLPALISWIKRKRQQ-
NH2 
b5 636.4 1 H-GIGAV y21 1356.8 2 LKVLTTGLPALISWIKRKRQQ-NH2 
b6 749.8 1 H-GIGAVL y21 905.3 3 LKVLTTGLPALISWIKRKRQQ-NH2 
b7 877.7 1 H-GIGAVLK y20 867.5 3 KVLTTGLPALISWIKRKRQQ-NH2 
b8 976.6 1 H-GIGAVLKV y19 1236.5 2 VLTTGLPALISWIKRKRQQ-NH2 
b9 1089.6 1 H-GIGAVLKVL y18 1186.5 2 LTTGLPALISWIKRKRQQ-NH2 
b10 1190.1 1 H-GIGAVLKVLT y17 1130.4 2 TTGLPALISWIKRKRQQ-NH2 
b12 1348.7 1 H-GIGAVLKVLTTG y16 1079.7 2 TGLPALISWIKRKRQQ-NH2 
b12 - H2O 1330.6 1 H-GIGAVLKVLTTG y15 1029.1 2 GLPALISWIKRKRQQ-NH2 
b12 - H2O  665.8 2 H-GIGAVLKVLTTG.l y14 1000.7 2 LPALISWIKRKRQQ-NH2 
b13 1462.2 1 H-GIGAVLKVLTTGL y13 944.5 2 PALISWIKRKRQQ-NH2 
b13 - H2O 1443.9 1 H-GIGAVLKVLTTGL 
y13 630.2 3 PALISWIKRKRQQ-NH2 
y12 896.0 2 ALISWIKRKRQQ-NH2 
y11 860.5 2 LISWIKRKRQQ-NH2 
y10 803.9 2 ISWIKRKRQQ-NH2 
y9 746.8 2 SWIKRKRQQ-NH2 
y8  703.8 2 WIKRQQ-NH2 
y5 489.9 2 RKRQQ-NH2 
y4  822.6 1 KRQQ-NH2 
*Oleoylation and palmitoylation sites are highlighted in red and blue respectively within the 
amino acid sequence of the peptide. 
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9.3. Appendix C: Supplementary information for Chapter 
four - New insight to integral membrane protein (AQP0) 
lipidation by membrane lipids 
 
Table 9.31. The deconvoluted m/z for non-acylated peptides identified from b-AQP0-
OC tryptic digestion (see Figure 4.16).  
AA 
Residues 
MCL
‡
 Sequence + Modification 
Theor m/z
 ‡
 
[M + H]
+ 
Meas m/z
‡
 
[M + H]
+
 
Error 
(ppm) 
[1-5] 0 MWELR 734.3654 734.3658 0.5 
[6-11] 0 SASFWR 753.3678 753.3687 1.2 
[12-33] 0 AICAEFFASLFYVFFGLGASLR 2429.2362 2429.237 0.3 
[114-152] 0 
GNLALNTLHPGVSVGQATIVEIFLTLQFVLCIFA
TYDER 
4263.2522 4263.2677 3.6 
[153-187] 2 
RNGRLGSVALAVGFSLTLGHLFGMYYTGAGM
NPAR [1×Deamidation] 
3655.8624 3655.8681 1.6 
[157-187] 0 LGSVALAVGFSLTLGHLFGMYYTGAGMNPAR 3171.6118 3171.6151 1.0 
[188-196] 0 SFAPAILTR 975.5622 975.5626 0.4 
[188-228] 2 
SFAPAILTRNFTNHWVYWVGPVIGAGLGSLLY
DFLLFPRLK 
4649.5224 4649.5286 1.3 
[188-233] 3 
SFAPAILTRNFTNHWVYWVGPVIGAGLGSLLY
DFLLFPRLKSVSER 
5207.7986 5207.7970 -0.3 
[197-226] 0 NFTNHWVYWVGPVIGAGLGSLLYDFLLFPR 3451.799 3451.8018 0.8 
[197-226] 0 
NFTNHWVYWVGPVIGAGLGSLLYDFLLFPR 
[1×O] 
3467.7939 3467.7932 -0.2 
[197-228] 1 NFTNHWVYWVGPVIGAGLGSLLYDFLLFPRLK 3692.978 3692.9811 0.8 
[197-228] 1 
NFTNHWVYWVGPVIGAGLGSLLYDFLLFPRLK 
[2×O] 
3724.9679 3724.9593 -2.3 
[197-233] 2 
NFTNHWVYWVGPVIGAGLGSLLYDFLLFPRLK
SVSER 
4251.2542 4251.2547 0.1 
[229-233] 0 SVSER 577.294 577.2942 0.3 
[229-238] 1 SVSERLSILK [1×P] 1211.6395 1211.6406 0.9 
[234-238] 0 LSILK 573.397 573.3972 0.3 
[234-238] 0 LSILK [1×P] 653.3634 653.364 0.9 
[234-259] 1 
LSILKGSRPSESNGQPEVTGEPVELK 
[1×Deamidation] 
2752.4363 2752.4389 0.9 
[239-259] 0 
GSRPSESNGQPEVTGEPVELK 
[1×Deamidation] 
2198.0571 2198.0585 0.6 
[239-259] 0 
GSRPSESNGQPEVTGEPVELK 
[1×Deamidation; 1×P] 
2278.0235 2278.024 0.2 
[239-263] 1 
GSRPSESNGQPEVTGEPVELKTQAL 
[1×Deamidation] 
2611.2846 2611.286 0.5 
[260-263] 0 TQAL 432.2453 432.2454 0.2 
‡Both theoretical (Theor) and measured (Meas) m/z are for the monoisotopic peak. 
Theoretical mass obtained from mMass software. (MCL) is number of missed cleavages. 
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Table 9.32. The deconvoluted m/z for identified acylated peptides followed trypsin 
digestion of b-AQP0-OC. 
Theor m/z
‡
  
[M + H]
+
 
Meas m/z
‡ 
[M + H]
+
 
RT 
(min)
 
 
Error 
(ppm) 
10
3
 × 
ALipidation
§
 
(a.u.) 
Assignment 
234
LSILKGSRPSESNGQPEVTGEPVELK
259
 
2990.6660 2990.6689 7.64 1.3 18.5 ± 2 
Peptide [234-259] + (C16:0) + 1 × 
Deamidation/Palmitoylation 
3016.6816 3016.6822 7.74 0.5 78 ± 8 
Peptide [234-259] + (C18:1) + 1 × 
Deamidation/Oleoylation 
3018.6973 3018.6964 7.99 0.03 6 ± 1 
Peptide [234-259] + (C18:0) + 1 × 
Deamidation/Stearoylation 
1
MWELR
5
 
1014.6056 1014.6039 9.59 -1.7 46 ± 18 
Peptide [1-5] + (C18:1) + O/  
Oleoylation 
970.5794 970.5791 9.64 -0.3 6 ± 1 
Peptide [1-5] + 
(C16:1)/Palmitoleoylation 
1020.5951 1020.5957 9.82 0.6 7 ± 2.5 
Peptide [1-5] + 
(C20:4)/Arachidonoylation 
972.5951 972.5951 10.05 0 65 ± 26 
Peptide [1-5] + (C16:0) / 
Palmitoylation 
1022.6107 1022.6125 10.17 1.8 17 ± 6 
Peptide [1-5] + (C20:3)/Dihomo-γ-
linolenoylation 
998.6107 998.6116 10.20 0.9 256 ± 81 Peptide [1-5] + (C18:1)/Oleoylation 
1024.6264 1024.6285 10.40 2.0 9 ± 2 
Peptide [1-5] + 
(C20:2)/Eicosadienoylation 
1000.6264 1000.6272 10.68 0.8 36 ± 12 Peptide [1-5] + (C18:0)/Stearoylation 
1026.6420 1026.6427 10.78 0.7 19 ± 3.5 
Peptide [1-5] + 
(C20:1)/Eicosenoylation 
‡ Both theoretical (Theor) and measured (Meas) m/z are for the monoisotopic peak. 
Theoretical mass obtained from mMass software. 
§ The peak area (A) represents the summation of peak area over all observed charge states 
for each acylated peptide, z=1-2 for peptide [1-5]; z=2-4 for peptide [234-259]. Errors 
reported as the standard error of the mean (SEM) of peak area when n=3. 
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Table 9.33. The deconvoluted m/z for non-acylated peptides identified from b-AQP0-
OC tryptic digestion, using digestion protocol Method-D and LC-MS Method-IIII on 
Synapt G2-s (see section 8.2.2.2.1).  
AA 
Residues 
MCL
‡
 Sequence + Modification 
Theor m/z
 ‡
 
[M + H]
+ 
Meas m/z
‡
 
[M + H]
+
 
Error 
(ppm) 
[1-5] 0 MWELR 734.3660 734.3664 0.5 
[6-11] 0 SASFWR 753.3684 753.3678 -0.8 
[12-33] 0 AICAEFFASLFYVFFGLGASLR 2429.2368 2429.2370 0.1 
[34-85] 0 
WAPGPLHVLQVALAFGLALATLVQAVGHIS 
GAHVNPAVTFAFLVGSQMSLLR 
5345.9507 5345.9558 1.0 
[86-113] 0 AICYMVAQLLGAVAGAAVLYSVTPPAVR 2804.5208 2804.5249 1.5 
[114-152] 0 
GNLALNTLHPGVSVGQATIVEIFLTLQFVLCIFA
TYDER 
4263.2529 4263.2689 3.8 
[153-156] 1 RNGR 502.2850 502.2906 11.1 
[153-187] 2 
RNGRLGSVALAVGFSLTLGHLFGMYYTGAGM
NPAR [1×Deamidation] 
3655.8630 3655.8628 -0.1 
[154-187] 1 
NGRLGSVALAVGFSLTLGHLFGMYYTGAGMN
PAR [1×Deamidation] 
3499.7620 3499.7622 0.1 
[157-187] 0 LGSVALAVGFSLTLGHLFGMYYTGAGMNPAR 3171.6123 3171.6054 -2.2 
[157-187] 0 
LGSVALAVGFSLTLGHLFGMYYTGAGMNPAR 
[1×O] 
3187.6072 3187.6102 0.9 
[188-196] 0 SFAPAILTR 975.5627 975.5668 4.2 
[188-226] 1 
SFAPAILTRNFTNHWVYWVGPVIGAGLGSLLY
DFLLFPR 
4408.3438 4408.3466 0.6 
[197-226] 0 NFTNHWVYWVGPVIGAGLGSLLYDFLLFPR 3451.7996 3451.8002 0.2 
[197-226] 0 
NFTNHWVYWVGPVIGAGLGSLLYDFLLFPR 
[2×O] 
3483.7893 3451.8002 -1.3 
[197-228] 1 NFTNHWVYWVGPVIGAGLGSLLYDFLLFPRLK 3692.9785 3692.9802 0.5 
[227-228] 0 LK 260.1974 260.1971 -1.2 
[229-233] 0 SVSER 577.2946 577.2943 -0.5 
[229-238] 1 k.SVSERLSILK.g [1×Phospho] 1211.6401 1211.6392 -0.7 
[229-259] 2 
SVSERLSILKGSRPSESNGQPEVTGEPVELK 
[1×Deamidation] 
3310.7131 3310.7133 0.1 
[234-238] 0 LSILK 573.3976 573.3913 -11.0 
[234-259] 1 
LSILKGSRPSESNGQPEVTGEPVELK 
[1×Deamidation] 
2752.4368 2752.4374 0.2 
[239-259] 0 
GSRPSESNGQPEVTGEPVELK 
[1×Deamidation; 1×P] 
2278.0240 2278.0249 0.4 
[239-263] 1 
GSRPSESNGQPEVTGEPVELKTQAL 
[1×Deamidation] 
2611.2852 2611.2883 1.2 
[242-259] 0 PSESNGQPEVTGEPVELK [1×Deamidation] 1897.9031 1897.9034 0.2 
[260-263] 0 TQAL 432.2458 432.2458 0 
‡Both theoretical (Theor) and measured (Meas) m/z are for the monoisotopic peak. 
Theoretical mass obtained from MassLynx software (V4.1). (MCL) is number of missed 
cleavages. 
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Table 9.34. The deconvoluted m/z for identified acylated peptides followed trypsin 
digestion of b-AQP0-OC.  
Entry 
Theor m/z
‡
 
[M + H]
+
 
Meas m/z
‡
 
[M + H]
+
 
RT 
(min)
 
 
Error 
(ppm) 
10
3
 × Total 
ALipidation
§
  
(a.u.) 
Assignment 
234
LSILKGSRPSESNGQPEVTGEPVELK
259
 
i 2990.6665 2990.6563 5.34 -3.4 3.5  ± 1 
Peptide [234-259] + (C16:0) + 1 × 
Deamidation/Palmitoylation 
ii 3016.6821 3016.6798 5.44 -0.8 6 ± 1 
Peptide [234-259] + (C18:1) + 1 × 
Deamidation/Oleoylation 
iii 3040.6821 3040.6807 5.48 -0.5 3 ± 0.1 
[Peptide 234-259] + (C20:3) + 1 × 
Deamidation/Dihomo-γ-
linolenoylation 
iv 3042.6978 3042.6892 5.50 -2.9 1 ± 0.1 
Peptide [234-259] + 
(C20:2)/Eicosadienoylation 
v 3096.6484 3096.6475 5.60 -0.5 0.4 ± 0.1 
Peptide [234-259] + (C18:1) + P + 1 
× Deamidation/Oleoylation 
vi 3018.6978 3018.7015 5.66 1.2 0.5 ± 0.4 
Peptide [234-259] + (C18:0) + 1 × 
Deamidation/Stearoylation 
vii 3044.7134 3044.7148 5.70 0.5 0.3 ± 0.2 
Peptide [234-259] + (C20:1) + 1 × 
Deamidation/Eicosenoylation 
1
MWELR
5
 
viii 1014.6062 1014.6044 6.48 -1.8 3 ± 2 
Peptide [1-5] + (C18:1) + O 
/Oleoylation 
ix 970.5800 970.5797 6.54 -0.3 2 ± 0.1 
Peptide [1-5] + 
(C16:1)/Palmitoleoylation 
x 1020.5956 1020.5946 6.64 -1.0 1 ± 0.1 
Peptide [1-5] + (C20:4) / 
Arachidonoylation 
xi 1046.6113 1046.6066 6.71 -4.5 0.4 ± 0.03 
[Peptide 1-5] + (C22:5) / 
Docosapentaenoylation 
xii 972.5956 972.5963 6.89 0.7 16.5 ± 0.5 
Peptide [1-5] + 
(C16:0)/Palmitoylation 
xiii 1022.6113 1022.6081 6.96 -3.1 6 ± 0.2 
Peptide [1-5] + (C20:3)/Dihomo-γ-
linolenoylation 
xiv 998.6113 998.6115 6.96 0.2 105 ± 4.5 Peptide [1-5] + (C18:1)/Oleoylation 
xv 1024.6269 1024.6262 7.09 -0.7 4 ± 1 
Peptide [1-5] + 
(C20:2)/Eicosadienoylation 
xvi 1000.6269 1000.6272 7.35 0.3 33 ± 2 
Peptide [1-5] + 
(C18:0)/Stearoylation 
xvii 1026.6426 1026.6417 7.39 -0.9 11 ± 0.2 
Peptide [1-5] + 
(C20:1)/Eicosenoylation 
xviii 1052.6582 1052.6520 7.51 -5.9 1 ± 0.1 
Peptide [1-5] + 
(C22:2)/Docosadienoylation 
‡ Both theoretical (Theor) and measured (Meas) m/z are for the monoisotopic peak. 
Theoretical mass obtained from MassLynx software (V4.1). 
§ The peak area (A) represents the summation of peak area over all observed charge states 
for each acylated peptide, z=1-2 for peptide [1-5]; z=2-4 for peptide [234-259]. Errors 
reported as SEM (n=2). 
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Table 9.35. Product ions identified following the isolation and fragmentation of the [M 
+ H]
+
 precursor ion N-stearoylated peptide [1-5] at m/z 1000.63. The amino acid 
residue highlighted in red indicates the site of stearoylation. 
Ion AA Residues Meas m/z z Sequence Ladder Error (ppm)
 
[M + H]
+
  [1-5] 1000.6289 1 MWELR 2.0 
[M + H]
+
 - H2O [1-5] 982.6109 1 MWELR -5.5 
b2 [1-2] 584.3873 1 MW -2.2 
b3 [1-3] 713.4268 1 MWE -6.2 
y2 [4-5] 288.2020 1 LR -5.2 
y4 [2-5] 603.3249 1 WELR -0.8 
y2-NH3 [4-5] 271.1772 1 LR 0.7 
y3-NH3 [3-5] 400.2202 1 ELR 1.5 
y4-NH3 [4-5] 586.3018 1 WELR 5.0 
im1 [1-1] 370.3099 1 M -11.9 
im2 [2-2] 159.0939 1 L 10.7 
 
 
Table 9.36. Product ions identified following the isolation and fragmentation of the [M 
+ 3H]
3+ 
precursor ion K238-stearoylated peptide [234-259] at m/z 1006.91. The amino 
acid residue highlighted in red indicates the site of stearoylation and the deamidation 
site in blue. 
Ion 
AA 
Residues 
Meas m/z z Sequence Ladder 
Error 
(ppm)
 
[M + 3H]
3+
 [1-26] 1006.8986 3 LSILKGHSRPSESNGQPEVTGEPVELK -5.9 
b3 [1-3] 314.2052 1 LSI -8.9 
b8 [1-8] 1121.8002 1 LSILKGSR -2.1 
b15 [1-15] 1822.0519 1 LSILKGSRPSESNGQ -9.4 
b15 [1-15] 911.5338 2 LSILKGSRPSESNGQ -5.0 
y2 [25-26] 260.1973 1 LK -0.4 
y3 [24-26] 389.2407 1 ELK 8.7 
y6 [21-26] 714.3996 1 EPVELK -5.9 
y7 [20-26] 771.4238 1 GEPVELK -1.8 
y8 [19-26] 872.4694 1 TGEPVELK -4.0 
y9 [18-26] 971.5373 1 VTGEPVELK -4.1 
y11 [16-26] 1197.6332 1 PEVTGEPVELK -2.9 
y11 [16-26] 599.3207 2 PEVTGEPVELK -2.5 
y14 [13-26] 749.3765 2 NGQPEVTGEPVELK 1.1 
y15 [12-26] 792.8932 2 SNGQPEVTGEPVELK 1.9 
y18 [9-26] 949.4553 2 PSESNGQPEVTGEPVELK -0.1 
y19 [8-26] 1027.5060 2 RPSESNGQPEVTGEPVELK 0.2 
y22 [5-26] 1296.7181 2 KGHSRPSESNGQPEVTGEPVELK 5.7 
y23 [4-26] 1339.2335 2 LKGHSRPSESNGQPEVTGEPVELK -2.6 
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Table 9.37. Product ions identified following the isolation and fragmentation of the [M 
+ H]
+
 precursor ion N-palmitoylated peptide [1-5] at m/z 972.59. The amino acid 
residue highlighted in red indicates the site of palmitoylation. 
Ion 
AA 
Residues 
Meas m/z z Sequence Ladder 
Error 
(ppm)
 
[M + H]
+
  [1-5] 972.5966 1 MWELR 1.0 
b2 [1-2] 556.3589 1 MW 2.9 
b3 [1-3] 685.4005 1 MWE 0.9 
b4 [1-4] 798.4790 1 MWEL -8.6 
y1 [5-5] 175.1185 1 R -5.7 
y2 [4-5] 288.2044 1 LR 3.1 
y4 [2-5] 603.3237 1 WELR -2.8 
y2-NH3 [4-5] 271.1783 1 LR -1.8 
y3-NH3 [3-5] 400.2203 1 ELR 1.7 
im1 [1-1] 342.2855 1 M 7.3 
im2 [2-2] 159.0926 1 L 2.5 
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Table 9.38. Product ions identified following the isolation and fragmentation of the [M 
+ 3H]
3+ 
precursor ion K238-palmitoylated peptide [234-259] at m/z 997.56. The amino 
acid residue highlighted in red indicates the site of palmitoylation and the 
deamidation site in blue. 
Ion 
AA 
Residues 
Meas m/z z Sequence Ladder 
Error 
(ppm)
 
[M + 3H]
3+
 [1-26] 997.5628 3 LSILKGHSRPSESNGQPEVTGEPVELK 2.1 
b3 [1-3] 314.2056 1 LSI -7.6 
b3-H2O [1-3] 296.1982 1 LSI 2.7 
b4 [1-4] 427.2928 1 LSIL 1.9 
b5 [1-5] 793.6164 1 LSILK -0.3 
b6 [1-6] 850.6384 1 LSILKG 0.4 
b8 [1-8] 1093.7694 1 LSILKGSR -1.7 
b11 [1-11] 1406.8931 1 LSILKGSRPSE -3.9 
b12 [1-12] 747.4749 2 LSILKGSRPSES 7.5 
b13 [1-13] 1608.9670 1 LSILKGSRPSESN 5.8 
b14 [1-14] 833.4949 2 LSILKGSRPSESNG 1.7 
b15 [1-15] 1794.0284 1 LSILKGSRPSESNGQ -5.2 
b15 [1-15] 897.5245 2 LSILKGSRPSESNGQ 1.9 
b21 [1-21] 1203.6644 2 LSILKGSRPSESNGQPEVTGE 2.8 
y2 [25-26] 260.1968 1 LK -2.3 
y3 [24-26] 389.2404 1 ELK 1.0 
y4 [23-26] 488.3069 1 VELK -3.1 
y5 [22-26] 585.3596 1 PVELK -2.7 
y7 [20-26] 771.4268 1 GEPVELK 2.1 
y8 [19-26] 872.4722 1 TGEPVELK -0.8 
y9 [18-26] 971.5446 1 VTGEPVELK 3.4 
y11 [16-26] 1197.6348 1 PEVTGEPVELK -1.6 
y11 [16-26] 599.3229 2 PEVTGEPVELK 1.2 
y12 [15-26] 663.3458 2 QPEVTGEPVELK -8.6 
y13 [14-26] 1382.7062 1 GQPEVTGEPVELK -7.6 
y15 [12-26] 792.8846 2 SNGQPEVTGEPVELK -8.9 
y18 [9-26] 949.4603 2 PSESNGQPEVTGEPVELK 5.2 
y19 [8-26] 1027.5173 2 RPSESNGQPEVTGEPVELK 11.2 
y21 [6-26] 1099.5316 2 GHSRPSESNGQPEVTGEPVELK -1.0 
y22 [5-26] 1282.6973 2 KGHSRPSESNGQPEVTGEPVELK 1.8 
y23 [4-26] 1339.2405 2 LKGHSRPSESNGQPEVTGEPVELK 2.6 
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Table 9.39. Product ions identified following the isolation and fragmentation of the [M 
+ H]
+
 precursor ion N-palmitoleoylated peptide [1-5]  at m/z 970.58. The amino acid 
residue highlighted in red indicates the site of palmitoleoylation. 
Ion AA Residues Meas m/z z Sequence Ladder 
Error 
(ppm)
 
[M + H]
+
  [1-5] 970.5789 1 MWELR -1.1 
[M + H]
+
 - H2O [1-5] 952.5670 1 MWELR -2.5 
b2 [1-2] 554.3373 1 MW -7.8 
b3 [1-3] 683.3859 1 MWE -2.5 
b4 [1-4] 796.4628 1 WELR -6.9 
y2 [4-5] 288.2043 1 LR 2.8 
y4 [2-5] 603.3277 1 WELR 3.8 
y2-NH3 [4-5] 271.1765 1 LR -1.5 
y3-NH3 [3-5] 400.2192 1 ELR -1.0 
y4-NH3 [4-5] 586.2954 1 WELR -6.0 
im1 [1-1] 340.2664 1 M -2.9 
im2 [2-2] 159.0921 1 L -0.6 
im5 [5-5] 129.1130 1 R -7.7 
im5-NH3 [5-5] 112.0877 1 R 2.7 
 
 
Table 9.40. Product ions identified following the isolation and fragmentation of the [M 
+ H]
+
 precursor ion N-dihomo-γ-linolenoylated peptide [1-5]  at m/z 1022.61. The amino 
acid residue highlighted in red indicates the site of dihomo-γ-linolenoylation. 
Ion AA Residues Meas m/z z Sequence Ladder 
Error 
(ppm)
 
[M + H]
+
  [1-5] 1022.6103 1 MWELR -1.0 
b2 [1-2] 606.3712 1 MW -2.8 
b3 [1-3] 735.4099 1 MWE -7.6 
y1 [5-5] 175.1179 1 R -9.1 
y2 [4-5] 288.2040 1 LR -1.7 
y3 [3-5] 417.2445 1 ELR -3.8 
y4 [2-5] 603.3189 1 WELR -10.8 
y2-NH3 [4-5] 271.1773 1 LR 1.1 
y3-NH3 [3-5] 400.2198 1 ELR 0.5 
y3-H2O [3-5] 399.2372 1 ELR 4.0 
y4-NH3 [4-5] 586.2949 1 WELR -6.8 
im1 [1-1] 392.3015 1 M 7.1 
im2 [2-2] 159.0917 1 L -3.1 
im5-NH3 [5-5] 112.0877 1 R 2.7 
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Table 9.41. Product ions identified following the isolation and fragmentation of the [M 
+ H]
+
 precursor ion N-eicosadienoylated peptide [1-5]  at m/z 1024.63. The amino acid 
residue highlighted in red indicates the site of eicosadienoylation. 
Ion AA Residues Meas m/z z Sequence Ladder 
Error 
(ppm)
 
[M + H]
+
  [1-5] 1024.6261 1 MWELR -0.8 
b2 [1-2] 608.3840 1 MW -7.6 
b3 [1-3] 737.4246 1 MWE -8.9 
y1 [5-5] 175.1199 1 R 2.3 
y2 [4-5] 288.2030 1 LR -1.7 
y4 [2-5] 603.3222 1 WELR -5.3 
y2-NH3 [4-5] 271.1766 1 LR -1.5 
y4-NH3 [4-5] 586.2977 1 WELR -2.0 
im1 [1-1] 394.3110 1 M -8.4 
im2 [2-2] 159.0923 1 L 0.6 
 
 
Table 9.42. Product ions identified following the isolation and fragmentation of the [M 
+ H]
+
 precursor ion N-eicosenoylated peptide [1-5]  at m/z 1026.64. The amino acid 
residue highlighted in red indicates the site of eicosenoylation. 
Ion AA Residues Meas m/z z Sequence Ladder 
Error 
(ppm)
 
[M + H]
+
  [1-5] 1026.6427 1 MWELR 0.1 
[M + H]
+
 - H2O [1-5] 1008.6314 1 MWELR -0.6 
b2 [1-2] 610.4014 1 MW -4.6 
b3 [1-3] 739.4454 1 MWE -1.9 
y1 [5-5] 175.1189 1 R -3.4 
y2 [4-5] 288.2024 1 LR -3.8 
y4 [2-5] 603.3210 1 WELR -7.3 
y1-NH3 [5-5] 158.0940 1 R 6.9 
y2-NH3 [4-5] 271.1771 1 LR 0.4 
y3-NH3 [3-5] 400.2192 1 ELR -1.0 
y3-H2O [3-5] 399.2348 1 ELR -2.0 
y4-NH3 [4-5] 586.2971 1 WELR -3.1 
im1 [1-1] 396.3283 1 M -4.3 
im2 [4-4] 159.0917 1 L -3.1 
im5-NH3 [5-5] 112.0877 1 R 2.7 
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Figure 9.1. The relative percentage of each single lipidation species and total 
lipidation on K238 AA site, using digestion protocol Method-D and LC-MS Method-IIII 
(see section 8.2.2.2.1). The normalisation of each acylation ratio is performed relative 
to the reference non-acylated peptide [234-259] as follows: the ratio of peptide [234-
259]pal = peak area peptide [234-259]pal/summed peak area (total of all lipidation on 
peptide [234-259] + reference peptide [234-259]); the ratio of peptide [234-259]
ole
 = 
peak area peptide [234-259]
ole
/summed peak area (total of all lipidation on peptide [23-
259] + reference peptide [234-259]) and etc. Errors represent SEM, when n=2. 
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Figure 9.2. Correlations between the amount of ester-linked transferrable fatty acyl 
content of bovine lens lipids and the peak areas for lipidated peptides (A
Lipidation
) of (A) 
b-AQP0-OC and (B) b-AQP0-IN, using digestion protocol Method-A (see section 
8.2.2.1.2) and LC-MS Method-II (see section 8.1.2.1.1). Lipid data obtained from 
lipidomics MS analysis
1
 (see Table 4.14). Peak areas for N-terminus acylation were 
calculated from EIC of each acylation on peptide [1-5], while peak areas for K238 
acylation were calculated from EIC of each acylation on non-truncated peptide [234-
259]. Errors plotted as X-axis SEM (fatty acyl content, n=4) and Y-axis SEM (peak area 
for lipidated peptides, n=2). The line and the R
2
 statistic are from linear regression 
analysis. The ρ-value represents the Pearson correlation coefficient (r) and the p-
value represents the t-test of the correlation coefficient.  
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Table 9.43. The deconvoluted m/z for non-acylated peptides identified from h-AQP0-N 
male donor age 22 (M22) tryptic digestion, using Method-D and LC-MS Method-IIII on 
Synapt G2-s (see experimental section 8.2.2.2.1). 
AA 
Residues 
MCL
‡
 Sequence + Modification 
Theor m/z
 ‡
 
[M + H]
+ 
Meas m/z
‡
 
[M + H]
+
 
Error 
(ppm) 
[1-5] 0 MWELR 734.3660 734.3642 -2.4 
[6-11] 0 SASFWR 753.3684 753.3670 -1.9 
[6-33] 1 SASFWRAIFAEFFATLFYVFFGLGSSLR 3237.6565 3237.6540 -0.8 
[12-33] 0 AIFAEFFATLFYVFFGLGSSLR 2503.3066 2503.3051 -0.6 
[34-85] 0 
WAPGPLHVLQVAMAFGLALATLVQSVGHISGA
HVNPAVTFAFLVGSQMSLLR 
5379.9019 5379.8970 -0.9 
[86-113] 0 AFCYMAAQLLGAVAGAAVLYSVTPPAVR 2810.4736 2810.4559 -6.3 
[86-113] 0 AFCYMAAQLLGAVAGAAVLYSVTPPAVR [1×O] 2826.4688 2826.4594 -3.3 
[114-152] 0 
GNLALNTLHPAVSVGQATTVEIFLTLQFVLCIFA
TYDER 
4265.2319 4265.2234 -2.0 
[114-153] 1 
GNLALNTLHPAVSVGQATTVEIFLTLQFVLCIFA
TYDERR 
4421.3330 4421.3298 -0.7 
[114-153] 1 
GNLALNTLHPAVSVGQATTVEIFLTLQFVLCIFA
TYDERR [1×Deamidation] 
4422.3174 4422.3076 -2.2 
[153-187] 1 
RNGQLGSVALAVGFSLALGHLFGMYYTGAGM
NPAR [1×Deamidation] 
3597.8098 3597.8078 -0.6 
[154-187] 0 
NGQLGSVALAVGFSLALGHLFGMYYTGAGMN
PAR [1×Deamidation] 
3441.7087 3441.7039 -1.4 
[154-187] 0 
NGQLGSVALAVGFSLALGHLFGMYYTGAGMN
PAR [1×Deamidation; 1×O] 
3457.7036 3457.6970 -1.9 
[188-226] 0 
SFAPAILTGNFTNHWVYWVGPIIGGGLGSLLYD
FLLFPR 
 4309.2642 4309.2650 0.2 
[188-228] 1 
r.SFAPAILTGNFTNHWVYWVGPIIGGGLGSLLY
DFLLFPRLK.s 
 4550.4434 4550.4294 -3.1 
[188-228] 1 
SFAPAILTGNFTNHWVYWVGPIIGGGLGSLLYD
FLLFPRLK [2×O] 
4582.4331 4582.4221 2.4 
[227-233] 1 LKSISER 832.4893 832.4845 -5.8 
[227-233] 1 LKSISER [1×P] 912.4556 912.4546 -1.1 
[227-238] 2 LKSISERLSVLK 1372.8528 1372.8484 -3.2 
[227-238] 2 LKSISERLSVLK [1×P] 1452.8191 1452.8146 -3.1 
[227-263] 3 
LKSISERLSVLKGAKPDVSNGQPEVTGEPVEL
NTQAL [2×Deamidation] 
3906.0710 3906.0678 -0.8 
[229-233] 0 SISER 591.3102 591.3093 -1.5 
[229-233] 0 SISER [1×P] 671.2766 671.2742 -3.6 
[229-238] 1 SISERLSVLK 1131.6737 1131.6704 -2.9 
[229-238] 1 SISERLSVLK [1×P] 1211.6401 1211.6386 -1.2 
[229-238] 1 SISERLSVLK [2×P] 1291.6064 1291.6008 -4.3 
[229-263] 2 
SISERLSVLKGAKPDVSNGQPEVTGEPVELNT
QAL [2×Deamidation] 
 3664.8921 3664.8949 0.8 
[229-263] 2 
SISERLSVLKGAKPDVSNGQPEVTGEPVELNT
QAL [2×Deamidation; 1×P] 
 3744.8584 3744.8542 -1.1 
[234-238] 0 LSVLK 559.3819 559.3809 -1.8 
[234-238] 0 LSVLK [1×P] 639.3483 639.3464 -3.0 
[234-263] 1 
LSVLKGAKPDVSNGQPEVTGEPVELNTQAL 
[2×Deamidation] 
3092.6003 3092.5994 -0.3 
[234-263] 1 
LSVLKGAKPDVSNGQPEVTGEPVELNTQAL 
[2×Deamidation; 1×P] 
317.5667 3172.5616 -1.6 
[239-263] 0 
GAKPDVSNGQPEVTGEPVELNTQAL 
[2×Deamidation] 
2552.2368 2552.2342 -1.0 
‡Both theoretical (Theor) and measured (Meas) m/z are for the monoisotopic peak. 
Theoretical mass obtained from MassLynx software (V4.1). (MCL) is number of missed 
cleavages. 
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Table 9.44. The deconvoluted m/z for identified acylated peptides followed trypsin 
digestion of h-AQP0-N male donor age 22 (M22). 
Entry 
Theor m/z
‡
 
[M + H]
+
 
Meas m/z
‡
 
[M + H]
+
 
RT 
(min)
 
 
Error 
(ppm) 
10
3
 × Total 
ALipidation
§
  
(a.u.) 
Assignment 
227
LKSISERLSVLKGAKPDVSNGQPEVTGEPVELNTQAL
263
 
i 4170.313 4170.3164 5.24 -0.8 4.3 
Peptide [227-263] + (C18:1) + 2 × 
Deamidation/Oleoylation 
229
SISERLSVLKGAKPDVSNGQPEVTGEPVELNTQAL
263
 
ii 3901.1006 3901.1062 4.98 -1.4 1.6 
Peptide [229-263] + (C16:1) + 2 × 
Deamidation/Palmitoleoylation 
iii 3903.1014 3903.1218 5.24 -5.2 2.3 
Peptide [229-263] + (C16:0) + 2 × 
Deamidation/Palmitoylation 
iv 3887.0866 3887.0906 5.24 -1.0 2.4 
Peptide [229-263] + (C15:1) + 2 × 
Deamidation/Pentadecenoylation 
v 3929.1307 3929.1375 5.31 -1.7 9.2 
Peptide [229-263] + (C18:1) + 2 × 
Deamidation/Oleoylation 
vi 4009.1074 4009.1038 5.34 0.9 2.6 
Peptide [229-263] + (C18:1) + P + 2 × 
Deamidation/Oleoylation 
vii 3931.0663 3931.1531 5.48 -22.1 1.6 
Peptide [229-263] + (C18:0) + 2 × 
Deamidation/Stearoylation 
1
MWELR
5
 
viii 970.5800 970.5803 6.48 0.3 0.5 
Peptide [1-5] + 
(C16:1)/Palmitoleoylation 
ix 1044.5956 1044.5916 6.54 -3.8 0.4 
Peptide [1-5] + 
(C22:6)/Docosahexaenoylation 
x 1020.5956 1020.5920 6.60 -3.5 0.7 
Peptide [1-5] + 
(C20:4)/Arachidonoylation 
xi 972.5956 972.5930 6.86 -2.7 3.1 Peptide [1-5] + (C16:0)/Palmitoylation 
xii 1070.5961 1070.5903 6.93 -5.4 0.7 
Peptide [1-5] + (C20:3) + 3 × O 
/Dihomo-γ-linolenoylation  
xiii 998.6113 998.6104 6.96 -0.9 20.6 Peptide [1-5] + (C18:1)/Oleoylation 
xiv 1014.6062 1014.6045 6.96 -1.7 2.7 
Peptide [1-5] + (C18:1) + O 
/Oleoylation 
xv 1000.6269 1000.6227 7.32 -4.2 1.0 Peptide [1-5] + (C18:0)/Stearoylation 
xvi 1026.6426 1026.6439 7.35 1.3 0.6 
Peptide [1-5] + 
(C20:1)/Eicosenoylation 
‡ Both theoretical (Theor) and measured (Meas) m/z are for the monoisotopic peak. 
Theoretical mass obtained from MassLynx software (V4.1). 
§ The peak area (A) represents the summation of peak area over all observed charge states 
for each acylated peptide, z=1-2 for peptide [1-5]; z=3-5 for peptide [227-263] and peptide 
[229-263]. 
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Table 9.45. Product ions identified for N-oleoyl (peptide [1-5]) h-AQP0-N male donor 
age 22 (M22), obtained from total ion chromatogram (TIC) at 6.94 min following MS
E
 
experiment on Synapt G2-s. The amino acid residue highlighted in red indicates the 
site of oleoylation. 
Ion AA Residues Meas m/z z Sequence Ladder 
Error 
(ppm)
 
[M + H]
+
  [1-5] 998.6102 1 MWELR -1.1 
[M + H]
+
 - H2O [1-5] 980.6007 1 MWELR 0 
b2 [1-2] 582.3674 1 MW -9.4 
b3 [1-3] 711.4145 1 MWE -1.4 
b4 [1-4] 824.501 1 MWEL 1.7 
y1 [5-5] 175.1186 1 R -5.1 
y2 [4-5] 288.203 1 LR -1.7 
y3 [3-5] 417.2462 1 ELR 0.2 
y4 [2-5] 603.3224 1 WELR -5.0 
y1-NH3 [5-5] 158.0927 1 R -1.3 
y2-NH3 [4-5] 271.1761 1 LR -3.3 
y3-NH3 [3-5] 400.2171 1 ELR -6.2 
y4-NH3 [4-5] 586.2999 1 WELR 1.7 
im1 [1-1] 368.2975 1 M -3.25 
im2 [2-2] 159.0923 1 W 0.6 
im4 [4-4] 86.097 1 L 1.2 
 
 
Table 9.46. Product ions identified for K238-oleoyl (peptide [229-263]) h-AQP0-N male 
donor age 22 (M22), obtained from total ion chromatogram (TIC) at 5.3 min following 
MS
E
 experiment on Synapt G2-s. The amino acid residue highlighted in red indicates 
the site of oleoylation and the deamidation sites in highlighted blue. 
Ion AA Residues Meas m/z z Sequence Ladder 
Error 
(ppm)
 
b2 [1-2] 201.1229 1 SI -4.5 
b5 [1-5] 573.2997 1 SISER 0.2 
b6 [1-6] 686.3854 1 SISERL 2.5 
b8 [1-8] 872.4871 1 SISERLSV 3.4 
b9 [1-9] 985.5652 1 SISERLSVL -3.0 
b10 [1-10] 1377.908 1 SISERLSVLK -0.4 
b12 [1-12] 1505.9694 1 SISERLSVLKGA 1.5 
b18 [1-18] 1074.1372 2 SISERLSVLKGAKPDVSN -1.2 
b19 [1-19] 1102.6251 2 SISERLSVLKGAKPDVSNG -21.8 
b20 [1-20] 1166.6754 2 SISERLSVLKGAKPDVSNGQ -2.6 
b26 [1-26] 1472.8207 2 SISERLSVLKGAKPDVSNGQPEVTGE 3.0 
b30 [1-30] 1691.9316 2 SISERLSVLKGAKPDVSNGQPEVTGEPVEL -5.1 
y2 [34-35] 203.1382 1 AL -6.4 
y5 [31-35] 547.2755 1 NTQAL 5.1 
y6 [30-35] 660.3559 1 LNTQAL -1.4 
y12 [24-35] 1272.6417 1 TGEPVELNTQAL 7.4 
y15 [21-35] 799.4006 2 PEVTGEPVELNTQAL -1.7 
y17 [19-35] 891.937 2 GQPEVTGEPVELNTQAL -5.5 
y18 [18-35] 949.4553 2 NGQPEVTGEPVELNTQAL -0.2 
338 
 
 
Figure 9.3. Correlations between the amount of ester-linked transferrable fatty acyl 
content of human lens lipids and the peak areas for lipidated peptides of (A) h-AQP0-
C male donor age 56 (M56) and (B) h-AQP0-N (M56). Lipid data obtained from 
lipidomics MS analysis
1
 (see Table 4.17). Peak areas for N-terminus acylation were 
calculated from EIC of each acylation on peptide [1-5], while peak areas for K238 
acylation were calculated from EIC of each acylation on non-truncated peptides 
(peptide [227-263] and peptide [229-263]) and truncated peptides (peptide [227-243], 
peptide [229-243], peptide [229-246] and peptide [234-246]). Errors plotted as X-axis 
SEM (fatty acyl content, n=4). The line and the R
2
 statistic are from linear regression 
analysis. The ρ-value represents the Pearson correlation coefficient (r) and the p-
value represents the t-test of the correlation coefficient.  
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Figure 9.4. Correlations between the amount of ester-linked transferrable fatty acyl 
content of human lens lipids and the peak areas for lipidated peptides of (A) h-AQP0-
C male donor age 80 (M80) and (B) h-AQP0-N (M80). Lipid data obtained from 
lipidomics MS analysis
1
 (see Table 4.17). Peak areas for N-terminus acylation were 
calculated from EIC of each acylation on peptide [1-5], while peak areas for K238 
acylation were calculated from EIC of each acylation on non-truncated peptides 
(peptide [227-263] and peptide [229-263]) and truncated peptides (peptide [227-243], 
peptide [229-243], peptide [229-246] and peptide [234-246]). Errors plotted as X-axis 
SEM (fatty acyl content, n=4). The line and the R
2 
statistic are from linear regression 
analysis. The ρ-value represents the Pearson correlation coefficient (r) and the p-
value represents the t-test of the correlation coefficient.  
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Figure 9.5. Correlations between the amount of ester-linked transferrable fatty acyl 
content of human lens lipids and the peak areas for lipidated peptides of (A) h-AQP0-
C female donor age 56 (F56) and (B) h-AQP0-N (F56). Lipid data obtained from 
lipidomics MS analysis
1
 (see Table 4.17). Peak areas for N-terminus acylation were 
calculated from EIC of each acylation on peptide [1-5], while peak areas for K238 
acylation were calculated from EIC of each acylation on non-truncated peptides 
(peptide [227-263] and peptide [229-263]) and truncated peptides (peptide [227-243], 
peptide [229-243], peptide [229-246] and peptide [234-246]). Errors plotted as X-axis 
SEM (fatty acyl content, n=4). The line and the R
2 
statistic are from linear regression 
analysis. The ρ-value represents the Pearson correlation coefficient (r) and the p-
value represents the t-test of the correlation coefficient.  
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Figure 9.6. Correlations between the amount of ester-linked transferrable fatty acyl 
content of human lens lipids and the peak areas for lipidated peptides of (A) h-AQP0-
C female donor age 76 (F76) and (B) h-AQP0-N (F76). Lipid data obtained from 
lipidomics MS analysis
1
 (see Table 4.17). Peak areas for N-terminus acylation were 
calculated from EIC of each acylation on peptide [1-5], while peak areas for K238 
acylation were calculated from EIC of each acylation on non-truncated peptides 
(peptide [227-263] and peptide [229-263]) and truncated peptides (peptide [227-243], 
peptide [229-243], peptide [229-246] and peptide [234-246]). Errors plotted as X-axis 
SEM (fatty acyl content, n=4). The line and the R
2 
statistic are from linear regression 
analysis. The ρ-value represents the Pearson correlation coefficient (r) and the p-
value represents the t-test of the correlation coefficient.  
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Table 9.47. HELIQUEST
2
 analysis of the [214-263] region of b-AQP0 and available at 
(http://heliquest.ipmc.cnrs.fr). 
Helix Hydrophobicity HMom* z Freq. Polar
†
 Freq. Non-polar
†
 D
§
 
1 0.766 0.119 1 0.389 0.611 0.4423 
2 0.636 0.028 0 0.444 0.556 0.0264 
3 0.580 0.080 1 0.444 0.556 0.4055 
4 0.677 0.148 1 0.389 0.611 0.4697 
5 0.580 0.146 1 0.444 0.556 0.4678 
6 0.586 0.141 1 0.444 0.556 0.4631 
7 0.627 0.171 1 0.444 0.556 0.4914 
8 0.614 0.165 3 0.444 0.556 1.1458 
9 0.515 0.262 3 0.500 0.500 1.2373 
10 0.418 0.279 3 0.500 0.500 1.2534 
11 0.268 0.134 4 0.611 0.389 1.4465 
12 0.208 0.135 4 0.611 0.389 1.4474 
13 0.166 0.174 4 0.667 0.333 1.4843 
14 0.187 0.185 2 0.667 0.333 0.8346 
15 0.090 0.133 2 0.722 0.278 0.7855 
16 0.112 0.111 1 0.722 0.278 0.4348 
17 0.114 0.112 1 0.722 0.278 0.4357 
18 0.034 0.039 1 0.778 0.222 0.3668 
19 0.076 0.026 1 0.722 0.278 0.3545 
20 0.076 0.026 1 0.722 0.278 0.3545 
21 0.200 0.124 0 0.667 0.333 0.1171 
22 0.120 0.145 0 0.722 0.278 0.1369 
23 0.122 0.144 0 0.722 0.278 0.1359 
24 -0.013 0.091 -1 0.778 0.222 -0.2441 
25 -0.068 0.037 -1 0.778 0.222 -0.2951 
26 0.055 0.128 -2 0.722 0.278 -0.5392 
27 0.019 0.148 -3 0.722 0.278 -0.8503 
28 0.116 0.112 -3 0.667 0.333 -0.8843 
29 0.117 0.113 -3 0.667 0.333 -0.8833 
30 0.092 0.124 -3 0.722 0.278 -0.8729 
31 0.082 0.132 -3 0.722 0.278 -0.8654 
32 0.134 0.175 -2 0.667 0.333 -0.4948 
33 0.231 0.227 -2 0.611 0.389 -0.4457 
*Hydrophobic moment (<μH>). 
†Frequency of polar and non-polar residues in the segment. 
§Discrimination factor calculated using the equation D = 0.944 (<μH>) + 0.33 (z).
3,4
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Table 9.48. HELIQUEST
2
 analysis of the [214-263] region of h-AQP0 and available at 
(http://heliquest.ipmc.cnrs.fr). 
Helix Hydrophobicity HMom* z Freq. Polar
†
 Freq. Non-polar
†
 D
§
 
1 0.798 0.087 1 0.389 0.611 0.4121 
2 0.668 0.046 0 0.444 0.556 0.0434 
3 0.612 0.077 1 0.444 0.556 0.4027 
4 0.709 0.162 1 0.389 0.611 0.4829 
5 0.612 0.175 1 0.444 0.556 0.4952 
6 0.586 0.197 1 0.444 0.556 0.5160 
7 0.627 0.226 1 0.444 0.556 0.5433 
8 0.614 0.219 3 0.444 0.556 1.1967 
9 0.515 0.315 3 0.500 0.500 1.2874 
10 0.438 0.329 3 0.500 0.500 1.3006 
11 0.288 0.181 4 0.556 0.444 1.4909 
12 0.229 0.188 4 0.556 0.444 1.4975 
13 0.146 0.265 3 0.611 0.389 1.2402 
14 0.270 0.341 2 0.556 0.444 0.9819 
15 0.173 0.299 2 0.611 0.389 0.9423 
16 0.195 0.277 1 0.611 0.389 0.5915 
17 0.197 0.277 1 0.611 0.389 0.5915 
18 0.085 0.169 1 0.667 0.333 0.4895 
19 0.127 0.153 1 0.611 0.389 0.4744 
20 0.127 0.153 1 0.611 0.389 0.4744 
21 0.251 0.247 0 0.556 0.444 0.2332 
22 0.171 0.232 0 0.611 0.389 0.2190 
23 0.173 0.230 0 0.611 0.389 0.2171 
24 0.070 0.219 -1 0.667 0.333 -0.1233 
25 0.016 0.165 -1 0.667 0.333 -0.1742 
26 0.138 0.181 -2 0.611 0.389 -0.4891 
27 0.103 0.215 -3 0.611 0.389 -0.7870 
28 0.180 0.222 -3 0.611 0.389 -0.7804 
29 0.202 0.242 -4 0.611 0.389 -1.0915 
30 0.176 0.257 -4 0.667 0.333 -1.0774 
31 0.207 0.238 -3 0.667 0.333 -0.7653 
32 0.156 0.194 -3 0.667 0.333 -0.8069 
33 0.253 0.249 -3 0.611 0.389 -0.7549 
*Hydrophobic moment (<μH>). 
†Frequency of polar and non-polar residues in the segment. 
§Discrimination factor calculated using the equation D = 0.944 (<μH>) + 0.33 (z).
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